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ABSTRACT 
  
 The purpose of this research was to examine whether short-term ingestion of a 
powdered tart cherry supplement surrounding intense resistance and endurance exercise 
attenuates muscle soreness, while reducing markers of muscle damage, inflammation, 
and oxidative stress. 
 23 healthy, resistance-trained men (20.9±2.6 yr, 14.2±5.4% body fat, 63.9±8.6 kg 
FFM) were recruited for the resistance study, while 27 endurance trained runners or 
triathlete (21.8±3.9 yr, 15.0±6.0% body fat, 67.4±11.8 kg) men and women were 
examined in the endurance study. Subjects were matched based on relative maximal 
back squat strength or average projected race pace, age, body weight, and fat free mass.  
Subjects were randomly assigned to ingest, in a double blind manner, capsules 
containing a placebo (P) or powdered tart cherries [CherryPURE®] (TC).  Participants 
supplemented one time daily (480 mg/d) for 10-d including the day of exercise up to 48-
hr post-exercise.  Resistance study subjects performed 10 sets of 10 repetitions at 70% 1-
RM back squat exercise, while endurance subjects completed a half-marathon run (21.1 
km) under 2-hr (111.98±11.9 min).  Fasting blood samples and quadriceps muscle 
soreness ratings were taken pre-exercise, 60-min, 24-h, and 48-h post-exercise and 
analyzed by MANOVA with repeated measures. 
 Muscle soreness perception in the vastus medialis (¼) (p=0.10) and the vastus 
lateralis (¼) (p=0.024) tended to be lower in TC over time compared to P following 
resistance exercise.  TC induced changes in serum creatinine (p=0.03, p=0.047) and total 
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protein (p=0.018, p=0.081) that were lower over time and smaller from pre-lift levels 
compared to P in trained individuals. Despite lower TAS activity pre-run in TC 
compared to P (endurance), changes from pre-run levels revealed a linear increase in 
TAS activity during recovery in TC that was statistically different from P and pre-run 
levels. IL-6 levels (endurance) were lower in TC compared to P over time (p=0.053).   
Subjects in the TC group tended to have smaller deviations from predicted race pace 
(p=0.091) compared to P (endurance).  Short-term supplementation of Montmorency 
powdered tart cherries surrounding a single bout of intense exercise, appears to be an 
effective dietary supplement to attenuate muscle soreness and markers of muscle 
catabolism, while reducing inflammatory stress, better maintaining redox balance, and 
increasing performance in trained individuals. 
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CHAPTER I  
INTRODUCTION AND RATIONALE
*
 
Background 
Acute bouts of strenuous aerobic performance facilitate an exercise-induced 
stress response characterized by mechanical muscle damage, oxidative damage, and 
inflammation that parallels the physiological stress response associated with many 
adverse traumatic cardiovascular events and illnesses (27, 54, 113, 129, 192, 195).  A 
single large volume, high intensity strength training workout also activates a repetitive 
load-induced stress response characterized by structural muscle damage, oxidative stress, 
and inflammation that facilitates the release of intramuscular proteins in the systemic 
circulation that typically is associated with cardiovascular dysfunction, invasive surgery, 
and disease (20, 27, 54, 86, 113, 129, 192, 195).  The repetitive nature of eccentric 
muscular contractions during bouts of high intensity exercise will cause muscular injury 
as a result of ultrastructural disruptions (60, 106, 163, 192) that ultimately leads to a 
muscular repair sequence of degeneration, inflammation, regeneration, and fibrosis (185, 
192).  Muscle soreness following exercise is not the direct result of inflammation, but 
rather a product of high nociceptor and mechanoreceptor sensitivity to the potent 
chemicals and by-products released during muscular degeneration.  As a result, higher 
volumes of repetitive muscular stress and/or large metabolic demands from the oxidative 
energy systems (12) significantly increases free radical production beyond the capacity 
                                                 
*
Portions reprinted from “Effects of powdered Montmorency tart cherry supplementation on an acute bout 
of intense lower body strength exercise in resistance trained males” by Levers K, Dalton R, Galvan, E, et 
al. 2015. Journal of the International Society of Sport Nutrition, 12, 1-23, Copyright 2015 by Kyle Levers. 
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of the endogenous antioxidant systems.  This muscle damaging exercise and subsequent 
free radical production ultimately facilitates excessive cell damage, altered cell signaling 
(9, 147, 148), decreased cellular performance (9, 114, 147, 148), lipid peroxidation, 
oxidation of proteins and glutathione, and subsequent DNA damage (113, 124).  
Millions of people, including athletes, around the world (163, 192) use non-
steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen to help 
reduce pain and inflammation.  NSAID use mitigates the inflammatory response via 
non-specific inhibition of the cyclooxygenase (COX -1 and COX-2) enzymes that 
regulate the production of inflammatory-stimulating prostaglandins (12, 163, 192).  The 
effectiveness of NSAIDs to relieve inflammation and perceptions of muscle soreness 
remains highly controversial due to conflicting reports when administration follows 
bouts of exercise (18, 51, 137, 145, 163, 186, 187, 192), despite popular utilization 
among athletes and the general active population.  To further complicate the NSAID use 
debate, researchers have demonstrated that muscle protein synthesis and the function of 
satellite cells in skeletal muscle hypertrophy are compromised when COX enzymes are 
inhibited (17, 122, 135, 159, 187), while other investigators have found no NSAID effect 
on the post-exercise anabolic processes within muscle (24, 123, 141). 
Effective and efficient recovery from exercise, including attenuation of pain and 
inflammation as a result of training stress and injury, is paramount to all athletes, 
particularly athletes during micro- or mesocycles of high training and/or competition 
volume that require an expedited return to peak performance (9, 13).   Antioxidant 
supplementation surrounding bouts of aerobic exercise has gained significant traction 
 3 
 
over the last 20 years (191), particularly with the uncertainty of NSAID effects, due to 
the success of these supplements and functional foods in the clinical population (7, 91, 
92, 139, 150, 207).  The use of antioxidant supplementation in athletic applications to 
help fortify the body’s endogenous antioxidant response while attenuating muscle 
damage and inflammation has spurred some success with supplements such as ascorbic 
acid (vitamin C) (6, 22, 57, 95, 120, 184) and α-tocopherol (vitamin E) (12, 57, 117, 
120, 142, 160).  Supplementation with vitamins C and E (independently or in 
combination with N-acetylcysteine, β-carotene, or α-lipoic acid) to improve exercise 
performance has also been met with controversy due to conflicting reports of 
effectiveness (8, 23, 67, 113, 157, 165, 181, 182, 205) and even risks of pro-oxidant 
effects that target muscle protein anabolism, (32, 37, 156, 179), endogenous antioxidant 
capacity (156), and mitochondrial biogenesis (176) in the post-exercise recovery period.  
However, some studies have demonstrated neither detriment nor benefit of these 
antioxidants to muscle recovery and endurance training adaptations (157, 205).   
Due to the debate surrounding the use of NSAIDs and individual antioxidant 
components (e.g. ascorbic acid and α-tocopherol) to reduce pain and inflammation in 
disease, health, and exercise applications, nutritional research has more recently shifted a 
focus toward the study of phytochemical-containing fruits and other functional foods 
that seem to provide a beneficial anti-inflammatory and antioxidant effect (11, 40).  
Particular phenolic compounds, such as flavonoids and anthocyanins, may act 
synergistically with other compounds contained within the fruit or food to provide an 
overall exercise recovery benefit that may not be derived from vitamin or synthetic 
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sources (9, 12).  A wide variety of antioxidant and polyphenol-containing functional 
foods such as purple sweet potatoes (33, 177, 180), beet root juice (203, 204, 210), green 
tea (87, 136), cranberries, grape extract (102), chokeberries (144), pomegranate juice 
and ellagitannin extract (189, 190), spinach (16), and blueberries (114) have verified 
performance enhancing and exercise recovery benefits.  Tart (e.g. Mortmorency) and 
sweet cherries (e.g. Bing) have received substantial attention within the clinical literature 
and the nutritional supplement industry due to their high anthocyanin content (29, 30, 
197) that has demonstrated consistent benefit as a naturally occurring intervention to aid 
improvement in health (82, 93, 119, 188), inflammatory-related disease states (e.g. 
cardiovascular disease, diabetes, osteoarthritis, gout) (15, 82, 93, 119, 164), and sleep 
quality (75, 143).  The increased clinical nutrition success of both tart cherry concentrate 
and cultivar-blended juice supplementation spurred the potential for exercise-based 
research and application to help increase performance by theoretically reducing muscle 
damage, oxidative stress, and inflammation (9).  The incorporation of a naturally 
occurring food component with phytochemicals (e.g. cherries) that has known 
antioxidant and anti-inflammatory properties (82, 93, 119, 126, 166, 188, 198, 199) into 
a post-exercise meal or supplement, such as a carbohydrate-protein mixture (38, 39, 77, 
162) known attenuate the muscle damaging and catabolic effects of prolonged endurance 
exercise, may prove to be highly beneficial in future acute situations of performance 
recovery.       
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Specific Aim 
Is supplementation with a powdered tart cherry supplement derived from tart 
cherry skins more efficacious than a placebo as well as previously studied tart cherry 
juices, blends, and concentrates in improving performance while reducing markers of 
oxidative stress, inflammation, muscle damage, muscle soreness, and strength losses 
during recovery?  
Purpose of the Research 
The primary objective of this research is to ascertain if this novel tart cherry 
supplement would facilitate similar attenuation of oxidative stress, inflammation, muscle 
damage, and muscle soreness as the tart cherry cultivar-blended juices and juice 
concentrates supplemented in the previous tart cherry supplementation-based studies in 
the literature.  The secondary objective of this study was to determine whether short-
term (10-d) supplementation with a powdered form of tart cherry skins prior to and 
following a single resistance or endurance exercise challenge will effectively reduce 
markers of oxidative stress, inflammation, muscle damage, muscle soreness, and/or 
attenuate resistance-exercise based strength losses during recovery. 
General Research Overview 
This will be a series of two double-blind 10-d supplementation studies that will 
compare the effects of CherryPURE™ (powdered tart cherry supplement) and a placebo 
on markers of oxidative stress, inflammation, muscle damage, muscle soreness, and 
strength changes during subsequent exercise performance surrounding acute bouts of 
intense endurance or resistance exercise. Subjects will be randomly assigned to one of 
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two groups in each of the studies in paired-match control format: 1) CherryPURE™ or 
2) Placebo. Both groups will return to the lab for a total of four testing sessions 
following the initial familiarization: baseline (approximately 1-wk pre-supplement), Day 
8 (T1-exercise and 60-m post-exercise), Day 9 (24-h post-exercise), and Day 10 (48-h 
post-exercise). Within the endurance study, anthropometrics, whole blood and serum 
markers of general clinical health, lipid profiles, measures of muscle soreness, markers 
of muscle damage, oxidative stress, inflammation, and immune cell counts will be 
recorded at each testing session, while measurement of body composition will only 
occur at baseline for purposes of subject stratification.  The resistance study will follow a 
similar structure with anthropometrics, isokinetic leg extension maximal voluntary 
contraction (MVC) performance on the dominant leg, whole blood and serum markers of 
general clinical health, lipid profiles, measures of muscle soreness, markers of muscle 
damage, oxidative stress, inflammation, and immune cell counts will be recorded at each 
testing session, while measurement of body composition and barbell back squat 1-
repetition maximum (1-RM) will only occur at baseline for purposes of subject 
stratification.  
Hypotheses 
Tart Cherry Resistance Central Hypotheses  
 Ho1: Isokinetic flexion, extension, and total work performed during the 48-h post-
lift recovery will be greater with tart cherry supplementation.  
Ho2: There will be no significant difference between groups in pre-lift isokinetic 
flexion, extension, and total work performed. 
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Ho3:  Vastus medalis (¼) muscle soreness perceptions over the 48-h post-lift 
recovery will be lower with tart cherry supplementation.  
Ho4:  Vastus lateralis (¼) muscle soreness perceptions over the 48-h post-lift 
recovery will be lower with tart cherry supplementation. 
Ho5: Vastus lateralis (½) muscle soreness perceptions 60-min post-lift will be 
lower with tart cherry supplementation. 
Ho6: There will be no significant differences between groups in vastus lateralis (½) 
muscle soreness pre-lift, 24-h, and 48-h post-lift. 
Ho7: There will be no significant difference between groups in pre-lift perceptions 
of quadriceps muscle soreness. 
Ho8: Serum markers of muscle catabolism, secondary muscle damage, and 
physiological/renal stress over the 48-hr post-lift recovery will be lower with 
tart cherry supplementation. 
Ho9: There will be no significant differences between groups in pre-lift serum 
markers of muscle catabolism, secondary muscle damage, and 
physiological/renal stress. 
Ho10: Serum cortisol levels (marker of physiological stress and the catabolic state) 
60-min post-lift will be lower with tart cherry supplementation. 
Ho11: There will be no significant differences between groups in serum cortisol 
levels pre-lift, 24-h, and 48-h post-lift. 
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Ho12: There will be no significant differences between groups in serum testosterone 
levels and the testosterone/cortisol ratio (measure of anabolic/catabolic 
activity) pre-lift or over the 48-h post-lift recovery. 
Ho13: There will no significant differences between groups in serum markers of free 
radical production, oxidative stress, or antioxidant/anti-radical activity pre-lift 
or over the 48-h post-lift recovery. 
Ho14: There will be no significant differences between groups in serum pro-
inflammatory cytokines and chemokines pre-lift or over the 48-h post-lift 
recovery. 
Ho15: There will be no significant differences between groups in serum anti-
inflammatory cytokines pre-lift or over the 48-h post-lift recovery. 
Ho16: There will be no significant differences between groups in whole blood 
immune cell counts pre-lift or over the 48-h post-lift recovery. 
Tart Cherry Endurance Central Hypotheses 
Ho17: There will be no significant differences between groups in half-marathon 
projected and actual finish times. 
Ho18:  Vastus medalis (¼) muscle soreness perceptions over the 48-hr post-run 
recovery will be lower with tart cherry supplementation. 
Ho19:  Vastus lateralis (¼) muscle soreness perceptions over the 48-hr post-run 
recovery will be lower with tart cherry supplementation. 
Ho20: Vastus lateralis (½) muscle soreness perception over the 48-hr post-run 
recovery will be lower with tart cherry supplementation. 
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Ho21: There will be no significant difference between groups in pre-run perceptions 
of quadriceps muscle soreness. 
Ho22: Serum markers of muscle catabolism, secondary muscle damage, and 
physiological/renal stress will be lower over the 48-hr post-run recovery with 
tart cherry supplementation. 
Ho23: There will be no significant group differences between groups in pre-run 
markers of muscle catabolism, secondary muscle damage, and 
physiological/renal stress. 
Ho24: Serum cortisol levels and the testosterone/cortisol ratio 60-min post-run will 
be lower with tart cherry supplementation. 
Ho25: There will be no significant differences between groups in pre-run, 24-h, and 
48-h post-run serum cortisol levels and the testosterone/cortisol ratio. 
Ho26: There will be no significant differences between groups in serum testosterone 
levels pre-run or over the 48-h post-run recovery. 
Ho27: Serum markers of free radical production and oxidative stress over the 48-hr 
post-run recovery will be lower with tart cherry supplementation. 
Ho28: Serum markers of antioxidant/anti-radical activity over the 48-hr post-run 
recovery will be higher with tart cherry supplementation. 
Ho29: There will be no significant difference between groups in pre-run serum 
markers of free radical production, oxidative stress, and antioxidant/anti-
radical activity. 
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Ho30: Serum pro-inflammatory cytokines and chemokines over the 48-hr post-run 
recovery will be lower with tart cherry supplementation. 
Ho31: There will be no significant difference between groups in pre-run serum pro-
inflammatory cytokines/chemokines anti-inflammatory cytokines. 
 
Ho32: Serum anti-inflammatory cytokines over the 48-hr post-run recovery will be 
lower with tart cherry supplementation. 
Ho33: There will no significant differences between groups in whole blood immune 
cell counts pre-run or over the 48-h post-run recovery. 
Delimitations 
Tart Cherry Resistance & Endurance Delimitations  
1.  Subjects refrained from the consumption of NSAIDs and all exercise 48-h prior to 
each testing session (familiarization, baseline, days 8-10).  
2.  Subjects completed a 4-d dietary record during the first 7-d of the 
 supplementation period and were advised to maintain a consistent diet over the 
 study duration. 
3.  Subjects were advised to maintain their normal workout/training regimen over the 
study duration (on permitted days).  
4.  Subjects fasted for at least 10-h prior to each testing session.  
5.  Subjects were instructed to consume all supplements according to directions 
provided, specifically ingesting one supplement capsule per day in the morning at 
0800 in conjunction with the breakfast meal. 
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6. Subjects had their body composition measured using dual x-ray absorptiometry 
(DEXA). 
7. Blood samples were obtained from subjects at the familiarization (pre-
supplementation), pre-exercise, 60-min, 24-h, and 48-h post-exercise. 
8. Perception of soreness measurements were determined using 50 N of force applied 
with an algometer and perceptions recorded on a graphic pain rating scale. 
9. Perceptions of muscle soreness were analyzed on the quadriceps muscle group at 
three distinct locations between the superior border of the patella and greater 
trochanter: ¼ of the distance on the vastus medalis, ¼ of the distance on the vastus 
lateralis, and ½ of the distance on the vastus lateralis. 
10. Perceptions of muscle soreness were analyzed pre-exercise, 60-min, 24-h, and 48-h 
post-exercise. 
11. Subjects refrained from the consumption of all food and beverages, except water, 
between pre-exercise testing and the exercise performance challenge. 
12. Subjects performed to their maximal ability on all exercise and testing measures. 
Tart Cherry Resistance Delimitations  
13.  This study included resistance trained males ages 18-40 with barbell back squat 
experience.  
14. The recruited subjects were required to squat at least 1.5 times their body weight. 
15. Subjects were paired based on relative barbell back squat strength, fat free mass, 
body weight, and age. 
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16. The exercise performance challenge was 10 sets of 10 repetitions at 70% of the 
subject’s 1-RM. 
17. Maximal voluntary contractions (MVC) were determined during isokinetic knee 
extension and flexion on the dominant leg at 60°/sec. 
18. Subjects self-reported their dominant leg to be tested during isokinetic maximal 
voluntary contractions. 
19. Isokinetic MVC performance was tested at the FAM session (pre-
supplementation), pre-lift, 60-min, 24-h, and 48-h post-lift. 
Tart Cherry Endurance Delimitations  
20.  This study included endurance trained males and females ages 18-40 with 
competitive runner experience.  
21. The recruited subjects were required to run a half-marathon (21.1 km) in less than 
2-h. 
22. Subjects were required to accurately report previous running performance. 
23. Subjects were paired based on previous performance running pace/predicted finish 
time, fat free mass, body weight, and age. 
24. The half-marathon race started at 0800 and be run on a pre-planned, closed road 
course on the campus of Texas A&M University.  The race will require subjects to 
run 2 laps around a 10.54 km road course. 
25. Subjects were provided water and glucose-electrolyte sports drinks at hydration 
stations located at 4 points along the planned route ad libitum.   
26. Subjects were allotted a 20-min warm-up period prior to the half-marathon. 
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27. Subjects were not allotted a running or active cool down following the half-
marathon.  Only minimal ambulation was allowed up to the 60-min post-run 
testing session. 
28. There were not any performance tests as part of the study protocol. 
Limitations 
1.  The subjects were individuals from the Texas A&M University community and 
 surrounding fitness facilities that respond to recruitment fliers and emails; 
 therefore the selection process will not truly random.  
2.  While there may be some variations in testing times and dietary intake, all efforts 
were made to conduct testing sessions at the same approximate time to account for 
diurnal variations.  Subjects were instructed to maintain a consistent diet 
throughout the duration of the study.  
3.  Subject intrinsic motivations and effort during the exercise bout and subsequent 
performance testing may not have been maximized at each testing session.  
4.  Subjects may not have followed the supplement instructions as defined during the 
 familiarization session or during supplement distribution.  
5.  All subjects were instructed to maintain their normal training program on permitted 
days as defined by the study protocol. However, exercise habits during the duration 
of the study may have changed and therefore changes in performance measures 
may have been influenced by individual differences in training rather than the 
assigned supplement.  
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6.  All equipment was calibrated according to manufacturer guidelines and all samples 
were run in duplicate to reduce likelihood of error. However, there may have still 
been some innate limitations of the laboratory equipment that was used for data 
collection and analysis.  
7. All blood samples were handled and processed uniformly across participants and 
 testing sessions.  However, due large subject volume in a limited amount of time 
 (TCE) and multiple laboratory staff working with study subjects there was a 
 possibility that sample handling may be completely consistent. 
8. Subjects were recruited into each study by set minimum study inclusion/exclusion 
criteria and matched based on specific study measures.  However, there still might 
have been innate imitations and variability in matching subjects based on a limited 
set of study measures compared to a cross over study design. 
Assumptions  
1.  Subjects followed the overall protocol that was explained to them during the 
 familiarization session.  
2. Subjects adhered to the 10-d supplementation protocol explained to them during 
 the familiarization session. 
3. Subjects refrained from NSAID utilization and any type of physical activity 48-h 
prior to each of the 5 testing sessions (familiarization, baseline, days 8-10). 
4.  Subjects answered the entrance questionnaires accurately and honestly prior  to 
 being accepted into the study.  
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5. Subjects honestly answered, to the best of their ability, the graphic pain rating scale 
(GPRS) in response to algometer quadriceps muscle soreness measurement within 
each of the 4 testing sessions. 
6.  All laboratory equipment was calibrated and functioning properly prior to all 
 testing sessions.  
7.  The population, which the sample was drawn from, was normally distributed.  
8.  The variance among the population sample was approximately equal.  
9.  The sample was randomly assigned to the different supplement groups. Subjects 
and researchers remained blinded to their assigned supplement throughout the 
study.  
10.  Subjects maintained a consistent dietary intake and exercise regimen (when 
 permitted) throughout the duration of their respective studies.  
11. Subjects performed at their maximal potential within the primary exercise bout and 
in subsequent performance testing (if required). 
12. Subjects who are dropped from study participation, particularly after starting 
 supplementation, were honest in their reasoning after their initial commitment 
 following the familiarization session and informed consent signing. 
13. Subjects honestly recorded their 4-d dietary intake during the first 7-d of 
 supplementation. 
14. Subjects fasted for 10-h prior to each testing session that involved a fasting blood 
draw (familiarization, baseline, days 8-10) and maintained a consistent hydration 
status across all testing sessions within the study protocol. 
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15. Tart cherry endurance subjects accurately and correctly reported past endurance 
 performance results in the initial study paperwork. 
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CHAPTER II  
REVIEW OF LITERATURE 
Introduction 
The primary goals of athletic competitors all stem from a common and continued 
desire to improve performance through optimization of training and recovery.  As a 
result of extensive training regimens and physiological demands of long duration, 
repetitive endurance exercise or highly intense resistance training bouts, the body 
progresses through a condition referred to as exercise-induced muscle damage.  The 
muscular damage, breakdown, and resulting inflammatory response as a result of 
demanding or unfamiliar exercise are typically associated with impaired muscle function 
and delayed onset muscle soreness (DOMS).  In training program design and 
implementation of periodization schemes, coaching professionals attempt to plan 
exercise sessions to account for this physiological response to training stress.  However, 
trained individuals likely have naturally adapted to handle increasing exercise demands 
as a result of a repetitive training load if the regimen remains consistent.  Unfamiliar 
exercise or additions to training programs typically cause greater exercise-induced 
muscle damage as a result of increased intramuscular stress, damage, and catabolism.   
Reducing muscle soreness, pain, and inflammation to help expedite the recovery of 
muscle function, athletes will traditionally resort to ingesting supplement remedies. 
Contributing Models of Delayed Onset Muscle Soreness 
 Delayed onset muscle soreness (DOMS) is clinically classified as a type I muscle 
strain that presents with tenderness and stiffness in the muscle belly with sensitivity 
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specifically associated with movement and/or palpation (31, 68).  Typically, the muscle 
tenderness and sensitivity is initially focused in the distal aspect of the muscle due to the 
high concentration of nocioreceptors in the myotendinous junction and will dissipate 
progressively over the 48-h post-damaging exercise period (31, 111).  Despite the 
prevalence of DOMS among recreationally trained individuals and athletes, there is not 
any one theory that has been identified to describe the primary mechanism of DOMS 
development following muscle damaging exercise.  Due to the fact that one model 
cannot explain all aspects of the DOMS phenomenon, researchers have proposed an 
integration of several models (4, 31, 171).  
 As part of the connective tissue and muscle damage theories, any type of 
eccentric muscle action or braking force produces higher tensile forces than those that 
may even be experienced during concentric muscle action (31, 36, 68).  The high 
muscular tension places great strain on connective tissue located at the myoteninous 
junction and immediately surrounding distal muscle fibers (31, 173).  As a result of this 
great muscular tension produced, the sarcolemma is significantly damaged, causing a 
large calcium accumulation.  This accumulation effects ATP production and calcium 
balance within the muscular environment that activates enzymes to breakdown the 
excessive calcium (31, 68).  Unfortunately, the activation of these enzymes causes major 
degradation of the sarcomere z-line and contractile proteins troponin and tropomyosin 
(4, 31, 68).  Further damage to the sarcolemma due to calcium accumulation can also be 
caused by activation of proteases and phospholipases responsible for the production of 
leukotrienes and prostaglandins (4, 5, 31).   
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As a result of the tissue damage, there is a large increase in circulating 
neutrophils to drive the immune response.  Due to the sarcomere damage and subsequent 
increases in muscle cell membrane permeability, intramuscular cellular components leak 
in to the surrounding sarcoplasm and plasma serving as common markers of muscle and 
tissue damage (e.g. CK, myoglobin, creatinine, hydroxproline) (21, 31, 128).  The 
circulating neutrophils over the hours post-exercise induced muscular injury are attracted 
to the site of damage through the progressive leakage of cellular components and 
histamines into the local plasma (31, 72).  The arrival of neutrophils at the site of 
muscular injury serves to call monocytes (eventually macrophages) to the area, peaking 
in concentration at 48-h post-exercise (31, 68).  As a result of the increase inflammatory 
environment, macrophages produce also prostaglandins (PGE2) to help sensitize the 
local nerve endings to changes in mechanical, chemical, or thermal stimulation (31).  
The breakdown of cellular components and phagocytosis as the repair process is initiated 
causes an accumulation of histamine, potassium, and kinins along with elevated fluid 
pressure and temperature within the muscular environment (31, 59, 68).  The previous 
activation and sensitization of nocioreceptors signals soreness and pain within the 
muscular area of damage (31).  While the composition of this proposed multiple theory 
model needs to be investigated through future research, this provides a sound basis for 
the examination of the theorized mechanisms of supplementation to aid in helping to 
attenuate effects of contributing mechanisms to muscle soreness and pain as well as 
primary and secondary muscle damage. 
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Oxidative Stress and Inflammatory Pathway Interrelationship 
At the cellular level, oxidative stress occurs due to an imbalance that occurs 
between oxidant production and the capacity of the cell to balance oxidant production 
through antioxidant mechanisms (146).  The cellular environment has a strategically 
constructed labyrinth of enzymatic and non-enzymatic antioxidants that exist both inside 
and outside of the cellular environment to effectively remove reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) to optimize redox balance (146).  More 
specifically, cells employ multiple strategies utilizing endogenous and exogenous 
antioxidants to help safely and effectively neutralize ROS/RNS production.  
Antioxidants have the ability to scavenge for ROS/RNS and convert potent ROS/RNS 
into less active forms to help reduce cellular damage potential and also act to prevent 
low potency ROS/RNS conversion to more damaging oxidant species forms (146).  
When ROS/RNS production overwhelms cellular antioxidant mechanisms to the point 
where oxidants outnumber the available antioxidants, oxidative stress occurs. 
Over the course of strenuous exercise bouts, contracting skeletal muscle produces 
free-radicals, ROS, and RNS from a multitude of cellular sources within the musculature 
(79, 146, 153).  Within the current literature, evidence points to mitochondrial radical 
production as the primary source within skeletal muscle during an exercise bout.  The 
mitochondria has been charged with producing skeletal muscle radicals as an ill-intended 
derivative of oxidative metabolism, namely generating xanthine oxidase, NADPH 
oxidase, and nitric oxide through nitric oxide synthase (79, 146, 153-155).  In addition to 
the mitochondria (complexes I and III of the electron transport chain), sarcoplasmic 
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reticulum, transverse tubules, sarcolemma, and the sarcoplasm/cytosol are also greatly 
responsible for ROS/RNS production (103, 149).  More specifically, production of 
superoxide within the triad of calcium release (e.g. sarcolemma, transverse tubules, and 
sarcoplasmic reticulum) is derived from NADPH oxidases (148) in addition to the 
potential for superoxide production from the sarcolemma due to phospholipase-A2 
dependent mechanisms (81, 103).  Intensive exercise bouts or repetitive eccentrically-
based muscle actions causing excessive muscle damage and eliciting an inflammatory 
response creates a secondary source of free-radical production within the muscle cell 
environment.  The aforementioned activation of phagocytosis and neutrophil respiratory 
bursts produce significant ROS that have been involved in creation of secondary muscle 
damage following the primary muscular mechanical disruption (77, 104).  Other 
secondary sources of ROS production within the muscular environment include 
autoxidation of catecholamines and radical formation from the breakdown of iron-
containing proteins (79, 148).   
Due to the multitude of free-radical and oxidant sources and significant increase 
in production within the muscular environment as a result of intense physical exercise, 
endogenous antioxidant capacities must be able to adapt to the increased demand to 
prevent oxidative damage to proteins, lipids, and DNA (146).  More specifically, in 
response to exercise-induced skeletal muscle contraction, the muscle environment 
contains multiple endogenous antioxidant enzymes that balance ROS concentrations 
including CuZn-superoxide dismutase (sarcoplasm), Mn-superoxide dismutase 
(mitochondria), catalase, and glutathione peroxidase (sarcoplasm and mitochondria) (55, 
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103).  Some of the lipid soluble components found within the sarcolemma (vitamin E 
and carotenes) and water soluble antioxidants located throughout the muscle cell 
(vitamin C and glutathione) are also found as primary bioactive constituents in tart 
cherries that may help to aid in the antioxidant defense during times of high oxidative 
stress (e.g. high-intensity or long duration exercise) or during low antioxidant 
concentrations (55, 103).  Glutathione as a water soluble component is the most effective 
and ubiquitous antioxidant within the muscle cell as usually monitored for an indication 
of redox balance within the cell via the ratio of oxidized glutathione (GSSG) to reduced 
glutathione (GSH) (55, 103).   
The exercise-induced production of ROS within contracting skeletal muscle 
provides an important link to inflammation through cytoplasm-nuclear communication 
and subsequent influences of gene expression.  The production of ROS within skeletal 
muscle has been proven to affect multiple signaling pathways, with the most notable 
being those pathways that govern the inflammatory and proteolytic/catabolic response.  
Responsible for inflammation among other cellular responses, cell signaling molecule 
NF-κB is activated as a free dimer to travel across the nuclear membrane through 
phosphorylation of its inhibitor molecule (IκB) by IκB kinase (IKK) and impact gene 
expression within the muscular nucleus leading to an increased inflammatory response 
(inflammatory mediators: cytokines, enzymes, chemokines, and adhesion molecules) 
[21,22,26]. During periods of high-intensity exercise, where endogenous antioxidant 
production may not be sufficient to deal with the elevated production of ROS, dietary 
consumption of an antioxidant supplement may help to attenuate the effect of ROS on 
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muscular cellular signaling pathways that affect the inflammatory response through 
alterations in gene expression.   
In addition to the production of ROS and RNS during exercise-induced skeletal 
muscle contraction that leads to a pro-inflammatory response, the synthesis of 
arachidonic acid and subsequent metabolites also significantly contribute to increases in 
post-exercise inflammation.  Arachidonic acid is a second messenger molecule released 
by phospholipase A2 (PLA2) at which point it is metabolized by cyclooxygenase I and II 
(COX I and COX 2) and lipoxygenase (LOX) pathways in various eicosanoids that 
produce prostaglandins and leukotrienes (66).  The COX enzymes are important in 
inflammatory processes as they are expressed in various organs (COX-1), microphages, 
and mast cells (COX-2) in addition to roles in angiogenesis, cell death/proliferation, and 
carcinogenesis (66, 126). Cyclooxygenases are stimulated to release prostaglandins that 
typically act as pro-inflammatory mediators (e.g. PGE2).  Lipoxygenases (typically 5-
LOX generated within neutrophils) in the metabolism of arachidonic acid produce 
hydroxy acids and leukotrienes that are charged as potent chemoattractant mediators of 
the inflammatory response (66).   
Cyclooxygenase enzyme or pathway inhibition can typically be accomplished by 
over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) as detailed in the next 
section, however, due to the inability to control the potential side-effects of these drugs, 
various anthocyanin, flavonoid, and polyphenol containing foods, juices, and nutritional 
supplements have been recommended instead due to their comparable effectiveness to 
the over-the-counter drugs.  Several of the bioactive phytochemicals contained within 
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functional foods (anthocyanins, flavonoids, and polyphenols) will be discussed in later 
sections to define their ability to inhibit enzymes and production of metabolites all along 
the arachidonic acid metabolic pathway to help reduce the subsequent pro-inflammatory 
stimulus following a bout of exercise.   
However, some NSAID and antioxidant research described in the upcoming 
sections have demonstrated that production of ROS may be required and beneficial for 
the normal and healthy muscular remodeling process (hypertrophy and mitochondrial 
biogenesis) to occur following a bout of exercise (80, 81, 148).  Therefore, a delicate 
balance must be found with anti-inflammatory, antioxidant supplementation via an 
effective supplement post-exercise to help boost the antioxidant and anti-inflammatory 
systems when endogenous sources are not enough, but still promoting the positive 
aspects of ROS cellular-signaling.   
NSAID Utilization Mechanism of Function and Theory 
 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that are 
commonly prescribed by a physician or taken over the counter by individuals in an 
attempt to help alleviate symptoms associated with exercise-induced muscle damage and 
restore proper muscle function (163).  Typical NSAID examples currently on the market 
and used by consumers are ibuprofen, acetylsalicylic acid (aspirin), naproxen, 
diclofenac, flurbiprofen, and ketoprofen (77).  The popularity of NSAID utilization is 
extremely high as exemplified in reports generated from the 2005 and 2010 National 
Health Interview Survey (NHIS). The NHIS report estimated that in 2010, 
approximately 43 million American adults (19.0%) took aspirin at least three times per 
 25 
 
week for longer than 3 months (57% increase over 2005 estimates) and greater than 29 
million American adults (12.1%) were NSAID regular users (41% increase over 2005 
estimates) (209).  The connection to the proposed research is based on the fact that 
regular NSAID utilization is heavily prevalent among athletes and recreationally active 
people engaging in vigorous forms of exercise (163, 202). 
 Expanding upon the initial discussion of muscle soreness and damage 
mechanisms, it is speculated that damage to skeletal muscle through strenuous activity or 
exercise leads to the activation of phospholipase A2 (46, 163).  Activation of this 
particular phospholipase enzyme cleaves arachidonic acid from the sarcolemma, causing 
cyclooxygenase (COX-1 and COX-2) enzymes to mediate production of prostaglandins 
(46, 163).  As mentioned in the previous muscle soreness mechanisms discussion, 
prostaglandins, specifically, prostanoids, are released from the muscle cell as result of 
the now increasingly permeable sarcolemma to interact with surface cell receptors 
helping to sensitize local nerve endings to environmental changes as a result of the 
muscular injury in addition to influencing other biological functions (31, 46, 163).  The 
primary NSAID mechanism of action according to the majority of the literature is based 
on the fact that NSAIDs reduce pain by inhibiting the activity of the COX pathway and 
thus the metabolism of arachidonic acid (31, 41, 68, 77, 163, 194).   
While this NSAID mechanism of action seems to logically promote reduction of 
muscle pain and soreness, the inhibition of the COX pathway may also have additional 
downstream negative consequences such as downregulation of muscle protein synthesis 
and satellite cell proliferation.  While much of the literature in this area remains 
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controversial, it is theorized that specific prostanoid receptors induce anabolic signaling 
following muscle damage through upstream stimulation of protein synthetic regulators 
(e.g. PI3K) (61, 163).  Additional information in the literature also has determined that 
prostanoid-mediated communication through calcium-dependent pathways influences 
satellite cell proliferation mechanism in direct relation to increases in muscle fiber 
growth following muscle damage (74, 163).  Thus, the inhibition of COX enzymatic 
activity through NSAID supplementation may theoretically promote positive effects on 
post-exercise muscle soreness, but could cause major anabolic deficiencies downstream 
particularly with regular, long-term NSAID use.    
Antioxidant Vitamin Mechanism of Function and Theory 
 When antioxidants are most commonly described, many people and the majority 
of antioxidant research focuses on vitamin C (ascorbic acid) and vitamin E (tocopherol) 
(77), but there are numerous other endogenous and exogenous enzymatic and non-
enzymatic antioxidants that act to protect against physiological injury caused by reactive 
oxygen species (ROS).  Including vitamins C and E, there are many lesser known non-
enzymatic endogenous antioxidants that exist in cellular components including 
glutathione, lipoic acid, carotenoids, uric acid, bilirubin, and ubiquinone (146).  Some of 
the most widely researched enzymatic endogenous antioxidants include superoxide 
dismutase (SOD), glutathione peroxidase (GPx), and catalase of which both SOD and 
GPx are located in both muscular mitochondria and cytosol.   
 Despite vitamins C and E acting as endogenous antioxidants, the majority of 
antioxidant and certainly antioxidant vitamin research focuses on additional exogenous 
 27 
 
vitamins C and E supplementation.  Vitamins C and E are typically supplemented via an 
exogenous source when endogenous production is downregulated or inhibited in some 
capacity or when oxidant production levels overwhelm the endogenous antioxidant 
mechanisms (e.g. response to strenuous exercise bouts).   
Vitamin E is a general class that contains several structural isomers of 
tocopherols and tocotrienols in which α-tocopherol is the most notable and potent 
antioxidant of the class (25, 85, 146).  Considered a lipid soluble vitamin, vitamin E is 
typically associated with lipid-rich cellular components such as the mitochondria, 
sarcoplasmic reticulum, and the plasma membrane (146).  Individuals with a consistently 
normal diet typically have relatively low tissue levels of vitamin E, but concentrations 
can be elevated with supplementation (85).  Vitamin E is an important antioxidant due to 
its ability to downregulate superoxide, hydroxyl and lipid peroxyl radicals to their less 
active forms.  Within the cellular membrane lipid bilayer, vitamin E also serves an 
integral role to break lipid peroxidation chain reactions (25, 146).  Supplementation of 
vitamin E after strenuous bouts of exercise may be beneficial due to the fact that vitamin 
E tissue concentrations are significantly decreased under oxidative stress when the 
vitamin is converted to a radical during oxidant scavenging.  Vitamin E can be converted 
back to its original state with the help of other antioxidants (e.g. vitamin C, glutathione) 
(146). 
Vitamin C or ascorbic acid is perhaps the most well-known vitamin antioxidant 
as is part of the water-soluble class of vitamins.  At physiological pH, vitamin C exists 
as ascorbate due to its lower pKa and is fairly ubiquitous across most tissues with 
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highest concentrations existing in the adrenal and pituitary glands (146, 208). Similar to 
the scavenging ability of vitamin E, vitamin C can serve as an oxidant scavenger for 
superoxide, hydroxyl and lipid hydroperoxide radicals.  As previously mentioned, 
vitamin C also acts to recycle vitamin E back to its reduced state  helping to protect the 
antioxidant system against free-radical and oxidative injury (146, 208).  However, 
excessive amount of vitamin C can lead to negative consequences surrounding pro-
oxidant effects in the presence of iron and copper due to their catalytic involvement in 
the production of free radicals (146, 208).   
Phytochemical and Functional Food Mechanism of Action and Theory 
As one of the primary phytochemical compounds contained within plant-derived 
fruits, vegetables, grains, legumes, teas, wines and coffee, polyphenols have 
demonstrated positive effects on many biological activities within the human system (14, 
151).  Polyphenols are defined by their chemical structure consisting of a characteristic 
aromatic ring with one or more attached hydroxyl groups that define their effective 
ability to act as free radical scavengers and metal chelators (14, 151).  The general class 
of polyphenols can be divided into four subclasses: flavonoids, stilbenes, lignans, and 
phenolic acids, of which flavonoids are the most widely distributed (14, 151).  Due to 
the large volume of various flavonoids, this subclass can be divided further into groups 
with specific common characteristics: flavonols, flavones, flavanols, isoflavones, 
anthocyanidins, and anthocyanins (151).   
As a generally described series of functions for any antioxidant, classes of 
polyphenolic phytochemicals can reduce inflammation by acting directly as an 
 29 
 
antioxidant or indirectly by promoting an increase in antioxidant gene or protein 
expression.  The link between the production of reactive oxygen species (ROS) and/or 
reactive nitrogen species (RNS) to promote redox imbalance and subsequent oxidative 
stress and inflammatory gene expression is mediated by the ROS/RNS triggering of 
redox-sensitive kinases (14, 34, 151).  Initially, apoptosis signal-regulating kinase 1 
(ASK-1) is triggered to changes in the redox state that will lead to the downstream 
activation of mitogen-activated protein kinases (MAPKs), nuclear factor-kappa B (NF-
κB), and activating protein-1 (AP-1) to influence inflammatory gene expression (34).  
The unique chemical structure of polyphenolic compounds defined by the high quantity 
of hydroxyl groups and associated aromatic rings allows this photochemical subclass to 
promote a strong antioxidant potential (14, 34, 151).  In addition to their antioxidant 
chemical structure, polyphenols also have the capacity to affect the genetic expression 
and subsequent physiological levels of key antioxidant (and indirectly anti-
inflammatory) enzymes such as superoxide dismutase (SOD) and glutathione peroxidase 
(GPx) (14, 34, 151).  According to recent literature, the increase in genetic expression of 
these antioxidant enzymatic pathways through polyphenol activation is carried out via 
the activation of the transcription factor nuclear factor-erythroid 2 (NF-E2)-related factor 
2 (Nrf2) (34, 151).  Therefore, the reduction or down regulation of ROS and RNS in 
addition to other free radicals via introduction of the polyphenol subclass of 
phytochemicals will aid in maintenance of proper redox balance via attenuation of 
oxidative stress and in the end aid in the reduction of inflammation (34).   
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One of the major players in the upregulation of the body’s inflammatory 
response is nuclear factor-kappa B (NF-κB) acting as an effector within the cytoplasm of 
a cell (14).  Upon activation, the inhibitor proteins (IκB) associated with the NF-κB 
dimer are phosphorylated by IκB kinase, allowing the NF-κB dimer  to translocate from 
the cytoplasm to the nucleus where it exerts an effect on gene expression, specifically 
transcription, to suppress cellular apoptosis, while initiating cellular transformation, 
proliferation, invasion metastasis, and inflammation (14, 66, 90, 161).  NF-κB is redox 
transcription factor that is highly sensitive to redox stability/instability and can be 
readily activated by increases in inflammatory stimuli, most notably the production and 
release of pro-oxidative free radicals (161).  A significant increase in ROS 
demonstrating a heightened state of physiological oxidative stress, favors expression of 
NF-κB to promote a greater stress and inflammatory response through the upregulation 
of genes that code for pro-inflammatory cytokines, chemokines, adhesion molecules, 
acute-phase proteins, immuno-receptors, and growth factors (14).  Due to the linkage 
between oxidative stress and the inflammatory response mediated by NF-κB 
translocation, anti-inflammatory agents such as dietary polyphenols, have the potential 
to prevent, delay, or treat acute or chronic inflammation (69, 161).  Polyphenol 
phytochemicals, through their anti-inflammatory properties, have been shown to 
modulate NF-κB activity by acting on multiple steps throughout the dimer activation 
process (151, 161).  More specifically, interference with that IκB kinase rapid 
phosphorylation activity as the key control point in the NF-κB activation pathway seems, 
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based on the available literature, seems to be the point of effectiveness for polyphenol 
modulation of the NF-κB pathway (66, 69, 161).   
The anti-inflammatory effects of polyphenols have various targets within the 
physiological system, but one of the most important targets is related to the arachidonic 
acid-dependent pathway.  Inhibition of eicosanoids generating enzymes within this 
pathway such as: cyclooxygenases (COX), phospholipases (phospholipase A2), and 
lipoxygenases, will aid in the reduction of prostranoid and leukotriene concentration (97, 
161).  Arachidonic acid release from membrane phospholipids is catalyzed by the 
cleavage of the phospholipase A2 enzyme, at which point the resultant arachidonic acid 
will be catalyzed by either the cyclooxygenase (COX) or lipoxygenase (LOX) pathways 
as an important mediator in the inflammatory pathway, despite minimal pro-
inflammatory effects at normal physiological levels in healthy humans (161, 206).  
Lipoooxygenases are enzymes defined by their ability to produce hydroxyl acid and 
leukotrienes from the aforementioned donation of arachidonic acid (121, 161).  
Cyclooxygenase exists in two major isoforms: COX-1 (expressed in a variety of tissues) 
and COX-2 (highly expressed in inflammatory-related cell types, particularly 
macrophages and mast cells post-pro-inflammatory cytokine stimulation, and is 
responsible for producing large amounts of prostalglandins) (3, 206).  Non-steroidal anti-
inflammatory drugs (NSAIDs), such as aspirin, irreversibly inhibit the activity of the 
COX-1 and COX-2 enzymes and the subsequent production of prostaglandins (e.g. 
PGE2) at low, therapeutic doses (3).  However, due to the lack of synthetic drug receptor 
binding control on a specific COX enzyme type within a specific area of the 
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physiological system, undesired or unknown side effects may result (161). Polyphenols, 
on the other hand, have been found to act as both an antioxidant and modulator of gene 
expression to exert their effect as COX-1 and COX-2 inhibitors at both the 
transcriptional and enzyme level (161).  For example, previous research has 
demonstrated that COX-2 activity and gene expression was modified after consumption 
of polyphenols derived from red wine (e.g. resveratrol) and black tea (e.g. theaflavins) 
(108).  Further, polyphenols derived from dietary sources have also been documented to 
inhibit both phospholipase A2 (PL A2) and lipoxygenase (LOX) enzymes in conjunction 
with COX to reduce arachidonic acid and the subsequent generation of prostaglandins 
and leukotrienes to exert anti-inflammatory effects on the arachidonic acid pathway 
(161, 206). 
Tart Cherry Mechanism of Action and Theory 
 While cherries are typically considered sweet or sour (tart), there are more than 
100 different cherry species (56).  Sweet and sour cherries are typically characterized by 
their simple sugar quantities (e.g. fructose and glucose) and the presence of malic acid 
within tart cherries (42).  Through extensive analysis, it has been determined in previous 
research that cherries contain both water and fat soluble vitamins, β-carotene, calcium, 
magnesium, phosphorous, potassium, and melatonin (in some types of tart cherries 
including Montmorency) (56).  Tart cherries are particularly identified by greater 
quantities of vitamin A, vitamin C, β-carotene, and total polyphenols per 100 g weight of 
cherries.  Both sweet and tart cherries contain a variety of polyphenols that include 
various cyanidins (e.g. anthocyanidins and anthocyanins), hydroxycinnamates, and 
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flavonols (e.g. catechins, epicatechins, and quercetins), of which tart cherries have 
greater concentrations of anthocyanins and hydroxycinnamic acids compared to sweet 
cherries (56, 96).  The greater concentrations of these compounds in tart cherries bodes 
well compared to berry species as previous lipid membrane-based research determined 
that the activity of anthocyanins, cyanidins, and hydroxycinnamic acids derived from 
sweet and tart cherries is greater than other berries such as blackberries, red raspberries, 
blueberries, and strawberries, providing a rationale for potentially greater antioxidant 
effectiveness (56, 73). 
 Similar to the general polyphenolic anti-inflammatory mechanisms mentioned in 
the previous section, some of the active anti-inflammatory properties of cherry 
polyphenols have been hypothesized based on previous cherry research to specifically 
inhibit COX-II activity that is most closely replicated by ingestion of particular NSAIDs 
(e.g. ibuprofen and naproxen) at typical therapeutic dosages (126, 199).  Previously 
described as one of the most active cherry anti-inflammatory components, previous in 
vitro studies have demonstrated that anthocyanins are able to inhibit production of a 
primary inflammatory mediator in macrophages, nitric oxide (NO) (126, 200).  While 
NO is a gaseous free radial that beneficial in some physiological processes, production 
of NO by the inducible (iNOS) isoform has been proposed to be a major factor involved 
in pathological vasodilation and tissue damage due to its inflammatory provoking nature 
(14, 161, 206).  More specifically, it has been postulated that multiple polyphenol 
compounds such as anthocyanins down regulate iNOS gene expression and 
lipopolysaccharide-induced NO production in macrophages through aforementioned 
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pathways of NF-κB inhibition (14, 88, 161, 206).  Overall, the inflammatory inhibitory 
pathways demonstrated in all functional foods, particularly the large concentration of 
various polyphenols within tart cherries, serve to demonstrate the potentially positive 
health and exercise recovery benefits of supplementation in certain populations. 
General Markers of Clinical Health 
Effects of Tart Cherry Supplementation  
 Tart (e.g. Mortmorency) and sweet cherries (e.g. Bing) have received substantial 
attention within the clinical literature due to their high anthocyanin content (29, 30, 197) 
proven to aid in health (82, 93, 119, 188), inflammatory-related disease states (e.g. 
cardiovascular disease, diabetes, osteoarthritis, gout) (15, 82, 93, 119, 164), and sleep 
quality (75, 143).  In a crossover study to determine the effect of a commercially 
available Montmorency tart cherry juice blend compared to a placebo on resistance to 
oxidative damage after acute stress, Traustadόttir et al. (188) employed a forearm 
ischemia/reperfusion (I/R) protocol on healthy, older adults across a 34-min time period 
at the end of the 14-d supplementation timeline.  Traustadόttir et al. (188) measured 
capacity to resist oxidative damage through pre/post-forearm I/R changes in F2-
isoprostance levels and the accumulation of oxidative damage in short-lived (e.g. lipids) 
and long-lived (e.g. DNA and RNA) molecules excreted in the urine.  This particular 
study found that supplementation with the tart cherry juice reduced the oxidative stress 
response and decreased long-term markers of oxidative damage in the urine.  No 
difference was reported in short-term markers of oxidative damage in the urine (188).   
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Jacob et al. (82), studying a small cohort of healthy, young women, analyzed the 
pre/post-treatment effects of acute Bing sweet cherry consumption (280 g) on markers of 
inflammation over a 5-h period.  The major finding by Jacob et al. (82) was that plasma 
urate levels significantly decreased over the 5-h post-consumption period with marginal 
decreases in plasma CRP and NO.  In a very recent crossover study conducted by Bell et 
al. (11), a small cohort of healthy volunteers were supplemented for two days with two 
different doses (30 or 60 mL) of Montmorency tart cherry juice concentrate.  Supporting 
the results reported by Jacob et al. comparing the pre/post-supplementation levels, Bell 
et al. (11) demonstrated a significant decrease in both serum urate and serum hsCRP as a 
result of tart cherry juice concentrate supplementation irrespective of dosage. In a second 
study looking at the consumption of Bing sweet cherries on plasma lipids and markers of 
inflammation to aid in reducing the risk of cardiovascular disease, Kelley et al. (93) 
treated a population of healthy men and women with 280 g/d of Bing sweet cherries for 
28-d.  Comparing pre/post-consumption concentrations over the 35-d study period, 
Kelley et al. (93) reported significantly decreased circulating concentrations of 
inflammatory markers hsCRP, NO, and RANTES (protein as a selective attractant for 
memory T-lymphocytes and monocytes).  This results support those reported by Jacob et 
al. (82) and Bell et al. (11) in the acute treatment condition.  However, sweet cherry 
consumption did not have any effect on total cholesterol, HDL, LDL, VLDL, fasting 
blood glucose, or insulin levels over the 28-d supplementation period (93).  More 
recently, Schumacher et al. (164) supplemented a large cohort of otherwise healthy 
patients diagnosed with osteoarthritis (OA) of the knee with 473 mL/d of either a 
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Monmorency tart cherry juice blend or placebo for 6-wks.  In support of the previous 
two inflammatory-related studies, Schumacher et al. reported a significant decrease in 
circulating hsCRP levels and improvements in both pain and function with tart cherry 
juice supplementation compared to placebo.  Despite links to greater Western Ontario 
McMaster Osteoarthritis Index (WOMAC) scores with lower hsCRP levels, there was no 
difference between treatment groups with respect to WOMAC scores (164). 
In another health aspect, Pigeon et al. (143) studied, in a crossover fashion, the 
effects of 2-wk Montmorency tart cherry juice blend supplementation compared to 
placebo on sleep enhancement in a small cohort of otherwise healthy older adults 
diagnosed with chronic insomnia.   Pigeon et al. (143) found some beneficial effects on 
sleep for these participants with significant reductions in insomnia severity compared to 
placebo, but no improvements observed in sleep latency, total sleep time, or sleep 
efficiency compared to placebo.  In a more comprehensive crossover sleep study, 
Howatson et al. (75) treated healthy men and women for 7-d with either a Montmorency 
tart cherry juice concentrate or placebo to observe differences in urinary melatonin 
levels and overall sleep quality.  Unlike the pilot study conducted by Pigeon et al. (143), 
Howatson et al. (75) demonstrated that the tart cherry juice concentrate supplementation 
increased time in bed, total sleep time, and sleep efficiency compared to placebo.  
Further, total melatonin content as measured in the urine was significantly elevated upon 
tart cherry juice treatment compared to placebo, thus providing a potential rationale for 
improved sleep patterns in these healthy participants.     
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Muscle Pain or Soreness Perception in Response to Endurance Exercise  
Effects of NSAIDs 
 Studying the effects of acute ibuprofen (8400 mg) ingestion against a placebo 
surrounding an eccentrically-based endurance bout in a crossover design study, Donnelly 
et al. (48) subjected young, healthy, and untrained male volunteers to a 45-min downhill 
treadmill run at 70% of their estimated maximum heart rate.  Donnelly et al. (48) 
assessed muscle soreness before and after the downhill running bouts using a 10 point 
VAS scale for the front lower leg, back lower leg, front thigh, and back thigh/buttocks.  
Interestingly, the researchers also employed the same 10 point VAS scale for the 
measurement of soreness in response to a fixed amount of pressure with a spring-loaded 
probe on three sites (distal, proximal, and middle) within each aforementioned leg region 
(48).  The overall muscle soreness response as derived from 20 soreness ratings found 
that leg muscle soreness significantly increased post-run, but no treatment effect was 
evident (48).  However, when reviewing individual probe soreness measurements, 
ibuprofen supplementation corresponded to significantly greater post-run muscle 
soreness in the hamstring muscle group compared to placebo (48).  In another crossover 
study with a similar design and subject cohort, Donnelley et al. (49) had volunteers 
supplement with diclofenac (50 mg) or a placebo 90-min before the previously described 
downhill running protocol and an additional 50 mg at 8-h intervals up to 72-h post-run.  
Employing the same subjective muscle soreness evaluation protocol as the previous 
study with three additional sites of measurement (abdomen, shoulders, and arms) for a 
total of 23 soreness values, Donnelley et al. (49) reported that overall muscle soreness 
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was unaffected by supplementation.  Despite inconsistent effects on individual sites of 
muscle soreness, diclofenac tended to have an attenuating effect on muscle soreness in 
the middle of the hamstring muscle group compared to placebo (49).   
Recruiting trained male and female ultramarathon runners competing in the 160 
km Western States Endurance Run event, Nieman et al. (130) categorized athletes as 
NSAID users and non-users based on self-reported NSAID utilization during the race.  
The overwhelming majority of NSAID users supplemented with ibuprofen.  In order to 
track DOMS, subjects were asked to record muscle soreness following the race and up to 
7-d post-race using a 10-point Likert scale.  NSAID use did not have any effect of 
DOMS over the post-race recovery.  In a more recent study from the same research 
group, the effects of NSAID use in trained male and female ultramarathon runners on 
muscle injury and oxidative stress was studied by McAnulty et al. (115) who recruited a 
large cohort of runners competing in the 160 km Western States Endurance Run event.  
Similar to the earlier study by Nieman et al. (130), McAnulty et al. (115) categorized 
subjects based on their self-selected NSAID use over the course of the race.  Muscle 
soreness ratings were recorded pre-race and up to 7-d post-race using a 10-point Likert 
scale.  As previously described by Nieman et al. (130), McAnulty et al. (115) reported 
that there were no overall differences in DOMS between NSAID users and non-users 
despite significantly greater DOMS 1-d post-race in NSAID users versus non-users.    
The consistency established with only two research groups primarily contributing 
to the literature in this category of NSAID effects on endurance performance provides 
confidence that the use of NSAIDs surrounding bouts of demanding, long duration 
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aerobic running activity does not aid in reducing post-run perceptions of muscle 
soreness.  Further, this conclusion is commonly shared across both previously inactive 
and highly trained populations within these studies. 
Effects of Antioxidant Vitamins 
In an eccentrically breaking endurance trial where physically active subjects ran 
downhill continuously for 30-min and were acutely supplemented with either ascorbic 
acid or a placebo, Close et al. (37) reported no significant differences in VAS pain 
ratings or pressure algometry between groups up to 14-d post-exercise on six lower 
extremity locomotion muscle groups.  With no effect on post-aerobic exercise delayed 
onset muscle soreness (DOMS) coupled with previous evidence in the literature, Close et 
al. (37) suggested a dissociation between post-exercise ROS production and DOMS.  In 
an aerobic based crossover study designed to simulate multi-sprint sports, Thompson et 
al. (183) recruited habitually active males to ingest a vitamin C supplement (1 g dose) or 
a placebo 2-h prior to a 90-min intermittent shuttle-running test.  The intensity of leg 
muscle soreness was rated on a 10-point VAS and Thompson et al. (183) reported that 
despite leg soreness increasing above baseline levels follow the LIST exercise bout, 
there were no differences in soreness ratings between supplement trials.  Utilizing a 
similar muscle soreness protocol, in another placebo-controlled, running-based study, 
Thompson et al. (184) supplemented subjects with vitamin C or placebo for 14-d 
surrounding a prolonged 90-min high-intensity intermittent shuttle running test (LIST). 
Subjects were supplemented twice daily (morning and evening) with vitamin C (400 
mg/d) or a placebo.  Thompson et al. (184) determined that overall general soreness 
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tended to be greater in the placebo group, but was significantly greater in the placebo 
group compared to baseline and vitamin C group levels 24-h and 48-h post-exercise.   
Despite two very different endurance-based running challenges of which one 
involved extra requirements for repetitive eccentric braking forces, both of the 
aforementioned studies concluded similarly to the NSAID published research.  Based on 
these articles, antioxidant vitamin supplementation also does not seem to have any 
significant effect on post-run muscle soreness in physically active or trained subjects. 
Effects of Tart Cherry Supplementation 
The apparent beneficial effect of tart cherry juice or concentrate supplementation 
on the perception of muscle soreness after strenuous exercise bout is not standardized 
among published studies of varying modalities.  In an endurance relay race-based study 
with trained runners (average running distance 26.3 km), Kuehl et al. (101) used a 100 
mm VAS to track muscle pain and in subjects who ingested 710 mL of supplement for 
8-d (7-d pre-race and day of race) surrounding the endurance challenge.  Kuehl et al. 
(101) reported that treatment with the Montmorency tart cherry juice blend significantly 
reduced post-race pain compared to a placebo.  Due to the relay nature of this particular 
endurance race, the time between race completion and muscle pain measurement in 
addition to individual subject running distance were not standardized across all 
participants (9).  In another endurance running-based study, Howatson et al. (76) 
supplemented recreational marathon runners for a total of 8-d (5-d pre-race, day of race, 
and 2-d post-race) surrounding a marathon event with either 473 mL (237 mL am 237 
mL pm) of a commercially available tart cherry juice blend or a placebo.   Unlike the 
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results reported by Kuehl et al. (101), Howatson et al. (76) reported no difference in 
DOMS over the 48-h post-race period between tart cherry juice and placebo 
supplementation using a 200 mm VAS protocol.  However, a baseline DOMS 
measurement was not conducted prior to supplementation.  In a more recent aerobic 
exercise study, Bell et al. (13) supplemented trained cyclists with 60 mL (30 mL at 0800 
and 30 mL at 1800) per day of Montmorency tart cherry concentrate or placebo for 7-d 
(4-d supplement loading pre-exercise and on each of the 3 trial days) prior to a 3-d bout 
of high intensity stochastic cycling.  Using the same 200 mm VAS protocol reported by 
Howatson et al. (76), Bell et al. (13), reported similar results with no difference in 
DOMS ratings between Montmorency tart cherry supplementation and placebo up to 72-
h post-exercise.   
Unlike the consistency in results established among the NSAID and antioxidant 
vitamin research, the tart cherry endurance-based research provided conflicting reports 
of supplementation effectiveness in reducing perceptions of muscle soreness surrounding 
a bout of challenging endurance exercise.  The lack of consistency in the literature with 
respect to tart cherry supplementation and endurance exercise is likely due to differences 
in method of muscle soreness perception measurement in addition to endurance exercise 
duration and modality (running versus cycling).  Further, despite each of the studies 
sharing a similar over all supplement timeline (7-8 days), there was a large deviation in 
how the supplement ingestion was distributed pre- and post-exercise that may have 
likely contributed to the inconsistency in research findings.   
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Muscle Pain or Soreness Perception in Response to Resistance-Based Exercise 
Effects of NSAIDs  
 Analyzing the effects ibuprofen supplementation over the course of 6-wk of 
contralateral biceps training, Krentz et al. (100) employed college-aged males and 
females with previous resistance training experience in this counter-balanced, double-
blinded design.  Subjects trained each arm on alternative days, 5-d/wk over the 6-wk 
training period in while they randomly received ibuprofen (400 mg/d) or a placebo 
immediately post-workout corresponding to arm training pattern.  Muscle soreness was 
recorded for both arms every day over the training period using a 0-9 rating scale (0=no 
soreness, 9=intense soreness).  Despite muscle soreness decreasing significantly from 
week 1 to week 2 of training, there was no significant change in soreness from weeks 2-
6 or between the ibuprofen and placebo arms (100).  The effects of ibuprofen 
supplementation on markers of muscle injury and performance following a bout of 
eccentrically-resisted arm curls were studied by Pizza et al. (145) in a crossover study 
using a small cohort of sedentary males.  Pizza et al. (145) supplemented subjects with 
either ibuprofen (2400 mg/d) or placebo for a total of 15-d (5-d pre-exercise and 10-d 
post-exercise) surrounding a bout of 25 single arm, eccentrically-resisted arm curls.  
Muscle soreness was assessed using a 10-point VAS to rate perceptions during passive 
arm movement though full range of motion.  Muscle tenderness was assessed on a total 
of 12 arm sites (5 upper arm and 7 forearm) using a metal probe paired with a load cell 
to find the point of tenderness (145).  Pizza et al. (145) reported significantly greater 
muscle soreness and tenderness throughout the recovery period compared to pre-
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eccentric exercise, but there was no difference demonstrated between treatments (145).  
In a similar study population of non-athletic males, Rahnama et al. (152) randomly 
assigned subjects to one of four study groups: physical activity, ibuprofen, physical 
activity + ibuprofen, or control.  The 20-min of physical activity (warm-up) performed 
by the subjects prior to the eccentric arm exercise consisted of walking and jogging (5-
min), hand and shoulder static stretching (10-min), and concentric movements with 
submaximal contractions (5-min). DOMS-inducing exercise involved performance of 70 
eccentric arm-curl contractions 3-sec in duration at 80% MVC with 12-sec rest between 
eccentric repetitions.  Ibuprofen ingestion occurred at 7 time points (400 mg/time point) 
over the study sequence, starting 1-h pre-eccentric exercise and ending 48-h post-
eccentric exercise for a total of 2800 mg/d.  Rahnama et al. (152) measured perception of 
muscle soreness using a 30-point scale (1=normal, 30=very, very sore) at full elbow 
extension.  Muscle soreness increased significantly from baseline during the recovery 
and peaked in all groups 24-h post-eccentric exercise.  As to be expected, the greatest 
soreness was recorded in the control group compared to the physical activity and 
combination groups at 24-h and 48-h post-eccentric exercise.  Despite not being 
statistically significant, muscle soreness in the physical activity and combination groups 
was 27% and 23% lower than the ibuprofen only group 24-h post-eccentric exercise 
(152).    
In an earlier resistance-based NSAID supplement study, Hasson et al. (72) 
employed healthy, untrained males and females to complete a 10-min bout of repeated 
bench step-ups with additional load of 10% body weight.  Subjects were either 
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supplemented with 3 doses of ibuprofen (1200 mg) over 24-h starting 4-h pre-exercise 
(prophylactic), a single dose of ibuprofen (400 mg) at 24-h post-exercise (therapeutic), 
placebo, or a control receiving no treatment.  Muscle soreness was determined on the 
anterior thigh at locations 2 cm apart using a metal probe (2 mm diameter tip) attached 
to a load cell and strain gauge with a gradually increasing force applied until subject 
discomfort was reached (72).  The force associated with discomfort was applied up to 50 
N of pressure.  Hasson et al. (72) published that the primary areas of muscle soreness 
were concentrated around the distal head of the vastus medialis and proximal head of the 
vastus lateralis.  More specifically, soreness perception for the prophylactic ibuprofen 
group was approximately 50% of that noted in all other groups 24-h post-exercise.  
Quadriceps soreness perception was also significantly less at 48-h post-exercise in both 
ibuprofen supplementation groups compared to placebo and control (72).   
As previously noted, muscle soreness and pain perception significantly increased 
over baseline levels in all study groups as a result of upper or lower body eccentrically-
resisted exercise.  Ibuprofen supplementation did not seem to have any effect on 
attenuating a post-exercise increase in muscle soreness following upper body involved 
exercise.  However, based on the results described by Rahnama et al. (152), it seems as 
though muscular activation through implementation of a warm-up protocol prior to the 
exercise is more effective than ibuprofen supplementation to aid in reduction of post-
upper body resistance exercise muscle soreness.  Contrarily, cutting the acute ibuprofen 
dosage in half surrounding a bout of lower body resistance-based exercise, results seem 
to conflict greatly with those mentioned previously following upper body resistance-
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based exercise.  With no basis of study comparison, Hasson et al. (72) published data 
indicating that post-resistance exercise soreness was reduced by 50% with acute, 
prophylactic ibuprofen supplementation compared to therapeutic ibuprofen ingestion, 
placebo, and control.  However, differences in all of these studies could lie in the method 
of soreness perception measurement, as Hasson et al. (72) used application of pressure 
coupled with a strain gauge as opposed to a simple VAS implemented in other studies. 
Effects of Antioxidant Vitamins 
 Healthy, non-resistance trained men, were recruited by Beaton et al. (8) to 
participate in a placebo-controlled study where subjects were supplemented for 30-d 
with either vitamin E (1200 IU/d) or a placebo.  Within this particular study, subjects 
performed an isokinetic protocol that compromised of 24 sets of 10 eccentrically-resisted 
knee extension/flexion contractions (8).  Beaton et al. (8) employed the Descriptor 
Differential Scale (DDS) (110) to assess the intensity and unpleasantness of muscle 
soreness as a result of the eccentric exercise bout.  As a result, Beaton et al. reported no 
differences in intensity and unpleasantness of muscle soreness between the 
supplementation groups (8).  In another cohort of healthy, untrained males, Bryer and 
Goldfarb (22) supplemented subjects for 18-d (14-d pre-exercise and 4-d post-exercise) 
three times daily with either vitamin C (3 g/d) or a placebo. Bryer and Goldfarb (22) had 
subjects perform 70 eccentrically-resisted elbow flexions on the non-dominant arm with 
10-sec rest allotted between repetitions.  The degree of elbow flexor muscle soreness 
was determined using a 10 point VAS in both a resting state and in response to 
palpation.  As a result of the eccentric exercise protocol, muscle soreness was 
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significantly greater than baseline in both groups across the 96-h recovery period (22).  
However, supplementation with vitamin C significantly attenuated muscle soreness in 
the non-dominant arm compared to placebo immediately, 4-h, and 24-h post-eccentric 
exercise (22).   
In an earlier eccentrically-based upper body exercise study, Childs et al. (32) 
supplemented previously untrained subjects with either a placebo or a vitamin C (12.5 
mg/kg body weight) + N-acetyl-cysteine (NAC) (10 mg/kg body weight) combination 
for 7-d after the exercise challenge.  As the exercise protocol, subjects were asked to 
perform 3 sets of 10 repetitions of eccentrically-resisted elbow flexion exercise at 80% 
of 1-RM on the non-dominant arm.  Unlike the results reported by Bryer and Goldfarb 
(22), supplementation with the antioxidant cocktail did not have any effect on increases 
in post-exercise muscle pain compared to placebo, despite an increase in muscle pain up 
to 2-d post-exercise.  Supplementing moderately active and healthy male volunteers for 
37-d with a combination of vitamin C (500 mg/d) and vitamin E (1200 IU/d) or a 
placebo, Shafat et al. (167) employed an exercise protocol comprised of 30 sets of 10 
eccentric knee extensions on their dominant leg using an isokinetic dynamometer.  
Shafat et al. (167) evaluated leg muscle soreness using a 10 point VAS on a total of 8 
upper leg sites (anterior and posterior) and determined that the antioxidant vitamin 
combination did not change the time course of muscle soreness in the exercise recovery 
period. 
Similar to the perception of muscle soreness results described by NSAID 
research, the use of antioxidant vitamins also provided some uncertainly with respect to 
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effectiveness of supplementation on muscle soreness.  The majority of the 
aforementioned antioxidant vitamin research published results that indicated no 
effectiveness of ingestion on perception of muscle soreness following eccentrically-
based resistance exercise compared to a placebo.  However, as the only study that did 
not use a combination of antioxidant vitamins as part of the supplementation regimen, 
Bryer and Goldfarb (22) asked subject to ingest a large quantity of vitamin C (compared 
to the dosage strategies of other studies) over the course of 18-d that may have 
contributed to the supplement’s effectiveness in significantly attenuating post-exercise 
muscle soreness.  The supplement time table, exercise modality and volume, method of 
soreness perception, and study population utilized by Bryer and Goldfarb (22) are not 
much different than other similar studies, thus pointing to the supplement itself as the 
likely contributor to different results.   
Effects of Phytochemicals and Functional Foods 
 In an acute eccentric exercise-based crossover study, Trombold et al. (189) 
recruited recreationally active males who were supplemented twice daily with either a 
pomegranate juice (960 mL/d) or a placebo (960 mL/d) over a 9-d period (4-d pre-
exercise, day of, and 4-d post-exercise) surrounding the eccentric exercise workout.  The 
single eccentric exercise session involved two sets of 20 maximal eccentric elbow 
flexions in which subjects were required to resist an isokinetic dynamometer for 3-sec 
followed by a 15-sec rest per repetition (189).  The degree of elbow flexor muscle 
soreness was determined using a 10 point VAS.  Over the course of the exercise 
recovery, Trombold et al. (189) found significantly attenuated muscle soreness 2-h post-
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exercise as a result of pomegranate juice supplementation versus placebo, but did not 
detect any other significant differences in ratings of muscle soreness between the two 
supplementation groups over the 96-h recovery period.  In a more recent pomegranate 
juice supplementation study, Trombold et al. (190) supplemented resistance-trained men 
surrounding a single workout of both unilateral resisted eccentric elbow flexion and knee 
extension exercises.  Subjects were supplemented twice daily with either a pomegranate 
juice (500 mL/d) or a placebo (500 mL/d) over a 15-d period (7-d pre-exercise, day of, 
and 7-d post-exercise) surrounding the exercise bout (190).  The single eccentric 
exercise bout involved three sets of 20 maximal eccentrically resisted elbow flexions on 
an isokinetic dynamometer and six sets of 10 unilateral eccentrically resisted (3-sec 
count) knee extensions at 110% unilateral 1-RM on a traditional isotonic leg extension 
machine (190).  The degree of elbow flexor and leg extensor muscle soreness was 
determined using a 10 point VAS.  Unlike the previous study conducted by Trombold et 
al. (190), elbow flexion soreness was significantly attenuated over the 168-h exercise 
recovery period in the supplement group with notable group differences at 48-h and 72-h 
post-exercise.  Despite an increase in knee extensor muscle soreness throughout the 168-
h recovery period, there were no significant differences between groups reported (190).   
In another study using eccentric exercise as a mechanism of muscular injury, 
Goldfarb et al. (65) supplemented subjects with a proprietary blend of fruit, vegetable, 
and berry powder concentrates over 28-d prior to the exercise bout and 4-d after.  This 
propriety blend of fruit, vegetable, and berry powder concentrates provided a source of 
β-carotene (7.5 mg/d), vitamin C (276 mg/d), and vitamin E (108 IU/d), in addition to a 
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natural source of flavonoids and anthocyanins (65).  The structure of the study required 
subjects to perform an exercise bout consisting of four sets of 12 repetitions of 
eccentrically resisted elbow flexions on the non-dominant arm at 20°/sec angular 
velocity surrounded by sets of MVICs to assess muscular strength.  A 10 point VAS was 
used to assess muscle soreness through a full range of motion and in response to 
palpation (65). Over the 72-h recovery period, both supplementation groups 
demonstrated similar increases in muscle soreness, peaking at 24-h post-eccentric 
exercise, but no group difference was reported at any time point (65).  In an fourth study 
examining the effects of eccentrically-resisted elbow flexions, Phillips et al. (142) 
treated untrained subjects with either a placebo or mixed functional food-derived 
antioxidant supplement for 14-d (7-d pre-exercise and 7-d post-exercise).  The mixed 
functional food supplement consisted of mixed tocopherols (300 mg/d), DHA, (800 
mg/d), and flavonoids (100 mg/d hesperetin and 200 mg/d quercetin).  Subjects were 
asked to perform 3 sets of 10 repetitions of eccentrically-resisted elbow flexion exercise 
at 80% of 1-RM on the non-dominant arm.  Similar to the protocol used by Goldfarb et 
al. (65), a 10 point VAS was used to assess muscle soreness in response to palpation and 
full range of motion movement.  Phillips et al. (142) reported that despite a significant 
increase in pain perception at 72-h post-exercise, there was no significant differences 
between the responses of the treatment groups throughout the entire 7-d recovery period. 
Examining intramuscular adaptations to a single bout (100 repetitions: 10 sets of 
10 repetitions) of eccentrically-resisted isokinetic leg extensions on the dominant leg, 
Kerksick et al. (94) supplemented active males for 14-d with either N-acetyl-cysteine 
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(NAC) (1,800 mg/d), epigallocatechin gallate (EGCG) (1,800 mg/d), or a placebo.  
Perception of muscle soreness was assessed using a 10 cm VAS scale (94).  Compared 
to baseline perceptions, muscle soreness was significantly greater 6-h, 24-h, 48-h, and 
72-h post-exercise with placebo supplementers revealing a significantly greater soreness 
level at 24-h post-exercise compared to ECGC and NAC groups. 
  After a careful review of this research segment, there is no clear evidence to 
support or refute the use of certain phytochemicals or functional foods to help reduce 
perceptions of muscle soreness following bouts of resistance-based exercise.  Even when 
sorting the research based on upper or lower body exercise, conflicting reports still exist 
as to the effectiveness of these supplements as a general class with respect to 
effectiveness in reducing perceptions of muscle soreness.  The lack of conclusive 
evidence mostly likely stems from the large variety of supplements utilized across all 
studies represented within this subsection.  However, even between two studies 
conducted by the same research group on similar study cohorts, utilizing the same 
pomegranate juice supplement, Trombold et al. reported conflicting reports between the 
two studies.   
Effects of Tart Cherry Supplementation 
In an eccentric resistance-based crossover study, Connolly et al. (40) 
supplemented healthy, college-aged males with 710 mL (355 mL am and 355 mL pm) of 
a Montmorency tart cherry juice blend or a placebo for 8-d (3-d pre-eccentric, day of 
eccentric, and 4-d post-eccentric exercise) surrounding a bout of eccentric elbow flexion 
contractions.  As a result of this exercise and supplementation protocol, Connolly et al. 
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(40) reported that consumption of a Montmorency tart cherry juice blend in healthy 
college-aged males significantly reduced pain in the elbow flexors after a bout of 
eccentric exercise using a visual analog scale (VAS).  Peak muscle pain was achieved 
24-h post-exercise in the tart cherry group compared to a continued increase in pain 48-h 
post-exercise in the placebo group.  In contrast, Connolly et al. (40), using a standard 
manual muscle myometer, reported no difference in pressure pain threshold (PPT) scores 
between the two experimental groups.  In a second resistance-based crossover study, 
Bowtell et al. (20), employed a strenuous single leg knee extension protocol in a cohort 
of well-trained male athletes in conjunction with 60 mL (30 mL am and 30 mL pm) per 
day of Montmorency tart cherry concentrate or placebo for 10-d (7-d pre-exercise, day 
of exercise, and 2-d post exercise), closely resembling the supplementation protocol 
employed by Bell et al. (10).  Bowtell et al. (20) demonstrated a trend in post-exercise 
muscle pain reduction via PPT (pain-pressure threshold) using an algometer with 
Montmorency tart cherry juice supplementation up to 48-h post-exercise compared to 
placebo.   
With only two research studies employing resistance-based exercise and tart 
cherry supplementation, it is difficult to make any conclusions from the evidence 
presented.  These two studies are very different from one another as one used upper 
body resistance-based exercise and the other lower-body.  Further, the supplements 
ingested by the subjects across the two studies is also different as one is a juice blend 
and the other is a concentrate despite having a similar supplementation duration.  At this 
point, evidence is inconclusive based on pain pressure threshold (PPT) measurements 
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taken surrounding a single bout of resistance-based exercise and short-term 
supplementation of a tart cherry supplement. 
Muscle Catabolic and Secondary Muscle Damage Response to Endurance Exercise 
Effects of NSAIDs 
In an endurance-based crossover study examining the effects of acute ibuprofen 
(8400 mg) ingestion surrounding an eccentrically-based endurance bout, Donnelly et al. 
(48) subjected young, healthy, and untrained male volunteers to a 45-min downhill 
treadmill run at 70% of their estimated maximum heart rate.  Donnelly et al. (48) 
reported an increase in serum CK, AST, and lactate dehydrogenase following the 
downhill running protocols with maximal activity of CK and AST occurring at 24-h 
post-run, while lactate dehydrogenase, creatinine, and urea peaked 6-h post-run.  The 
results of the study revealed that both serum CK and urea levels were significantly 
higher after ibuprofen supplementation compared to placebo throughout the post-
downhill run recovery (48).  In another crossover study with a similar design and subject 
cohort, Donnelley et al. (49) required volunteers to supplement with diclofenac (50 mg) 
or a placebo 90-min before the previously described downhill running protocol and an 
additional 50 mg every 8-h up to 72-h post-run.  Serum peaks of all markers measured 
were identical to the previously mentioned study, but the results of this study revealed 
that there were no differences in serum biochemical markers of muscle damage or 
catabolism between diclofenac and placebo supplementation (49).   
Recruiting trained male and female ultramarathon runners competing in the 160 
km Western States Endurance Run event, Nieman et al. (130) categorized athletes as 
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NSAID users and non-users based on self-reported NSAID utilization during the race.  
The overwhelming majority of NSAID users supplemented with ibuprofen.  Measuring 
serum creatine phosphokinase (CPK) as an indicator of muscle damage, Nieman et al. 
(130) found no differences in plasma CPK levels in NSAID users versus non-users 
throughout the post-exercise period.  McAnulty et al. (115) also recruited a large cohort 
of runners competing in the 160 km Western States Endurance Run event to study the 
effects of NSAID supplementation and categorized them based on their self-selected 
NSAID use over the course of the race.  Muscle damage was assessed by McAnulty et 
al. (115) through measurement of serum CPK and similar to previous findings by 
Nieman et al. (130), research also reported no differences in plasma CPK levels between 
NSAID users and non-users over the course of the 7-d protocol (115).   
The endurance-based research listed in this section should be considered fairly 
reliable and consistent as both sets of 2 studies utilized the same exercise protocol and 
similar study populations.  One of study sets consisted of two pieces of supplement 
intervention research that utilized healthy, but untrained subjects to complete a highly 
intense eccentrically-based endurance workout.  While one study found negative effects 
of ibuprofen supplementation, the other study did not find any difference between 
another NSAID, diclofenac, when compared to a placebo.  Similar to the study involving 
diclofenac supplementation, two additional ultramarathon studies utilizing a non-
supplementation intervention protocol reported similar ineffective results in highly 
trained endurance runners.  Based on this research, no positive effects of NSAID 
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ingestion surrounding bouts of intense endurance exercise were published with respect to 
attenuating post-exercise muscle damage.    
Effects of Antioxidant Vitamins 
In an aerobically based study conducted by Kang et al. (89), researchers 
compared a polyphenol-rich extract derived from litchi fruit (OLFE), a vitamin C (800 
mg/d) + vitamin E (1200 IU/d) combination, and a placebo on outcomes of endurance 
performance capacity following 30-d of supplementation in healthy, recreationally 
trained endurance subjects.  The vitamin combination (C + E) demonstrated a 4-fold 
increase in LDH response following exercise 30-d after supplementation compared to 
baseline measures, while the OLFE and placebo groups demonstrated a decrease in post-
exercise LDH response following 30-d of supplementation (89).  Analyzing only an 
antioxidant vitamin combination, Peterson et al. (140), supplemented male 
recreationally-trained runners with either an vitamin C (500 mg/d) + vitamin E (400 
mg/d) combination or a placebo for 14-d before and 7-d after a 90-min treadmill run at a 
5% decline and 75% VO2 max.  As a result of the eccentrically-braked endurance 
running challenge, Peterson et al. (140) reported a 6-fold increase in plasma CK levels 
24-h post-exercise with no differences exhibited by supplementation.   
Attempting to simulate multi-sprint sports, Thompson et al. (183) recruited 
habitually active males within a crossover design study to ingest a vitamin C supplement 
(1 g dose) or a placebo 2-h prior to a 90-min intermittent shuttle-running test.  As 
measures of muscle damage, Thompson et al. (183) reported that serum CK and AST 
activity increased above baseline levels during and after the 90-min LIST exercise.  AST 
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activity peaked immediately post-exercise but remained elevated above baseline 72-h 
post, while CK levels peaked 24-h post-LIST and returned to baseline levels by the end 
of the testing protocol (72-h) with no differences reported between supplementation 
treatments (183).  Thompson et al. (184) supplemented subjects with vitamin C or 
placebo for 14-d surrounding a prolonged 90-min high-intensity intermittent shuttle 
running test (LIST). Subjects were supplemented twice daily (morning and evening) 
with vitamin C (400 mg/d) or a placebo.  As a result of the differences in 
supplementation, Thompson et al. (184) reported that serum CK levels increased and 
returned to baseline values at 72-h of recovery similarly in both groups as a result of the 
LIST exercise challenge.  As another marker of muscle damage, plasma myoglobin 
concentrations peaked 1-h post-exercise and remained above baseline values through 24-
h of recovery, irrespective of supplementation groups.  Vassilakopoulos et al. (105) 
supplemented healthy, non-athlete volunteers with an antioxidant combination (60-d of 
vitamins A, C, and E; 15-d of allopurinol; and 3-d of N-acetylcysteine) prior to a 45-min 
bout of cycling at 70% VO2 max.  Blood samples were drawn at baseline, immediately, 
30-min, and 120-min post-exercise.  Vassilakopoulos et al. (105) reported no post-
exercise change in plasma CK level up to 24-h of recovery as a result of the exercise 
bout or antioxidant cocktail supplementation. 
Despite various supplementation and endurance exercise challenges, the 
consensus of all research described in this section is that supplementation with an 
antioxidant vitamin or vitamin combination does not provide any more benefit than a 
placebo in reducing markers of muscle damage.  The study by Kang et al. (89) 
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demonstrates a detrimental effect of antioxidant supplementation as LDH levels 
increased significantly post-exercise after 30-d of supplementation compared to post-
exercise levels at baseline, whereas the opposite pattern was demonstrated in the placebo 
and OLFE supplementation groups. 
Effects of Phytochemicals and Functional Foods 
In an endurance-based study, Pilaczynska-Szczesniak et al. (144) recruited male 
members of the Polish rowing team to ingest 150 mL/d (3x 50 mL) of chokeberry juice 
or placebo over the course of their 4-wk training camp.  At the beginning and end of the 
training camp, the crew athletes performed a 2000-m rowing test followed by an 
incremental rowing session after 1-d rest with 3-min stages of increasing intensity and 
30-sec recovery between intervals (144).  Hematological testing by Pilaczynska-
Szczesniak et al. (144) showed significantly lower CK levels in the chokeberry 
supplemented rowers compared to placebo at 1-min post-incremental test.   In another 
placebo-controlled study utilizing a cohort of highly trained male rowers of the Polish 
national team, Skarpanska-Stejnborn et al. (169) supplemented similar athletes with 
artichoke-leaf extract (1,200 mg/d) or a placebo 3 times per day for 5-wk.  Skarpanska-
Stejnborn et al. (169) required subjects to perform a 2,000 m maximum-effort test on a 
rowing ergometer as the exercise performance intervention with blood samples drawn 
pre-exercise, 1-min, and 24-hr post-exercise.  Supplementation did not have any effect 
on CK levels following 5-wk of ingestion.  In a more recent study within the same 
rowing athlete population, Skarpanska-Stejnborn et al. (168) supplemented subjects with 
Rhodiola rosea extract (200 mg/d) or a placebo 2 times per day for 4-wk.  Following the 
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same maximal rowing test and blood sample timeline, Skarpanska-Stejnborn et al. (168) 
reported similar results to the previous study with no supplementation effect on plasma 
CK levels.   
Lafay et al. (102) employed a crossover design study with a variety of elite male 
sportsman to investigate the effects of a polyphenol-rich grape extract (400 mg/d) 
compared to placebo (400 mg/d) supplementation over a 30-d training and competition 
period.  In measurement of creatine phosphokinase (CPK) as a biomarker of skeletal 
muscle damage, Lafay et al. (102) demonstrated no significant differences between 
groups or within groups across the 30-d supplementation and training period.  Another 
aerobically based study conducted by Kang et al. (89) compared a polyphenol-rich 
extract derived from litchi fruit (OLFE), a vitamin C + vitamin E combination, and a 
placebo on outcomes of endurance performance capacity following 30-d of 
supplementation in healthy, recreationally trained endurance subjects.  Kang et al. (89) 
described a stark difference in lactate dehydrogenase (LDH) response patterns following 
an incremental treadmill VO2 max test as OLFE attenuated the post-exercise LDH 
response after 30-d of supplementation compared to levels at baseline testing and 
patterns reported by antioxidant vitamin and placebo supplementers.  Interestingly, in a 
crossover design study conducted in trained cyclists by Morillas-Ruiz et al. (125), 
subjects performed a 90-min submaximal endurance time trial at 70% VO2 max on a 
cycle ergometer while consuming a commercial antioxidant beverage containing fruit 
concentrates and carbohydrates over the testing protocol.  Morillas-Ruiz et al. (125) 
reported that CK levels increased significantly immediately post-exercise with no 
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difference between groups.  LDH levels did not increase over pre-exercise levels and no 
differences were found between groups.   
The effects of phytochemical or functional food supplementation surrounding 
bouts of challenging endurance exercise are inconclusive with regards to attenuation of 
the rise in post-exercise serum markers of muscle damage.  While the first three studies 
were conducted by the same research group within a similar study cohort and under 
nearly identical training conditions, only the chokeberry juice compared to the two 
extract supplements demonstrated an enhanced effect on post-exercise CK levels.  It 
could be concluded that the polyphenol-rich chokeberry juice likely has a positive effect 
on the secondary effects resulting from the initial physiological muscle damage as a 
result of repetitive muscular contraction.  With its high polyphenol polymer content, 
antioxidant capacity, and bioavailability, OLFE supplementation in the study conducted 
by Kang et al. (89) further supported the chokeberry juice results.  However, 
supplementing with another polyphenol-rich supplement, grape extract, Lafay et al. 
(102) did not find any significant differences compared to a placebo.  This may be due to 
the variety of athletes supplemented in this study or a lower bioavailability of grape-
extract compared to OLFE.  Overall, it seems that there may be some promising 
advantages of supplementation with natural sources of polyphenol or catechin-rich 
antioxidants following bouts of endurance exercise on the secondary muscle damage 
response. 
 
 
 59 
 
Effects of Tart Cherry Supplementation 
  Bell et al. (13) in an acute endurance study following a combination of cycling 
sprints and time trial over a 109-min period that was repeated over three consecutive 
days, demonstrated a small mean increase in creatine kinase (CK) across the trial period, 
but no differences between Montmorency tart cherry concentrate and placebo 
supplementation.  Unlike the unloaded cycling study conducted by Bell et al. (13), 
Howatson et al. (76), following marathon running demonstrated a trend of lower post-
resistance exercise creatine kinase (CK) levels when supplementing with tart cherry 
juice compared to placebo up to 48-h of post-marathon recovery.  Following a treadmill 
incremental exercise protocol with thoroughbred horses, Ducharme et al. (50) also 
reported a trending attenuation in CK levels during exercise recovery when 
supplementing with a tart cherry juice blend compared to placebo.  As a secondary 
marker of muscle damage and stress, Ducharme et al. (50) reported that AST was 
significantly mitigated during and following the incremental exercise protocol in the tart 
cherry-treated horses compared to placebo (9).     
Interestingly, two of the three tart cherry supplementation studies involved 
biomechanically loaded running compared to a cycling activity.  The running-based 
research also both supplemented subjects with a tart cherry juice beverage compared to 
the unloaded cycling study that supplemented cyclists with a tart cherry concentrate.  
Both running studies supplementing subjects with tart cherry juice, similar to the 
previously mentioned chokeberry-juice supplementation study, demonstrated beneficial 
effects on post-exercise attenuation of serum markers of muscle damage compared to a 
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placebo.  Contrastingly, the unloaded cycling study having subjects ingest a tart cherry 
concentrate did not find any significant difference in muscle damaging effects when 
compared to supplementing with a placebo.  Without a direct comparison of supplements 
across both aerobically-based exercise challenges, it is difficult to attribute the cause of 
result differences.  However, the tart cherry juice as part of the entire polyphenolic juice-
based supplementation class exhibits positive effects worth exploring in future research. 
Muscle Catabolic and Secondary Muscle Damage Response to Resistance Exercise 
Effects of NSAIDs 
 The effects of ibuprofen supplementation on markers of muscle injury and 
performance following a bout of eccentrically-resisted arm curls were studied by Pizza 
et al. (145) in a crossover study using a small cohort of sedentary males.  Pizza et al. 
(145) supplemented subjects with either ibuprofen (2400 mg/d) or placebo for a total of 
15-d (5-d pre-exercise and 10-d post-exercise) surrounding a bout of 25 single arm, 
eccentrically-resisted arm curls.  As a marker of muscle injury, Pizza et al. (145) 
reported significantly lower serum CK levels at 3-d post-eccentric exercise with 
ibuprofen supplementation compared to placebo with a significant increase in serum CK 
levels from baseline and pre-exercise in both treatments at 2-d, 3-d, and 4-d of recovery.  
In a placebo-controlled fashion, Rahnama et al. (152) randomly assigned non-athletic 
male subjects to one of four study groups: physical activity, ibuprofen, physical activity 
+ ibuprofen, or control.  The physical activity groups performed 20-min of warm-up 
activity prior to the eccentric exercise. DOMS-inducing exercise involved performance 
of 70 eccentric arm-curl contractions 3-sec in duration at 80% MVC with 12-sec rest 
 61 
 
between eccentric repetitions.  Ibuprofen ingestion occurred at 7 time points (400 
mg/time point) over the study sequence, starting 1-h pre-eccentric exercise and ending 
48-h post-eccentric exercise for a total of 2800 mg/d.  Following the eccentric exercise 
bout, Rahnama et al. (152) showed an increase in serum CK levels across all groups.  
CK activity was significantly greater in the control group compared to all of the other 
supplementation groups across most recovery time points, however CK activity was also 
higher in the ibuprofen group compared to the physical activity group at 48-h post-
eccentric exercise.   
In an earlier resistance-based NSAID supplement study, Hasson et al. (72) 
employed healthy, untrained males and females to complete a 10-min bout of repeated 
bench step-ups with additional load of 10% body weight.  Subjects were either 
supplemented with 3 doses of ibuprofen (1200 mg) over 24-h starting 4-h pre-exercise 
(prophylactic), a single dose of ibuprofen (400 mg) at 24-h post-exercise (therapeutic), 
placebo, or a control receiving no treatment.  As a marker of muscle damage, serum CK 
levels were significantly elevated above baseline levels 24-h and 48-h post-exercise, but 
unlike the results reported by Pizza et al. (145), Hasson et al. (72) did not find any post-
exercise difference between treatments. 
While all three aforementioned resistance-based studies supplemented subjects 
with ibuprofen, each of the authors published differing results. Pizza et al. (145) 
described a positive effects of ibuprofen supplementation on serum CK levels compared 
to equivocal and negative impacts reported in the other two studies.  The most effects of 
ibuprofen supplementation may likely be attributed to the longer supplementation 
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period, more specifically, ingestion throughout the extended recovery period up to 10-d 
post-exercise.  Despite some differences in exercise modalities, two studies utilized 
similar upper body eccentrically-based resistance protocols with congruent subject 
cohorts.  There does not seem to be any conclusive evidence with NSAID 
supplementation and effects on markers of markers of muscle damage surrounding a 
single bout of intense resistance exercise. 
Effects of Antioxidant Vitamins 
Healthy, non-resistance trained men, were recruited by Beaton et al. (8) to 
participate in a placebo-controlled study where subjects were supplemented for 30-d 
with either vitamin E (1200 IU/d) or a placebo.  Within this particular study, subjects 
performed an isokinetic protocol that compromised of 24 sets of 10 eccentrically-resisted 
knee extension/flexion contractions (8).  Over the 7-d post-eccentric exercise recovery 
period, serum CK levels increased over baseline levels and remained significantly 
greater than baseline at day 7 (8).  There was a significantly greater elevation in serum 
CK levels 3-d post-eccentric exercise in the placebo group compared to the vitamin E 
supplemented group, but CK levels were once again similar between groups at recovery 
day 7 (8).  In another cohort of healthy, untrained males, Bryer and Goldfarb (22) 
supplemented subjects for 18-d (14-d pre-exercise and 4-d post-exercise) three times 
daily with either vitamin C (3 g/d) or a placebo. Bryer and Goldfarb (22) had subjects 
perform 70 eccentrically-resisted elbow flexions on the non-dominant arm with 10-sec 
rest allotted between repetitions.  Plasma CK activity was greater than baseline levels 
48-h, 72-h, and 96-h post-eccentric exercise in both groups with a trend of vitamin C 
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supplementation attenuating the CK response during that same recovery time period 
compared to placebo (22).    
In an earlier eccentrically-based upper body exercise study, Childs et al. (32) 
supplemented previously untrained subjects with either a placebo or a vitamin C (12.5 
mg/kg body weight) + N-acetyl-cysteine (NAC) (10 mg/kg body weight) combination 
for 7-d after the exercise challenge.  As the exercise protocol, subjects were asked to 
perform 3 sets of 10 repetitions of eccentrically-resisted elbow flexion exercise at 80% 
of 1-RM on the non-dominant arm.  Blood was drawn pre-exercise, days 2, 3, 4, and 7 
following the exercise bout.  Childs et al. (32) reported that plasma CK and LDH in 
addition to serum myoglobin were elevated on days 2, 3, and 4 following exercise with 
plasma CK and LDH levels higher in the antioxidant supplementation group compared 
to placebo.  Contrarily, serum myoglobin levels tended to be lower in the antioxidant 
supplemented group compared to placebo.   
  All three studies involved some variation of eccentrically-resisted elbow flexion 
movements in untrained subjects.  Supplementing with a single antioxidant vitamin 
(vitamin C or E) for approximately 3-4-wks prior to the resistance exercise challenge 
proved to be effective in attenuating the post-exercise rise in serum markers of muscle 
damage compared to a placebo.  Results in the last study mentioned conducted by Childs 
et al. (32) likely produced inconsistent results due to the lack of pre-exercise 
supplementation and the significantly lower exercise volume compared to the other two 
studies described in this section.  Further, the supplementation combination of vitamin C 
and NAC may have been another cause of varied results.  Future research with 
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resistance-based exercise and antioxidant vitamin supplementation likely needs to 
compare multiple antioxidant vitamins and combinations within the same study to start 
painting a clearer picture of the overall effects of supplementation on muscle damage 
markers. 
Effects of Phytochemicals and Functional Foods 
Utilizing a crossover study design, Trombold et al. (189) recruited recreationally 
active males to supplement twice daily with either a pomegranate juice (960 mL/d) or a 
placebo (960 mL/d) over a 9-d period (4-d pre-exercise, day of, and 4-d post-exercise) 
surrounding a single workout involving two sets of 20 maximal eccentrically-resisted 
elbow flexions.  Trombold et al. (189) measured serum CK and myoglobin as markers of 
muscle damage, but found no significant differences between supplementation groups 
despite increased levels of both markers above baseline levels over the course of the 96-
h recovery period.  Representing a longer supplement timeline, Goldfarb et al. (65) 
recurited healthy, college-aged males to ingest a fruit, berry, and vegetable concentrate 
or placebo twice daily for 4-wks (28-d pre-eccentric exercise, day of, and 4-d post-
eccentric exercise).  This propriety blend of fruit, vegetable, and berry powder 
concentrates provided a source of β-carotene (7.5 mg/d), vitamin C (276 mg/d), and 
vitamin E (108 IU/d), in addition to a natural source of flavonoids and anthocyanins 
(65).  Subjects were required to perform an eccentric exercise bout of eccentrically 
resisted elbow flexions surrounded by sets of MVICs to assess muscular strength (65).  
Goldfarb et al. (65) reported increases in serum CK levels 24-h to 72-h post-eccentric 
exercise, but the pattern of change was similar between groups.   
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In an third study examining the effects of eccentrically-resisted elbow flexions, 
Phillips et al. (142) treated untrained subjects with either a placebo or mixed functional 
food-derived antioxidant supplement for 14-d (7-d pre-exercise and 7-d post-exercise).  
The mixed functional food supplement consisted of mixed tocopherols (300 mg/d), 
DHA, (800 mg/d), and flavonoids (100 mg/d hesperetin and 200 mg/d quercetin).  
Subjects were asked to perform 3 sets of 10 repetitions of eccentrically-resisted elbow 
flexion exercise at 80% of 1-RM on the non-dominant arm.  Serum LDH and CK levels 
demonstrated significant increases above baseline values 72-h post-exercise and a 
decrease to baseline levels at 7-d of recovery.  No differences between treatment groups 
were reported.  Phillips et al. (142) reported a similar pattern in plasma AST and ALT 
(markers of secondary muscle damage and renal stress) between treatments that followed 
a 72-h post-exercise peak with a congruent marker fall to day 7 of recovery where levels 
remained elevated above baseline.  Examining intramuscular adaptations to a single bout 
(100 repetitions: 10 sets of 10 repetitions) of eccentrically-resisted isokinetic leg 
extensions, Kerksick et al. (94) supplemented active males for 14-d with either N-acetyl-
cysteine (NAC) (1,800 mg/d), epigallocatechin gallate (EGCG) (1,800 mg/d), or a 
placebo.  There were no significant differences in serum markers of muscle damage (CK 
and LDH) across supplementation groups, however, CK was significantly elevated over 
baseline levels at 6-h, 24-h, and 48-h post-exercise, while LDH peaked 6-h post-
exercise.   
Through a multitude of various phytochemical and functional food supplements 
likely to contain differing levels and combinations of antioxidants and polyphenolics, all 
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of the literature relating to supplementation surrounding a bout of resistance-based 
exercise concluded that ingestion did not have any greater attenuating effect over a 
placebo on post-exercise markers (primary and secondary) of muscle catabolism.  
Research results were also consistent across both upper and lower body resistance-based 
exercise modalities.     
Effects of Tart Cherry Supplementation 
In a resistance-based exercise study, Bowtell et al. (20), following exhaustive leg 
extension exercise, reported trends for greater total serum CK activity and larger 
absolute increases in CK activity levels when supplementing with tart cherry juice 
compared to placebo up to 48-h of recovery despite never reaching statistical 
significance (9).  In lieu of these results, Bowtell et al. (20) also demonstrated a trend for 
a smaller percent change from pre-exercise levels in post-exercise CK levels up to 48-h 
of exercise recovery.  Unfortunately, with no other tart cherry supplement study as a 
basis for comparison when utilizing a resistance-based exercise modality, the results 
presented demonstrates conflicting, non-significant evidence that needs additional 
research support.  A smaller percentage change from pre-exercise levels in the tart 
cherry supplemented group compared to placebo may begin to establish evidence for 
potential post-exercise secondary muscle damage attenuation, but can only be 
speculative at this point.   
Inflammatory and Anti-Inflammatory Response to Endurance Exercise 
 Previous research in the literature seems to conclude that the inflammatory 
process is mediated by both pro-inflammatory cytokines (63) and neuroendocrinological 
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factors (138).  However, it has also been demonstrated that as major players in the 
development of secondary muscle damage, neutrophils, may also amplify the release of 
inflammatory cytokines (26, 172). 
Effects of NSAIDs 
 Recruiting trained male and female ultramarathon runners competing in the 160 
km Western States Endurance Run event, Nieman et al. (130) categorized athletes as 
NSAID users and non-users based on self-reported NSAID utilization during the race.  
The overwhelming majority of NSAID users supplemented with ibuprofen.  As a result 
of the ultramarathon event, Nieman et al. (130) described significant increases over pre-
run levels in all seven cytokines measured: IL-6 (125-fold increase over pre-race), IL-10 
(24-fold), granulocyte colony-stimulating factor (G-CSF) (12-fold), IL-8 (5-fold), 
monocyte chemotactic protein 1 (MCP-1) (3-fold), and macrophage inflammatory 
protein 1β (MIP-1β) (1.2-fold).  More importantly, Nieman et al. (130) reported greater 
post-run increases in markers of IL-6, IL-8, G-CSF, MCP-1, and MIP-1β for those self-
described as NSAID users versus those who refrained from NSAID use during the 
ultramarathon event.  As an important notation, Nieman et al. (130) determined from 
statistical analysis that self-selected supplementation with antioxidants either in the 
months before or during the race had no effect on DOMS, serum CPK, or changes in 
cytokines.   
 Although there is only one study that has analyzed the inflammatory response to 
a single bout of endurance exercise with NSAID supplementation, the results seems 
consistent across several markers.  However, this particular study was not designed as a 
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supplement intervention study and relied on subject self-reporting to determine criteria 
for NSAID intake over the course of the ultramarathon race.  With less structure, this 
self-reported study design allows for greater variability in supplementation type, dose, 
and frequency.  However, the smaller amount of structure also provides for a more 
realistic, free living snap shot of NSAID supplement effects rather than a more 
controlled study design that may not be as applicable.  Based on the results of this study, 
it seems as though supplementation with NSAIDs (primarily ibuprofen) over the course 
of an ultra-distance endurance race contributes to greater release of inflammatory 
markers into the plasma compared to those who refrained from NSAID usage. 
Effects of Antioxidant Vitamins 
 In an endurance-based cycling study recruiting healthy, moderately trained 
males, Davison and Gleeson (133) supplemented subjects with four different 
interventions before and during the exercise bout: placebo, carbohydrate (6% w/v or 
approximately 137 g CHO) only beverage, vitamin C (0.15% w/v or approximately 3400 
mg) only beverage, or a combination beverage consisting of carbohydrate + vitamin C.  
The endurance exercise challenge completed by subjects within the study was a 2.5-h 
cycling bout at 60% VO2 max.  Post-exercise plasma IL-6 concentrations was not 
affected by vitamin C supplementation alone, but when combined with a carbohydrate 
source, post-exercise IL-6 levels tended to be lower compared to placebo (133).  In a 
second study conducted by Davison and Gleeson (165) the following year employing 
well-trained cyclists and the same endurance cycling bout described in the previously 
study, subjects were supplemented vitamin C (1000 mg/d) or a placebo for 14-d.  Similar 
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to the first study in the healthy, active males, there was no significant effect of 
supplementation reported by Davison and Gleeson (165) on plasma IL-6 concentrations 
following the 2.5-h cycling bout despite an IL-6 increase immediately and 1-h post-
exercise.  Similar to the first study cohort and endurance exercise protocol utilized by 
Davison and Gleeson (133), Hagobian et al. (70) studied the effects of supplementing 
recreationally trained men with an antioxidant cocktail for 3-wk prior to an 3-h high-
altitude (4300 m elevation) cycling bout at 55% VO2 max.  In this placebo-controlled 
study, participants were supplemented with either the antioxidant supplement (10,000 IU 
β-carotene, 200 IU α-tocopherol acetate, 250 mg ascorbic acid, 50 µg selenium, 15 mg 
zinc) or a placebo twice per day for 3-wk.  Blood samples were taken at rest, 
immediately, 2, 4, and 20-h post-exercise.  Hagobian et al. (70) reported plasma IL-6 
elevations at all post-exercise time points compared to pre-exercise values and elevated 
plasma CRP levels at 20-h post-exercise with no effect of supplementation on either 
response.  Further, Hagobian et al. (70) described a plasma TNF-α concentration that 
remained unaffected by the exercise bout or supplementation.   
In a shorter endurance-cycling based study in healthy, non-athlete volunteers, 
Vassilakopoulos et al. (105) supplemented subjects with an antioxidant combination (60-
d of vitamins A, C, and E; 15-d of allopurinol; and 3-d of N-acetylcysteine) prior to a 45-
min bout of cycling at 70% VO2 max.  Blood samples were drawn at baseline, 
immediately, 30-min, and 120-min post-exercise.  As a result of the antioxidant cocktail, 
plasma post-exercise concentrations of IL-1β, TNF-α, and IL-6 were significantly 
attenuated compared to post-exercise levels prior to supplementation. Further, the 
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pharmacokinetic response as measured by area under the curve (AUC) for IL-1β, TNF-α, 
and IL-6 were all significantly smaller than the AUC values calculated following 
exercise prior to supplementation.   
Peterson et al. (140) in a placebo-controlled study, supplemented male 
recreationally-trained runners with either an vitamin C (500 mg/d) + vitamin E (400 
mg/d) combination or a placebo for 14-d before and 7-d after a 90-min treadmill run at a 
5% decline and 75% VO2 max.  Despite a 20-fold increase in plasma IL-6 and 3-fold 
increase in plasma IL-1ra post-exercise, Peterson et al. (140), described no effect of the 
antioxidant vitamin combination on plasma anti-inflammatory cytokines.  Thompson et 
al. (184) supplemented subjects with vitamin C or placebo for 14-d surrounding a 
prolonged 90-min high-intensity intermittent shuttle running test (LIST). Subjects were 
supplemented twice daily (morning and evening) with vitamin C (400 mg/d) or a 
placebo.  As a result of the differences in supplementation, Thompson et al. (184) 
demonstrated that serum IL-6 concentrations increased 8-fold immediately post-exercise, 
but returned to baseline levels by 24-h post-exercise in both groups.  IL-6 concentrations 
in the vitamin C group began to decrease 1-h post-exercise compared to a continued IL-6 
increase in the placebo group so much so that vitamin C group levels were significantly 
lower than placebo 2-h post-exercise.  In response to the LIST exercise challenge, 
Thompson et al. (184) also published that the serum CRP response was not different 
between groups, but increased 2-fold over pre-exercise values 24-h post-exercise and 
remained elevated through 48-h of recovery.   
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Over the course of the studies listed in this section, there is a lack of congruent 
evidence with respect to the effectiveness of antioxidant vitamins or antioxidant vitamin 
combinations on markers inflammation.  With a direct effect on redox balance within the 
muscle cell environment, the magnitude of inflammation could have been affected if the 
absorption pharmacokinetics of these supplements were greater than the placebo.  Many 
of the studies listed in this section tested for the same serum markers of inflammation, 
but provided inconsistent results.  The inconsistency may be due to the large variation in 
type of supplement, exercise modality, duration of exercise, duration and quantity of 
supplementation, study population (trained versus untrained), previous dietary 
antioxidant status, and endogenous antioxidant status.   
Effects of Phytochemicals and Functional Foods 
  A study by Nieman et al. (131) supplemented trained cyclists with 400 mg of 
quercetin, quercetin-EGCG (epigallocatechin 3-gallate), or placebo soft chews for 24-d 
surrounding 3-d of consecutive bouts of 3-h submaximal cycling.  Nieman et al. (131) 
reported a significant decreases in plasma concentrations of both inflammatory and anti-
inflammatory markers (CRP, IL-6, and IL-10) immediately post-exercise on the third 
consecutive exercise day in the quercetin-EGCG group compared to placebo.  An acute 
supplementation study providing moderately active subjects with 48 g of anthocyanin-
rich black currant extract immediately surrounding a single bout of high-intensity rowing 
conducted by Lyall et al. (109) demonstrated a significant post-exercise attenuation of 
pro-inflammatory cytokine production from LPS-stimulated cells following extract 
supplementation compared to placebo.  Lyall et al. (109) postulated from subsequent in 
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vitro experimentation that this reduced cytokine production may have resulted from 
anthocyanin-based inhibition of NF-κB-mediated mechanisms.  Lafay et al. (102) 
employed a crossover design study with a variety of elite male sportsman to investigate 
the effects of a polyphenol-rich grape extract (400 mg/d) compared to placebo (400 
mg/d) supplementation over a 30-d training and competition period.  As inflammatory 
biomarker, Lafay et al. (102) reported a significant increase in urinary excretion of 
isoprostanes with placebo supplementation compared to no change from baseline values 
with grape extract ingestion. Supplementing highly trained male rowers of the Polish 
national team with plant superoxide dismutase extract (GliSODin) daily (500 mg/d) for 
6-wk, Skarpanska-Stejnborn et al. (170) required subjects to perform a 2,000 m 
maximum-effort test on a rowing ergometer with blood samples drawn pre-exercise, 1-
min, and 24-hr post-exercise.  Skarpanska-Stejnborn et al. (170) demonstrated that CRP 
levels were significantly lower in the GliSODin group compared to placebo pre-exercise, 
immediately post-exercise, and 24-h of recovery. 
Subjects across all four of these studies were supplemented with very different 
phytochemical and functional food supplements surrounding bouts of varying endurance 
exercise.  However, the results from all four of these studies agree that supplementation 
with natural phytochemicals derived from food-based sources likely to contain large 
amounts of polyphenols and anthocyanins is effective in attenuating inflammation within 
the muscular environment in response to exercise-induced muscle damage.  
Mechanistically, the attenuated muscle damage markers are a result of better redox 
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balance and decreased impetus of perceived stress within the sarcoplasmic and 
myocellular environment. 
Effects of Tart Cherry Supplementation 
 In an aerobic-based crossover study, Ducharme et al. (50) performed a standard 
stepwise treadmill running protocol on a small cohort of healthy, but untrained horses 
that were administered either a tart cherry juice blend or placebo for 14-d prior to the 
exercise.  Ducharme et al. (50) analyzed serum amyloid A (SAA) as a marker of 
inflammation and reported a significant increase in SAA concentration in response to the 
incremental exercise protocol with no significant differences between treatments.  In a 
study examining the effects of supplementation on endurance-trained humans, Howatson 
et al. (76) reported significantly lower markers of inflammation (IL-6 and C-reactive 
protein (CRP)) after running a marathon that coincided with quicker recovery of knee 
extensor maximal strength following the marathon in Montmorency tart cherry juice 
supplemented subjects compared to placebo.  IL-6 markers where significantly 
attenuated immediately post-race, whereas CRP levels were significantly lower 24-h and 
48-h post-run with tart cherry consumption compared to placebo (9, 76).  Dimitriou et al. 
(47) also recently conducted a marathon-based study on recreationally trained marathon 
runners and supplemented subjects with either a Montmorency cherry juice blend or 
placebo for 8-d (5-d pre-race, day of race, and 2-d post-race) surrounding the marathon 
race.  Similar marathon-based study conducted by Howatson et al. (76), Dimitriou et al. 
(47) also reported significantly lower CRP levels 24-h and 48-h post-run with blended 
tart cherry juice consumption versus placebo.   In support of these two marathon-based 
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studies, Kelley et al. (93) demonstrated decreases in circulating hsCRP in healthy 
volunteers following 4-wk of Bing sweet cherry supplementation, helping to further 
elucidate the anti-inflammatory benefits of anthocyanins (9). 
 As seen in the previous section with the phytochemicals and functional foods, 
tart cherry juice supplementation in humans following bouts of endurance challenges, 
specifically a marathon, researchers commonly reported decreased markers of 
inflammation compared to those supplementing with a placebo.  Despite supplementing 
race horses with a similar tart cherry juice, Ducharme et al. (50) only measured SAA as 
a marker of inflammation, leaving no basis of comparison to the other endurance-based 
studies.  Further, the small cohort of racehorse subjects by Ducharme et al. (50) could 
have also been a confounding factor.   
Inflammatory and Anti-Inflammatory Response to Resistance-Based Exercise 
Effects of Antioxidant Vitamins 
 In a resistance exercise-based, placebo-controlled study, Fischer et al. (57) 
supplemented a cohort of physically active males with a combination of vitamin C (500 
mg/d) and RRR-α-tocopherol (400 IU/day) 4-wk prior to and 1-d after a resistance 
exercise challenge.  As part of the study protocol, subjects performed 3-h of two-legged 
dynamic knee-extensor exercise at 60 leg extensions per minute at 50% their maximum 
power output.  Blood samples were obtained from the femoral vein at rest (0-h), during 
exercise (0.5, 1, 2, and 3-h), and during post-exercise recovery (3.5, 4, 5, and 6-h) with 
the last study blood sample obtained from an antecubital vein and 23-h post-exercise.  
As a result of plasma IL-6, IL-1 receptor agonist (IL-1ra), and CRP analysis, Fischer et 
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al. (57) reported a post-exercise attenuation in plasma inflammatory marker 
concentration as a result of the antioxidant combination supplementation compared to 
placebo.  In an upper body-based resistance exercise bout, Childs et al. (32) 
supplemented previously untrained subjects with either a placebo or a vitamin C (12.5 
mg/kg body weight) + N-acetyl-cysteine (NAC) (10 mg/kg body weight) combination 
for 7-d after a resistance exercise challenge.  Within the exercise protocol, subjects were 
asked to perform 3 sets of 10 repetitions of eccentrically-resisted elbow flexion exercise 
at 80% of 1-RM on the non-dominant arm.  As a result of the eccentric-exercise bout, 
IL-6 levels were significantly elevated over pre-exercise levels at 48-h post-exercise 
with no treatment effect.  However, Childs et al. (32) measured myeloperoxidase (MPO) 
as a secondary mechanism to quantify the severity of inflammation.  Similar to the IL-6 
response, MPO was significantly elevated 48-h post-exercise in both supplementation 
groups, but those supplementing with the vitamin C + NAC combination demonstrated a 
33% attenuation compared to placebo at that same time point.   
 The quantity of muscular involvement and volume of exercise between the two 
studies was greatly different as Fischer et al. (57) asked subjects to perform an 
eccentrically resisted double leg extension for 3-h compared to Childs et al. (32) only 
requiring subjects to perform 3 sets of 10 eccentrically-resisted arm curls.  Both studies 
produced some type of inflammatory response as indicated by the significant increase in 
IL-6 levels over baseline values.  Additionally, Childs et al. (32) only supplemented 
subjects following the eccentric exercise bout, which may explain only the partial 
effectiveness of antioxidant vitamin supplementation on attenuation of post-exercise 
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markers of inflammation compared to a placebo.  Overall, both studies indicate that there 
may be some promise with acute antioxidant vitamin supplementation on attenuation of 
post-resistance exercise inflammatory markers. 
Effects of Phytochemicals and Functional Foods 
Utilizing a crossover study design, Trombold et al. (189) recruited recreationally 
active males to supplement twice daily with either a pomegranate juice (960 mL/d) or a 
placebo (960 mL/d) over a 9-d period (4-d pre-exercise, day of, and 4-d post-exercise) 
surrounding a single workout involving two sets of 20 maximal eccentrically-resisted 
elbow flexions.  Trombold et al. (189) tested IL-6 and CRP as serum markers of 
inflammation surrounding the exercise bout and found no significant alterations over 
time or between groups for either maker as a result of the eccentric exercise.  In an 
earlier study examining the effects of eccentrically-resisted elbow flexions, Phillips et al. 
(142) treated untrained subjects with either a placebo or mixed functional food-derived 
antioxidant supplement for 14-d (7-d pre-exercise and 7-d post-exercise).  The mixed 
functional food supplement consisted of mixed tocopherols (300 mg/d), DHA, (800 
mg/d), and flavonoids (100 mg/d hesperetin and 200 mg/d quercetin).  Nearly identical 
to the exercise protocol used by Childs et al. (32), subjects were asked to perform 3 sets 
of 10 repetitions of eccentrically-resisted elbow flexion exercise at 80% of 1-RM on the 
non-dominant arm.  Phillips et al. (142) published that subjects ingesting the functional-
food antioxidant combination for 14-d (7-d pre-exercise and 7-d post-exercise) 
surrounding a bout of eccentrically-resisted arm curls, had a smaller elevation from pre-
exercise levels of IL-6 3-d post-exercise compared to placebo. Phillips et al. (142)  also 
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found that supplementation with the functional food antioxidant combination correlated 
to a significant attenuation in CRP elevation from baseline levels 72-h post-exercise 
compared to placebo.  Examining intramuscular adaptations to a single bout of 
eccentrically-resisted isokinetic leg extensions on the dominant leg, Kerksick et al. (94) 
supplemented active males for 14-d with either N-acetyl-cysteine (NAC) (1,800 mg/d), 
epigallocatechin gallate (EGCG) (1,800 mg/d), or a placebo.  Assessment of 
inflammation as a result of the eccentric-exercise bout, Kerksick et al. (94) demonstrated 
no supplementation effect on TNF-α or the neutrophil:lymphocyte ratio.  Over time, 
whole blood neutrophil:lymphocyte levels peaked 6-h post-exercise and remained 
elevated above baseline over the course of the entire 72-h recovery (94).  No changes 
over time were reported for TNF-α. 
The evidence across these three resistance-based, functional food supplement 
studies seems to be equivocal.  The two studies conducted with recreationally trained or 
active subjects did not find any significant effects of supplementation on markers of 
inflammation compared to the study conducted by Phillips et al. (142) on untrained 
subjects.  However, the comprehensive phytochemical supplementation concoction 
utilized by Phillips et al. (142) may have been simply more effective than the 
supplements utilized in the other two studies.  Within this research grouping, the lower 
body resistance-based study conducted by Kerksick et al. (94) did not follow the pattern 
of the previous antioxidant vitamin studies as this research group did not find any 
significant differences in inflammatory markers across the treatment groups.  However, 
the markers of inflammation analyzed in this study were not comparable to the other two 
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conducted with similar supplementation, making the comparison difficult.  In the end, 
current inflammatory research among resistance-based studies implementing functional 
food and phytochemical supplementation remains inconclusive.   
Effects of Tart Cherry Supplementation 
Acute, intensive resistance exercise (> 60% 1-RM) has been reported to 
significantly increase muscular mechanical trauma as the initial phase of injury (20, 78).  
In a strength-based supplement study with resistance trained subjects, Bowtell et al. (20) 
was not able to detect any significant effects on markers of inflammation (IL-6 and 
hsCRP).  However, this study did report a trend for greater hsCRP levels in the placebo 
group following the bout of eccentric leg extensions compared to Montmorency cherry 
juice concentrate supplementation (9, 20).   
With no basis of study comparison, even with the three studies utilizing other 
phytochemical and functional food supplements, it is difficult to align the inconclusive 
results of this study as the aforementioned lower body resistance-based study conducted 
by Kerksick et al. (94) did not measure CRP levels and the two previously mentioned 
upper body resistance-based studies found conflicting evidence.  Unfortunately, the 
trend for attenuated hsCRP levels coupled with no significant effects on IL-6 reported by 
Bowtell et al. (20) provides less clarification on tart cherry, anthocyanin, and polyphenol 
supplementation effects on post-exercise markers of inflammation following bouts of 
resistance-based exercise.  
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Hormonal Physiological Stress in Response to Exercise 
The increase in inflammatory-related cytokines and chemokines such as TNF-α, 
IL-1β, IL-6, and IL-8 during and immediately following exercise has been shown in 
previous research (63, 134, 138) and closely resembles the inflammatory response in the 
current study.  As described in previous research, the increase in serum IL-6 within both 
groups 60-min post-lift in the current study can likely be attributed to the large release of 
muscle-derived IL-6 as a result of the contracting muscle fibers (63, 175).  The influx of 
muscle-derived IL-6 within the systemic circulation may be one of the triggers for 
subsequent cortisol release in response to exercise-induced stress (63, 174).  
Glucocorticoids, specifically cortisol, and anti-inflammatory cytokines such as IL-4, IL-
10, and IL-13 are released during strenuous exercise and typically demonstrate an 
immunosuppressive influence to help modulate the immune response balance (64).  
However, extended immunodepression due to elevated plasma cortisol during the post-
exercise period, particularly following long bouts of intense training in the fasted state 
(63), may hinder recovery and subsequent performance.  Glucocorticoids, specifically 
cortisol, released due to activation of the stress response through muscle mechanical 
microtrauma and ROS production have demonstrated an immunosuppressive influence. 
Effects of Antioxidant Vitamins 
Previous research conducted by McAnulty et al. (116) in trained endurance 
athletes reported a significant cortisol increase over time, but no significant difference in 
immediate and 1.5-h post-race cortisol levels with 2-month vitamin E supplementation 
compared to placebo.  Davison and Gleeson (133), in an investigation of moderately 
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trained males during 2.5-h moderate intensity cycling compared the effects of a beverage 
containing a vitamin C supplement with and without carbohydrate before and during 
endurance exercise.  This study revealed a significant increase in plasma cortisol levels 
immediately and 1-h post-exercise in both the placebo and vitamin C only supplemented 
groups with no significant difference between these two groups at 1-h post-exercise 
(133).  The addition of carbohydrates (alone or with vitamin C) significantly lowered the 
cortisol response during the exercise recovery up to 1-h post-exercise (133).  This result 
demonstrates a potentially lower physiological stress in the short-term post-exercise 
period due to a higher energy state.  In the second study conducted by Davison and 
Gleeson (165) the following year employing well-trained cyclists to complete a 2.5-h 
endurance cycling bout at 60% VO2 max, subjects were supplemented vitamin C (1000 
mg/d) or a placebo for 14-d.  Contrary to the results of the previous study using healthy, 
active males, Davison and Gleeson (165) determined that there was a tendency for 
supplementation to have an effect on plasma cortisol levels immediately and 1-h 
following the 2.5-h cycling bout.  In an endurance running-based study, Thompson et al. 
(184) supplemented subjects with vitamin C or placebo for 14-d surrounding a 
prolonged 90-min high-intensity intermittent shuttle running test (LIST). Subjects were 
supplemented twice daily (morning and evening) with vitamin C (400 mg/d) or a 
placebo.  As a result of the LIST exercise challenge, Thompson et al. (184) demonstrated 
an increase in serum cortisol levels above pre-exercise values immediately and 1-h post-
exercise in both treatment groups, with a tendency for serum cortisol to be lower in the 
vitamin C group versus placebo.  
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In a placebo-controlled study, Fischer et al. (57) supplemented a cohort of 
physically active males with a combination of vitamin C (500 mg/d) and RRR-α-
tocopherol (400 IU/day) 4-wk prior to and 1-d after a resistance exercise challenge.  
Subjects performed 3-h of two-legged dynamic knee-extensor exercise at 60 leg 
extensions per minute at 50% their maximum power output.  Fischer et al. (57) reported 
a post-exercise increase in plasma cortisol levels from 0-h to 6-h of recovery, compared 
to a blunted plasma cortisol response during the same time period in subjects ingesting 
the antioxidant vitamin combination.   
Although not with full certainly from all studies listed, a trend that seems to be 
developing toward beneficial effects of vitamin C or an antioxidant combination 
incorporating vitamin C on the reduction of post-exercise serum cortisol levels following 
both endurance and resistance exercise bouts.  The supplementation protocol utilized in 
the study conducted by Davison and Gleeson (133) may have produced varying results 
dependent on carbohydrate incorporation to help lower the physiological perception of 
stress due to the beverage formulation of the supplement.  The beverage containing 
vitamin C compared to a vitamin C supplement may have altered the absorption kinetics 
enough to alter the effectiveness of the antioxidant supplement.  Further, both studies 
that reported no significant differences in post-exercise cortisol levels among the 
treatment groups employed trained athletes as subjects.  The training status of the subject 
cohort could have certainly altered the research outcome compared to research using 
untrained or only recreationally trained individuals due to the differences in overall 
physiological adaptations to exercise-related stress. 
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Effects of Phytochemicals and Functional Foods 
Comparing 14-d supplementation of N-acetyl-cysteine (NAC), epigallocatechin 
gallate (EGCG), or a placebo in active males surrounding a single bout of eccentric 
knee-extensor exercise, Kerksick et al. (94) found a significant decrease in serum 
cortisol levels 6-h post-exercise, but no differences between groups up to 72-h post-
exercise despite a significant blunting of muscle soreness perception 24-h post exercise 
in the two supplement groups compared to placebo.  The current study demonstrated an 
increase in cortisol levels 60-min post-lift compared to pre-lift in both groups. 
The results of this particular study do not align with those reported by the other 
resistance-based exercise and antioxidant supplementation study Fischer et al. (57) 
published.  However, the extremely high volume of the study conducted by Fischer et al. 
(57) may be better classified as a muscular endurance study rather than resistance-based.  
The aforementioned findings published by Kerksick et al. (94) allude to the fact that 
either the NAC or EGCG supplement mechanism of action to aid in blunting muscle 
soreness is disconnected from physiological perceptions of stress.  With limited research 
previously conducted in this category, future investigations are necessary to solidify 
potential mechanisms.   
Effects of Tart Cherry Supplementation 
 Dimitriou et al. (47) in the marathon-based study on recreationally trained 
marathon runners is the only tart cherry supplementation-based study that measured a 
cortisol response.  Despite an elevated salivary cortisol level immediately post-race 
compared to pre-race levels, Dimitriou et al. (47) reported that these levels returned to 
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pre-race values within 24-h post-marathon with no difference in salivary cortisol across 
treatment groups up to 48-h of marathon recovery.   
 Similar to the findings described by Kerksick et al. (94), the salivary cortisol 
findings of this particular endurance-based exercise study did not find any significant 
effect with tart cherry supplementation compared to placebo.  This is the only study that 
examined exercise and tart cherry supplementation with any type of hormonal catabolic 
or anabolic marker, providing no basis for comparison.  Further, nearly all of the 
previous research mentioned used serum or plasma cortisol tests to determine changes, 
also leaving this study employing salivary cortisol measurement difficult to compare to 
others.  Once again, further research is necessary to solidify results and elucidate 
potential mechanisms.   
Antioxidant and Antiradical Activity Response to Exercise 
 Within the literature, there are multiple methodologies employed to analyze 
antioxidant and antiradical activity.  Oxygen radical absorbance capacity (ORAC) can be 
measured in plasma samples and is widely used in biological sample analysis of 
antioxidant capacity (102).  The ORAC method is based on the thermal-decomposition 
of azo compounds that inhibits peroxy-radical-induced oxidation (28, 102).  Ferric 
reducing ability of plasma (FRAP) can also be employed to analyze antioxidant capacity.  
This particular technique is based upon the fact that water soluble reducing agents or 
antioxidants in the blood plasma will act to reduce ferric ions to ferrous ions, preparing 
the ions for reaction with chromogen as a detecting agent (115).   
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Effects of NSAIDs 
McAnulty et al. (115) recruited a large cohort of runners competing in the 160 
km Western States Endurance Run event to study the effects of NSAID supplementation 
and categorized them based on their self-selected NSAID use over the course of the race.  
McAnulty et al. (115) employed the FRAP method to detect changes in plasma 
antioxidant potential and determined that despite a significant post-race FRAP elevation, 
there were no detectable differences between the NSAID users and non-users over the 
course of the 7-d recovery.   
While this particular stands by itself within the literature with respect to self-
reported NSAID supplementation surrounding an ultra-endurance event, NSAID 
supplementation did not seem to have an effect on systemic reducing or antioxidant 
capacities within the plasma over the course of the 7-d recovery period.  Utilizing the 
FRAP method to analyze changes in plasma antioxidant potential does make it difficult 
to compare to other endurance and resistance-based studies due to the low number of 
studies employing that methodology.  Further research and studies need to be conducted 
in this area to confirm these results. 
Effects of Antioxidant Vitamins 
Childs et al. (32) analyzing TAS following arm eccentric exercise-induced injury 
also demonstrated significantly greater TAS levels with vitamin C + NAC 
supplementation compared to placebo 48-h through 7-d post-exercise recovery in 
healthy, untrained males.  Comparatively, the placebo group did not show any 
significant change from baseline line plasma TAS activity in the 7-d following the 
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eccentric-exercise challenge.  Davison and Gleeson (133), in an investigation of healthy 
and active males during 2.5-h moderate intensity cycling compared the effects of a 
beverage containing a vitamin C supplement with and without carbohydrate before and 
during endurance exercise.  As a result of acute beverage ingestion, plasma antioxidant 
capacity (PAC) levels were significantly elevated above placebo immediately post-
exercise when supplemented with vitamin C only and 1-h post-exercise when 
supplemented with the CHO + vitamin C combination.  In the second study conducted 
by Davison and Gleeson (165) the following year using well-trained cyclists to complete 
a 2.5-h endurance cycling bout at 60% VO2 max, subjects were supplemented vitamin C 
(1000 mg/d) or a placebo for 14-d.  Unlike the results of the previous study, Davison and 
Gleeson (165) demonstrated changes in PAC over the study time period, but no effect of 
vitamin C supplementation following endurance exercise compared to placebo.   
Based on comparing the results of these three studies, it seems at first glance that 
all of the vitamin C based supplements had a positive effect on antioxidant status in the 
untrained populations, but no effect compared to placebo in the trained population.  This 
conclusion is perhaps most evident in the two cycling-based endurance studies 
conducted by Davison and Gleeson (133, 165) where the same duration of exercise was 
utilized with similar comparable supplements in both the trained and untrained 
populations.  Further, the supplementation period was very different across these studies 
as one employed more of an acute supplementation timeline and other was conducted 
over 14-d prior to the endurance exercise bout.  Due to the differences in study design, 
subject population, and time course of supplementation, it is difficult to formulate a 
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definitive conclusion with antioxidant vitamin supplementation on overall changes in 
antioxidant capacity during exercise recovery. 
Effects of Phytochemicals and Functional Foods 
Interestingly, in a crossover design study conducted in trained cyclists by 
Morillas-Ruiz et al. (125), subjects performed a 90-min submaximal endurance time trial 
at 70% VO2 max on a cycle ergometer while consuming a commercial antioxidant 
beverage containing fruit concentrates (black grape, raspberry, and red currant) and 
carbohydrates at 15-min intervals over the course of the entire testing protocol for a total 
juice consumption of 1600 ml.  Assessing plasmatic antioxidant activity, Morillas-Ruiz 
et al. (125) found no difference in TAS immediately and 45-min post-exercise between 
antioxidant beverage and placebo groups despite levels lower than the typical adult 
population (125).   Evaluating a wide variety of male sportsman during their training and 
competitive seasons, Lafay et al. (102) employed a crossover study design to investigate 
the effects of a polyphenol-rich grape extract (400 mg/d) compared to placebo (400 
mg/d) supplementation over a 30-d period.  Lafay et al. (102) used two different 
methods to determine changes in plasma antioxidant capacity: 1) ORAC and 2) FRAP.  
Both analysis methods conferred on an increase in plasma antioxidant capacity with 
grape extract consumption compared to placebo.  Specifically, grape extract 
consumption via the ORAC analysis method increased plasma antioxidant capacity after 
30-d of supplementation versus the placebo levels that remained unchanged over the 
same period (102).  Utilizing the FRAP method, plasma antioxidant capacity 
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significantly decreased with placebo supplementation, while levels were maintained 
within the grape extract group (102).   
In the first placebo-controlled study utilizing a cohort of highly trained male 
rowers of the Polish national team, Skarpanska-Stejnborn et al. (169) supplemented 
athletes with artichoke-leaf extract (1,200 mg/d) or a placebo 3 times per day for 5-wk.  
Skarpanska-Stejnborn et al. (169) required subjects to perform a 2,000 m maximum-
effort test on a rowing ergometer as the exercise performance intervention with blood 
samples drawn pre-exercise, 1-min, and 24-hr post-exercise.  As a result of the 
supplementation, plasma TAC was significantly higher in the artichoke-leaf extract 
group before, immediately post, and 24-h post-maximal rowing exercise.  In the second 
study using this rowing athlete population, Skarpanska-Stejnborn et al. (168) 
supplemented subjects with Rhodiola rosea extract (200 mg/d) or a placebo 2 times per 
day for 4-wk.  This study reported the same TAC results as those demonstrated with 
artichoke-leaf extract supplementation.  Supplementing highly trained male rowers of 
the Polish national team with plant-based superoxide dismutase extract (GliSODin) daily 
(500 mg/d) for 6-wk in their most recent study, Skarpanska-Stejnborn et al. (170) 
required subjects to perform the same 2,000 m maximum-effort test on a rowing 
ergometer.  TAC levels increased significantly over pre-exercise levels immediately 
post-exercise and returned to pre-exercise levels 24-h post-exercise in both groups.   
Within the endurance studies listed in this particular section, the various 
polyphenol-based supplements utilized seem to have been effective in maintaining an 
increased level of antioxidant capacity over the course of the recovery period.  The 
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superoxide dismutase extract derived from a plant source implemented in the third of 
three studies conducted on rowers from the Polish national team by Skarpanska-
Stejnborn et al. (170) did not have any effect on antioxidant status compared to the 
placebo and the other two polyphenol-derived supplements used in the previous two 
studies.  In this grouping of studies, the training status of the subjects did not seem to be 
a major factor in the study outcome.  The endurance-based study conducted in trained 
cyclists by Morillas-Ruiz et al. (125) did not report any differences between the 
antioxidant beverage supplement and a placebo due likely to the short time duration of 
the ingestion only over the course of the 90-min study protocol.  This short duration of 
ingestion may have limited the effectiveness of the supplement with respect to 
improving antioxidant capacity.   
Effects of Tart Cherry Supplementation 
The increase in antioxidant bioavailability from acute tart cherry supplementation 
containing high levels of flavonoids and anthocyanins (166, 199) has been hypothesized 
to be one of the primary benefits in support of endogenous antioxidant systems 
following strenuous exercise and excessive ROS-production.  Howatson et al. (84) 
analyzed plasma TAS, as a measure of antioxidant or antiradical activity across all 
biological components, following a full marathon in trained endurance runners, and 
found that TAS was significantly greater in the tart cherry supplemented group 
compared to control across all time points (pre-race and up to 48-h post-race) (9, 76, 
172).  Unlike the tart cherry group, the placebo group fell below baseline values 48-h 
post-run, thus failing to maintain TAS or redox balance following the endurance 
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exercise.  This demonstrates possible tart cherry antioxidant effectiveness on excessive 
ROS production with bouts of endurance exercise (9).   
The effectiveness of the tart cherry supplement within this study surrounding a 
full marathon run in trained endurance runners appears to closely align with the results 
found in the previous studies listed in the phytochemical and functional food section.  
The increase in antioxidant and antiradical activity as a result of tart cherry 
supplementation may be due to the anthocyanin effects on iNOS gene expression and 
subsequent attenuation of nitric oxide production helping the system maintain a more 
balanced redox status compared to runners supplemented with the placebo. Additional 
studies in the future utilizing a similar protocol, supplement, and study cohort would 
help solidify these initial mechanistic speculations. 
Free Radical and Oxidative Stress Response to Endurance Exercise 
 Evidence in the literature utilizing lipid peroxidation (TBARS assays) analysis 
has presented a potential lack of oxidative damage detection specificity in human studies 
that may also explain the variability in results among previous studies (9, 12, 13, 193).  
Similarly, measurement of protein carbonyls (PC) as a marker of protein oxidation and 
overall oxidative stress surrounding bouts of exercise has sparked controversy in the 
literature due to the lack of reliability and specificity of the marker to discriminate 
between sources of oxidative damage (9, 193).   
Effects of NSAIDs 
Before the 160 km Western States Endurance Run event, McAnulty et al. (115) 
recruited a large cohort of runners competing in the race to study the effects of NSAID 
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supplementation on muscle injury and oxidative stress.  As a result, the researchers 
categorized the runners based on their self-selected NSAID use over the course of the 
race.  Measuring differences in oxidative stress as a result of the endurance race, 
McAnulty et al. (115) observed changes in plasma F2-isoprostanes, lipid hydroxides 
(LOOH), and protein carbonyls (PC).  The endurance run caused significant increases in 
plasma F2-isoprostane levels when both groups were combined, but there were not any 
significant changes between groups as a result of supplementation differences.  Both the 
endurance event and NSAID ingestion status had no effect on LOOH levels over the 
course of the study protocol.  PC plasma concentrations, a marker of protein oxidation, 
were significantly increased over pre-exercise levels in the NSAID user group with the 
response being significantly greater than non-NSAID users (115).   
Despite an increase in markers of protein oxidation in NSAID self-reported 
users, McAnulty et al. (115) did not report any significant differences between NSAID 
users and non-users with respect to serum markers of muscle damage and catabolism.  
The increase in plasma PC concentrations does not align with the results of the other two 
free radical and oxidative stress markers measured.  Additional research needs to be 
conducted in the future to confirm these protein oxidative results when supplementing 
with NSAIDs during and post-ultra-endurance exercise as PC assay results can be highly 
variable. 
Effects of Antioxidant Vitamins 
As a highly reactive oxide metabolite of nitric oxide, peroxynitrate-bound 
tyrosine residues forming nitrotyrosine (NT) (196) was measured by Sureda et al. (178) 
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following supplementation of vitamin C + vitamin E surrounding a half-marathon.  
Suerda et al. (178) reported a significant increase in NT immediately post-race and 3-h 
post-race in the placebo group compared to the vitamin C + vitamin E supplemented 
group, indicating that antioxidant supplementation may have a dampening effect on 
oxidation of nitrogen-containing compounds with endurance exercise.  Attempting to 
simulate multi-sprint sports, Thompson et al. (183) recruited habitually active males 
within a crossover design study to ingest a vitamin C supplement (1 g dose) or a placebo 
2-h prior to a 90-min intermittent shuttle-running test.  In measuring MDA as a marker 
of oxidative stress, Thompson et al. (183) reported that plasma MDA concentrations 
significantly increased over baseline values immediately post-LIST exercise, but then 
returned to baseline levels up to 72-h post-LIST with no differences described between 
supplementation trials.  In another placebo-controlled, running-based study conducted by 
Thompson et al. (184) within the same year in physically active males, supplementation 
of vitamin C or placebo was carried out for 14-d surrounding a prolonged 90-min high-
intensity intermittent shuttle running test (LIST). Subjects were supplemented twice 
daily (morning and evening) with vitamin C (400 mg/d) or a placebo.  Within this 
particular study, Thompson et al. (184) reported an increase in plasma MDA 
concentrations, with no statistical differences reported between treatments.  However, 
Thompson et al. (184) stated that plasma MDA concentrations at 24-h post-LIST 
exercise were significantly greater than pre-exercise levels in the placebo group versus 
MDA concentrations in the vitamin C group that were not different than baseline levels.  
Further, Thompson et al. (184) described an increase post-exercise in serum uric acid 
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concentrations that remained above baseline levels at 24-h of recovery with no effect of 
treatment. 
 In an investigation conducted by Davison and Gleeson (165) recruiting well-
trained cyclists to complete a 2.5-h endurance cycling bout at 60% VO2 max, subjects 
were supplemented vitamin C (1000 mg/d) or a placebo for 14-d.  Contrary to the results 
published by Thompson et al. (183), Davison and Gleeson (165) reported that plasma 
MDA levels were unaffected by the cycling exercise bout and vitamin C 
supplementation had no effect on MDA immediately and 1-h following the 2.5-h cycling 
bout.   
The only study that reported differing results supplemented trained runners with 
a vitamin C + E combination that may have been more effective than the other three 
studies conducted using endurance-based exercise and vitamin C supplementation.  
However, in this particular study, Sureda et al. (178) only measured NT as a marker of 
nitric oxide metabolism compared to the other three studies that utilized MDA as a 
marker of oxidative stress. Both the differences in antioxidant vitamin supplement and 
marker to measure oxidative stress may have contributed to the differences in results 
across the four studies listed in this section.  
Effects of Phytochemicals and Functional Foods 
In an endurance-based study, Pilaczynska-Szczesniak et al. (144) recruited male 
members of the Polish rowing team to ingest 50 mL of chokeberry juice or placebo three 
times daily (150 mL/d) over the course of their 4-wk training camp.  At the beginning 
and end of the training camp, the crew athletes performed a 2000-m rowing test followed 
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by an incremental rowing session after a 1-d rest.  At the end of the 4-wk training camp 
and supplementation period, Pilaczynska-Szczesniak et al. (144) reported that serum 
TBARS levels were significantly attenuated in the chokeberry supplemented group 
compared to placebo at 1-min and 24-h post-incremental rowing test.  Additionally, 
subjects supplementing with chokeberry juice demonstrated lower glutathione 
peroxidase (GPx) activity 1-min post-incremental test and lower SOD activity 24-h post 
incremental test compared to placebo (144).  Utilizing a similar cohort of highly trained 
male rowers of the Polish national team, Skarpanska-Stejnborn et al. (169) supplemented 
athletes with artichoke-leaf extract (1,200 mg/d) or a placebo 3 times per day for 5-wk.  
Skarpanska-Stejnborn et al. (169) required subjects to perform a 2,000 m maximum-
effort test on a rowing ergometer as the exercise performance intervention with blood 
samples drawn pre-exercise, 1-min, and 24-hr post-exercise.  While there was no 
significant differences reported in SOD activity between the groups as a result of 
supplementation, Skarpanska-Stejnborn et al. (169) described a tendency for a decrease 
in SOD activity with artichoke-extract supplementation compared to an increasing SOD 
activity trend in the placebo group.  Despite no significant group interaction with respect 
to TBARS levels, Skarpanska-Stejnborn et al. (169) reported a greater increase in 
TBARS levels above pre-exercise values immediately after the rowing exercise in the 
placebo group compared to artichoke-extract (35% vs. 12%).  Further, TBARS 
concentrations returned pre-exercise levels 24-h post-exercise in the artichoke group, 
while TBARS remained elevated during recovery in the placebo group.   
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In the second study using this rowing athlete population, Skarpanska-Stejnborn et 
al. (168) supplemented subjects with Rhodiola rosea extract (200 mg/d) or a placebo 2 
times per day for 4-wk.  Similar to the results published by Pilaczynska-Szczesniak et al. 
(144), Skarpanska-Stejnborn et al. (168) described a significant effect of Rhodiola rosea 
extract  supplementation on SOD activity as levels were significantly lower immediately 
and 24-h post-exercise in the Rhodiola rosea group compared to placebo.  However, 
contrary to data reported by Pilaczynska-Szczesniak et al. (144) in a similar study 
cohort, GPx activity was unaffected by supplementation and did not change significantly 
as a result of the exercise.  Skarpanska-Stejnborn et al. (168) also divulged that serum 
uric acid (UA) and TBARS concentrations significantly increased as a result of the 
exercise bout and remained elevated above pre-exercise levels at 24-h of recovery, but 
both were unaffected by differences in supplementation.  Continuing to work with 
trained male rowers of the Polish national team and supplementing with a unique plant 
superoxide dismutase extract (GliSODin) derived from a SOD-rich melon extract daily 
(500 mg/d) for 6-wk, Skarpanska-Stejnborn et al. (170) required subjects in this placebo-
controlled study to perform a 2,000 m maximum-effort test on a rowing ergometer.  GPx 
levels increased significantly over pre-exercise values immediately post-exercise, but 
only GPx activity in the GliSODin supplemented group returned to pre-exercise levels at 
24-h of recovery.  Skarpanska-Stejnborn et al. (170) further reported that SOD activity 
was significantly greater in the GliSODin group compared to placebo pre-exercise, 
immediately post-exercise, and 24-h of recovery.  TBARS levels were not affected by 
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supplementation, but concentrations significantly increased over pre-exercise levels 
immediately following exercise (170).   
 Lafay et al. (102) employed a crossover design study with a variety of elite male 
sportsman to investigate the effects of a polyphenol-rich grape extract (400 mg/d) 
compared to placebo (400 mg/d) supplementation over a 30-d training and competition 
period.  After 30-d of supplementation, Lafay et al. (102) found no significant difference 
in SOD, catalase, and oxidized LDL activities between groups.  However, contrary to the 
findings reported by Pilaczynska-Szczesniak et al. (144) and Skarpanska-Stejnborn et al. 
(170) in trained rowers, Lafay et al. (102) described a decrease in GPx activity with 
placebo supplementation compared to a maintenance of baseline GPx activity with grape 
extract ingestion.  As another oxidative stress and inflammatory biomarker, Lafay et al. 
(102) also reported a significant increase in urinary excretion of isoprostanes with 
placebo supplementation compared to no change from baseline values with grape extract 
ingestion.  Utilizing trained cyclists, Morillas-Ruiz et al. (125) had subjects perform a 
90-min submaximal endurance time trial on a cycle ergometer while consuming a 
commercial antioxidant beverage containing fruit concentrates and carbohydrates.  
Mortillas-Ruiz et al. (125) measured plasma levels of lipid peroxidation through 
TBARS, indicating a significant increase in TBARS immediately post-exercise only in 
the placebo group with levels returning to pre-exercise values at 45-min of recovery.  
Oxidative stress was also measured through protein oxidation (PC) and Mortillas-Ruiz et 
al. (125) reported a significant polyphenol supplementation-induced decrease in PC 
levels post-exercise compared to baseline and placebo supplementation.   
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 Across this large collection of endurance exercise studies conducted mostly in 
trained athletes, researchers found that on the whole, various phytochemical or 
polyphenol-derived supplements had an attenuating effect on markers of oxidative stress 
or free-radical production.  While there was no similarity across supplements, most of 
the research reported a decrease in GPx, TBARS, and SOD activity as a result of 
phytochemical or polyphenol-derived supplementation compared to a placebo.  The 
study conducted in elite male sportsman by Lafay et al. (102) provided conflicting 
results among the free radical and oxidative stress markers tested that may have been 
due to the incongruence in the study population or the long duration cross over research 
design. 
Effects of Tart Cherry Supplementation  
Ducharme et al. (9) piloted the first endurance-based study to investigate the 
effects of Montmorency tart cherry juice supplementation on oxidative stress created by 
an exhaustive incremental treadmill running protocol in thoroughbred horses.  Overall 
indications of exercise-induced oxidative stress were reported through significant 
elevations in lipid hydroperoxidation decomposition products over time as measured by 
TBARS (58), but no differences between groups were reported (50).  In an endurance 
study, Howatson et al. (76) examined the effects of tart cherry juice supplementation on 
oxidative stress following a marathon run.  Supplementing with a tart cherry juice blend 
or placebo for 8-d surrounding the marathon, Howatson et al. (76) demonstrated 
significantly lower TBARS levels 48-h post-marathon in the tart cherry supplemented 
group versus placebo.  Following the marathon, Howatson et al. (76) contrastingly 
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demonstrated no significant difference in protein carbonyls (PC) as a marker of protein 
oxidation between groups.  In coordination with Howatson et al. (76), an endurance-
based study in trained cyclists conducted by Bell et al. (12) in response to repeated days 
of high-intensity stochastic cycling reported on a marker formed in the initial stages of 
lipid peroxidation, serum lipid hydroperoxide (LOOH) (32, 71) was significantly 
attenuated across the entire trial period with Montmorency cherry concentrate 
supplementation compared to placebo (13).   
The two endurance-based studies conducted in humans agreed on the positive 
effects of tart cherry supplementation on attenuation of oxidative stress markers and 
reported similar findings to those stated in the majority of research within the previous 
section.  The reliability of the results derived from the two human-based studies would 
assume to be high considering that both reports were published out of the same research 
group.  Due to a lack of comparison to other tart cherry supplement studies in race 
horses, it is difficult to ascertain if these results differed from those in human due to the 
small study cohort size, previous training status, or differences in acute physiological 
adaptations to endurance based exercise between race horses and humans. 
Free Radical and Oxidative Stress Response to Resistance-Based Exercise 
Effects of Antioxidant Vitamins 
Childs et al. (32) supplemented previously untrained subjects with either a 
placebo or a vitamin C (12.5 mg/kg body weight) + N-acetyl-cysteine (NAC) (10 mg/kg 
body weight) combination for 7-d after a resistance exercise challenge.  Within the 
exercise protocol, subjects were asked to perform 3 sets of 10 repetitions of 
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eccentrically-resisted elbow flexion exercise at 80% of 1-RM on the non-dominant arm.  
As a result of the eccentric flexion exercise challenge, Childs et al. (32) described a 
significant elevation in plasma SOD activity in both treatment groups, with a greater 
elevation in the vitamin C + NAC group over the course of the 7-d exercise recovery 
period.  Despite a lack of significant elevation in plasma GPx levels above baseline 
values, Childs et al. (32) found a significantly greater GPx activity 2-d post-exercise in 
the vitamin C + NAC group compared to placebo.  Determining the effects of 
supplementation on lipid peroxidation, Childs et al. (32) reported increased LOOH levels 
on days 2, 3, and 4 post-exercise in both groups, but a significant LOOH increase in 
those ingesting vitamin C + NAC on days 2 and 3 compared to placebo supplementers.  
Further, 8-isoprostane (8-iso-PGF2α) as a marker formed from the oxidation of 
arachidonic acid, also increased in the plasma as a result of the eccentrically-braked arm 
flexion exercise with a significant increase following supplementation of the antioxidant 
combination compared to placebo.   
In a more recent, yet similar, study of healthy, untrained males, Bryer and 
Goldfarb (22) supplemented subjects for 18-d (14-d pre-exercise and 4-d post-exercise) 
three times daily with either vitamin C (3 g/d) or a placebo. Bryer and Goldfarb (22) had 
subjects perform 70 eccentrically-resisted elbow flexions on the non-dominant arm with 
10-sec rest allotted between repetitions (22).  Within this particular study design, 
oxidative stress was measured through glutathione activity and the ratio of oxidized to 
total glutathione (GSSG/TGSH).  While there was no change evident in the whole blood 
total glutathione levels over the course of the study, however, Bryer and Goldfarb 
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reported a significant increase in the GSSG/TGSH ratio at 4-h and 24-h post-eccentric 
exercise in only the placebo group compared to lower levels in the vitamin C 
supplemented group.  Using a more traditional resistance training exercise in a long 
duration placebo-controlled protocol, Fischer et al. (57) supplemented a cohort of 
physically active males with a combination of vitamin C (500 mg/d) and RRR-α-
tocopherol (400 IU/day) 4-wk prior to and 1-d after a resistance exercise challenge.  
Subjects performed 3-h of two-legged dynamic knee-extensor exercise at 60 leg 
extensions per minute at 50% their maximum power output.  As a specific measure of 
plasma lipid peroxidation indicative of overall oxidative stress, Fischer et al. (57) 
described a stabilization in plasma F2-isoprostane concentration at pre-exercise levels in 
those supplementing with the antioxidant vitamin combination versus a significant 
increase demonstrated in the placebo group during post-exercise recovery. 
The two more recent studies that supplemented subjects for a period of 
approximately 4-wk prior to the resistance-based exercise challenge demonstrated 
beneficial effects of antioxidant vitamin supplementation through attenuation of post-
exercise oxidative stress markers compared to a placebo.  Once again, the upper body 
resistance-based study with ingestion of an antioxidant vitamin combination only in the 
post-exercise period conducted by Childs et al. (32) produced overwhelmingly 
conflicting results compared to research supplementing subjects before and after a single 
strenuous exercise bout.  Future research needs to be conducted where the time course of 
supplementation is varied but the supplement itself remains the same to help clarify any 
 100 
 
speculation with respect to antioxidant vitamin supplementation surrounding bouts of 
resistance-based exercise. 
Effects of Phytochemicals and Functional Foods  
In an eccentrically-based resistance exercise study, Goldfarb et al. (65) 
supplemented healthy, college-aged males with a fruit, berry, and vegetable concentrate 
or placebo twice daily for 4-wks (28-d pre-eccentric exercise, day of, and 4-d post-
eccentric exercise) surrounding a session of 4 sets of 12 repetitions of eccentrically-
resisted elbow flexions.  In a series of blood oxidative stress measurements, Goldfarb et 
al. (65) reported a significant increase in protein oxidation via PC and malondialdehyde 
(MDA) in the placebo group over the course of the 72-h recovery period that was 
different from the baseline-maintained PC levels of the FVC-treated group.  Further, 
lipid hydroperoxide (LOOH) were unaffected by the eccentric exercise bout, thus no 
difference between groups.  Goldfarb et al. (65) also analyzed glutathione status in the 
subjects through the GSSH/TGSH ratio, revealing that both groups had significantly 
elevated levels immediately post-eccentric exercise.  However, at 6-h post-exercise, the 
ratio only remained elevated in the placebo group compared to the FVC-treated group, 
indicating a significant effect of the supplement on this marker of oxidative stress (65).   
Examining intramuscular adaptations to a single bout of eccentrically-resisted 
isokinetic leg extensions on the dominant, Kerksick et al. (94) supplemented healthy, 
active males for 14-d with either N-acetyl-cysteine (NAC) (1,800 mg/d), 
epigallocatechin gallate (EGCG) (1,800 mg/d), or a placebo.  Kerksick et al. (94) 
assessed oxidative stress through serum concentrations of 8-isoprostane and SOD, but 
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levels were not affected by differences in supplementation despite a post-exercise 
increase in serum SOD concentrations.  
The contrasting results displayed across these two studies are likely exemplified 
by major differences in the study supplement, resistance exercise modality used, and 
duration of supplementation.  While the study subject population was similar, there was 
not any common free-radical or oxidative analyses run between the two studies, making 
comparison of the results extremely difficult.  Future research needs to integrate both 
upper and lower body eccentrically-resisted exercise in order to start development of 
conclusive evidence surrounding phytochemical and functional food supplementation 
when paired with resistance-based exercise. 
Effects of Tart Cherry Supplementation  
Unlike the protein oxidation results from Howatson et al. (76), the first tart 
cherry supplemented resistance training study in the literature to analyze hematological 
markers conducted by Bowtell et al. (20) reported a trend of lower PC 24-h post-
eccentric resistance exercise with Montmorency cherry juice supplementation compared 
to placebo.  Bowtell et al. (20), surrounding the intensive resistance exercise workout of 
repeated leg extensions in resistance trained males, also found no difference in serum 
NT measures between supplementation groups in the post-strength exercise period.  
None of the exercise-based tart cherry supplementation studies in the literature tested 
changes in SOD as a result of the intervention. 
As a result of tart cherry supplementation, results of this study begin to define a 
potential attenuating effect on post-exercise protein oxidation with no differences in 
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nitric oxide metabolic markers.  Although these measures are positive concerning 
supplementation with tart cherries compared to a placebo, they do not closely align with 
the aforementioned endurance-based studies.  Resistance-based exercise relies less on 
oxidative mechanisms and mitochondrial function for energy production compared to 
endurance exercise, thus likely defining the inconsistency in results between resistance 
and endurance-based tart cherry supplementation studies.  Tart cherry supplementation 
surrounding resistance exercise challenges needs to be studied more extensively moving 
forward to help build supporting evidence in the literature.  
Performance and Muscle Function Recovery in Response to Endurance Exercise 
Effects of NSAIDs 
 Studying the effects of acute ibuprofen supplementation against a placebo in a 
crossover design study, Donnelly et al. (48) subjected young, healthy, and untrained 
male volunteers to a 45-min downhill treadmill run at 70% of their estimated maximum 
heart rate.  Subjects ingested either 600 mg of ibuprofen or placebo 30-min prior to the 
downhill run and an additional 600 mg of supplement every 6-hrs post-run up to 72-h of 
recovery for a total administration of 8400 mg (48).  Expired air was collected during the 
45-min run from the 19
th
 to 21
st
 minute and the 39
th
 to 41
st
 minute in addition to the last 
2-min of a 5-min pre-run trial using an automated gas analysis system.  Supplementation 
did not have any effect on running speed or oxygen consumption (48).  As a result of the 
endurance performance, Donnelly et al. (48) assessed muscle function of each leg using 
a MVIC protocol and a measurement of isometric endurance at 50% of MVIC pre-run 
and at several time points throughout the post-run recovery.  The assessment of muscle 
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function demonstrated a significant decline in isometric muscle strength and 50 percent 
endurance time throughout the 72-h recovery, but the decline was unaffected by 
ingestion of ibuprofen compared to placebo (48).  In another crossover study with a 
similar design and subject cohort, Donnelley et al. (49) had volunteers supplement with 
diclofenac (50 mg) or a placebo 90-min before the previously described downhill 
running protocol and an additional 50 mg at 8-h intervals up to 72-h post-run.  This 
second study by Donnelley et al. (49) also reported that there was no supplement effect 
on treadmill running speed and oxygen consumption.   
 Similar to other research groupings, this pair of endurance exercise studies with 
NSAID supplementation by Donnelley et al. (48, 49) provides a fairly comprehensive 
picture due to the utilization of a similar subject cohort and study design.  There does not 
seem to be any effect of NSAID supplementation on running performance and 
associated makers in untrained males following an intense bout of downhill running.   
Effects of Antioxidant Vitamins  
An endurance-based training study conducted by Aguilό et al. (2) examined 
aerobically trained amateur athletes from a variety of specialties in which they 
supplemented daily for 90-d during their respective competitive seasons with a 
combination of vitamin E (500 mg/d), β-carotene (30 mg/d), and vitamin C (1,000 mg/d 
for final 15-d only) compared to a placebo.  During this supplementation period, athletes 
were asked to adhere to their normative training regimen and Aguilό et al. (2) measured 
changes in maximal and submaximal physiological parameters.  All of the subjects 
within the study that continued their respective training programs over the 90-d study 
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period improved VO2 max, maximal blood lactate concentration, and maximal workload 
attained during the maximal aerobic capacity test on the cycle ergometer (2).  However, 
Aguilό et al. (2) reported that those who supplemented with the antioxidant vitamin 
combination had a lower blood lactate concentration at maximal workload and attained a 
greater percentage of VO2 max at anaerobic threshold compared to placebo.  A second 
antioxidant vitamin supplementation study combined with 8-wks of endurance training 
in a previously untrained population was conducted by Gomez-Cabrera et al. (67).  The 
researchers supplemented their subjects with either 1000 mg/d of Vitamin C or a placebo 
over the 8-wk period in which all of the subjects trained 3 times/wk over the course of 
the study period.  Gomez-Cabrera et al. (67) found opposing results compared to the 
previous study conducted in the endurance trained population by Aguilό et al. (2), 
demonstrating only an increase in maximal aerobic capacity (VO2 max) as measured on 
a cycle ergometer in the placebo group compared to maintenance of pre-intervention 
capacity in the vitamin C supplemented subjects over the 8-wks.   A third study 
conducted by Kang et al. (89) compared a polyphenol-rich extract derived from litchi 
fruit with a vitamin C + vitamin E combination on outcomes of aerobic performance 
following 30-d of supplementation in healthy, recreationally trained endurance subjects.  
Kang et al. (89) reported that supplementation with the vitamin C (800 mg/d) + vitamin 
E (1200 IU/d) combination significantly reduced VO2 max from baseline measures to 
post-supplementation, while having no effect on both time to exhaustion during a time 
trial performance and anaerobic threshold.   
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In an aerobic based crossover study designed to simulate multi-sprint sports, 
Thompson et al. (183) recruited habitually active males to ingest a vitamin C supplement 
(1 g dose) or a placebo 2-h prior to a 90-min intermittent shuttle-running test (183).  
Specifically, the Loughborough Intermittent Shuttle Test (LIST) implemented in this 
study protocol consists of 90-min variable intensity shuttle running (walking, jogging, 
and sprinting) over a 20 m distance.  Thompson et al. (183) assessed muscle function on 
both leg extensors and flexors using a five stage test on an isokinetic dynamometer, 
requiring a series of submaximal, maximal, and isometric flexion/extension contractions.  
As a result of the post-LIST testing, muscle function in the leg extensors did not change 
significantly from baseline or between supplementation trials (183).  However, 
Thompson et al. (183) did report a drop in leg flexor function of both legs during the 
isometric and slower isokinetic sets up to 48-h post-LIST of the vitamin C supplemented 
trial.  In another placebo-controlled, running-based study conducted by Thompson et al. 
(184) within the same year in physically active males, supplementation of vitamin C or 
placebo was carried out for 14-d surrounding a prolonged 90-min high-intensity 
intermittent shuttle running test (LIST). Subjects were supplemented twice daily 
(morning and evening) with vitamin C (400 mg/d) or a placebo.  Thompson et al. (184) 
utilized a similar muscle function test as the previous study, reporting that both leg 
extensors and flexors demonstrated a decrease in peak torque production below pre-
exercise levels during both isometric and concentric contractions.  However, peak torque 
in the leg flexors tended to be greater with vitamin C supplementation in the post-
exercise period.    
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Given the large body of evidence within this section, the effects of antioxidant 
vitamin supplementation on performance variables was highly inconsistent even among 
two similar intermittent shuttle-based endurance studies conducted by Thompson et al. 
(183, 184).  The inconsistency is likely derived from the variation in antioxidant 
supplement combinations, supplement ingestion timelines, and subject training status.  
Due to the large differences in study results, it is difficult to draw overarching 
conclusions concerning antioxidant vitamin supplementation effects on endurance 
exercise performance variables.   
Effects of Phytochemicals and Functional Foods  
 Perhaps one of the most frequently researched phytochemical and polyphenol 
supplements in relation to changes in exercise performance are quercetin supplements 
due to their longer half-life within blood circulation (127).  Utilizing a pre-test/post-test 
control group design in recreationally active male subjects, Cureton et al. (43) 
supplemented their study cohort 1 time/d over a variable time period of 7-16-d with a 
sports hydration beverage that contained 1g quercetin.  The study subjects were 
aerobically tested pre/post supplementation using both a 10-min maximal work cycling 
test followed by a 1-h bout of moderate intensity cycling (43).  As a result of the study 
testing, Cureton et al. (43) determined that there was no statistically significant pre-
treatment to post-treatment changes in VO2 peak, perception of effort during the 
submaximal cycling test, and total work done throughout the 10-min maximal effort 
cycling bout between quercetin and placebo supplementation groups.  In a crossover 
study of healthy, untrained subjects in which the subjects were supplemented with a 
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beverage containing 500 mg quercetin or simply the beverage as a placebo twice daily 
(1000 mg/d total quantity) for 7-d, Davis et al. (44) implemented both a cycling VO2 
max test (supplementation day 7) and a cycling endurance ride to exhaustion 
(supplementation day 8) at the end of each treatment period.  As a result of 7-d of 
supplementation, Davis et al. (44) reported a significant increase in both cycling VO2 
max and ride time to exhaustion in the quercetin group compared to placebo.  In a 
second quercetin and exercise crossover study published in the same year as Davis et al. 
(44), Ganio et al. (62) supplemented untrained, sedentary males and females with either 
a placebo or quercetin-containing (1000 mg/d) food bar for 5-d.  Ganio et al. (62) 
reported that 5-d of quercetin supplementation did not influence VO2 max or any other 
related cardiorespiratory variables, even when accounting for gender, compared to a 
placebo.   
 Moving away from utilizing a VO2 max test as the primary measure of 
performance or cardiovascular improvement, two other studies took a different 
approach.  Similar to some of the previous quercetin research, Nieman et al. (132) 
employed untrained volunteers, specifically young adult males, in this crossover design.  
Study volunteers were supplemented for 2-wk with quercetin (1000 mg/d) or a placebo 
that were made undetectable by dissolving supplements in sugarless PowerAde (132).  
As the measure of performance, study volunteers performed a preload treadmill exercise 
protocol that involved a 60-min run at 60% VO2 max with a 10% treadmill grade (132).  
This preload protocol was then followed by a 12-min treadmill time trial at a 15% grade 
at a self-selected speed and previous research has determined that this particular protocol 
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is a more consistent method of performance determination compared to a time trial.  
Nieman et al. (132) demonstrated that those volunteers supplemented with quercetin 
achieved greater net change in running distance compared to placebo.  MacRae and 
Mefferd (112) took a different approach compared to some of the previously published 
quercetin research as they first used elite cyclist as volunteers.  In this particular 
crossover design, the cyclists were supplemented twice daily for 6-wk with either an 
antioxidant beverage containing green tea extract (300 mg), vitamin C (150 mg), and 
vitamin E (50 mg) or the same antioxidant beverage plus quercetin (300 mg) (112).  No 
placebo was used as a basis of comparison in this particular study.  MacRae and Mefferd 
(112) showed similar performance results as Nieman et al. (132) as consumption of the 
antioxidant supplement containing quercetin significantly improved the overall 30 km 
time trial performance in addition to greater performance over the last 5 km of the time 
trial.  Further, cyclists ingesting quercetin-containing antioxidant supplements 
demonstrated greater average and relative peak power compared to the other antioxidant 
supplement (112). 
 Phytochemicals and polyphenols are typically derived from whole fruits or fruit-
based supplements, but it is most common to see studies analyzing a fruit extract 
compared to a fruit juice (127).  In one of the few polyphenol-rich juice and exercise 
supplementation studies other than those using tart cherry juice, Pilaczynska-Szczesniak 
et al. (144) recruited male members of the Polish rowing team to ingest 50 mL of 
chokeberry juice or placebo three times daily (150 mL/d) over the course of their 4-wk 
training camp.  At the beginning and end of the training camp, the crew athletes 
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performed a 2000-m rowing test where maximal power achieved during the test reached 
450-500 W.  After 1-d rest, the subjects performed an incremental rowing session that 
was broken down into 3-min pieces with increasing percentage of maximal power 
required with each progressing rowing piece (144).  Although no performance-based 
measurements were reported, Pilaczynska-Szczesniak et al. (144) demonstrated via 
finger stick method a significantly lower blood lactate level with chokeberry 
supplementation compared to placebo.  As one of the polyphenol fruit extract studies 
measuring changes in performance as an outcome variable, Kang et al. (89) recruited 
healthy, recreationally trained aerobic Koreans to receive either oligomerized lychee 
fruit extract (OLFE) (200 mg/d), a vitamins C + E mixture (800 mg vitamin C + 1200 IU 
vitamin E/d), or a placebo (200 mg/d) twice per day for 30-d.  Subjects were required to 
perform a submaximal (80% HRmax) treadmill running test to exhaustion and a graded 
treadmill VO2 max test as part of the study protocol (89).  Kang et al. (89) described a 
significant increase in submaximal endurance time to exhaustion from baseline to post-
supplementation in only the OLFE group with no change in maximal oxygen 
consumption.  However, after supplementation, the subjects that supplemented with 
OLFE demonstrated a significant increase in anaerobic threshold compared to no 
significant changes in the vitamin and placebo groups (89).      
 Within the quercetin-based supplementation and endurance exercise challenge 
studies, the majority of evidence seems to support an increase in performance-related 
variables as a result of quercetin supplementation compared to a placebo.  Two quercetin 
supplementation and endurance performance studies did report no significant 
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performance differences when compared to a placebo.  However, the first study 
conducted by Cureton et al. (43) supplemented subjects on a variable time scale from 7-
16-d potentially contributing to inconsistent results.  The second study in question 
published by Ganio et al. (62), supplemented subjects with a food-based supplement 
containing quercetin compared to all other studies that supplemented subjects through 
liquid-based ingestion.  With minimal additional phytochemical and functional food-
based studies beyond quercetin supplementation, there still seems to be some evidence 
that this type of longer-term supplementation (4-wk) may also be beneficial to increasing 
aerobic performance outcomes over placebo supplementation. 
Effects of Tart Cherry Supplementation 
 The endurance running-based Montmorency cherry juice supplementation versus 
placebo trial conducted by Howatson et al. (76) surrounding a full marathon reported 
that the difference between predicted finish time and actual race finish time was greater 
in the placebo group (19 min discrepancy) compared to the tart cherry juice group (7 min 
discrepancy) despite never reaching significance.  This performance-related trend is 
interesting considering that there was no statistically significant differences between 
groups on highest weekly training mileage, longest training run, and number of previous 
marathons (e.g. marathon experience) (76).  Further, Howatson et al. (76) also tested the 
effects of supplementation on maximal voluntary isometric contractions (MVICs) 
following the marathon race using a standardized protocol on the non-dominate leg that 
included three submaximal 3-sec trials (50%, 70%, 90% of perceived max) followed by 
two maximal isometric 3-sec trials.  Howatson et al. (76) reported a decrement in MVIC 
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strength following the marathon compared to baseline levels that was similar across 
groups, however, there was significantly faster recovery of strength over the 48-h post-
race period with tart cherry juice supplementation versus placebo.   
 This single marathon study with short-term tart cherry supplementation supports 
the evidence described in the previous section of phytochemical and functional food 
research as both endurance performance seemed to be faster with supplementation along 
with quicker recovery of muscular strength recovery in the post-exercise period.  
Additional research needs to be continued in this area of short-term tart cherry 
supplementation surrounding bouts of strenuous endurance performance to help confirm 
the aforementioned findings published by Howatson et al. (76). 
Performance and Muscle Function Recovery in Response to Resistance Exercise 
Effects of NSAIDs  
Employing a counter-balanced, double-blinded study design to analyze the 
effects ibuprofen supplementation over the course of 6-wk of contralateral biceps 
training, Krentz et al. (100) recruited college-aged males and females with previous 
resistance training experience.  Subjects trained each arm on alternative days, 5-d/wk 
over a 6-wk training period in while they randomly received ibuprofen (400 mg/d) or a 
placebo immediately post-workout corresponding to arm training pattern.  Elbow flexor 
strength was assessed by Krentz et al. (100) through a 1-RM concentric concentration 
curl test.  As a result of the training, Krentz et al. (100) reported no effect of ibuprofen 
supplementation on elbow flexor strength measures compared to placebo.   
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Attempting to ascertain the effects of ibuprofen supplementation on markers of 
muscle injury and performance following a bout of eccentrically-resisted arm curls, 
Pizza et al. (145) designed a crossover study using a small cohort of sedentary males.  
Pizza et al. (145) supplemented subjects with either ibuprofen (2400 mg/d) or placebo 
for a total of 15-d (5-d pre-exercise and 10-d post-exercise).  The primary resistance 
exercise performed was 25 repetitions of a single arm, eccentrically-resisted arm curl.  
Muscle function and performance was assessed using a 4-sec duration MVIC protocol 
with the arm bent at 90° elbow flexion (145).  Joint angle integrity (relaxed and flexed) 
was also measured using a standard goniometer.  Pizza et al. (145) reported no 
difference in average and peak force developed during the eccentric arm exercise 
between treatments.  Further, MVIC strength and joint angle integrity (relaxed and 
flexed) decreased significantly following the eccentric exercise bout, but the 
measurements were not significantly different between treatments (145).  Rahnama et al. 
(152) recruited and randomly assigned non-athletic male subjects to one of four study 
groups: physical activity, ibuprofen, physical activity + ibuprofen, or control.  The 
physical activity groups performed 20-min of warm-up activity prior to the eccentric 
exercise. DOMS-inducing exercise involved performance of 70 eccentric arm-curl 
contractions 3-sec in duration at 80% MVC with 12-sec rest between eccentric 
repetitions.  Rahnama et al. (152) measured muscular performance through comparison 
of maximum eccentric contraction and discovered that the reduction from baseline levels 
in maximal eccentric performance in the control and ibuprofen groups was significantly 
greater compared to the physical activity (24-h and 48-h post-exercise) and combination 
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(48-h post-exercise) groups. Muscular performance returned to baseline levels at 48-h 
post-eccentric exercise in the physical activity and combination groups, but still 
remained significantly depressed below baseline in the control and ibuprofen groups.   
In an earlier resistance-based NSAID supplement study, Hasson et al. (72) 
employed healthy, untrained males and females to complete a 10-min bout of repeated 
bench step-ups with additional load of 10% body weight.  Subjects were either 
supplemented with 3 doses of ibuprofen (1200 mg) over 24-h starting 4-h pre-exercise 
(prophylactic), a single dose of ibuprofen (400 mg) at 24-h post-exercise (therapeutic), 
placebo, or a control receiving no treatment.  Using an isokinetic dynamometer, Hasson 
et al. (72) assessed muscular performance through concentric and eccentric knee 
extension peak torque production at 60°/sec over 5 repetitions on the left leg.  Knee 
extension MVICs were also measured at 60° of knee flexion over three attempts also on 
the left leg.  Similar to the muscle soreness results, Hasson et al. (72) reported a 
significant attenuation in isometric force decline with prophylactic ibuprofen 
supplementation compared to the other three treatment groups at 24-h post-exercise.  
Both ibuprofen groups significantly attenuated the isokinetic concentric and eccentric 
contraction performance as well as MVIC decline at 48-h post-exercise compared to the 
placebo and control groups.    
As a common characteristic between all four of these studies, ibuprofen was used 
as the NSAID supplement surrounding each bout of resistance-based exercise.  Despite 
this similarity, the results and effectiveness of ibuprofen supplementation on resistance 
exercise performance and recovery of post-exercise muscle function was equivocal.  
 114 
 
While three studies employed an eccentrically-resisted arm curls as their exercise 
protocol, only two found similar non-significant results with regard to ibuprofen 
supplementation compared to placebo.  The final study mentioned in this section 
conducted by Hasson et al. (72) utilized a lower body step-up protocol as the method of 
fatiguing exercise, which may have been a significant contributor to the difference in 
results compared to the other three upper-body resistance-based studies.  Another source 
of variability between studies potentially contributing to the inconsistent results was the 
discrepancy in volume and dosage of ibuprofen ingestion across all four studies.  
Additional research needs to be performed to help clarify these study discrepancies and 
solidify supporting or refuting evidence for NSAID supplementation to help improve 
resistance exercise performance and recovery. 
Effects of Antioxidant Vitamins 
In a placebo-controlled study conducted with healthy, non-resistance trained 
men, Beaton et al. (8) supplemented subjects for 30-d with either vitamin E (1200 IU/d) 
or a placebo.  Within this particular study, subjects performed an isokinetic protocol that 
compromised of 24 sets of 10 eccentrically-resisted knee extension/flexion contractions 
(8).  As a measure of muscle strength and integrity, Beaton et al. (8) also had subjects 
perform 5-sec duration MVICs and 3 reps of maximal, low velocity isokinetic leg 
extensions pre-eccentric exercise and at several post-eccentric exercise time points.  
Beaton et al. (8) reported that despite torque values that fell below pre-exercise values 
over the course of the eccentric exercise recovery period, there were no significant 
differences between groups for any of the aforementioned torque measures.  Further, 
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there was no change or difference between supplementation groups in thigh diameter 
when measured at the largest mid-thigh circumference point as a gross measure of 
edema following the eccentric exercise bout (8).  In a second study conducted on 
healthy, untrained males, Bryer and Goldfarb (22) supplemented subjects for 18-d (14-d 
pre-exercise and 4-d post-exercise) three times daily with either vitamin C (3 g/d) or a 
placebo. Bryer and Goldfarb (22) had subjects perform 70 eccentrically-resisted elbow 
flexions on the non-dominant arm with 10-sec rest allotted between repetitions.  As part 
of the assessment protocol, subjects performed three MVCs on both their dominant and 
non-dominant arms to determine maximum isometric force pre-eccentric exercise and at 
several post-eccentric exercise time points (22).  Post-eccentric exercise testing revealed 
a significant reduction in maximal isometric force and range of motion across the 96-h 
recovery with similar patterns of force loss and progression back to baseline among the 
supplement groups (22).  Supplementing moderately active and healthy male volunteers 
for 37-d with a combination of vitamin C (500 mg/d) and vitamin E (1200 IU/d) or a 
placebo, Shafat et al. (167) employed an exercise protocol comprised of 30 sets of 10 
eccentric knee extensions on their dominant leg using an isokinetic dynamometer.  As 
part of the assessment protocol, subjects performed three MVICs on their dominant leg 
to determine maximal contraction force of the knee extensors pre-eccentric exercise and 
at several post-eccentric exercise time points (167).  Analysis of peak concentric torque 
production, total work, and maximal isometric force production revealed that there was a 
significant decline in all three measures post-eccentric exercise, but this decline was 
significantly attenuated with the vitamin C + E supplementation combination compared 
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to placebo (167).  Despite the positive effects on muscle function, there were no 
significant differences between groups reported with changes in thigh volume, thus 
muscle edema, despite an overall volume increase as a result of the eccentric exercise 
bout when measured around the thigh at its largest point of circumference (167).    
Similar to previous positive reports in this literature review, the vitamin C + E 
supplementation combination reported beneficial effects in post-eccentric exercise 
performance recovery compared to a placebo.  These results reported by Shafat et al. 
(167) were not supported by the other two studies that described no significant 
differences in functional performance recovery when only supplementing with vitamin C 
or vitamin E.  While the duration of vitamin supplementation is different among each of 
the studies, with the longest time period being most effective, it does not seem justified 
that this would be the primary cause of the large discrepancy in results.  Future research 
must focus on combining all three antioxidant vitamin supplementation combinations 
into a single resistance-based study to help clarify the results reported across these three 
individual studies. 
Effects of Phytochemicals and Functional Foods 
A crossover study of elite male athletes from varying athletic endeavors was 
conducted by Lafay et al. (102).  This particular research group was interested in 
investigating the effects of a polyphenol-rich grape extract (400 mg/d) compared to 
placebo (400 mg/d) supplementation over a 30-d training and competition period on 
physical performance (102).  Lafay et el. (102) measured repeated jumping force 
capacity at baseline and post-supplementation, reporting a significant improvement in 
 117 
 
jumping force capacity (physical performance) and explosive power in the handball 
athlete group (n=10) with grape extract supplementation over placebo.  In an acute 
eccentric exercise-based crossover study, Trombold et al. (189) recruited recreationally 
active males who were supplemented twice daily with either a pomegranate juice (960 
mL/d) or a placebo (960 mL/d) over a 9-d period (4-d pre-exercise, day of, and 4-d post-
exercise) surrounding the exercise bout.  The single eccentric exercise bout involved two 
sets of 20 maximal eccentric elbow flexions in which subjects were required to resist an 
isokinetic dynamometer for 3-sec followed by a 15-sec rest per repetition (189).  
Measurement of elbow flexion strength was assessed using an isometric strength test at 
both 150° and 135° of elbow flexion.  Trombold et al. (189) reported that strength loss 
was similar between groups 2-h post-exercise and did not completely recover to baseline 
measures even at 96-h post-exercise.  However, supplementation with pomegranate juice 
seemed to hasten strength recovery as strength was significantly greater at 48-h and 72-h 
of recovery compared to placebo (189).   
In a more recent pomegranate juice supplementation study, Trombold et al. (190) 
supplemented resistance-trained men surrounding a single workout of both unilateral 
resisted eccentric elbow flexion and knee extension exercises.  Subjects were 
supplemented twice daily with either a pomegranate juice (500 mL/d) or a placebo (500 
mL/d) over a 15-d period (7-d pre-exercise, day of, and 7-d post-exercise) surrounding 
the exercise bout (190).  The single eccentric exercise bout involved three sets of 20 
maximal eccentrically resisted elbow flexions on an isokinetic dynamometer (performed 
as described in the previous study (189)) and six sets of 10 unilateral eccentrically 
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resisted (3-sec count) knee extensions at 110% unilateral 1-RM on a traditional isotonic 
leg extension machine (190).  Measurement of elbow flexion (30° and 45° above full 
elbow extension) and knee extension (45° and 90° below full knee extension) strength 
were assessed using isometric strength tests.  Utilizing these isometric strength tests, 
Trombold et al. (190) reported significantly greater isometric elbow flexion strength 
throughout the 168-h recovery period in the pomegranate group compared to placebo, 
but no differences between supplementation groups were shown in isometric knee 
extension strength despite a common post-eccentric exercise isometric strength loss.  In 
the same publication year, Goldfarb et al. (65) published a study in a cohort of healthy, 
college-aged volunteers that supplemented with a fruit, berry, and vegetable concentrate 
or placebo twice daily for 4-wks (28-d pre-eccentric exercise, day of, and 4-d post-
eccentric exercise).  This propriety blend of fruit, vegetable, and berry powder 
concentrates provided a source of β-carotene (7.5 mg/d), vitamin C (276 mg/d), and 
vitamin E (108 IU/d), in addition to a natural source of flavonoids and anthocyanins 
(65).  Subjects were required to perform 3-sec MVICs with both their dominant and non-
dominant elbow flexors on an isokinetic dynamometer at baseline, pre-exercise, and 
several post-exercise time points (65).  The eccentric exercise performed consisted of 
four sets of 12 repetitions of eccentrically resisted elbow flexions on the non-dominant 
arm at 20°/sec angular velocity (65).  Unlike the performance results reported by 
Trombold et al. (189) in the initial pomegranate juice study, Goldfarb et al. (65) 
demonstrated a similar drop in non-dominant arm elbow flexor MVIC and range of 
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motion between groups following the eccentric exercise bout with no between group 
differences up to 72-h of recovery.   
Examining intramuscular adaptations to a single bout (100 repetitions: 10 sets of 
10 repetitions) of eccentrically-resisted isokinetic leg extensions on the dominant leg, 
Kerksick et al. (94) supplemented healthy, active males for 14-d with either N-acetyl-
cysteine (NAC) (1,800 mg/d), epigallocatechin gallate (EGCG) (1,800 mg/d) as a 
catechin and polyphenol combination derived from green tea, or a placebo.  Muscle 
strength was assessed isometrically on the dominant leg where 3 individual leg extension 
MVICs were each completed over 5 seconds at 90° of flexion (94).  Peak isometric 
torque was significantly lower compared to baseline values at 6-h and 24-h post-
exercise, but no difference was exhibited across supplementation groups. 
While there seems to be some promising results with respect to faster strength 
recovery and muscle function utilizing some of the phytochemical and food-derived 
supplements, there is not conclusive evidence across the majority of studies described in 
this section.  As previously mentioned, the lack of conclusive evidence is likely due to 
the differences in supplement as each phytochemical and food-derived supplement has a 
unique composition of polyphenols and other antioxidant compounds that may alter the 
supplements effectiveness when ingested surrounding a resistance exercise bout.  For 
this reason, individual phytochemicals and functional food-derived components should 
be investigated both individually and synergistically to help derive the safest and most 
effective naturally-based supplement.  Future research directions may also need to focus 
on directly comparing different phytochemical or food-derived supplements in response 
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to both resistance and endurance exercise challenges to help clarify potential 
mechanisms.   
Effects of Tart Cherry Supplementation  
 Within the eccentric exercise and resistance-related literature, Connolly et al. 
(40) conducted a crossover study on healthy college-aged males that were supplemented 
with a tart cherry juice blend or a placebo two times per day for 8-d surrounding a bout 
of 40 maximal eccentric elbow flexion contractions.  Relaxed end point range of motion 
for the elbow flexors at the elbow joint was measured by via a standard goniometer.  
Despite an overall elbow range of motion loss over the 96-h post-exercise recovery, no 
significant difference was reported between groups (40).  Similar to the recovery 
performance assessment by Howatson et al. (76) following marathon running, Connolly 
et al. also measured isometric elbow flexion strength, performing two 3-sec maximal 
isometric trials at each elbow angle (130°, 90°, and 30°).  Connolly et al. (40) reported 
that overall isometric elbow flexion strength loss was significantly attenuated in the tart 
cherry supplement group compared to placebo when strength measures were averaged 
across all isometric test angles.  In more recent resistance-based crossover study in 
trained athletes, Bowtell et al. (20) supplemented these subjects for 10-d surrounding a 
bout of single-leg leg extensions with either Montmorency tart cherry juice or a placebo.  
Similar to the two previous studies, Bowtell et al. (20) measured knee extension 
maximal voluntary contractions (MVCs) pre-exercise, immediately, 24-h, and 48-h post-
exercise using an inline force transducer calculating force over 1-sec periods.  As 
reported in the previous study by Connolly et al. (40) with elbow flexor force 
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production, a significant drop in post-exercise force production was demonstrated by this 
cohort, but pre-exercise normalized MVC force recovery occurred significantly faster 
with tart cherry juice concentrate versus placebo over the 48-h recovery period (20). 
 These two resistance-based tart cherry studies reported attenuated the loss of 
post-exercise strength and expedited recovery of muscle function.  Both of these studies 
demonstrate that short-term tart cherry supplementation surrounding a bout of 
resistance-based exercise can be an effective recovery aid following both upper and 
lower body dominant resistance exercise.  The results of these studies resonate with the 
expedited muscle function recovery results reported following a marathon run, 
demonstrating a universal effectiveness with tart cherry supplementation across various 
exercise modalities.  Future research would be best suited to focus on confirming the 
results of these studies and comparing multiple forms of tart cherry supplementation 
within the same study design.   
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CHAPTER III  
METHODS
*
 
Tart Cherry Resistance 
Overall Study Design 
This study was conducted in a randomized, double-blind, and placebo-controlled 
manner utilizing two treatment groups.  All subjects eligible to participate in the study 
completed a morning familiarization session where they were provided detailed 
information regarding the study design, testing procedures, and supplementation 
protocols.  Approximately 10-d prior to the resistance exercise intervention, eligible 
subjects returned to the lab for a morning baseline testing session to determine body 
weight, height, and body composition.  Following baseline measurements subjects were 
matched based on relative maximal back squat strength, fat free mass, body weight, and 
age and randomly separated into two groups: 1) a placebo group (P) or 2) a powdered 
tart cherry group (TC).  Dietary intake was not controlled, but subjects were asked to not 
change their dietary habits in any way throughout the study (upon start of 
supplementation).  This was monitored by subject documentation of dietary intake for 4-
d of the first 7 supplementation days prior to the resistance exercise challenge.  Subjects 
were also instructed to maintain their normal resistance training program on study days 
where physical activity was not restricted (e.g. up to 48-h prior to each testing session). 
 
                                                 
*Portions reprinted from “Effects of powdered Montmorency tart cherry supplementation on an acute bout 
of intense lower body strength exercise in resistance trained males” by Levers K, Dalton R, Galvan, E, et 
al. 2015. Journal of the International Society of Sport Nutrition, 12, 1-23, Copyright 2015 by Kyle Levers. 
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Independent and Dependent Variables 
 The independent variable of interest was the type of supplement ingested.  
Dependent variables were quadriceps muscle soreness perception; serum markers of 
mechanical muscle damage, secondary muscle damage, and physiological stress; serum 
markers of the anabolic and catabolic hormone response; serum markers of the 
inflammatory and anti-inflammatory response; serum markers of free radical production, 
oxidative stress, and antioxidant activity; whole blood immune cell counts; and recovery 
strength performance.  Table 1 lists the components specifically examined for each 
independent variable. 
Study Site 
 All laboratory testing was conducted in the Exercise & Sport Nutrition 
Laboratory.  This laboratory is based in the Department of Health and Kinesiology and 
College of Education and Human Development at Texas A&M University in College 
Station, Texas.   
Subjects 
 Twenty-three (23) healthy, resistance-trained men (20.9±2.6 yr, 
14.2±5.4% body fat, 63.9±8.6 kg FFM) participated as subjects in this study.  Recruited 
subjects were required to have been involved in a progressive resistance training 
program that included regular squat exercise for at least six months prior to study 
recruitment and to be able to perform a standard barbell back squat in a power rack of at 
least 1.5 times their body weight.  Figure 1 demonstrates the breakdown of the subject 
population as it pertains to the study progression.  Discontinuation of any subject 
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participation was not related to any aspect of the supplementation or testing protocol.  
All subjects signed informed consent documents and the study was approved by the 
Texas A&M University Institutional Review Board prior to any data collection.  
Subjects were not allowed to participate in this study if they reported any of the 
following: 1) any metabolic disorders or taking any thyroid, hyperlipidemic, 
hypoglycemic, anti-hypertensive, anti-inflammatory (e.g. NSAIDs), and/or androgenic 
medications; 2) history of hypertension, hepatorenal, musculoskeletal, autoimmune, 
and/or neurological disease(s); 3) allergy to cherries or any cherry components (e.g. 
polyphenols, anthocyanins, anthocyanidins).  Using this study exclusion criteria, 33 
resistance-trained subjects qualified to participate in this study (see Figure 1) out of 86 
total men screened.   
Experimental Design 
Figure 2 shows the experimental design to be used in this study.  The study was 
conducted in a randomized, double-blind, and placebo-controlled manner.  All subjects 
eligible to participate in the study completed a morning familiarization (FAM) session 
where they were provided detailed information regarding the study design, testing 
procedures, and supplementation protocols.  Informed consent, medical history, and 
endurance training history questionnaires were also completed during the familiarization 
session.  A research nurse reviewed medical history documents and performed a physical 
exam on each subject to ensure safety and participation eligibility. A fasting blood 
sample was taken at the end of the familiarization session if the subject met entrance 
criteria as a pre-supplementation reference. 
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Table 1: Study Dependent Variables [Resistance] 
Muscle 
Soreness 
Perception 
Pro- 
Inflammatory 
Cytokines & 
Chemokines 
Anti- 
Inflammatory 
Cytokines 
Free Radical 
Production  
& Oxidative 
Stress 
Antioxidant 
Status 
Muscle 
Catabolism 
Physiological 
Stress & 
Secondary 
Muscle  
Damage 
Anabolic & 
Catabolic 
Hormone 
Status 
Whole  
Blood 
Immune 
Cell Counts 
Recovery 
Strength 
Performance 
Vastus TNF-α IL-4   TBARS   TAS   CK   AST Cortisol WBC  Isokinetic MVCs 
Medialis (¼) IFN-γ IL-5   NT         ALT Testosterone LYMPH    
 IL-1β IL-7   SOD         Creatinine Test/Cortisol GRAN    
Vastus IL-2 IL-10            Urea/BUN    Ratio MID    
Lateralis (¼) IL-6 
IL-8 
IL-13 
           
BUN/Creatinine 
   
Hemoglobin 
  
     Ratio HCT  
Vastus  IL-12             Total Protein    RBC    
Lateralis (½)              Total Bilirubin    GM-CSF   
              Uric Acid        
Abbreviations: IK = isokinetic; MVC = maximal voluntary contraction; AST = Aspartate aminotransferase; ALT= Alanine aminotransferase; BUN = Blood urea nitrogen; 
CK = Creatine kinase; Test/Cortisol = Testosterone/Cortisol ratio; TBARS = Thiobarbituric acid reactive substances; TAS = Total antioxidant status; SOD = Superoxide 
dismutase; TNF-α = Tumor necrosis factor alpha; IFN-γ = Interferon gamma; IL = interleukin; WBC = White blood cell; LYMPH = Lymphocytes; MID = Mid-range 
absolute count; GRAN = Granulocyte absolute count; GM-CSF = Granulocyte-macrophage colony-stimulating factor 
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Figure 1.  Tart Cherry Resistance Study Population Consort Diagram  
 
 
 
  Subjects were asked to not change their dietary habits in any way throughout 
the study (upon start of supplementation).  This was monitored by subject documentation 
of dietary intake for 4-d (3 weekdays and 1 weekend day) of the first 7 supplementation 
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days prior to the resistance exercise challenge.  Ten days (10-d) prior to the resistance 
exercise intervention, eligible subjects returned to the lab for a morning baseline testing 
session (BASE) to determine body weight, height, and body composition.  The subjects 
then were familiarized with the maximal voluntary contraction (MVC) protocol using 
their dominant leg on the isokinetic knee extension dynamometer followed by a 5-min 
recovery before determination of their barbell back squat 1-reptetion maximum (1-RM) 
in a power rack/smith machine. Following baseline measurements subjects were 
matched based on relative maximal back squat strength, fat free mass, body weight, and 
age and randomly separated into two groups: 1) a placebo group or 2) a powdered tart 
cherry group.  
Subjects were instructed to begin supplementation 7-d prior to the resistance 
exercise challenge (Day 0).  Subjects were asked to fast overnight for 10-h to account for 
diurnal variations as well as abstain from exercise and consumption of NSAIDs for 48-h 
prior to all testing days.  On the day of the resistance exercise challenge, the subjects 
reported to the lab where body weight, resting heart rate, and resting blood pressure were 
measured.  Subjects then donated a fasting venous blood sample (approximately 20 ml) 
using standard clinical procedures to measure pre-run effects of supplementation on all 
hemodynamic variables and rated perceptions of muscle soreness to a standardized 
application of pressure on their dominant thigh at 3 designed locations using a graphic 
pain rating scale (GPRS).  The subjects then completed the MVC protocol using their 
dominant leg on the isokinetic dynamometer followed by a 5-min recovery before the 
barbell back squat protocol was completed with a Tendo power and speed analyzer 
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attached to the bar.  Fasting (except 60-min post-lift) blood samples, GPRS ratings of 
quadriceps muscle soreness, and the isokinetic leg extension MVC protocol were 
completed at 60-min, 24-h and 48-h post-lift recovery.  The last day of supplementation 
correlated with 48-h post-lift recovery. 
Tart Cherry Resistance Exercise Protocol 
Isokinetic Knee Extension Maximal Voluntary Contractions 
At baseline, before the squat exercise, 60-min after the squat exercise, 24-h and 
48-h post-lift exercise, subjects performed an isokinetic knee extension MVC test using 
their dominant leg on a Kin-Kom 125AP Isokinetic Dynamometer (Chattanooga-DJO 
Global Inc., Vista, CA, USA).  During the baseline familiarization of the isokinetic leg 
extension MVC protocol, standard procedures were used to determine and record proper 
subject positioning on the Kin-Kom to ensure accurate repeatability of the testing 
protocol across all five sessions.  The subject warmed-up on the isokinetic dynamometer 
by performing 3-sets of 5 repetitions of dominant knee extension/flexion at 50% of their 
MVC (determined during the familiarization) with 1-min recovery between sets.  After 
the 1-min recovery following the third warm-up set, the subject performed 3 knee 
extension/flexion MVCs in succession with no rest between contractions.  Subjects were 
allotted a 5-min recovery between the isokinetic MVC and barbell back squat protocols. 
Test to test variability of performing this test yielded average CV values of ±8.47% with 
a test retest correlation of r=0.88. 
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Barbell Back Squat 1-Repetition Maximum Determination 
At baseline (BASE), following the 5-min recovery after the isokinetic MVCs, subjects 
performed 3-sets of 5 repetitions of the barbell back squat on a Smith Machine (Life 
Fitness, Schiller Park, IL, USA, model SSM) at 50% of their anticipated 1-RM with 2-
min recovery between sets.  Following the warm-up protocol, the barbell back squat 1-
RM was determined on the Smith Machine using a standard 1-RM protocol defined by 
the National Strength and Conditioning Association (NSCA) with 2-min recovery 
periods between 1- repetition sets of increasing weight.   All 1-RM determinations were 
made within 3-5 sets beyond the warm-up.  In order to successfully complete each set, 
the subject was required to reach parallel as determined by a NSCA Certified Strength 
and Conditioning Coach providing a verbal “up” cue during spotting.   
Barbell Back Squat Exercise Protocol 
On Day 8, following the 5-min recovery after the isokinetic MVCs, subjects 
performed 1 warm-up set of 10 repetitions of the barbell back squat at 50% 1-RM 
(determined during BASE).  After 3-min recovery, the subjects performed 10 sets of 10 
repetitions of barbell back squat at 70% 1-RM with 3-min recovery between sets.  A 
TENDO Power and Speed Analyzer (TENDO Sports Machines, Trencin, Slovak 
Republic, model PSA310) was attached to the bar during all 100 repetitions to be 
completed during the squat protocol to determine peak power, average force, and total 
work for each repetition. Following the squat protocol, subjects were only permitted to 
stretch with limited ambulation until the 60-min post-lift testing protocol was completed.   
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Figure 2. Tart Cherry Resistance Study Research Design Schematic 
DEXA = dual-energy X-Ray absorptiometer, MVC = maximal voluntary contraction, 1-RM = 1-repetition maximum, NSAID = non-steroidal anti-inflammatory drugs, 
GPRS = graphic pain rating scale, 7-d = 7-day, 48-h = 48-hour. 
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Tart Cherry Endurance 
Overall Study Design 
This study was conducted in a randomized, double-blind, and placebo-controlled 
manner utilizing two treatment groups.  All subjects eligible to participate in the study 
completed a morning familiarization session where they were provided detailed 
information regarding the study design, testing procedures, and supplementation 
protocols.  Ten days (10-d) prior to the endurance exercise intervention, eligible subjects 
returned to the lab for a morning baseline testing session to determine body weight, 
height, and body composition.  Following baseline measurements subjects were matched 
based on average reported race pace, fat free mass, body weight, and age and randomly 
separated into two groups: 1) a placebo group (P) or 2) a powdered tart cherry group 
(TC).  Dietary intake was not controlled, but subjects were asked to not change their 
dietary habits in any way throughout the study (upon start of supplementation).  This 
was monitored by subject documentation of dietary intake for 4-d of the first 7 
supplementation days prior to the endurance exercise challenge.  Subjects were also 
instructed to maintain their normal exercise training program on study days where 
physical activity was not restricted (e.g. 48-h prior to each testing session). 
Independent and Dependent Variables 
 The independent variable of interest was the type of supplement ingested.  
Dependent variables include serum markers of mechanical muscle damage, secondary 
muscle damage, and physiological stress; serum markers of the anabolic and catabolic 
hormone response; serum markers of the inflammatory and anti-inflammatory response; 
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serum markers of free radical production, oxidative stress, and antioxidant activity; 
whole blood immune cell counts; serum clinical markers of health; quadriceps muscle 
soreness perception; and endurance race running performance.  Table 2 lists the 
components specifically examined for each independent variable.   
Study Site 
 The tart cherry study half-marathon race course was completed on a previously 
planned road course on the campus of Texas A&M University in College Station, Texas 
(see Appendix G).  All laboratory testing was conducted in the Exercise & Sport 
Nutrition Laboratory.  This laboratory is based in the Department of Health and 
Kinesiology and College of Education and Human Development at Texas A&M 
University in College Station, Texas.   
Subjects 
27 endurance trained runners or triathlete (21.8±3.9 yr, 15.0±6.0% body fat, 
67.4±11.8 kg) men (n=18) and women (n=9) participated as subjects in this study.  To 
ensure training intensity and volume consistency, we aimed to recruit endurance runners 
or triathletes from those respective Texas A&M club teams.  All recruited subjects were 
required to be involved in a consistent running program for at-least one-year and able to 
run a half-marathon (21.1 km) in less than 2 hours.  Figure 3 demonstrates the 
breakdown of the subject population as it pertains to the study progression.  
Discontinuation of any subject participation was not related to any aspect of the 
supplementation or testing protocol.   
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Table 2: Study Dependent Variables [Endurance] 
Muscle 
Soreness 
Perception 
Pro- 
Inflammatory 
Cytokines & 
Chemokines 
Anti- 
Inflammatory 
Cytokines 
Free Radical 
Production  
& Oxidative 
Stress 
Antioxidant 
Status 
Muscle 
Catabolism 
Physiological 
Stress & 
Secondary 
Muscle  
Damage 
Anabolic & 
Catabolic 
Hormone 
Status 
Whole  
Blood 
Immune 
Cell Counts 
Endurance  
(½ Marathon) 
Running 
Performance 
Vastus TNF-α IL-4   TBARS   TAS   CK   AST Cortisol WBC  Split Time 
Medialis (¼) IFN-γ IL-5   NT         ALT Testosterone LYMPH  Finish Time 
 IL-1β IL-7   SOD         Creatinine Test/Cortisol GRAN  Proj. Race Pace 
Vastus IL-2 IL-10            Urea/BUN    Ratio MID  Actual Race Pace 
Lateralis (¼) IL-6 
IL-8 
IL-13 
           
BUN/Creatinine 
   
Hemoglobin 
  
     Ratio HCT  
Vastus  IL-12             Total Protein    RBC    
Lateralis (½)              Total Bilirubin    GM-CSF   
              Uric Acid        
Abbreviations: IK = isokinetic; MVC = maximal voluntary contraction; AST = Aspartate aminotransferase; ALT= Alanine aminotransferase; BUN = Blood urea nitrogen; CK 
= Creatine kinase; Test/Cortisol = Testosterone/Cortisol ratio; TBARS = Thiobarbituric acid reactive substances; TAS = Total antioxidant status; SOD = Superoxide 
dismutase; TNF-α = Tumor necrosis factor alpha; IFN-γ = Interferon gamma; IL = interleukin; WBC = White blood cell; LYMPH = Lymphocytes; MID = Mid-range absolute 
count; GRAN = Granulocyte absolute count; GM-CSF = Granulocyte-macrophage colony-stimulating factor; Proj. = Projected 
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All subjects signed informed consent documents and the study will be approved 
by the Texas A&M University Institutional Review Board prior to any data collection.  
Subjects were not allowed to participate in this study if they reported any of the 
following: 1) any metabolic disorders or taking any thyroid, hyperlipidemic, 
hypoglycemic, anti-hypertensive, anti-inflammatory (e.g. NSAIDs), and/or androgenic 
medications; 2) history of hypertension, hepatorenal, musculoskeletal, autoimmune, 
and/or neurological disease(s); 3) allergy to cherries or any cherry components (e.g. 
polyphenols, anthocyanins, anthocyanidins).  Using this study exclusion criteria, 34 
endurance-trained subjects qualified to participate in this study (see Figure 1) out of 62 
total individuals screened.   
Experimental Design 
Figure 4 outlines the experimental design used in this study.  The study was conducted 
in a randomized, double-blind, and placebo-controlled manner.  All subjects eligible to 
participate in the study completed a morning familiarization session where they were 
provided detailed information regarding the study design, testing procedures, and 
supplementation protocols.  Informed consent, medical history, and endurance training 
history questionnaires were also completed during the familiarization session.  A 
research nurse reviewed medical history documents and perform a physical exam on 
each subject to ensure safety and participation eligibility.  A fasting blood sample was 
taken at the end of the familiarization session if the subject met entrance criteria as a pre-
supplementation reference.  Subjects were asked to not change their dietary habits in any 
way throughout the study (upon start of supplementation).  This was monitored by 
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subject documentation of dietary intake for 4-d (3 weekdays and 1 weekend day) of the 
first 7 supplementation days prior to the resistance exercise challenge.  Ten days (10-d) 
prior to the endurance exercise challenge, eligible subjects returned to the lab for a 
morning baseline testing session to determine body weight, height, and body 
composition.  Following baseline measurements subjects were matched based on 
average reported/projected race pace, fat free mass, body weight, and age and randomly 
separated into two groups: 1) a placebo group or 2) a powdered tart cherry group. 
 Subjects were instructed to begin supplementation 7-d prior to the endurance 
exercise challenge (Day 0).  Subjects were asked to fast overnight for 10-h to account for 
diurnal variation as well as abstain from exercise and consumption of non-steroidal anti-
inflammatory medications (NSAIDs) for 48-h prior to all testing days.  On the day of the 
endurance exercise challenge, subjects reported to the lab where body weight, resting 
heart rate, and resting blood pressure will be measured.  Subjects then donated a fasting 
venous blood sample (approximately 20 ml) using standard clinical procedures to 
measure pre-run effects of supplementation on all hemodynamic variables and rated 
perceptions of muscle soreness to a standardized application of pressure on their 
dominant thigh at 3 designed locations using a graphic pain rating scale (GPRS).  
Twenty minutes prior to the start of the half-marathon race, subjects were allowed to 
warm-up as they normally would before running a road race.  Subjects completed a half-
marathon (21.1 km) run outdoors at their normal race/competition pace.  Both water and 
glucose-electrolyte drinks, individually labeled for each runner to match their race bib 
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Figure 3. Tart Cherry Endurance Study Population Consort Diagram 
 
number, were provided to the runners at four individually spaced intervals during the 
race.   
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Figure 4.  Tart Cherry Endurance Study Research Design Schematic 
DEXA = dual-energy X-Ray absorptiometer, MVC = maximal voluntary contraction, 1-RM = 1-repetition maximum, NSAID = non-steroidal anti-inflammatory drugs, 
GPRS = graphic pain rating scale, 7-d = 7-day, 48-h = 48-hour. 
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Fasting (except 60-min post-run) blood samples and GPRS ratings of quadriceps 
muscle soreness were completed at 60-min, 24-h and 48-h of post-run recovery.  The last 
or tenth day of supplementation correlated with 48-hours post-run recovery.   
Tart Cherry Endurance Exercise Protocol 
Half-Marathon (21.1 km) Run 
On the morning of supplementation endurance exercise challenge, all subjects 
performed an outdoor half-marathon (21.1 km) run together on a planned and closed 
Texas A&M University campus course under simulated race day conditions (see 
Appendix G).  The race course was planned completely on concrete and pavement 
surfaces.  All subjects were given 20-min for individual warm-up routines before the 
start of the half-marathon.  At regular intervals (4 total locations) throughout the race, 
fluids (water and/or glucose-electrolyte beverages) were made available to the runners.  
Each runner had their own water and glucose-electrolyte beverage bottle labeled with a 
number that corresponds to their race bib number.  All fluid bottles were weighed before 
and after the race to determine fluid consumption for each subject.  Official race splits 
and finish times were recorded by designated lab staff.  Following the race, subjects 
were not allowed to run to cool down, only stretching and minimal ambulation was 
permitted until the 60-min post-run testing session. 
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Tart Cherry Resistance and Endurance Common Study Methods 
Supplementation Protocol 
Subjects were assigned in a double-blinded and randomized manner to ingest a 
rice flour placebo (P) or powdered tart cherry (TC).  Subjects were matched into one of 
the two groups according to the previously described criteria listed for each study.  
Subjects were instructed to ingest the supplements with breakfast at 0800 for 7-d prior 
to, the day of, and for 2-days following the respective exercise challenge (resistance or 
endurance) for a total supplementation timeline of 10-d.  The tart cherry supplements 
contained 480 mg of freeze dried Montmorency tart cherry skin powder derived from 
tart cherry skins obtained after juicing (CherryPURE™ Freeze Dried Tart Cherry 
Powder, Shoreline Fruit, LLC, Transverse City, MI, USA).  Prior analytical testing 
conducted in 2012 by Atlas Bioscience (Tuscon, AZ, USA) demonstrated that 290 mg of 
CherryPURE™ provides at least 600 mg of phenolic compounds and 40 mg of 
anthocyanins per serving, which is equivalent to consuming 10.5 fluid ounces of tart 
cherry juice.  Based on the results of the previous analytical testing, the 480 mg/d 
CherryPURE™ dosage supplemented in the current studies provides at least 993 mg of 
phenolic compounds and 66 mg of anthocyanins per serving/day.  The supplements were 
prepared for distribution by Shoreline Fruit, LLC and sent to Advanced Laboratories 
(Salt Lake City, UT, USA) to quantify total phenolic compound and anthocyanin content 
of the powdered tart cherry supplements.  Both supplements were prepared in 
 140 
 
 
 
standardized color capsules and packaged in generic bottles by Shoreline Fruit, LLC for 
double blind administration. 
Tart Cherry Resistance and Endurance Common Study Procedures 
Dietary Inventories 
Within the first 7-d of supplementation, subjects were instructed to record all 
food and fluid intake over a 4-d period (3 weekdays, 1 weekend day), which is reflective 
of their normal dietary intake.  Dietary inventories were then reviewed by a registered 
dietician and analyzed for average energy, macronutrient, and dietary antioxidant intake 
using Food Processor (Version 8.6) Nutritional Analysis software (ESHA Research Inc., 
Salem, OR, USA).   
Anthropometrics and Body Composition 
At the beginning of every testing session, subjects had their height and body 
mass measured according to standard procedures using a Healthometer Professional 
500KL (Pelstar LLC, Alsip, IL, USA) self-calibrating digital scale with an accuracy of 
±0.02 kg.  Whole body bone density and body composition measures (excluding 
cranium) was determined with a Hologic Discovery W Dual-Energy X-ray 
Absorptiometer (DEXA; Hologic Inc., Waltham, MA, USA) equipped with APEX 
Software (APEX Corporation Software, Pittsburg, PA, USA) by using procedures 
previously described (1, 98). Mean test-retest reliability studies performed on male 
athletes in our lab with this DEXA machine have revealed mean coefficients of variation 
for total bone mineral content and total fat free/soft tissue mass of 0.31-0.45% with a 
 141 
 
 
 
mean intraclass correlation of 0.985 (43).  On the day of each test, the equipment was 
calibrated following the manufacturer’s guidelines.  
Muscle Soreness Perception Assessment 
Pressure application to the three specified areas of the quadriceps muscle group 
on the subject’s dominant leg was standardized to 50 N of pressure using a handheld 
Commander Algometer (JTECH Medical, Salt Lake City, UT, USA).  The standard 
amount of pressure was applied to the vastus lateralis (VL) at both 25% and 50% of the 
distance between the superior border of the patella to the greater trochanter of the femur 
at the hip and to the vastus medalis (VM) at 25% of the distance between the 
aforementioned landmarks.  These three specific locations were measured and marked 
with a permanent marker on each participant during the baseline muscle soreness 
perception measurement before the exercise challenge (resistance or endurance).  The 
participants were asked to maintain these 3 marked locations between testing sessions to 
avoid error with secondary measurement.  The subject was seated in a reclined supine 
position and given the algometer GPRS sheet to evaluate the perception of muscle 
soreness at each of the three quadriceps locations.  The order of pressure application was 
standardized across all sessions and participants: 25% VM, 25% VL, and 50% VL.  The 
50 N of pressure was applied to a relaxed quadriceps at each of the 3 locations using the 
algometer for a period of 3-sec to give the subject enough time to record their soreness 
evaluation on the GPRS.  Perceptions of muscle soreness were recorded by measuring 
the distance (centimeters) of the participant mark on the GPRS from 0 cm (no pain).   
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Blood Collection 
Subjects were required to fast (except for the 60-min post-exercise session) for 
10-h prior to donating approximately four teaspoons (20 milliliters) of venous blood 
from an antecubital vein using standard phlebotomy procedures.  Blood analyzed for 
markers of muscle damage, oxidative stress, inflammation, and clinical chemistry panels 
were collected in two 7.5 mL BD Vacutainer® serum separation tubes (Becton, 
Dickinson and Company, Franklin Lakes, NJ, USA), left at room temperature for 15-
min, and then centrifuged at 3500 rpm for 10-min using a standard, refrigerated (4°C) 
bench top Thermo Scientific Heraeus MegaFuge 40R Centrifuge (Thermo Electron 
North America LLC, West Palm Beach, FL, USA).  Serum supernatant was removed and 
stored at -80°C in polypropylene microcentrifuge tubes for later analysis.  Blood was 
also collected in a single 3.5 mL BD Vacutainer® lavender top tube containing K2 
EDTA (Becton, Dickinson and Company, Franklin Lakes, NJ, USA), left at room 
temperature for 15-min, and refrigerated for approximately 3-4 h before complete blood 
count analysis.  
Clinical Chemistry Analysis 
Whole blood samples were analyzed for complete blood count with platelet 
differentials (hemoglobin, hematocrit, red blood cell counts (RBC), white blood cell 
counts (WBC), lymphocytes, granulocytes (GRAN), and mid-range absolute count 
(MID) using a Abbott Cell Dyn 1800 (Abbott Laboratories, Abbott Park, IL, USA) 
automated hematology analyzer.  The internal quality control for Abbott Cell Dyn 1800 
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was performed using three levels of control fluids purchased from the manufacturer to 
calibrate acceptable standard deviation (SD) and coefficients of variation (CV) values for 
all aforementioned whole blood cell counts.  Serum samples were analyzed using a 
Cobas c111 (Roche Diagnostics GmbH, Indianapolis, IN, USA) automated clinical 
chemistry analyzer that was calibrated and optimized according to manufacturer 
guidelines.  This analyzer has been known to be highly valid and reliable in previously 
published reports (19).  Each serum sample was assayed for a standard partial metabolic 
panel [(aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total 
bilirubin)] and clinical markers of protein and fatty acid metabolism [(uric acid, 
creatinine, blood urea nitrogen (BUN), BUN:creatinine ratio, total protein, and creatine 
kinase (CK)].  The internal quality control for the Cobas c111 was performed using two 
levels of control fluids purchased from the manufacturer to calibrate acceptable SD and 
CV values for all aforementioned assays.  Samples were re-run if the observed values 
were outside control values and/or clinical norms according to standard procedures. 
Markers of Anabolic/Catabolic Hormone Status 
Serum samples were assayed using standard commercially available enzyme-
linked immunosorbent assay kits (ELISAs) for cortisol and testosterone (ALPCO 
Diagnostics, Salem, NH, USA) hormone analysis.  Serum concentrations were 
determined calorimetrically using a BioTek ELX-808 Ultramicroplate reader (BioTek 
Instruments Inc., Winooski, VT, USA) at an optical density of 450 nm against a known 
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standard curve using manufacturer recommended procedures.  Samples were run in 
duplicate according to standard procedures to ensure validity of measurement.   
Markers of Oxidative Stress 
Serum samples were assayed using standard commercially available ELISA kits 
for Superoxide Dismutase (SOD Activity Assay kit), Total Antioxidant Status (TAS, 
Antioxidant Assay kit), Thiobarbituric Acid Reactive Substance (TBARS, 
Malondialdehyde-MDA, TCA method kit) (Cayman Chemical Company, Ann Arbor, 
MI, USA), and Nitrotyrosine (ALPCO Diagnostics, Salem, NH, USA).  Serum 
concentrations for SOD and Nitrotyrosine were determined calorimetrically using a 
BioTek ELX-808 Ultramicroplate reader (BioTek Instruments Inc., Winooski, VT, USA) 
at an optical density of 450 nm against a known standard curve using standard 
procedures.  Serum concentrations for TAS were also determined calorimetrically using 
a BioTek ELX-808 Ultramicroplate reader (BioTek Instruments Inc., Winooski, VT, 
USA) at an optical density of 405 nm against a known standard curve using standard 
procedures.  Lastly, serum concentrations for TBARS were also determined 
fluorometrically using a SpectraMax Gemini multimode plate reader (Molecular Devices 
LLC, Sunnyvale, CA, USA) at an excitation wavelength of 530 nm and an emission 
wavelength of 550 nm against a known standard curve using standard procedures.  
Samples were run in duplicate according to standard procedures to ensure validity of 
measurement.   
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Cytokine/Chemokine Markers of Inflammation 
Serum markers of inflammation [(interleukin-1β (IL-1β), IL-2, IL-4, IL-5, IL-6, 
IL-7, IL-8, IL-10, IL-12p70, IL-13, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-
γ), and granulocyte-macrophage colony-stimulating factor (GM-CSF)] were measured 
by using a commercially available Milliplex MAP 13-Plex Human High Sensitivity T-
Cell Magnetic Bead Panel kit (EMD Millipore Corporation, St. Charles, MO, USA) that 
is optimized for human serum samples.  A minimum of 100 positive beads for each 
cytokine/chemokine is acquired with a Luminex MagPix instrument (Luminex 
Corporation, Austin, TX, USA).  This instrument has been proven to be highly valid and 
reliable in previously published reports across many disciplines (52, 83, 107, 201).  
Manufacture supplied controls were used to monitor the coefficients of variation.  
Samples were run in duplicate according to standard procedures to ensure validity of 
measurement.   
Statistical Analysis 
Individual group and time data presented throughout the dissertation text and in 
all tables as means (± SD), while group effects will be presented as means (± SEM).  All 
related variables were grouped and analyzed using repeated measures MANOVA in 
IBM SPSS Statistics Software version 22.0 for Windows (IBM Corporation, Armonk, 
NY, USA) to assess values observed and changes from pre-exercise levels in response to 
the supplement administered.  Any collected study variables determined to potentially 
affect study outcomes of other independent variables were implemented as a covariate in 
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subsequent ANCOVA analyses to ensure that significant changes reported are due to 
differences in supplementation treatment.  Post-hoc LSD pairwise comparisons were 
used to analyze any significance among groups where needed with Cohen’s d 
calculations employed to determine effect magnitude.  Data was considered statistically 
significant when the probability of error was less than 0.05 and will be considered to be 
trending when the probability of error was less than 0.10.  Statistical trends (p<0.05 
to p<0.10) were noted as is common practice in studies with relatively small sample size 
(165). 
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CHAPTER IV 
RESULTS
*
 
Tart Cherry Resistance 
Subject Baseline Characteristics 
 A total of 23 healthy, resistance-trained men completed the protocol for this 
study.  Participants were 20.9±2.6 years, 81.7±10.3 kg, 14.2±5.4% body fat, and 
63.9±8.6 kg fat free mass.  Participant demographic data are presented in Table 3.  One-
way ANOVA revealed no significant differences (p>0.05) in baseline demographic 
markers.  No significant differences in back squat 1-RM (p=0.70) and relative squat 
strength ratio (p=0.85) were reported across groups, hence the groups were generally 
well matched and differences observed.  One-way ANOVA analysis also demonstrated 
no differences in total work performed (p=0.79) across groups, indicating that similar 
work was performed during the exercise intervention and differences can likely be 
attributed to the nutritional intervention. 
Nutritional Intake and Compliance 
 Nutritional intake was monitored over a 4-d period within the first 7-d of 
supplementation.  Relevant nutritional components analyzed are listed in Table 4.  No 
statistically significant interactions were observed across groups with respect to dietary 
intake.   
                                                 
*
Portions reprinted from “Effects of powdered Montmorency tart cherry supplementation on an acute bout 
of intense lower body strength exercise in resistance trained males” by Levers K, Dalton R, Galvan, E, et 
al. 2015. Journal of the International Society of Sport Nutrition, 12, 1-23, Copyright 2015 by Kyle Levers. 
 148 
 
 
 
 
Table 3: Demographics by Study Group [Resistance] 
Variable Group Mean 
Group                                         
(SEM) p-value 
N                   P 12 n/a n/a 
TC 11 n/a 
 
Total 23 n/a   
Age 
(yrs)                    
P 20.58 ± 1.78 0.51 0.593 
TC 21.18 ± 3.34 1.01 
 
Total 20.87 ± 2.60 0.54   
Height                                                    
(cm) 
P 177 ± 5.28 1.52 0.651 
TC 178 ± 10.71 3.23 
 
Total 177 ± 8.17 1.70   
Weight                                              
(kg) 
P 82.62 ± 7.39 2.13 0.659 
TC 80.64 ± 13.16 3.97 
 
Total 81.67 ± 10.35 2.16   
Baseline HR                                            
(bpm) 
P 61.17 ± 10.40 3.00 0.195 
TC 66.09 ± 6.67 2.01 
 
Total 63.52 ± 8.98 1.87   
BMD                                                       
(g/cm
2
) 
P 1.16 ± 0.10 0.03 0.389 
TC 1.12 ± 0.14 0.04 
 
Total 1.14 ± 0.12 0.02   
LM                                                    
(kg) 
P 61.41 ± 4.87 1.41 0.970 
TC 61.55 ± 11.16 3.36 
 
Total 61.48 ± 8.27 1.73   
FFM                                                    
(kg) 
P 63.83 ± 5.06 1.46 0.981 
TC 63.92 ± 11.64 3.51 
 
Total 63.87 ± 8.62 1.80   
FM                                                         
(kg) 
P 11.81 ± 5.44 1.57 0.595 
TC 14.10 ± 13.58 4.09 
 
Total 12.90 ± 10.00 2.08   
Body Fat                                                               
(%) 
P 15.31 ± 6.27 1.81 0.338 
TC 13.09 ± 4.31 1.30 
 
Total 14.25 ± 5.42 1.13   
Back Squat 1-RM                              
(kg) 
P 144.2 ± 28.1 8.18 0.696 
TC 138.8 ± 37.2 11.21 
 
Total 142.0 ± 32.2 6.72   
Relative Squat Strength  
Ratio 
P 1.75 ± 0.27 0.08 0.855 
TC 1.73 ± 0.34 0.10 
 
Total 1.74 ± 0.30 0.06   
Workout Total Work  
(kJ) 
P 0.68 ± 0.14 0.04 0.798 
TC 0.70 ± 0.23 0.07 
 
Total 0.69 ± 0.18 0.04   
Mean data expressed as means ± SD. One-way ANOVA p-levels listed for each 
variable: * represents p<0.05 difference between groups, § represents p<0.10 
difference between groups. HR = heart rate; BMD = bone mineral density; LM = lean 
mass; FFM = free-fat mass; FM = fat mass; 1-RM = 1-Repetition maximum. 
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Muscle Soreness Perception Assessment 
 Table 5 presents perceptions of muscle soreness across the resistance exercise 
protocol.  The overall MANOVA analysis revealed a significant overall Wilks’ Lambda 
time (p<0.001) interaction and a non-significant overall group x time effect (p=0.20).  
Perception of muscle soreness in all three muscle testing locations irrespective of group 
significantly increased over time, peaking 48-h post-lift, indicating the onset of muscle 
soreness as a result of the lifting protocol.  A significant difference between groups over 
time was found in vastus lateralis (¼) soreness perception (p=0.024) where ratings 
increased by 55-170% from pre-lift values in P, but only 35-104% in TC over the 
recovery.  Post-hoc analysis indicated a significantly attenuated increase in muscle 
soreness perception 24-h post-lift for TC supplementing subjects compared to P (see 
Figure 5).  Effects of supplementation tended to be different in the perception of vastus 
medialis (¼) soreness (p=0.10) with significantly lower muscle soreness in TC versus P 
up to 48-h post-lift (see Figure 5).  Soreness perception ratings in the vastus medialis (¼) 
increased by 28-83% from pre-lift values in P, but ranged from a 6% decrease to only a 
58% increase in TC over the recovery. 
Isokinetic Maximal Voluntary Contraction Performance Assessment 
 Table 6 reports the total work performed during the 3-repetition isokinetic 
flexion/extension MVC test.  The overall MANOVA analysis revealed both a non-
significant Wilks’ Lambda time interaction (p=0.96) and a non-significant group x time 
effect (p=0.75).  The 3-repetition work summation univariate measures for extension 
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(p<0.001), flexion (p=0.022), and total (p<0.001) demonstrated significant changes over 
time, with the lowest work attained 60-min post-lift in all three measures. No aspect of 
the isokinetic strength recovery work performed demonstrated a significant group effect 
over time.   While changes from pre-lift were not statistically significant between groups 
across time, the drop in 3-repetition summation of flexion (p=0.21; d=0.45), extension 
(p=0.23; d=0.45), and total work (p=0.15; d=0.55) performed 60-min post-lift 
demonstrates a likely attenuation with a larger n-size in TC compared to P based upon  
 
 
Table 4: Dietary Analysis by Study Group [Resistance] 
Variable Group Mean 
Group                                         
(SEM) p-value 
Average Daily Caloric 
Consumption                          
(kcal) 
P 2617 ± 721 208 0.605 
TC 2455 ± 753 227 
 
Total 2540 ± 724 151   
Dietary Protein                                                   
(g) 
P 147.86 ± 43.13 12.45 0.871 
TC 153.06 ± 100.39 30.27 
 
Total 150.35 ± 74.28 15.49   
Dietary Carbohydrates                                         
(g) 
P 244.47 ± 62.58 18.07 0.460 
TC 223.52 ± 70.90 21.38 
 
Total 234.45 ± 66.01 13.76   
Dietary Fat                                            
(g) 
P 84.54 ± 23.55 6.80 0.427 
TC 95.23 ± 38.55 11.62 
 
Total 89.65 ± 31.35 6.54   
Dietary Beta-Carotene  
(mcg) 
P 2954 ± 3436 992 0.651 
TC 2111 ± 5260 1586 
 
Total 2551 ± 4320 901   
Dietary Vitamin C    
[Ascorbic Acid]                               
(mg)                            
P 80.79 ± 65.99 19.05 0.199 
TC 50.56 ± 38.41 11.58 
 
Total 66.33 ± 55.55 11.58   
Dietary Vitamin E                               
[Alpha-Tocopherol]                               
(mg) 
P 5.91 ± 6.04 1.74 0.910 
TC 6.24 ± 7.44 2.24 
 
Total 6.07 ± 6.59 1.37   
Mean data expressed as means ± SD. One-way ANOVA p-levels listed for each variable: * 
represents p<0.05 difference between groups, § represents p<0.10 difference between groups. 
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Table 5: Quadriceps Muscle Soreness Perception [Resistance] 
Variable Group Pre-Lift 60-min Post 24-hr Post 48-hr Post 
Group  
Mean p-value (GG) p-value (WSC) 
Algo I                
(cm) 
P 4.34 ± 2.52 5.53 ± 3.15 7.78 ± 2.93 7.94 ± 2.92 6.40 ± 0.76 G= 0.139    
TC 3.80 ± 2.86 3.59 ± 2.76 5.50 ± 2.68 5.99 ± 3.59 4.72 ± 0.79 T< 0.001* TL< 0.001* 
Time Mean 4.07 ± 0.56 4.56 ± 0.62 6.64 ± 0.59
Ψ◊
 6.96 ± 0.68
Ψ◊
       G X T= 0.236 G X Tq= 0.172 
Algo II              
(cm)             
P 2.44 ± 1.60 3.76 ± 2.24
Ψ
 6.60 ± 2.99^
Ψ◊
 6.20 ± 3.64
Ψ◊
 4.75 ± 0.69 G= 0.773    
TC 2.98 ± 2.70 4.03 ± 2.93
Ψ
 4.76 ± 3.03
Ψ
 6.07 ± 3.67
Ψ◊#
 4.46 ± 0.72 T< 0.001* TL< 0.001* 
Time Mean 2.71 ± 0.46 3.90 ± 0.54
Ψ
 5.68 ± 0.63
Ψ◊
 6.14 ± 0.76
Ψ◊
       G X T= 0.187 G X Tq= 0.024* 
Algo III                   
(cm)                                      
P 3.25 ± 2.65 3.42 ± 3.24 6.55 ± 3.80 6.18 ± 3.36 4.85 ± 0.81 G= 0.609    
TC 2.68 ± 2.67 3.76 ± 3.18 4.89 ± 3.87 5.64 ± 3.74 4.24 ± 0.85 T< 0.001* TL< 0.001* 
Time Mean 2.96 ± 0.55 3.59 ± 0.67 5.72 ± 0.80
Ψ◊
 5.91 ± 0.74
Ψ◊
       G X T= 0.427 G X TL= 0.690 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the participant soreness perception in 
the quadriceps muscle group at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x 
time (p=0.199).  Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-
Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance 
indicated by the following super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the 
following superscripts: ^ represents p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 60-min 
post, # represents p<0.05 difference from 24-hr post.  Algo I = Algometer location #1: Vastus Medalis 1/4; Algo II = Algometer location #2: Vastus Lateralis 1/4; Algo 
III = Algometer location #3: Vastus Lateralis 1/2; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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Figure 5. Perceptions of Muscle Soreness [Resistance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post. 
 
 
the moderate to large Cohen’s d effect size calculations.  Average recovery decreases in 
flexion, extension, and total work performance from pre-lift values were 5%, 19%, and 
14% respectively in P, but only 2%, 16%, and 10% in TC. 
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Table 6: Isokinetic Maximal Voluntary Contraction Knee Extension/Flexion Total Work Performance 
[Resistance] 
Variable Group Baseline Pre-Lift 60-min Post 24-hr Post 48-hr Post 
Group  
Mean p-value (GG) p-value (WSC) 
IK Total  
Extension  
Work (N) 
P 1791 ± 207 1682 ± 235 1278 ± 275 1408 ± 296 1387 ± 291 1509 ± 90 G= 0.870    
TC 1757 ± 378 1612 ± 437 1298 ± 422 1418 ± 463 1352 ± 383 1487 ± 94 T< 0.001* TL< 0.001* 
Time Mean 1774 ± 295 1648 ± 340
†
 1288 ± 345
†Ψ
 1413 ± 376
†Ψ◊
 1370 ± 331
†Ψ
       G X T= 0.792 G X Tq= 0.662 
IK Total  
Flexion  
Work (N) 
P 971 ± 126^ 962 ± 141^ 913 ± 174^ 925 ± 153^ 910 ± 113^
†
 936 ± 58 G= 0.181    
TC 1073 ± 252 1060 ± 277 1064 ± 225 1058 ± 305 1010 ± 289
†
 1053 ± 61 T= 0.087
§
 TL= 0.022* 
Time Mean 1020 ± 199 1009 ± 218 986 ± 210 989 ± 242 958 ± 217
†Ψ
       G X T= 0.663 G X Tq= 0.206 
IK Total  
Work (N) 
P 2762 ± 293 2644 ± 354 2191 ± 388 2333 ± 407 2296 ± 373 2445 ± 141 G= 0.646    
TC 2829 ± 611 2673 ± 687 2363 ± 603 2476 ± 733 2362 ± 644 2540 ± 148 T< 0.001* TL< 0.001* 
Time Mean 2794 ± 462 2658 ± 527
†
 2273 ± 498
†Ψ
 2401 ± 577
†Ψ◊
 2328 ± 509
†Ψ
       G X T= 0.692 G X Tq= 0.470 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the isokinetic MVC knee extension and 
flexion performance each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.960) and group x time (p=0.748).  
Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis 
and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following 
super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ 
represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0 .05 difference from pre-lift, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  IK = isokinetic; MVC = maximal voluntary contraction; G = group p-level; T = time p-level; 
G x T = interaction; q = quadratic p-level; L = linear p-level. 
 
 
 154 
 
 
 
Markers of Mechanical Damage and Physiological Stress 
 Table 7 presents the serum mechanical damage and physiological stress markers 
tested in the standard clinical safety panel.  The overall MANOVA analysis revealed a 
significant overall Wilks’ Lambda time (p<0.001) effect, but no difference between 
groups over time (p=0.50).  Univariate measures for uric acid (p<0.001), total bilirubin 
(p=0.026), creatinine (p=0.003), and total protein (p<0.001) demonstrated significant 
changes over time, peaking 60-min post-lift.  CK (p=0.025) and AST (p=0.003) also 
significantly changed over time, peaking 24-h post-lift.  Significant group differences 
over time and group by time changes from pre-lift were reported for creatinine (p=0.030, 
delta p=0.024) and total protein (p=0.018, delta p=0.006).  Analyzing the change from 
pre-lift levels, significant differences across groups for creatinine (p=0.007) and total 
protein (p=0.004) were also evident.  Serum creatinine increased on average 2% over 
pre-lift values during the recovery in P, but actually decreased 7% below pre-lift in TC.  
Serum total protein increased 2-9% over pre-lift values during the recovery in P, but 
decreased 0-4% below pre-lift in TC.  Subsequent post-hoc analysis indicated a 
significantly attenuated TC creatinine response 48-h post-lift and a TC total protein level 
that never differed from pre-lift measures 60-min and 48-h post-lift compared to 
deviations in P (see figure 6).  Increases in serum CK levels tended to be lower in TC 
over time compared to P (p=0.10).  Serum CK levels increased on average 135% over 
pre-lift values during the recovery in P, but increased only 98% in TC.  No other 
significant differences between groups over time or deviations from normal human  
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Figure 6. Markers of Protein Catabolism [Resistance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post. 
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Table 7: Markers of Muscle Catabolism, Secondary Muscle Damage, and Physiological Stress [Resistance] 
Variable Group Baseline Pre-Lift     60-min Post     24-hr Post     48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
AST                                
(U/L) 
P 31.85 ± 9.6 27.47 ± 6.40 30.79 ± 7.88 41.39 ± 13.3 37.67 ± 10.3 33.83 ± 2.19 G= 0.919    
TC 37.70 ± 17.6 28.39 ± 7.62 29.53 ± 6.46 40.59 ± 17.5 31.32 ± 11.5 33.51 ± 2.29 T= 0.003* Tq= 0.759 
Time Mean 34.78 ± 2.93 27.93 ± 1.46
†
 30.16 ± 1.51
Ψ
 40.99 ± 3.2
Ψ◊
 34.50 ± 2.2
Ψ#
       G X T= 0.316 G X TL= 0.162 
ALT                    
(U/L) 
P 33.81 ± 18.4 32.21 ± 12.2 34.19 ± 13.6 36.78 ± 14.9 35.80 ± 13.8 34.56 ± 4.19 G= 0.455    
TC 31.78 ± 13.2 30.01 ± 19.3 28.32 ± 15.8 31.08 ± 19.5 28.54 ± 17.4 29.94 ± 4.38 T= 0.529 TL= 0.180 
Time Mean 32.79 ± 3.41 31.11 ± 3.34 31.26 ± 3.07 33.93 ± 3.6
Ψ◊
 32.17 ± 3.27       G X T= 0.521 G X TL= 0.266 
Total Billirubin                  
(umol/L) 
P 8.00 ± 3.67 7.25 ± 3.47 9.08 ± 5.31 8.14 ± 3.82 7.35 ± 3.21 7.96 ± 1.01 G= 0.395    
TC 9.65 ± 3.85 9.98 ± 4.95 9.58 ± 4.01 9.79 ± 5.20 7.19 ± 3.21 9.24 ± 1.06 T= 0.064
§
 Tq= 0.026* 
Time Mean 8.83 ± 0.78 8.61 ± 0.89 9.33 ± 0.99 8.97 ± 0.95 7.27 ± 0.67
†Ψ◊#
       G X T= 0.306 G X TL= 0.125 
Urea/BUN                    
(mmol/L) 
P 6.59 ± 1.54 6.16 ± 1.74 6.07 ± 1.59 6.48 ± 1.96 5.92 ± 2.33 6.24 ± 0.44 G= 0.794 
  
TC 6.49 ± 1.39 6.75 ± 1.30 6.40 ± 1.33 6.59 ± 1.83 5.83 ± 1.66 6.41 ± 0.46 T= 0.061
§
 TL= 0.055
§
 
Time Mean 6.54 ± 0.31 6.46 ± 0.32 6.24 ± 0.31 6.53 ± 0.40 5.88 ± 0.43
†Ψ#
       G X T= 0.594 G X Tq= 0.238 
Creatinine                            
(umol/L) 
P 96.50 ± 13.2 97.19 ± 19.2 102.76 ± 17.2^ 98.91 ± 21.1^ 95.20 ± 17.7^
◊
 98.11 ± 4.05 G= 0.273 
 
  
TC 91.82 ± 11.9 96.84 ± 15.2 95.42 ± 14.3 91.52 ± 11.2 81.99 ± 14.8
†Ψ◊#
 91.52 ± 4.23 T= 0.004* Tq= 0.003* 
Time Mean 94.16 ± 2.64 97.02 ± 3.65 99.09 ± 3.33 95.21 ± 3.58 88.60 ± 3.4
†Ψ◊#
       G X T= 0.178 G X TL= 0.030* 
BUN/ 
Creatinine  
Ratio                          
P 17.11 ± 4.38 15.97 ± 3.99 14.82 ± 3.66 16.66 ± 5.67 15.50 ± 5.26 16.01 ± 1.08 G= 0.353    
TC 17.65 ± 3.76 17.51 ± 3.83 16.82 ± 3.74 17.85 ± 4.35 17.64 ± 3.80 17.50 ± 1.13 T= 0.214 Tq= 0.225 
Time Mean 17.37 ± 4.01 16.71 ± 3.90 15.78 ± 3.75
†Ψ
 17.23 ± 5.00 16.53 ± 4.64       G X T= 0.721 G X TL= 0.388 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the response to muscle catabolism, 
mechanical damage, and physiological stress at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and 
group x time (p=0.504).  Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the 
Greenhouse-Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with 
significance indicated by the following super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is 
indicated by the following superscripts: ^ represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents  p<0.05 
difference from pre-lift, ◊ represents p<0.05 difference from 60-min post, # represents p<0.05 difference from 24-hr post.  AST = Aspartate aminotransferase; ALT= 
Alanine aminotransferase; BUN = Blood urea nitrogen; CK = Creatine kinase; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-
level. 
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Table 7: Markers of Muscle Catabolism, Secondary Muscle Damage, and Physiological Stress [cont.] 
[Resistance] 
Variable Group Baseline Pre-Lift     60-min Post     24-hr Post     48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
Uric Acid   
(umol/L) 
P 328 ± 66 317 ± 66 444 ± 136 367 ± 80 349 ± 88 361 ± 20.37 G= 0.647    
TC 306 ± 52 310 ± 54 470 ± 117 350 ± 93 302 ± 79 347 ± 21.28 T< 0.001* Tq< 0.001* 
Time Mean 317 ± 12 314 ± 13 457 ± 27
†Ψ
 358 ± 18
†Ψ◊
 325 ± 17
◊#
       G X T= 0.298 G X Tq= 0.146 
CK                                       
(U/L) 
P 468 ± 288 322 ± 243 451 ± 267 967 ± 700 855 ± 981 613 ± 82 G= 0.487    
TC 843 ± 1156 259 ± 146 355 ± 198 770 ± 470 415 ± 213 529 ± 86 T= 0.025* Tq= 0.222 
Time Mean 656 ± 172 291 ± 42
†
 403 ± 49
Ψ
 869 ± 126
Ψ◊
 635 ± 151
Ψ
       G X T= 0.209 G X TL= 0.100
§
 
Total  
Protein            
(mmol/L) 
P 78.6 ± 6.11 67.5 ± 7.96^
†
 72.2 ± 6.47
†Ψ
 68.6 ± 9.45
†
 73.6 ± 11.11
†Ψ#
 72.1 ± 1.52 G= 0.305 
  
TC 80.5 ± 4.60 74.1 ± 2.62
†
 74.5 ± 4.18
†
 72.4 ± 6.72
†
 70.6 ± 7.92
†Ψ◊
 74.4 ± 1.59 T< 0.001* Tq< 0.001* 
Time Mean 79.6 ± 1.14 70.8 ± 1.26
†
 73.4 ± 1.15
†Ψ
 70.5 ± 1.72
†
 72.1 ± 2.03
†
       G X T= 0.091
§
 G X Tq= 0.018* 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the response to muscle catabolism, 
mechanical damage, and physiological stress at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) 
and group x time (p=0.504).  Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the 
Greenhouse-Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with 
significance indicated by the following super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is 
indicated by the following superscripts: ^ represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 
difference from pre-lift, ◊ represents p<0.05 difference from 60-min post, # represents p<0.05 difference from 24-hr post.  AST = Aspartate aminotransferase; ALT= 
Alanine aminotransferase; BUN = Blood urea nitrogen; CK = Creatine kinase; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear 
p-level. 
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clinical ranges were observed for kidney/liver enzymes [e.g. AST (p=0.16), ALT 
(p=0.27)] or markers of protein catabolism [bilirubin (p=0.12), BUN:creatinine ratio 
(p=0.39), uric acid (p=0.15)].  However, further post-hoc analyses revealed TC 
facilitated post-lift attenuations in bilirubin, AST, and ALT 48-h post-lift compared to P 
(see figures 6 and 7).   
Anabolic/Catabolic Hormone Response Markers 
 Table 8 shows the serum anabolic and catabolic hormone markers analyzed in 
response to exercise.  The overall MANOVA analyses revealed both non-significant 
overall Wilks’ Lambda time (p=0.29) and overall group changes across time (p=0.46).  
Cortisol levels tended to change over time (p=0.093).  Serum cortisol levels were 
significantly different between groups over time (p=0.029) and revealed how 
supplementation caused significant variability (p=0.032) in cortisol changes from pre-lift 
levels across the recovery period.  Serum cortisol levels increased on average 13% over 
pre-lift values during the recovery in P, but only 8% in TC.  The delta post-hoc analysis 
revealed that TC cortisol levels were not different from pre-lift levels and were 
significantly lower at 48-h post-lift compared to rising cortisol levels in P (see figure 7). 
Markers of Free Radical Production and Oxidative Stress 
 Table 9 reports the serum markers of free radical production [reactive oxygen 
species (ROS) and reactive nitrogen species (RNS)] analyzed in response to exercise.  
The overall MANOVA analysis revealed no significant overall Wilks’ Lambda time 
(p=0.32) interaction and no overall group differences over time (p=0.76).  None of the 
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Figure 7.  Physiological Stress and Secondary Muscle Damage Indices [Resistance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post.  
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Table 8: Anabolic/Catabolic Hormone Response [Resistance] 
Variable Group Baseline Pre-Lift    60-min Post      24-hr Post      48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
Cortisol                
(ug/dL) 
P 28.3 ± 13.1^ 23.3 ± 8.8 26.4 ± 7.3 25.1 ± 10.2^ 27.7 ± 11.2^ 26.2 ± 2.2 G= 0.167    
TC 21.5 ± 7.0 20.5 ± 7.9 26.8 ± 12.1
†
 19.7 ± 5.6
◊
 19.7 ± 6.8
◊
 21.6 ± 2.3 T= 0.093
§
 TL= 0.611 
Time Mean 24.9 ± 2.2 21.9 ± 1.7 26.6 ± 2.1
Ψ
 22.4 ± 1.7
◊
 23.7 ± 1.9       G X T= 0.170 G X Tq= 0.029* 
Testosterone               
(ng/mL)             
P 9.86 ± 3.46 9.37 ± 3.45 9.25 ± 2.92 10.17 ± 3.55 9.94 ± 3.42 9.72 ± 0.75 G= 0.025*    
TC 7.24 ± 2.22 7.17 ± 2.00 6.97 ± 1.95 7.20 ± 2.00 6.91 ± 1.70 7.10 ± 0.79 T= 0.428 Tq= 0.427 
Time Mean 8.55 ± 0.61 8.27 ± 0.60 8.11 ± 0.52 8.68 ± 0.61 8.42 ± 0.57       G X T= 0.556 G X TL= 0.174 
Test/Cort  
Ratio                                      
P 0.037 ± 0.009 0.043 ± 0.014 0.037 ± 0.013 0.045 ± 0.019 0.040 ± 0.018 0.040 ± 0.003 G= 0.538 
 
  
TC 0.037 ± 0.015 0.040 ± 0.020 0.031 ± 0.015 0.039 ± 0.013 0.040 ± 0.019 0.037 ± 0.004 T= 0.152 TL= 0.516 
Time Mean 0.037 ± 0.012 0.042 ± 0.017 0.034 ± 0.014 0.042 ± 0.016 0.040 ± 0.018       G X T= 0.815 G X Tq= 0.196 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the stress and sex hormone response at 
each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p=0.293) and group x time (p=0.458).  Univariate ANOVA p-
levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the 
within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following 
super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ 
represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  Test/Cort = Testosterone/Cortisol ratio; G = group p-level; T = time p-level; G x T = 
interaction; q = quadratic p-level; L = linear p-level. 
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univariate measures for markers of free radical production, lipid peroxidation, and 
antioxidant capacity/activity (NT, TBARS, TAS, and SOD) reported main time effects 
or differences between groups over time.  
Inflammatory Response Markers 
 Table 10 shows the serum inflammatory cytokine and chemokine markers 
analyzed in response to exercise.  The overall MANOVA analysis revealed a significant 
overall Wilks’ Lambda time (p<0.001) interaction, but a non-significant overall group x 
time effect (p=0.30).  Univariate measures for TNF-α (p=0.001), IL-1β (p=0.030), IL-6 
(p=0.023), and IL-8 (p=0.018) demonstrated significant changes over time and from 
baseline measures, peaking 24-h post-lift.  No significant differences between groups 
were observed over time for any of the inflammatory cytokines or chemokines. 
Anti-Inflammatory Response Markers 
 Table 11 presents the serum anti-inflammatory cytokine markers analyzed in 
response to exercise.  The overall MANOVA analysis revealed a significant overall 
Wilks’ Lambda time (p<0.001) interaction, but a non-significant overall effect of 
treatment over time (p=0.45).  Univariate measures for IL-4 (p=0.001) and IL-7 
(p=0.033) reported significant main time effects with IL-13 levels approaching 
significance across time (p=0.055), peaking 60-min post-lift.  No significant group 
effects over time were reported for any of the anti-inflammatory cytokine markers.   
Clinical Markers of Immune-Related Complete Blood Counts 
 Table 12 displays immune response-related complete blood count markers
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Table 9: Markers of Free Radical Production and Oxidative Stress [Resistance] 
Variable Group Baseline Pre-Lift 60-min Post     24-hr Post    48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
Nitrotyrosine                 
(nM) 
P 305 ± 267 306 ± 311 297 ± 289 297 ± 330 294 ± 305 300 ± 74 G= 0.940    
TC 303 ± 193 319 ± 254 277 ± 190 275 ± 202 283 ± 203 292 ± 78 T= 0.280 TL= 0.146 
Time Mean 304 ± 230 312 ± 279 288 ± 241 287 ± 270 289 ± 256
Ψ
       G X T= 0.613 G X TL= 0.483 
TBARS                  
(uM)             
P 7.84 ± 2.69 7.27 ± 2.91 8.60 ± 2.67 8.03 ± 3.34 8.43 ± 3.74 8.03 ± 0.81 G= 0.913    
TC 7.74 ± 4.24 8.24 ± 4.03 7.44 ± 3.84 8.19 ± 3.46 7.91 ± 3.35 7.90 ± 0.84 T= 0.937 TL= 0.539 
Time Mean 7.79 ± 3.44 7.73 ± 3.44 8.05 ± 3.26 8.10 ± 3.32 8.18 ± 3.49       G X T= 0.569 G X TL= 0.649 
TAS                                         
(mM) 
P 2.90 ± 1.34 2.83 ± 1.77 3.02 ± 1.85 2.95 ± 1.47 2.80 ± 1.81 2.90 ± 0.39 G= 0.752    
TC 2.69 ± 1.17 2.39 ± 1.14 2.99 ± 1.07 2.73 ± 1.36 2.81 ± 1.34 2.72 ± 0.41 T= 0.323 Tq= 0.419 
Time Mean 2.80 ± 1.23 2.62 ± 1.48 3.01 ± 1.49 2.84 ± 1.39 2.81 ± 1.57       G X T= 0.706 G X TL= 0.442 
SOD              
(U/mL) 
P 0.58 ± 0.07 0.59 ± 0.05 0.59 ± 0.09 0.56 ± 0.08 0.58 ± 0.06 0.58 ± 0.02 G= 0.668    
TC 0.55 ± 0.12 0.60 ± 0.09 0.54 ± 0.09 0.57 ± 0.10 0.57 ± 0.11 0.57 ± 0.02 T= 0.264 Tq= 0.827 
Time Mean 0.56 ± 0.10 0.60 ± 0.07
†
 0.57 ± 0.09 0.57 ± 0.08 0.58 ± 0.09       G X T= 0.335 G X TL= 0.784 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the response to reactive oxygen and 
nitrogen species production in addition to antioxidant activity at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda 
time (p=0.321) and group x time (p=0.756).  Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed 
first by the Greenhouse-Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time 
interaction with significance indicated by the following super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc 
analysis is indicated by the following superscripts: ^ represents p<0.05 difference between groups, † represents p<0.05  difference from baseline value, Ψ represents 
p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 60-min post, # represents p<0.05 difference from 24-hr post.  TBARS = Thiobarbituric acid reactive 
substances; TAS = Total antioxidant status; SOD = Superoxide dismutase; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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Table 10: Pro-inflammatory Cytokines and Chemokines [Resistance] 
Variable Group       Baseline        Pre-Lift   60-min Post     24-hr Post     48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value 
 (WSC) 
TNF-α                  
(pg/mL) 
P 2.82 ± 1.33 3.30 ± 1.59 3.33 ± 1.88 2.98 ± 1.45 2.85 ± 1.41 3.05 ± 0.36 G= 0.212    
TC 2.12 ± 0.92 2.55 ± 1.15 2.61 ± 1.00 2.44 ± 0.82 2.23 ± 0.94 2.39 ± 0.37 T= 0.003* Tq= 0.001* 
Time Mean 2.47 ± 0.24 2.92 ± 0.29
† 
 2.97 ± 0.32
†
  2.71 ± 0.25
◊
 2.54 ± 0.25
Ψ◊
       G X T= 0.873 G X TL= 0.649 
IFN-γ                   
(pg/mL) 
P 14.92 ± 31.51 18.91 ± 44.08 18.99 ± 44.51 21.33 ± 51.78 21.56 ± 51.82 19.14 ± 9.41 G= 0.365    
TC 6.19 ± 5.69 6.46 ± 5.01 7.12 ± 5.19 7.11 ± 5.98 5.78 ± 6.02 6.53 ± 9.83 T= 0.287 Tq= 0.136 
Time Mean 10.56 ± 4.83 12.68 ± 6.70 13.06 ± 6.77 14.22 ± 7.87 13.67 ± 7.88
#
       G X T= 0.314 G X TL= 0.295 
IL-1β                    
(pg/mL) 
P 0.77 ± 0.32 0.84 ± 0.35 0.87 ± 0.39 0.83 ± 0.38 0.83 ± 0.35 0.83 ± 0.10 G= 0.048*    
TC 0.75 ± 0.35 0.75 ± 0.34 0.82 ± 0.26 0.85 ± 0.30 0.82 ± 0.34 0.80 ± 0.10 T= 0.047* Tq= 0.030* 
Time Mean 0.76 ± 0.07 0.80 ± 0.07
†
  0.85 ± 0.07
†
  0.84 ± 0.07 0.82 ± 0.07       G X T= 0.411 G X Tq= 0.488 
IL-2                   
(pg/mL) 
P 1.86 ± 1.86 2.00 ± 2.18 1.97 ± 2.16 1.91 ± 2.15 1.87 ± 2.09 1.92 ± 0.71 G= 0.956 
  
TC 1.70 ± 2.96 1.73 ± 2.73 2.06 ± 2.65 2.26 ± 3.13 2.15 ± 3.03 1.98 ± 0.74 T= 0.292 TL= 0.214 
Time Mean 1.78 ± 0.51 1.87 ± 0.51 2.02 ± 0.50 2.08 ± 0.56 2.01 ± 0.54       G X T= 0.230 G X TL= 0.163 
IL-6                              
(pg/mL) 
P 1.19 ± 0.95 1.34 ± 1.36 1.61 ± 1.60 1.33 ± 1.38 1.26 ± 1.21 1.35 ± 0.37 G= 0.724    
TC 0.87 ± 1.34 1.09 ± 1.31 1.54 ± 1.38 1.20 ± 1.49 1.07 ± 1.43 1.16 ± 0.39 T= 0.020* Tq= 0.023* 
Time Mean 1.03 ± 0.24 1.22 ± 0.28 1.57 ± 0.31
†Ψ
 1.27 ± 0.30
†
 1.17 ± 0.28
◊#
       G X T= 0.761 G X TL= 0.512 
IL-8                          
(pg/mL) 
P 4.25 ± 3.99 5.07 ± 5.74 5.04 ± 6.16 5.16 ± 6.41 4.94 ± 6.32 4.89 ± 1.23 G= 0.496    
TC 2.95 ± 1.56 3.45 ± 1.75 4.14 ± 1.29 4.02 ± 1.78 3.74 ± 1.91 3.66 ± 1.28 T= 0.042* Tq= 0.018* 
Time Mean 3.60 ± 0.64 4.26 ± 0.90
† 
 4.59 ± 0.95
†
 4.59 ± 1.00 4.34 ± 0.99       G X T= 0.697 G X TL= 0.736 
IL-12p70   
(pg/mL) 
P 2.27 ± 4.13 3.03 ± 6.51 3.05 ± 6.63 3.01 ± 6.42 2.78 ± 5.68 2.83 ± 1.33 G= 0.577    
TC 1.70 ± 2.67 1.76 ± 2.59 1.68 ± 2.15 1.91 ± 2.76 1.66 ± 2.61 1.74 ± 1.39 T= 0.279 Tq= 0.264 
Time Mean 1.99 ± 0.73 2.39 ± 1.05 2.37 ± 1.05 2.46 ± 1.05 2.22 ± 0.94       G X T= 0.377 G X TL= 0.351 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the pro-inflammatory response at each 
test session during the 10 day intervention. MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.302).  Univariate ANOVA p-levels 
from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the within-
subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following super/subscripts: * 
indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ represents p<0.05 
difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 60-
min post, # represents p<0.05 difference from 24-hr post.  TNF-α = Tumor necrosis factor alpha; IFN-γ = Interferon gamma; IL = interleukin; G = group p-level; T = time 
p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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analyzed in response to exercise.  The overall MANOVA analysis demonstrated 
significant overall Wilks’ Lambda time interaction (p<0.001), but a non-significant 
overall difference between groups over time (p=0.68).  Univariate measures for 
lymphocytes (p<0.001) and MID (p<0.001) demonstrated significant changes over time 
and from baseline measures, most depressed 60-min post-lift.  WBC (p=0.004) and 
GRAN (p=0.003) also significantly changed over time, with lowest values 48-h post-lift.  
MID levels tended to be different between groups over time (p=0.062).  Significant 
group changes over time (p=0.015) and differences in group effects from pre-lift levels 
over the recovery period (p=0.013) were reported for lymphocytes.  Lymphocyte levels 
decreased on average 23% below pre-lift values during the recovery in P, but only 11% 
in TC.  Subsequent post-hoc analysis showed a significantly greater lymphocyte counts 
24-h and 48-h post-lift in TC compared to P, but unlike those supplementing with P, TC 
lymphocyte counts returned to pre-lift values by the end of the recovery (48-h post-lift).  
A significant group effect over time was also reported for WBC (p=0.020).  WBC 
decreased on average 8% below pre-lift values during the recovery in P, but only 3% in 
TC.  Post-hoc analysis demonstrated significant WBC differences pre-lift, 24-h, and 48-
h post-lift between TC and P that became insignificant once changes were calculated 
from pre-lift levels. 
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Table 11: Anti-inflammatory Cytokines [Resistance] 
Variable Group    Baseline         Pre-Lift 60-min Post 24-hr Post 48-hr Post 
Group  
Mean p-value (GG) p-value (WSC) 
IL-4            
(pg/mL)             
P 6.03 ± 3.18 7.86 ± 5.06 8.26 ± 5.22 7.44 ± 4.95 7.83 ± 5.10 7.48 ± 1.05 G= 0.273    
TC 4.16 ± 1.91 5.45 ± 2.04 6.38 ± 2.49 6.36 ± 2.45 6.54 ± 3.01 5.78 ± 1.09 T= 0.001* Tq= 0.001* 
Time Mean 5.10 ± 0.55 6.65 ± 0.82
†
 7.32 ± 0.87
†
 6.90 ± 0.83
†◊
 7.19 ± 0.88
†
       G X T= 0.421 G X TL= 0.405 
IL-5               
(pg/mL) 
P 0.69 ± 0.37 0.70 ± 0.41 0.70 ± 0.46 0.64 ± 0.37 0.65 ± 0.40 0.68 ± 0.11 G= 0.749    
TC 0.75 ± 0.43 0.72 ± 0.40 0.71 ± 0.37 0.77 ± 0.43 0.70 ± 0.42 0.73 ± 0.12 T= 0.716 TL= 0.325 
Time Mean 0.72 ± 0.08 0.71 ± 0.09 0.70 ± 0.09 0.71 ± 0.08 0.68 ± 0.09       G X T= 0.438 G X TL= 0.582 
IL-7                
(pg/mL) 
P 4.73 ± 2.19 5.41 ± 2.49 5.94 ± 3.71 5.52 ± 2.75 5.46 ± 2.57 5.41 ± 0.63 G= 0.414    
TC 4.15 ± 1.86 4.45 ± 2.00 5.31 ± 2.18 4.91 ± 1.61 4.47 ± 1.54 4.66 ± 0.65 T= 0.041* Tq= 0.033* 
Time Mean 4.44 ± 0.43 4.93 ± 0.48
†
 5.62 ± 0.64
†
 5.21 ± 0.48
†
 4.97 ± 0.45
†
       G X T= 0.843 G X TL= 0.757 
IL-10             
(pg/mL) 
P 4.52 ± 3.85 3.69 ± 1.82 4.21 ± 1.92 3.48 ± 1.70 3.45 ± 1.74 3.87 ± 0.56 G= 0.869    
TC 2.77 ± 1.74 3.49 ± 2.03 6.02 ± 5.70 3.33 ± 2.54 3.07 ± 2.54 3.74 ± 0.59 T= 0.103
§
 Tq= 0.157 
Time Mean 3.65 ± 0.63 3.59 ± 0.40 5.12 ± 0.87
Ψ
 3.41 ± 0.45 3.26 ± 0.45       G X T= 0.182 G X Tq= 0.120 
IL-13             
(pg/mL) 
P 3.30 ± 2.89 3.33 ± 3.30 3.40 ± 3.48 3.24 ± 3.64 3.27 ± 3.56 3.31 ± 0.78 G= 0.449    
TC 1.96 ± 1.74 2.26 ± 1.66 2.75 ± 2.09 2.78 ± 2.18 2.45 ± 2.34 2.44 ± 0.81 T= 0.393 Tq= 0.055
§
 
Time Mean 2.63 ± 0.50 2.80 ± 0.55 3.08 ± 0.61 3.01 ± 0.63 2.86 ± 0.64       G X T= 0.402 G X Tq= 0.133 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the anti-inflammatory response at 
each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.447).  Univariate ANOVA 
p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the 
within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following 
super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ 
represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  IL = interleukin; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-
level; L = linear p-level. 
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Table 12: Markers of Immune-Related Complete Blood Counts [Resistance] 
Variable Group          Baseline           Pre-Lift       60-min Post       24-hr Post        48-hr Post 
Group  
Mean p-value (GG) p-value (WSC) 
LYMPH               
(K/uL) 
P 1.93 ± 0.54 2.21 ± 0.69 1.45 ± 0.43
†Ψ
 1.86 ± 0.71^
Ψ◊
 1.78 ± 0.48^
Ψ◊
 1.85 ± 0.20 G= 0.311    
TC 2.09 ± 0.86 2.36 ± 1.05
†
 1.49 ± 0.58
†Ψ
 2.62 ± 1.51
†Ψ◊
 2.15 ± 0.78
◊#
 2.14 ± 0.21 T< 0.001* Tq= 0.136 
Time Mean 2.01 ± 0.15 2.28 ± 0.18
†
 1.47 ± 0.11
†Ψ
 2.24 ± 0.24
◊
 1.97 ± 0.13
Ψ◊
       G X T= 0.143 G X TL= 0.015* 
WBC                
(K/uL)             
P 5.88 ± 1.23 6.61 ± 2.21^ 6.38 ± 1.45 6.16 ± 1.62^ 5.75 ± 1.61^ 6.16 ± 0.40 G= 0.337    
TC 5.54 ± 1.25 7.18 ± 2.03
†
 6.98 ± 2.04
†
 7.40 ± 2.17
†
 6.55 ± 1.23
†#
 6.73 ± 0.42 T= 0.004* Tq= 0.004* 
Time Mean 5.71 ± 0.26 6.90 ± 0.44
†
 6.68 ± 0.37
†
 6.78 ± 0.40
†
 6.15 ± 0.30
Ψ
       G X T= 0.207 G X TL= 0.020* 
MID                               
(K/uL) 
P 0.43 ± 0.12 0.64 ± 0.19 0.43 ± 0.14 0.53 ± 0.13 0.48 ± 0.13 0.50 ± 0.03 G= 0.866    
TC 0.42 ± 0.10 0.61 ± 0.24 0.38 ± 0.10 0.60 ± 0.19 0.55 ± 0.16 0.51 ± 0.03 T< 0.001* TL= 0.100
§
 
Time Mean 0.43 ± 0.02 0.63 ± 0.05
†
 0.41 ± 0.03
Ψ
 0.56 ± 0.03
†◊
 0.51 ± 0.03
†Ψ◊
       G X T= 0.324 G X TL= 0.062
§
 
GRAN                   
(K/uL) 
P 3.50 ± 0.97 3.76 ± 1.47 4.51 ± 1.20 3.78 ± 1.33 3.48 ± 1.32 3.80 ± 0.33 G= 0.577    
TC 3.04 ± 0.48 4.22 ± 1.77 5.11 ± 2.35 4.17 ± 1.61 3.84 ± 0.98 4.08 ± 0.35 T< 0.001* Tq= 0.002* 
Time Mean 3.27 ± 0.16 3.99 ± 0.34
†
 4.81 ± 0.38
†Ψ
 3.97 ± 0.31
†◊
 3.66 ± 0.03
◊
       G X T= 0.332 G X TL= 0.119 
GM-CSF                                        
(pg/mL) 
P 8.12 ± 8.23 8.18 ± 8.33 7.87 ± 7.38 7.54 ± 7.67 7.39 ± 7.49 7.82 ± 2.71 G= 0.512    
TC 10.37 ± 11.40 10.51 ± 10.83 10.52 ± 10.48 10.67 ± 11.19 10.09 ± 10.89 10.43 ± 2.83 T= 0.446 TL= 0.277 
Time Mean 9.24 ± 2.06 9.34 ± 2.00 9.20 ± 1.88 9.10 ± 1.99 8.74 ± 1.93       G X T= 0.624 G X TL= 0.450 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents immune cellular response markers at 
each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.684).  Univariate ANOVA p-
levels from MANOVA analysis are presented for each variable. Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the 
within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following 
super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ 
represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  LYMPH = Lymphocytes; WBC = White blood cell; MID = Mid-range absolute count; GRAN 
= Granulocyte absolute count; GM-CSF = Granulocyte-macrophage colony-stimulating factor; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-
level; L = linear p-level. 
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Tart Cherry Endurance 
Subject Baseline Characteristics 
 A total of 27 healthy, endurance trained or triathlete men (n=18) and women 
(n=9) completed the study protocol.  Participants were 21.8±3.9 years, 67.4±11.8 kg, 
15.0±6.0% body fat, and 51.2±11.4 kg fat free mass.  Participant demographic data are 
presented in Table 13.  One-way ANOVA revealed no significant differences (p>0.05) 
in baseline demographic or anthropometric markers.  Specifically, no significant 
differences in resting heart rate (p=0.70) were reported across groups, hence the groups 
were generally well matched and endurance trained.  Observed differences can likely be 
attributed to the nutritional intervention. 
Nutritional Intake and Compliance 
 Table 14 lists relevant nutrition components analyzed in the 4-d dietary recall 
completed by all subjects during the first 7-d of supplementation.  According to the data 
listed in Table 14, P group tended to consume a smaller amount of average daily calories 
compared to the TC group (31.0 kcal/kg vs. 37.4 kcal/kg, p=0.094).  This differential is 
likely due dropped subjects (see Figure 3) causing a greater proportion of females in the 
placebo group (nf=3/11, 27.3%) versus the powdered tart cherry group (nf=6/16, 37.5%).  
Stratifying the statistical dietary analysis by gender within each group, average daily 
calorie (p=0.441) and dietary carbohydrate (p=0.644) consumption was the same across 
groups.  No other statistically significant interactions were observed across groups with 
respect to dietary intake.  
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Table 13: Demographics by Study Group 
[Endurance] 
Variable Group Mean 
Group                                         
(SEM) p-value 
N                   P 16 n/a n/a 
TC 11 n/a 
 
Total 27 n/a   
Age 
(yrs)                    
P 22.44 ± 4.86 1.214 0.305 
TC 20.82 ± 1.89 0.569 
 
Total 21.78 ± 3.95 0.761   
Height                                                    
(cm) 
P 173 ± 11.43 2.851 0.592 
TC 175 ± 8.59 2.589 
 
Total 174 ± 10.25 1.972   
Weight                                              
(kg) 
P 65.48 ± 12.07 3.018 0.317 
TC 70.17 ± 11.25 3.392 
 
Total 67.39 ± 11.76 2.263   
Baseline HR                                            
(bpm) 
P 58.50 ± 9.02 2.255 0.703 
TC 59.64 ± 4.46 1.343 
 
Total 58.96 ± 58.96 1.426   
BMD                                                       
(g/cm
2
) 
P 1.04 ± 0.11 0.028 0.458 
TC 1.08 ± 0.13 0.038 
 
Total 1.06 ± 0.12 0.023   
FFM                                                    
(kg) 
P 48.67 ± 11.32 2.830 0.171 
TC 54.85 ± 11.01 3.319 
 
Total 51.19 ± 11.41 2.195   
FM                                                         
(kg) 
P 9.81 ± 3.20 0.801 0.085
§
 
TC 7.76 ± 2.44 0.735 
 
Total 2.44 ± 3.04 0.585   
Body Fat                                                               
(%) 
P 16.87 ± 6.40 1.599 0.051
§
 
TC 12.31 ± 4.42 1.333 
 
Total 15.01 ± 6.03 1.160   
Mean data expressed as means ± SD. Data represents general study 
population demographics and anthropometric measures. One-way 
ANOVA p-levels listed for each variable: * represents p<0.05 difference 
between groups, § represents p<0.10 difference between groups. HR = 
heart rate; BMD = bone mineral density; LM = lean mass; FFM = free-fat 
mass; FM = fat mass. 
 
Half-Marathon Performance Measures 
 Table 15 presents half-marathon split and finish times in addition to projected 
versus actual average race paces as records of endurance performance.  There was no 
difference in projected race finish times between groups (p=0.304).  Subjects in the TC 
group had faster half-marathon split (p=0.002) and race finish times (p=0.001) 
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Table 14: Relative Dietary Analysis by Study Group 
[Endurance] 
Variable Group Mean 
Group                                         
(SEM) p-value 
Average Daily Caloric 
Consumption                          
(kcal/kg) 
P 30.89 ± 8.75 2.19 0.094
§
 
TC 37.71 ± 11.65 3.51 
 
Total 33.67 ± 10.40 2.00   
Dietary Protein                                                   
(g/kg) 
P 1.29 ± 0.56 0.14 0.146 
TC 1.62 ± 0.58 0.17 
 
Total 1.42 ± 0.58 0.11   
Dietary Carbohydrates                                         
(g/kg) 
P 3.54 ± 1.50 0.37 0.138 
TC 4.57 ± 2.00 0.60 
 
Total 3.96 ± 1.76 0.34   
Dietary Fat                                            
(g/kg) 
P 1.24 ± 0.49 0.12 0.886 
TC 1.27 ± 0.72 0.22 
 
Total 1.25 ± 0.58 0.11   
Dietary Beta-Carotene  
(mcg/kg) 
P 38.01 ± 71.15 17.79 0.611 
TC 54.22 ± 92.29 27.83 
 
Total 44.62 ± 79.13 15.23   
Dietary Vitamin C    
[Ascorbic Acid]                               
(mg/kg)                            
P 0.92 ± 0.69 0.17 0.277 
TC 1.46 ± 1.78 0.54 
 
Total 1.14 ± 1.25 0.24   
Dietary Vitamin E                               
[Alpha-Tocopherol]                               
(mg/kg) 
P 0.099 ± 0.095 0.024 0.853 
TC 0.106 ± 0.107 0.032 
 
Total 0.102 ± 0.098 0.019   
Mean data expressed as means ± SD. Data represents nutritional analysis from 
subject 4-d dietary records accounting for subject body mass as a computation of 
relative dietary components.  One-way ANOVA p-levels listed for each variable: * 
represents p<0.05 difference between groups, § represents p<0.10 difference 
between groups.  
 
 
corresponding to a quicker overall race pace compared to P.  There was an increase in 
actual race pace over projected race pace across both groups (p<0.001), but the 
difference between projected versus actual race pace tended to be smaller (p=0.091) in 
TC compared to P.  Due to the significant difference in race performance and thus 
running intensity, half-marathon finish time was used as a covariate in subsequent 
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ANCOVA analyses to determine if other statistical outcomes were attributed to running 
intensity or to supplementation.   
 
 
Table 15: Running Performance by Study Group 
[Endurance] 
Variable Group Mean 
Group                                         
(SEM) p-value 
½ Marathon Split Time  
(min) 
P 54.30 ± 4.18 1.045 0.002* 
TC 49.03 ± 3.65 1.099 
 
Total 52.15 ± 4.71 0.906   
½ Marathon Finish Time  
(min) 
P 118 ± 9.72 2.429 0.001* 
TC 103 ± 9.28 2.798 
 
Total 112 ± 11.86 2.283   
½ Marathon Projected  
Race Pace (min/km) 
 
P 12.00 ± 1.28 0.338 0.304 
TC 11.45 ± 1.45 0.407  
Total 11.77 ± 1.35 0.264  
½ Marathon Actual  
Race Pace (min/km) 
 
P 14.48 ± 1.19 0.293 0.002* 
TC 12.70 ± 1.14 0.354  
Total 13.76 ± 1.45 0.230  
Mean data expressed as means ± SD.  Data represents ½ marathon race 
performance.  Data represents the half-marathon performance measures.  Half-
marathon projected race pace figures were calculated based upon subjects’ self-
reported previous endurance running race performances.  The overall MANOVA 
analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.091).  
Univariate ANOVA p-levels from the MANOVA analysis are presented for both 
pacing variables. One-way ANOVA p-levels listed for each timing variable: * 
represents p<0.05 difference between groups, § represents p<0.10 difference 
between groups.  
 
 
 
Markers of Mechanical Damage and Physiological Stress 
 Table 16 presents the serum mechanical damage and physiological stress markers 
tested in the standard clinical safety panel.  The overall MANOVA analysis revealed a 
significant Wilks’ Lambda time (p<0.001) effect, but a non-significant difference 
between groups over time (p=0.70).  All of the univariate measures for markers of 
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muscle damage and physiological stress reported significant changes over time.  
Univariate measures for serum creatinine (p=0.087), urea/BUN (p=0.095), and total 
protein (p=0.066) approached statistical significance in differences between groups over 
time.  Serum creatinine and urea/BUN makers increased on average 19% and 21%, 
respectively, over pre-run values during the recovery in P, but only 6% and 3% in TC.  
Serum total protein content increased on average 4% over pre-run values during the 
recovery in P, but actually decreased 3% below pre-lift in TC.  Accounting for running 
intensity differences, ANCOVA revealed that serum creatinine, urea/BUN, and total 
protein all maintained significant group differences over time.  Analyzing the change 
from pre-run levels demonstrated significant (or approaching significant trends) changes 
across groups and group differences over time for creatinine (p=0.047, group p=0.007), 
urea/BUN (p=0.048, group p=0.004), and total protein (p=0.081, group p=0.060) that 
were further supported by ANCOVA analyses accounting for running intensity.  
Subsequent post-hoc analysis indicated a significantly attenuated serum creatinine levels 
60-min post-run in TC and a moderated urea/BUN response in TC compared to P 24-h 
post-run (see figure 8).  The total protein response never increased above pre-run levels 
over the 48-h recovery in TC compared to significant elevations in P markers of total 
protein 60-min and 48-h post-run (see figure 9). 
Anabolic/Catabolic Hormone Response Markers  
 Table 17 shows the serum anabolic and catabolic hormone markers analyzed in 
response to exercise.  The overall MANOVA analysis revealed a significant Wilks’ 
 172 
 
 
 
 
Table 16: Markers of Muscle Catabolism, Secondary Muscle Damage, and Physiological Stress 
[Endurance]    
Variable Group Baseline Pre-Run     60-min Post     24-hr Post     48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
RFT Covariate                   
p-value (WSC) 
AST                                
(U/L) 
P 32.69 ± 33.67 26.62 ± 14.97 37.20 ± 17.36 50.52 ± 22.96 43.33 ± 16.68 38.07 ± 3.98 G= 0.911    G= 0.402 
TC 29.46 ± 10.54 26.30 ± 7.48 36.96 ± 9.68 49.97 ± 31.12 44.14 ± 24.60 37.37 ± 4.80 T= 0.002* TL= 0.005* Tq= 0.593 
Time Mean 31.08 ± 5.27 26.46 ± 2.45 37.08 ± 2.89
†Ψ
 50.25 ± 5.20
†Ψ◊
 43.74 ± 3.96
†Ψ#
       G X T= 0.859 G X Tq= 0.740 G X TL= 0.707 
ALT                    
(U/L) 
P 22.09 ± 13.55 20.32 ± 7.15 23.65 ± 8.04 26.42 ± 7.36 28.53 ± 8.02 24.20 ± 2.15 G= 0.576    G= 0.057§ 
TC 23.06 ± 8.22 23.13 ± 10.39 26.36 ± 10.22 27.94 ± 14.22 30.07 ± 14.80 26.11 ± 2.59 T= 0.008* TL= 0.006* Tq= 0.677 
Time Mean 22.57 ± 2.29 21.73 ± 1.68 25.01 ± 1.76
Ψ
 27.18 ± 2.09
Ψ◊
 29.30 ± 2.20
†Ψ◊#
       G X T= 0.842 G X Tq= 0.603 G X TL= 0.869 
Total 
Billirubin                  
(umol/L) 
P 9.01 ± 2.87 8.15 ± 3.03 13.03 ± 4.68 8.44 ± 4.06 7.65 ± 3.45 9.25 ± 0.76 G= 0.756    G= 0.614 
TC 8.71 ± 4.64 7.60 ± 3.75 11.65 ± 4.50 8.99 ± 4.22 7.46 ± 2.75 8.88 ± 0.91 T< 0.001* Tq= 0.001* Tq= 0.484 
Time Mean 8.86 ± 0.72 7.88 ± 0.65 12.34 ± 0.90
†Ψ
 8.71 ± 0.81
◊
 7.55 ± 0.62
◊
       G X T= 0.699 G X TL= 0.694 G X Tq= 0.591 
Urea/ 
BUN                    
(mmol/L) 
P 4.75 ± 1.08 5.45 ± 1.36 6.36 ± 1.14 7.13 ± 1.15 6.33 ± 1.44 6.00 ± 0.21 G= 0.857  G= 0.426 
TC 5.11 ± 0.69 6.02 ± 1.17 6.16 ± 1.01 6.40 ± 1.44 6.03 ± 1.58 5.94 ± 0.26 T< 0.001* TL< 0.001* TL= 0.026* 
Time Mean 4.93 ± 0.19 5.74 ± 0.25
†
 6.26 ± 0.21
†Ψ
 6.77 ± 0.25
†Ψ
 6.18 ± 0.29
†#
       G X T= 0.144 G X TL= 0.095
§
 G X TL= 0.014* 
Creatinine                            
(umol/L) 
P 71.71 ± 15.07 74.29 ± 11.54 106.56 ± 15.45
†Ψ
 79.85 ± 10.88
†◊
 78.20 ± 11.17
†
 82.12 ± 3.12 G= 0.651    G= 0.522 
TC 77.20 ± 15.93 82.29 ± 13.96 100.44 ± 25.52
†Ψ
 81.54 ± 15.08
◊
 80.34 ± 12.72 84.36 ± 3.77 T< 0.001* Tq< 0.001* TL= 0.007* 
Time Mean 74.45 ± 3.02 78.29 ± 2.46 103.50 ± 3.94
†Ψ
 80.70 ± 2.49
†◊
 79.27 ± 2.31
◊
       G X T= 0.087
§
 G X TL= 0.246 G X TL= 0.010* 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the response to muscle 
catabolism, mechanical damage, and physiological stress at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' 
Lambda time (p<0.001) and group x time (p=0.504).  Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate 
ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential 
shape of the time or group x time interaction with significance indicated by the following super/subscripts: * indicates p<0.05 p-level significance,  § 
indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ represents p<0.05 difference between groups, 
† represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 60-min post, # 
represents p<0.05 difference from 24-hr post.  AST = Aspartate aminotransferase; ALT= Alanine aminotransferase; BUN = Blood urea nitrogen; CK = 
Creatine kinase; RFT = race finish time; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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Table 16: Markers of Muscle Catabolism, Secondary Muscle Damage, and Physiological Stress [cont.] 
[Endurance] 
Variable Group Baseline Pre-Run     60-min Post     24-hr Post     48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
RFT Covariate                   
p-value(WSC) 
BUN/ 
Creatinine  
Ratio                          
P 16.60 ± 3.05 18.58 ± 5.58 15.22 ± 4.38 22.49 ± 4.61 20.36 ± 5.29 18.65 ± 0.90 G= 0.589    G= 0.329 
TC 16.97 ± 3.87 18.33 ± 3.50 15.80 ± 3.53 19.50 ± 3.61 18.79 ± 5.26 17.88 ± 1.09 T< 0.001* TL= 0.001* Tq= 0.240 
Time Mean 16.75 ± 3.34 18.48 ± 4.77 15.46 ± 3.99
Ψ
 21.27 ± 4.41
†Ψ◊
 19.72 ± 5.23
†◊#
       G X T= 0.158 G X TL= 0.140 G X TL= 0.103
§ 
Uric Acid   
(umol/L) 
P 271 ± 46 292 ± 44 373 ± 48 321 ± 48 308 ± 47 313 ± 11 G= 0.789    G= 0.724 
TC 290 ± 50 308 ± 52 364 ± 64 326 ± 82 302 ± 65 318 ± 14 T< 0.001* Tq< 0.001* TL= 0.014* 
Time Mean 280 ± 9 300 ± 9
†
 369 ± 11
†Ψ
 324 ± 13
†Ψ◊
 305 ± 11
†◊#
       G X T= 0.444 G X TL= 0.188 G X TL= 0.015* 
CK                                       
(U/L) 
P 606 ± 1696 276 ± 510 532 ± 627 907 ± 683 593 ± 525 583 ± 144 G= 0.626    G= 0.806 
TC 298 ± 317 228 ± 191 474 ± 253 870 ± 771 490 ± 395 472 ± 173 T= 0.036* TL= 0.139 Tq= 0.836 
Time Mean 452 ± 260 252 ± 81 503 ± 100
Ψ
 889 ± 141
Ψ◊
 541 ± 93
Ψ#
       G X T= 0.680 G X Tq= 0.416 G X Tq= 0.599 
Total  
Protein            
(mmol/L) 
P 67.51 ± 8.56 72.93 ± 5.41
†
 76.78 ± 4.95
†
 70.77 ± 5.35
◊
 80.21 ± 6.48
†Ψ#
 73.64 ± 0.87 G= 0.746    G= 0.846 
TC 68.70 ± 8.06 76.28 ± 4.78
†
 74.94 ± 8.85
†
 67.83 ± 4.52
◊
 78.20 ± 6.84
†#
 73.19 ± 1.05 T< 0.001* TL< 0.001* TL= 0.008* 
Time Mean 68.11 ± 1.64 74.61 ± 1.01
†
 75.86 ± 1.33
†
 69.30 ± 0.99
Ψ◊
 79.20 ± 1.30
†Ψ◊#
       G X T= 0.316 G X TL= 0.066
§
 G X TL= 0.004* 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the response to muscle 
catabolism, mechanical damage, and physiological stress at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' 
Lambda time (p<0.001) and group x time (p=0.504).  Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate 
ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential 
shape of the time or group x time interaction with significance indicated by the following super/subscripts: * indicates p<0.05 p-level significance,  § 
indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ represents p<0.05 difference between groups, 
† represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 60-min post, # 
represents p<0.05 difference from 24-hr post.  AST = Aspartate aminotransferase; ALT= Alanine aminotransferase; BUN = Blood urea nitrogen; CK = 
Creatine kinase; RFT = race finish time; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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Figure 8. Secondary Indices of Muscle Damage and Protein Catabolism [Endurance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post. 
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Lambda time (p<0.001) interaction while group measures tended to be different over 
time (p=0.10).  Univariate measures for anabolic/catabolic hormones demonstrated 
significant changes over time and from baseline measures, peaking (elevated or 
depressed) 60-min post-run.  Significant group differences over time and group changes 
from pre-run over time were reported for serum cortisol (p=0.012, delta p=0.016).  
Serum cortisol levels 60-min post-run increased 44% over pre-run values in P, but only 
Figure 9. Markers of Protein Catabolism and Physiological Stress [Endurance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post. 
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15% in TC.  Subsequent post-hoc analysis indicated a significantly attenuated serum 
cortisol levels in TC compared to P measures 60-min and 24-h post-run (see figure 9). 
These results were further supported by ANCOVA analyses accounting for differences 
in running intensity. 
Markers of Free Radical Production and Oxidative Stress 
 Table 18 shows the markers of free radical production and oxidative stress in 
response to the aerobic exercise.  The overall MANOVA analysis revealed no significant 
Wilks’ Lambda time (p=0.70) interaction and no effect among groups over time 
(p=0.90).  None of the univariate measures for free radical production or oxidative stress 
demonstrated significant changes over time.  Serum TAS levels tended to be different 
between groups over time (p=0.089), which was attributed to supplement differences 
after using an ANCOVA analysis to account for running intensity variation between 
study groups.  Serum TAS levels decreased from pre-run 1-8% in P over the 48-h 
recovery, but increased 15-31% over pre-run levels in TC.  A significant difference in 
delta changes from pre-run levels over the post-run recovery was also reported for serum 
TAS (p=0.046) within the MANOVA univariate analysis.  Post-hoc analysis 
demonstrated a linear increase in serum TAS activity from pre-run levels in TC that was 
statistically different from P and pre-run values at 48-h of recovery (see Figure 10).   
Inflammatory Response Markers 
 Table 19 shows the serum inflammatory cytokine and chemokine markers 
analyzed in response to exercise. The overall MANOVA analysis revealed a significant 
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Wilks’ Lambda time (p<0.001) effect, but non-significant differences between groups 
over time (p=0.83).  Univariate measures for all inflammatory markers demonstrated 
significant changes over time (excluding IFN-γ), peaking 60-min post-run.  IL-6 levels 
tended to be different between groups over time (p=0.053) coupled with a significant 
difference solely across groups (p=0.017).  Accounting for running intensity differences 
using an ANCOVA analysis, both IL-2 (p=0.089) and IL-6 (p=0.064) measures tended 
to be different between groups over time.   Serum IL-2 levels on average increased 0.2% 
from pre-run levels over the post-run recovery in P, but decreased 28% from pre-run in 
TC.  Further, serum IL-6 levels increased 64% on average from pre-run in P, but only 
17% in TC.   The IL-2 group (p=0.069) and group over time (p=0.079) differences from 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.  Changes in Antioxidant Activity with Supplementation and Endurance Exercise [Endurance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-run, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post. 
 178 
 
 
 
 
 
 
 
Table 17: Anabolic/Catabolic Hormone Response [Endurance] 
Variable Group Baseline Pre-Run 60-min Post 24-hr Post 48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
RFT Covariate                   
p-value (WSC) 
Cortisol                
(ug/dL) 
P 20.92 ± 7.21 24.04 ± 5.16 34.63 ± 10.14^
†Ψ
 19.17 ± 4.87
Ψ◊
 21.14 ± 5.83
◊
 23.98 ± 1.23 G= 0.408    G= 0.868 
TC 21.34 ± 6.68 22.14 ± 7.35 25.48 ± 7.45 20.36 ± 5.93
◊
 22.50 ± 4.77 22.36 ± 1.48 T< 0.001* Tq< 0.001* TL= 0.259 
Time Mean 21.13 ± 1.37 23.09 ± 1.20 30.06 ± 1.80
†Ψ
 19.76 ± 1.04
Ψ◊
 21.82 ± 1.06
◊#
       G X T= 0.005* G X Tq= 0.012* G X Tq= 0.030* 
Testost.               
(ng/mL)             
P 7.22 ± 3.90 6.77 ± 3.55 6.34 ± 3.55 6.48 ± 3.32 6.74 ± 3.41 6.71 ± 0.88 G= 0.745    G= 0.497 
TC 6.65 ± 4.24 6.52 ± 3.89 5.59 ± 3.48 6.21 ± 3.75 6.31 ± 3.69 6.26 ± 1.06 T= 0.058
§
 Tq= 0.042* Tq= 0.026* 
Time Mean 6.94 ± 0.79 6.64 ± 0.72 5.96 ± 0.69
†Ψ
 6.34 ± 0.69 6.53 ± 0.69       G X T= 0.848 G X TL= 0.881 G X TL= 0.171 
Test/Cort 
Ratio 
P 0.037 ± 0.026 0.030 ± 0.018 0.019 ± 0.010 0.035 ± 0.024 0.034 ± 0.020 0.031 ± 0.005 G= 0.874 
 
  G= 0.546 
TC 0.035 ± 0.023 0.035 ± 0.023 0.026 ± 0.023 0.034 ± 0.024 0.030 ± 0.021 0.032 ± 0.006 T= 0.001* Tq= 0.009* Tq= 0.588 
Time Mean 0.036 ± 0.024 0.032 ± 0.020 0.022 ± 0.016
†Ψ
 0.035 ± 0.023
◊
 0.032 ± 0.020
◊
       G X T= 0.327 G X Tq= 0.101
§
 G X Tq= 0.290 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the stress and sex hormone response at 
each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.102).  Univariate ANOVA p-
levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the 
within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following 
super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ 
represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-run, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  Testost. = Testosterone; Cort/Test = Cortisol/Testosterone ratio; RFT = race finish time; G 
= group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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Table 18: Markers of Free Radical Production and Oxidative Stress [Endurance]   
Variable Group Baseline Pre-Run  60-min Post 24-hr Post 48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
 
RFT Covariate  
p-value (WSC) 
Nitrotyrosine                 
(nM) 
P 279 ± 305 214 ± 164 231 ± 180 193 ± 139 198 ± 156 223 ± 71 G= 0.493    G= 0.852 
TC 305 ± 425 284 ± 382 319 ± 436 260 ± 352 302 ± 435 294 ± 85 T= 0.177 TL= 0.183 Tq= 0.667 
Time Mean 292 ± 70 249 ± 53 275 ± 60Ψ 227 ± 48Ψ◊ 250 ± 58◊       G X T= 0.699 G X TL= 0.619 G X TL= 0.597 
TBARS                  
(uM)             
P 8.24 ± 4.62 7.59 ± 2.54 7.01 ± 4.24 7.35 ± 3.52 7.73 ± 3.39 7.59 ± 0.71 G= 0.484    G= 0.840 
TC 8.34 ± 4.06 7.94 ± 4.08 7.91 ± 3.46 8.93 ± 4.52 8.79 ± 4.09 8.38 ± 0.86 T= 0.690 Tq= 0.332 Tq= 0.462 
Time Mean 8.29 ± 0.86 7.77 ± 0.64 7.46 ± 0.77 8.14 ± 0.77 8.26 ± 0.72       G X T= 0.783 G X TL= 0.547 G X TL= 0.520 
TAS                                         
(mM) 
P 3.13 ± 0.85 3.20 ± 0.88^ 3.08 ± 0.89 3.18 ± 1.08 2.96 ± 0.95 3.11 ± 0.17 G= 0.476    G= 0.381 
TC 2.99 ± 0.84 2.50 ± 0.97 2.87 ± 1.07 2.96 ± 1.26 3.27 ± 0.87Ψ 2.92 ± 0.20 T= 0.713 Tq= 0.321 TL= 0.436 
Time Mean 3.06 ± 0.17 2.85 ± 0.18 2.98 ± 0.19 3.07 ± 0.23 3.12 ± 0.18       G X T= 0.239 G X Tq= 0.089
§ G X Tq= 0.089
§ 
SOD             
(U/mL) 
P 0.49 ± 0.09 0.52 ± 0.11 0.50 ± 0.12 0.49 ± 0.08 0.49 ± 0.14 0.50 ± 0.02 G= 0.198    G= 0.285 
TC 0.45 ± 0.10 0.46 ± 0.16 0.47 ± 0.15 0.42 ± 0.15 0.48 ± 0.10 0.46 ± 0.02 T= 0.687 TL= 0.756 TL= 0.155 
Time Mean 0.47 ± 0.02 0.49 ± 0.03 0.49 ± 0.03 0.46 ± 0.02 0.48 ± 0.03       G X T= 0.808 G X TL= 0.564 G X TL= 0.656 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the response to reactive 
oxygen and nitrogen species production in addition to antioxidant activity at each test session during the 10 day intervention.  MANOVA analysis 
revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.684).  Univariate ANOVA p-levels from MANOVA analysis are presented for each 
variable. Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to 
demonstrate the potential shape of the time or group x time interaction with significance indicated by the following super/subscripts: * indicates 
p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ represents p<0.05 
difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  TBARS = Thiobarbituric acid reactive substances; TAS = Total antioxidant 
status; SOD = Superoxide dismutase; RFT = race finish time; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-
level. 
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pre-run values throughout the recovery also approached significance.  Delta post-hoc 
analyses demonstrated significant attenuation of serum IL-6 measures 60-min post-run 
from pre-run levels in TC compared to P (104% TC increase vs. 210% P increase).  
Serum IL-2 markers also showed significantly decreasing activity in TC compared to P 
and pre-run measures over the 48-h recovery (see Figure 11).   
Anti-Inflammatory Response Markers 
 Table 20 presents the serum anti-inflammatory cytokine markers analyzed in 
response to exercise.  The overall MANOVA analysis revealed a significant Wilks’ 
Lambda effect over time (p<0.001), but no differences between groups over time 
(p=0.88).  Univariate measures for all inflammatory markers demonstrated significant 
changes over time, peaking 60-min post-run.  Accounting for running intensity utilizing 
an ANCOVA, serum IL-13 levels were significantly different across groups (p=0.031) 
and tended to be different between groups over time (p=0.053).  Serum IL-13 markers 
decreased only 6% on average from pre-run over the 48-h recovery in P, compared to a 
13% average decrease in TC.  Specifically, at 60-min post-run, serum IL-13 markers 
increased 5% over pre-run values in P, but actually decreased 7% below pre-run in TC.  
The serum IL-13 group (p=0.029) and group by time (p=0.014) differences from pre-run 
levels over the recovery period were also significant (see Figure 11). 
Clinical Markers of Immune-Related Complete Blood Counts 
 Table 21 demonstrates the immune response-related complete blood count 
markers analyzed in response to exercise.  The overall MANOVA analysis demonstrated  
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Table 19: Pro-inflammatory Cytokines and Chemokines [Endurance] 
  
Variable Group Baseline Pre-Run 60-min Post 24-hr Post 48-hr Post 
Group 
Mean 
p-value  
(GG) 
p-value  
(WSC) 
 
RFT Covariate 
p-value (WSC) 
TNF-α                  
(pg/mL) 
P 2.34 ± 1.23 2.74 ± 1.22 3.02 ± 1.55 2.48 ± 1.04 2.49 ± 0.90 2.61 ± 0.26 G= 0.922 
 
G= 0.654 
TC 2.49 ± 0.98 2.82 ± 0.90 2.93 ± 1.36 2.60 ± 0.91 2.42 ± 0.82 2.65 ± 0.31 T= 0.003* Tq= 0.003* TL= 0.156 
Time Mean 2.40 ± 1.12 2.77 ± 1.08
†
 2.98 ± 1.45
†
 2.53 ± 0.97
Ψ◊
 2.46 ± 0.85
Ψ◊
       G X T= 0.779 G X TL= 0.504 G X TL= 0.151 
IFN-γ                   
(pg/mL) 
P 7.67 ± 6.52 8.02 ± 7.77 8.73 ± 9.49 7.36 ± 7.15 7.75 ± 7.78 7.91 ± 2.55 G= 0.382 
 
  G= 0.570 
TC 10.96 ± 11.44 10.71 ± 9.14 11.51 ± 12.50 12.47 ± 17.61 11.68 ± 15.42 11.47 ± 3.08 T= 0.604 Tq= 0.184 TL= 0.424 
Time Mean 9.01 ± 8.81 9.12 ± 8.29 9.86 ± 10.67 9.44 ± 12.46 9.35 ± 11.41       G X T= 0.388 G X TL= 0.456 G X Tq= 0.461 
IL-1β                    
(pg/mL) 
P 0.67 ± 0.15 0.85 ± 0.21 0.84 ± 0.19 0.75 ± 0.20 0.69 ± 0.16 0.76 ± 0.08 G= 0.059
§
 
 
G= 0.058
§
 
TC 0.93 ± 0.51 1.12 ± 0.58 1.05 ± 0.39 0.98 ± 0.44 0.93 ± 0.40 1.00 ± 0.09 T< 0.001* Tq< 0.001* TL= 0.559 
Time Mean 0.78 ± 0.36 0.96 ± 0.42
†
 0.92 ± 0.30
†
 0.85 ± 0.33
Ψ◊
 0.79 ± 0.30
Ψ◊
       G X T= 0.860 G X Tq= 0.662 G X TL= 0.465 
IL-2                   
(pg/mL) 
P 1.18 ± 0.96 1.33 ± 1.10 1.51 ± 1.38 1.23 ± 0.85 1.27 ± 0.94 1.30 ± 0.28 G= 0.939 
 
G= 0.786 
TC 1.17 ± 1.20 1.64 ± 2.18 1.32 ± 0.99 1.12 ± 1.01 1.11 ± 1.06 1.27 ± 0.34 T= 0.070
§
 Tq= 0.001* TL= 0.293 
Time Mean 1.17 ± 1.04 1.46 ± 1.60
†
 1.43 ± 1.22
†
 1.18 ± 0.90
◊
 1.21 ± 0.97
◊
       G X T= 0.290 G X TL= 0.195 G X TL= 0.089
§
 
IL-6                              
(pg/mL) 
P 0.63 ± 0.54^ 0.75 ± 0.53^ 2.33 ± 1.38
†Ψ
 0.69 ± 0.44^
◊
 0.68 ± 0.43 1.02 ± 0.19 G= 0.017* 
 
  G= 0.509 
TC 0.94 ± 1.00 1.14 ± 1.27
†
 2.32 ± 1.69
†Ψ
 0.89 ± 0.97
Ψ◊
 0.79 ± 0.76
Ψ
 1.21 ± 0.23 T< 0.001* Tq< 0.001* Tq= 0.648 
Time Mean 0.76 ± 0.76 0.91 ± 0.90
†
 2.33 ± 1.48
†Ψ
 0.77 ± 0.69
Ψ◊
 0.72 ± 0.58
Ψ◊
       G X T= 0.550 G X TL= 0.053
§
 G X TL= 0.064
§
 
IL-8                          
(pg/mL) 
P 2.74 ± 1.58 2.84 ± 1.29 6.21 ± 3.51 2.94 ± 1.24 2.52 ± 1.01 3.45 ± 0.41 G= 0.002*    G= 0.637 
TC 3.31 ± 1.87 3.24 ± 1.71 5.39 ± 2.78 3.26 ± 2.08 2.74 ± 1.47 3.59 ± 0.49 T< 0.001* Tq< 0.001* Tq= 0.185 
Time Mean 2.98 ± 1.69 3.00 ± 1.46 5.88 ± 3.20
†
 3.07 ± 1.61
◊
 2.61 ± 1.20
Ψ◊#
       G X T= 0.287 G X Tq= 0.269 G X Tq= 0.166 
IL-12p70   
(pg/mL) 
P 1.79 ± 1.83 1.84 ± 1.75 1.95 ± 1.93 1.70 ± 1.56 1.81 ± 1.93 1.82 ± 0.42 G= 0.009*    G= 0.706 
TC 1.54 ± 1.78 1.59 ± 1.52 1.75 ± 1.93 1.34 ± 1.29 1.27 ± 1.12 1.50 ± 0.51 T= 0.012* Tq= 0.008* Tq= 0.893 
Time Mean 1.69 ± 1.78 1.74 ± 1.63 1.87 ± 1.89
†
 1.55 ± 1.44
Ψ◊
 1.59 ± 1.65
Ψ◊
       G X T= 0.310 G X Tq= 0.124 G X Tq= 0.167 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the pro-inflammatory response at each 
test session during the 10 day intervention. MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.302).  Univariate ANOVA p-levels 
from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the within-
subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following super/subscripts: * 
indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ represents p<0.05 
difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post.  TNF-α = Tumor necrosis factor alpha; IFN-γ = Interferon gamma; IL = interleukin; RFT = race finish time; 
G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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Figure 11. Markers of the Inflammatory and Anti-Inflammatory Response [Endurance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-run, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post. 
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significant Wilks’ Lambda time interaction (p<0.001), but non-significant group changes 
over time (p=0.69).  Univariate measures for all immune-related complete blood counts 
demonstrated significant changes over time.  There were no significant changes in 
immune-related complete blood counts between groups over the study period. 
Muscle Soreness Perception Assessment 
 Table 22 presents perceptions of muscle soreness across the resistance exercise 
protocol.  Perceptions were not measured at baseline.  The overall MANOVA analysis 
revealed a significant Wilks’ Lambda time (p<0.001) interaction and group changes that 
tended to be different over time (p=0.093).  Univariate measures for all locations of 
muscle soreness measurement demonstrated significant changes over time, peaking 60-
min post-run.  Significant differences between groups over time were found in vastus 
medalis (¼) soreness perception (p=0.035) that was confirmed when using an ANCOVA 
analysis to account for running intensity discrepancies.  Subsequent post-hoc analysis 
indicated significantly attenuated pre-run vastus medalis (¼) soreness in TC compared to 
P with no differences in soreness perception between groups at any of the recovery time 
points (see Figure 12).  The other two locations of quadriceps soreness perception testing 
did not reveal any significant differences between supplementation groups, particularly 
when accounting for running intensity using ANCOVA analyses.  The change from pre-
run vastus medalis (¼) soreness was smaller in P soreness perception compared to TC 
(p=0.035) over the 48-h recovery.   
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Table 20: Anti-inflammatory Cytokines [Endurance] 
  
Variable Group Baseline Pre-Run 60-min Post 24-hr Post 48-hr Post 
Group 
Mean 
p-value  
(GG) 
p-value  
(WSC) 
RFT Covariate 
p-value (WSC) 
IL-4            
(pg/mL)             
P 4.57 ± 2.02 5.51 ± 2.31 5.20 ± 2.15 4.02 ± 1.49 4.21 ± 1.63 4.70 ± 1.28 G= 0.304    G= 0.165 
TC 6.93 ± 8.98 8.71 ± 11.72 6.65 ± 6.37 5.41 ± 5.13 6.38 ± 7.03 6.82 ± 1.55 T= 0.012* Tq= 0.012* TL= 0.309 
Time Mean 5.53 ± 5.89 6.82 ± 7.64 5.79 ± 4.34 4.59 ± 3.45
Ψ◊
 5.09 ± 4.66
Ψ◊#
       G X T= 0.320 G X Tq= 0.189 G X TL= 0.189 
IL-5               
(pg/mL) 
P 0.57 ± 0.37 0.63 ± 0.42 0.66 ± 0.47 0.66 ± 0.46 0.61 ± 0.40 0.62 ± 0.14 G= 0.102
§
    G= 0.013* 
TC 0.96 ± 0.75 1.01 ± 0.73 1.07 ± 0.76 1.01 ± 0.80 0.87 ± 0.59 0.98 ± 0.16 T= 0.093
§
 Tq= 0.013* Tq= 0.452 
Time Mean 0.73 ± 0.58 0.78 ± 0.59 0.82 ± 0.62 0.80 ± 0.63 0.71 ± 0.49
Ψ◊#
       G X T= 0.542 G X TL= 0.185 G X TL= 0.205 
IL-7                
(pg/mL) 
P 3.75 ± 1.63 3.37 ± 1.57 4.66 ± 2.61 3.72 ± 1.81 3.47 ± 1.15 3.80 ± 0.43 G= 0.295    G= 0.427 
TC 4.66 ± 2.54 4.27 ± 1.84 5.12 ± 2.22 4.55 ± 1.69 4.01 ± 1.42 4.52 ± 0.52 T< 0.001* Tq= 0.010* TL= 0.845 
Time Mean 4.12 ± 2.06 3.74 ± 1.71
†
 4.85 ± 2.42
†Ψ
 4.06 ± 1.78
◊
 3.69 ± 1.27
◊#
       G X T= 0.708 G X TL= 0.492 G X TL= 0.485 
IL-10             
(pg/mL) 
P 2.91 ± 3.13 2.77 ± 1.89 24.17 ± 26.99 2.77 ± 1.78 2.68 ± 1.68 7.06 ± 1.36 G= 0.683    G= 0.948 
TC 3.31 ± 2.74 3.99 ± 5.07 17.16 ± 18.60 3.66 ± 3.69 2.79 ± 1.98 6.18 ± 1.64 T= 0.001* Tq= 0.001* Tq= 0.691 
Time Mean 3.07 ± 2.93 3.27 ± 3.51 21.31 ± 23.79
†Ψ
 3.13 ± 2.70
◊
 2.72 ± 1.77
◊
       G X T= 0.421 G X Tq= 0.495 G X TL= 0.509 
IL-13             
(pg/mL) 
P 1.52 ± 0.95 1.77 ± 1.14 1.86 ± 1.27 1.55 ± 1.00 1.58 ± 0.86 1.65 ± 0.36 G= 0.091
§
    G= 0.031* 
TC 2.56 ± 2.01 2.96 ± 2.37 2.74 ± 1.75 2.56 ± 2.00 2.40 ± 1.66 2.65 ± 0.43 T= 0.006* Tq= 0.003* Tq= 0.027* 
Time Mean 1.94 ± 1.53 2.25 ± 1.80
†
 2.22 ± 1.52
†
 1.96 ± 1.54
Ψ◊
 1.91 ± 1.29
Ψ◊
       G X T= 0.538 G X TL= 0.236 G X Tq= 0.053
§
 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the anti-inflammatory response at 
each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.447).  Univariate ANOVA 
p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the 
within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following 
super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ 
represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  IL = interleukin; RFT = race finish time; G = group p-level; T = time p-level; G x T = 
interaction; q = quadratic p-level; L = linear p-level. 
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Table 21: Markers of Immune-Related Complete Blood Counts [Endurance] 
  
Variable Group Baseline Pre-Run 60-min Post 24-hr Post 48-hr Post 
Group  
Mean 
 p-value  
(GG) 
p-value  
(WSC) 
RFT Covariate 
p-value (WSC) 
LYMPH                
(K/uL) 
P 1.83 ± 0.58 2.50 ± 0.81 1.47 ± 0.54 2.04 ± 0.69 2.26 ± 0.35 2.02 ± 0.11 G= 0.732    G= 0.414 
TC 1.82 ± 0.53 2.63 ± 0.72 1.43 ± 0.25 1.75 ± 0.45 2.18 ± 0.46 1.96 ± 0.14 T< 0.001* Tq= 0.013* Tq= 0.509 
Time Mean 1.83 ± 0.11 2.56 ± 0.15
†
 1.45 ± 0.09
†Ψ
 1.90 ± 0.12
Ψ◊
 2.22 ± 0.08
†Ψ◊#
       G X T= 0.404 G X TL= 0.905 G X TL= 0.200 
WBC                
(K/uL)             
P 5.93 ± 1.45 6.54 ± 1.71 12.61 ± 3.39^
†Ψ
 6.64 ± 1.84
◊
 5.14 ± 0.84 7.37 ± 0.29 G= 0.314    G= 0.398 
TC 5.83 ± 1.50 6.85 ± 1.61 10.80 ± 3.40
†Ψ
 5.73 ± 1.20
◊
 5.33 ± 1.05 6.91 ± 0.35 T< 0.001* Tq< 0.001* TL= 0.613 
Time Mean 5.88 ± 0.29 6.70 ± 0.33
†
 11.71 ± 0.66
†Ψ
 6.18 ± 0.32
◊
 5.24 ± 0.18
†Ψ◊#
       G X T= 0.223 G X Tq= 0.162 G X Tq= 0.500 
MID                               
(K/uL) 
P 0.45 ± 0.14 0.53 ± 0.20 0.67 ± 0.23
†
 0.49 ± 0.19
◊
 1.10 ± 0.25
†Ψ◊#
 0.65 ± 0.03 G= 0.477    G= 0.607 
TC 0.43 ± 0.11 0.61 ± 0.19
†
 0.54 ± 0.15 0.40 ± 0.10
Ψ
 1.10 ± 0.32
†Ψ◊#
 0.61 ± 0.04 T< 0.001* TL= 0.022* Tq= 0.495 
Time Mean 0.44 ± 0.03 0.57 ± 0.04
†
 0.60 ± 0.04
†
 0.44 ± 0.03
Ψ◊
 1.10 ± 0.06
†Ψ◊#
       G X T= 0.276 G X Tq= 0.388 G X Tq= 0.562 
GRAN                   
(K/uL) 
P 3.59 ± 1.07 3.53 ± 1.04 10.49 ± 3.49^
†Ψ
 4.09 ± 1.28
◊
 1.76 ± 0.59
†Ψ◊#
 4.69 ± 0.24 G= 0.349    G= 0.566 
TC 3.59 ± 1.41 3.64 ± 0.86 8.83 ± 3.35
†Ψ
 3.58 ± 0.98
◊
 2.05 ± 1.00
◊
 4.34 ± 0.29 T< 0.001* Tq< 0.001* TL= 0.326 
Time Mean 3.59 ± 0.24 3.58 ± 0.19 9.66 ± 0.67
†Ψ
 3.84 ± 0.23
◊
 1.90 ± 0.15
†Ψ◊#
       G X T= 0.259 G X Tq= 0.168 G X Tq= 0.493 
GM-CSF                                        
(pg/mL) 
P 26.38 ± 41.92 25.49 ± 31.29 26.08 ± 34.72 22.64 ± 30.21 22.41 ± 29.72 24.60 ± 9.15 G= 0.485    G= 0.696 
TC 42.26 ± 47.28 37.37 ± 45.40 35.27 ± 46.54 29.52 ± 38.02 29.41 ± 36.03 34.77 ± 11.04 T= 0.056
§
 TL= 0.022* Tq= 0.794 
Time Mean 34.32 ± 8.64 31.43 ± 7.36 30.68 ± 7.81 26.08 ± 6.57
†Ψ◊
 25.91 ± 6.34
†Ψ◊
       G X T= 0.407 G X TL= 0.221 G X TL= 0.319 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the complete blood count immune 
response markers at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time (p=0.684).  
Univariate ANOVA p-levels from MANOVA analysis are presented for each variable. Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis 
and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following 
super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following superscripts: ^ 
represents p<0.05 difference between groups, † represents p<0.05 difference from baseline value, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 
difference from 60-min post, # represents p<0.05 difference from 24-hr post.  LYMPH = Lymphocytes; WBC = White blood cell; MID = Mid-range absolute count; GRAN 
= Granulocyte absolute count; GM-CSF = Granulocyte-macrophage colony-stimulating factor; RFT=race finish time; G = group p-level; T = time p-level; G x T = 
interaction; q = quadratic p-level; L = linear p-level. 
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Figure 12.  Perception of Quadriceps Muscle Soreness [Endurance] 
Data expressed as means ± SE and LSD post hoc analysis is indicated by the following superscripts: ^ represents 
p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-run, ◊ represents p<0.05 difference from 
60-min post, # represents p<0.05 difference from 24-hr post. 
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Table 22: Quadriceps Muscle Soreness Perception [Endurance] 
  
Variable Group Pre-Run 60-min Post 24-hr Post 48-hr Post 
Group  
Mean 
p-value  
(GG) 
p-value  
(WSC) 
RFT Covariate 
p-value (WSC) 
Algo I                
(cm) 
P 5.99 ± 2.94^ 6.98 ± 3.35 6.44 ± 2.69 5.95 ± 3.01 6.34 ± 0.66 G= 0.523    G= 0.660 
TC 3.96 ± 2.15 6.43 ± 3.15
Ψ
 6.31 ± 3.43
Ψ
 5.98 ± 3.04
Ψ
 5.67 ± 0.80 T= 0.003* Tq= 0.002* TL= 0.440 
Time Mean 4.98 ± 0.52 6.71 ± 0.64
Ψ
 6.38 ± 0.59
Ψ
 5.96 ± 0.59
Ψ
       G X T= 0.110 G X TL= 0.035* G X TL= 0.028* 
Algo II              
(cm)             
P 5.02 ± 2.55 5.77 ± 2.91 5.58 ± 2.56 4.78 ± 3.02 5.29 ± 0.60 G= 0.393    G= 0.847 
TC 4.15 ± 2.66 5.12 ± 3.01 4.51 ± 3.10 4.08 ± 2.30 4.47 ± 0.72 T= 0.122 Tq= 0.013* TL= 0.229 
Time Mean 4.59 ± 0.51 5.45 ± 0.58 5.05 ± 0.55 4.43 ± 0.54       G X T= 0.921 G X Tq= 0.889 G X Tq= 0.458 
Algo III                   
(cm)                                      
P 4.65 ± 3.04^ 6.41 ± 2.91^
Ψ
 6.04 ± 2.90^
Ψ◊
 4.41 ± 2.90
◊#
 5.38 ± 0.67 G= 0.098
§
    G= 0.226 
TC 2.59 ± 2.45 4.43 ± 2.89
Ψ
 3.48 ± 2.92 3.84 ± 3.11
Ψ
 3.58 ± 0.80 T< 0.001* Tq< 0.001* TL= 0.508 
Time Mean 3.62 ± 0.55 5.42 ± 0.57
Ψ
 4.76 ± 0.57
Ψ
 4.12 ± 0.59
◊
       G X T= 0.058
§
 G X Tq= 0.053
§
 G X Tq= 0.257 
Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the participant soreness perception in 
the quadriceps muscle group at each test session during the 10 day intervention.  MANOVA analysis revealed overall Wilks' Lambda time (p<0.001) and group x time 
(p=0.199).  Univariate ANOVA p-levels from MANOVA analysis are presented for each variable.  Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser 
(GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by 
the following super/subscripts: * indicates p<0.05 p-level significance, § indicates p<0.10 p-level significance.  LSD post hoc analysis is indicated by the following 
superscripts: ^ represents p<0.05 difference between groups, Ψ represents p<0.05 difference from pre-lift, ◊ represents p<0.05 difference from 60-min post, # 
represents p<0.05 difference from 24-hr post.  Algo I = Algometer location #1: Vastus Medalis 1/4; Algo II = Algometer location #2: Vastus Lateralis 1/4; Algo III = 
Algometer location #3: Vastus Lateralis 1/2; RFT = race finish time; G = group p-level; T = time p-level; G x T = interaction; q = quadratic p-level; L = linear p-level. 
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CHAPTER V 
DISCUSSION AND CONCLUSION
*
 
Tart Cherry Resistance 
Introduction 
 This is the first study to investigate the effect of freeze dried Montmorency tart 
cherry skin powder on acute resistance exercise performance and recovery.  It was 
hypothesized that supplementation with this novel powdered tart cherry skin supplement 
surrounding an acute bout of intense resistance exercise would reduce perceptions of 
muscle soreness, markers of muscle damage, oxidative stress, and inflammation, thus 
better maintaining subsequent performance within the first 48-h of recovery. The results 
of the present study demonstrate that this powered tart cherry formulation is effective in 
promoting decreased perceptions of muscle soreness following intense resistance 
exercise.  Tart cherry powder reduced perceptions of muscle soreness in the distal vastus 
medalis and lateralis.  In accordance with decreased perceptions of muscle soreness, tart 
cherry powder supplementation reduced serum markers of muscle catabolism and 
physiological stress over the 48-h post-lift period compared to placebo.  As a result of 
the resistance exercise, markers of oxidative stress, lipid peroxidation, and antioxidant 
activity did not significantly change over time and was not affected by differences in 
supplementation.  The inflammatory response increased from pre-lift values during the 
                                                 
*Portions reprinted from “Effects of powdered Montmorency tart cherry supplementation on an acute bout 
of intense lower body strength exercise in resistance trained males” by Levers K, Dalton R, Galvan, E, et 
al. 2015. Journal of the International Society of Sport Nutrition, 12, 1-23, Copyright 2015 by Kyle Levers. 
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recovery period, but the change was not significantly different between supplement 
groups.   
 The attenuation of quadriceps muscle soreness in conjunction with reduced 
hemodynamic markers of muscle catabolism following the resistance training bout 
indicates that the consumption of tart cherry powder dampened the effects of the 
secondary muscle damage response.  The initial injury to the muscle microstructure is 
defined by a mechanical disruption of the myofibrils, particularly in response to high 
volume and intensity eccentric exercise (35, 53, 76).  The damage to the muscle 
microstructure triggers a local inflammatory response characterized by infiltration of 
fluid, plasma proteins, and free radicals that all exacerbate the initial mechanical muscle 
damage, creating a secondary injury incidence (4, 31, 35, 76, 111, 171).  Decreased 
perceptions of quadriceps muscle soreness and muscle catabolism indices reveal that 
supplementation with powdered tart cherry aids in blunting the secondary muscle 
damage effects compared to placebo.  
Muscle Soreness Perception 
 The apparent beneficial effect of tart cherry powder supplementation on the 
perception of muscle soreness after a resistance exercise bout is consistent with some of 
the previously published findings. Connolly et al. (40) reported that consumption of a 
Montmorency tart cherry juice in healthy college-aged males significantly reduced pain 
in the elbow flexors after a bout of eccentric exercise using a visual analog scale (VAS).  
Peak muscle pain was achieved 24-h post-exercise in the tart cherry group compared to a 
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continued increase in pain 48-h post-exercise in the placebo group.  In contrast, 
Connolly et al. (40) reported no difference in pressure pain threshold (PPT) scores 
between the two experimental groups.  Using a strenuous single leg knee extension 
protocol in a cohort of well-trained male athletes, Bowtell et al. (20) demonstrated a 
trend in post-exercise muscle pain reduction via PPT with Montmorency tart cherry juice 
supplementation up to 48-h post-exercise compared to placebo.  The positive results in 
the current study are similar to previous tart cherry supplementation research findings, 
showing that powdered tart cherry supplementation significantly attenuates muscle 
soreness perceptions throughout the 48-h post-lift recovery compared to placebo.  Slight 
differences in study outcomes may lie in the disparity of muscle pain or soreness 
measures, tart cherry supplements, quantity of musculature involvement, and/or exercise 
modality.  With respect to the disparity among the discussed research, Connolly et al. 
(40) utilized both a VAS and a separate PPT  in upper extremity exercise, Bowtell et al. 
(20) only utilized PPT surrounding single leg exercise, while the current study employed 
a combination of constant pressure with a GPRS (version of VAS).  Measurement of 
muscle soreness perception in the present study utilizing both an algometer and a GRPS 
was implemented to help ameliorate the purely subjective nature of a VAS as the only 
measure of pain or soreness.   
Muscle Damage and Catabolism 
 The attenuation in post-lift muscle soreness with powdered tart cherry 
supplementation may be described by underlying catabolic mechanisms.  Similar to the 
 191 
 
 
 
results of the current study, Bowtell et al. (20), following exhaustive leg extension 
exercise, demonstrated a faster post-exercise recovery of knee extensor force coupled 
with a trend for a smaller CK percent change from pre-exercise levels up to 48-h post-
exercise with tart cherry supplementation compared to placebo (9).  Following a 
treadmill incremental exercise protocol with thoroughbred horses, Ducharme et al. (50) 
reported an attenuation trending toward significance in CK levels during exercise 
recovery when supplementing with a tart cherry juice blend compared to placebo.  
Similar to the post-lift attenuations of ALT (60-min and 48-h post) and AST (48-h post) 
as secondary markers of muscle damage in the current study, Ducharme et al. (50) 
reported that AST was significantly mitigated during and following an incremental 
exercise protocol in the tart cherry-treated horses compared to placebo (9).  In an 
endurance-based crossover study examining the effects of acute ibuprofen (8400 mg) 
ingestion surrounding a 45-min downhill treadmill run, Donnelly et al. (48) reported an 
increase in serum CK, AST, and lactate dehydrogenase post-run with maximal activity 
of CK and AST occurring at 24-h post-run, while lactate dehydrogenase, creatinine, and 
urea peaked 6-h post-run.  Donnelly et al. (48) revealed that serum CK and urea levels 
were significantly higher after ibuprofen supplementation compared to placebo 
throughout the post-run recovery.  Analyzing hemodynamic clinical chemistry makers 
before, 4-h, and 24-h post-Boston marathon, Kratz et al. (99) reported significant 
increases in total CK, AST, ALT, total protein, uric acid, and creatinine 4-h post-race 
and confirmed that CK, creatinine, uric acid, ALT, and AST remained significantly 
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elevated over pre-race values 24-h post-race.  The attenuation of these markers in the 
current study, demonstrates beneficial powdered tart cherry supplementation effects on 
the post-resistance exercise catabolic, muscle damage, and stress response.   
Inflammatory Response 
 Acute, intensive resistance exercise (> 60% 1-RM) has been reported to 
significantly increase muscular mechanical trauma as the initial phase of injury (20, 78) 
coupled with a secondary inflammatory injury phase that occurs as a result of plasma 
protein and inflammatory cell infiltration of the damaged tissue   (20, 35, 111).  In a 
strength-based supplement study with resistance trained subjects, Bowtell et al. (20) was 
also not able to detect any significant effects on IL-6 as a marker of inflammation.  
Further, Trombold et al. (189) reported similar non-significant inflammatory (IL-6) 
findings in a study involving non-resistance trained subjects performing repeated bouts 
of eccentric elbow flexor muscle contractions with consumption of pomegranate-derived 
ellagitannin (20).  Supplementation in the current study did not affect the inflammatory 
response to muscular trauma as markers peaked 60-min post-lift with no response 
differences between supplementation groups.  Attenuation of muscle soreness 
perceptions and markers of muscle damage are not likely attributed to changes in 
inflammation following a single resistance exercise bout.  Differences in results between 
studies are likely attributed to variation in intensity, duration, and modality of the 
aforementioned exercise protocols. 
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Catabolic and Physiological Stress Hormone Response 
 The increase in inflammatory-related cytokines and chemokines such as TNF-α, 
IL-1β, IL-6, and IL-8 during and immediately following exercise has been shown in 
previous research (63, 134, 138) and closely resembles the inflammatory response in the 
current study.  As described in previous literature, the increase in serum IL-6 within both 
groups 60-min post-lift in the current study can likely be attributed to the large release of 
muscle-derived IL-6 as a result of the contracting muscle fibers (63, 175).  The influx of 
muscle-derived IL-6 within the systemic circulation may be one of the triggers for 
subsequent cortisol release in response to exercise-induced stress (63, 174).  
Glucocorticoids, specifically cortisol, and anti-inflammatory cytokines such as IL-4, IL-
10, and IL-13 are released during strenuous exercise and typically demonstrate an 
immunosuppressive influence to help modulate the immune response balance (64).  
However, extended immunodepression due to elevated plasma cortisol during the post-
exercise period, particularly following long bouts of intense training in the fasted state 
(63), may hinder recovery and subsequent performance.  Previous research conducted by 
McAnulty et al. (116) in trained endurance athletes reported a significant cortisol 
increase over time, but no significant difference in immediate and 1.5-h post-race 
cortisol levels with 2-month vitamin E supplementation compared to placebo.  
Comparing 14-d supplementation of N-acetyl-cysteine (NAC), epigallocatechin gallate 
(EGCG), or a placebo in active males surrounding a single bout of eccentric knee-
extensor exercise, Kerksick et al. (94) found a significant decrease in serum cortisol 
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levels 6-h post-exercise, but no differences between groups up to 72-h post-exercise 
despite a significant blunting of muscle soreness perception 24-h post exercise in the two 
supplement groups compared to placebo.  The current study demonstrated an increase in 
cortisol levels 60-min post-lift compared to pre-lift in both groups.  However, unlike the 
cortisol and muscle soreness perception results reported by Kerksick et al. (94), the 
current study demonstrated significantly elevated cortisol levels and muscle soreness in 
the placebo group compared to the powdered tart cherry group 24-h and 48-h post-lift.   
Immune Cellular Counts  
 The placebo group elevations in serum cortisol levels in the latter recovery 
period may be linked to differences in the immune response and the degree of secondary 
muscle injury.  Previous research by McCarthy et al. (118) and Robson et al. (158) 
demonstrate that in response to repetitive muscular contraction during and immediately 
after acute, intense exercise, there is a large increase in circulating neutrophils (GRAN) 
and lymphocytes.  According to data collected by Robson et al. (158), plasma neutrophil 
levels tend to peak 2-3 hours post-exercise, but remain elevated above pre-exercise 
levels for up to 10-h post-exercise due to elevations in plasma cortisol (e.g. perception of 
stress) that facilitate the release of neutrophils from the bone marrow.  The current study 
demonstrated a plasma neutrophil (GRAN) peak 60-min post-lift, but effects of 
supplementation could not be determined as levels returned to pre-lift concentrations by 
24-h.  Unlike the neutrophil response to acute exercise, lymphocytes respond in a 
biphasic pattern, where plasma levels are significantly elevated during and immediately 
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post-exercise followed by a drop below pre-exercise levels during the initial recovery 
period due to a efflux from the blood circulation, and a slow return to baseline levels as 
equilibrium is reached again (64, 158).  Robson et al. (158) demonstrated that serum 
cortisol levels influence both the influx of neutrophils and efflux of lymphocytes from 
systemic circulation. The results of the current study demonstrated that lymphocyte 
levels in the placebo group never returned to pre-lift levels during the 48-h recovery.  
This may be linked to the elevated plasma cortisol levels in the placebo group 
representing an increased physiological perception of exercise stress 48-h post-lift 
compared to pre-lift and powdered tart cherry group levels.  As previously mentioned, 
the secondary injury phase occurs as a result of significant plasma protein and 
inflammatory cell influx within the damaged tissue (20, 35, 111).  Powdered tart cherry 
supplementation may have aided in reducing secondary muscular injury through an 
initial dampening of the immune response paired with the attenuated cortisol response 
later in exercise recovery.  However, immune cell count changes in response to 
supplementation and the resistance exercise stimulus are speculative due to the lack of 
cellular count data corresponding to typical patterns of immune cell responses during 
and immediately following the barbell back squat challenge. 
Free Radical Production, Antioxidant Response, and Redox Balance 
 The increase in antioxidant bioavailability from tart cherries containing high 
levels of flavonoids and anthocyanins (166, 199) has been hypothesized to be one of the 
main benefits of tart cherry supplementation.  Antioxidant bioavailability is important in 
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maintaining adequate redox balance to support the endogenous antioxidant systems 
following excessive ROS-producing strenuous exercise.   Ducharme et al. (50) 
investigated the effects of Montmorency tart cherry juice supplementation on oxidative 
stress in thoroughbred horses following a stepwise incremental treadmill running 
protocol (9).  Overall indications of oxidative stress as a result of exercise were reported 
through significant elevations in lipid hydroperoxidation (TBARS) (50), but similar to 
the current study, no differences between groups were shown.  In an endurance study 
examining the effects of tart cherry juice supplementation on oxidative stress following a 
marathon run, Howatson et al. (76) demonstrated significantly lower TBARS levels in 
the tart cherry supplemented group versus placebo 48-h post-marathon.  As a highly 
reactive oxide metabolite of nitric oxide, peroxynitrate-bound tyrosine residues forming 
nitrotyrosine (NT) (196) were measured by Sureda et al. (178) following 
supplementation of vitamin C + E surrounding a half-marathon.  Suerda et al. (178) 
reported a significant increase in both NT immediately post-race and 3-h post-race in the 
placebo group compared to the vitamin C + E supplemented group, indicating that 
antioxidant supplementation may have an attenuating effect on the oxidation of nitrogen-
containing compounds surrounding endurance exercise.  Contrarily, both Bowtell et al. 
(20) and the current study found no difference between supplementation groups with 
regard to oxidation of nitric oxide (NT) in the post-strength exercise period.  A 
difference in outcome may be attributable to the difference in exercise modality and thus 
the minimal reliance on aerobic metabolism demands during resistance exercise.  
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Further, evidence in the literature utilizing lipid peroxidation (TBARS) analyses have 
presented a potential lack of oxidative damage detection specificity in human studies 
that may also explain the variability in results between the current and previous studies 
(9, 12, 13, 193).   
 In a study analyzing the recovery from a marathon run, Howatson et al. (76) 
analyzed plasma TAS, as a measure of antioxidant or antiradical activity (84), and found 
that TAS fell below baseline 48-h post-marathon in the placebo group (9).  Unlike the 
tart cherry group, the placebo group failed to maintain TAS or redox balance following 
the endurance exercise, demonstrating possible antioxidant effectiveness on excessive 
ROS production with bouts of endurance exercise (9).  Childs et al. (32) analyzing TAS 
following arm eccentric exercise-induced injury demonstrated significantly greater TAS 
levels with vitamin C + NAC supplementation compared to placebo 48-h through 7-d 
post-exercise in healthy, untrained males.  A resistance training-related study conducted 
by Lafay et al. (102) investigating the effects of a polyphenol-rich grape extract on 
repeated jumping force capacity, found a significant jumping force capacity 
improvement in the grape extract group over placebo.  However, similar to the current 
study, Lafay et al. (102) found no significant difference in SOD activity between the 
groups.  The current resistance training study also did not demonstrate any significant 
change in TAS activity across time or between groups possibly attributed to differences 
in study population and the low metabolic cost associated with resistance/eccentric 
exercise versus endurance exercise.   
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Research Investigation Strengths and Weaknesses  
 The strengths of this particular study revolve around the analysis of a large 
cohort of muscle soreness, performance, muscle damage, inflammatory, and oxidative 
damage measures to contribute a comprehensive analysis to the existing body of 
published literature.  This type of comprehensive hemodynamic analysis has not been 
conducted in a tart cherry supplement study paired with resistance exercise.  Further, the 
current study employed one of the largest subject cohorts among recent studies 
examining polyphenolic, vitamin, or NSAID supplementation effects on performance 
and related hemodynamic markers.  The utilization of this supplement within the free-
living resistance trained population demonstrated its effectiveness under normative 
training, diet, and performance conditions.  The ease associated with consuming an 
encapsulated powdered supplement versus a potentially inconvenient or unpalatable 
juice most likely enhanced subject compliance with supplementation.  Potential 
limitations and weakness of the current study should also be considered.  The placebo-
control matched design of this study was effective in equalizing study subject exposure 
to the resistance protocol irrespective of supplement group, however compared to a 
cross-over design, there might have been some variability associated with subject 
pairing.  Differences in resistance training experience and overall state of training 
beyond the study inclusion/exclusion criteria may also have been a source of variability 
in study cohort recruitment.  Due to the large number of hemodynamic markers 
measured in this study, the five selected time points of blood draws over the course of 
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the experimental period may have not captured the entire pharmacokinetic profile for 
each marker.  Despite controlling 48-h training activity and acute NSAID intake with a 
10-h fast before each session, nutritional intake and hydration status of each subject was 
not controlled nor tested.  Differences in nutrition and hydration among study subjects 
could have been a potential source of variability in hemodynamic markers or 
performance measures in a cohort of this size.  The 48-hour NSAID ingestion limitation 
may not have been a sufficient washout time for all NSAID-type medications 
considering the large range in reported half-life of common NSAIDs (1.6 to 30-h), which 
may have also been a contributing source of acute variability.  However, chronic or 
habitual NSAID users were excluded from the study pool during the initial study 
screening process, so the 48-h NSAID restriction was utilized as a secondary control 
point to help eliminate potential effects of acute NSAID ingestion and strengthen study 
validity.  The major overriding strengths of this study are that this is the first practical 
study to be conducted surrounding an acute bout of strength exercise incorporating 
significant muscle mass recruitment and it is the first study to be conducted utilizing a 
powdered form of cherries rather than a juice or concentrate.   
Conclusion 
 The current study demonstrated that consumption of a Montmorency powdered 
tart cherry supplement 7-d before, the day of, and 2-d after completing a single bout of 
high volume, high-intensity resistance exercise, appears to be an effective dietary 
supplement in reducing muscle soreness in the most biomechanically loaded region of 
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the quadriceps near the distal patellar attachment and markers of muscle catabolism in 
resistance trained individuals.  Short-term supplementation with powdered tart cherry 
surrounding a single bout of resistance training did not demonstrate any definitive effect 
on markers of oxidative damage or inflammation.  Due to the inconclusive oxidative 
damage and inflammatory evidence, mechanisms of short-term powdered tart cherry and 
other related phytochemical-containing nutritional supplements surrounding bouts of 
high intensity, anaerobic and resistance exercise need to be further investigated.  
Additional examination of powdered tart cherry supplementation with other forms of 
exercise that are known to promote a more pronounced effect on inflammation and 
oxidative stress (e.g. endurance exercise) is also needed.   However, the initial 
effectiveness in reducing perceptions of muscle soreness and markers of muscle 
catabolism in resistance-trained men demonstrates that powdered tart cherry 
supplementation provides similar benefits as previously studied tart cherry juices or 
concentrates following acute bouts of lower body strength-based exercise. 
Tart Cherry Endurance 
Introduction 
 Previous research has investigated the efficacy of tart cherry supplementation 
surrounding bouts of endurance exercise, however, this is the first study to investigate 
the effect of Montmorency tart cherry skin powder on acute endurance performance 
recovery.  It was hypothesized that supplementation with this novel powdered tart cherry 
skin supplement prior to a single bout of high volume endurance exercise would 
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attenuate markers of muscle damage, oxidative stress, inflammation, and perceptions of 
muscle soreness in facilitation of faster recovery.  Tart cherry ingestion reduced post-run 
serum markers of muscle catabolism, secondary muscle damage, and physiological 
stress over the 48-h recovery period compared to the placebo.  Reduced serum markers 
of muscle catabolism and stress are indicative of the attenuated 48-h recovery 
inflammatory response with tart cherry supplementation versus placebo.  Despite lower 
levels of TAS activity observed in the tart cherry group prior to performing the run 
versus those supplemented with the placebo, antioxidant activity in those who ingested 
tart cherry was greater than the placebo, particularly 24-h and 48-h post-run.   Despite 
increases in actual race pacing over projected race pace times reported from previous 
running performances in both groups, the tart cherry group demonstrated smaller pace 
differences compared to placebo.  Medial quadriceps soreness in tart cherry 
supplementers was significantly lower pre-run compared to those ingesting the placebo.  
However, results indicated a smaller change from pre-run medial quadriceps soreness in 
placebo supplementers over the 48-h recovery period compared to the tart cherry group.   
Endurance Performance 
 Despite significantly faster half-marathon finish race times and a smaller 
difference between projected and actual race pace reported in the tart cherry group 
compared to the placebo group in the current study, the performance benefits cannot 
solely be attributed to differences in supplementation due to the study design not 
including a monitored pre-supplementation half-marathon run as a basis for comparison.  
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Compared to projected race pacing, the increase in actual race pace is likely attributed to 
the 10-h fast and blood draw prior to the day of the endurance exercise challenge that 
would have not been experienced prior to any other race.  The apparent beneficial effect 
of tart cherry powder supplementation on the increase in endurance performance through 
a decrease in race completion time is consistent with some of the previously published 
findings in the exercise and polyphenol supplementation literature.  In a study conducted 
on aerobically fit males and females, Davis et al., supplemented 500 mg/d of quercetin 
or placebo for 7-d prior to an incremental VO2 max test on a cycle ergometer and a 
cycling time trial to fatigue on the same ergometer (44).  Davis et al. demonstrated an 
increase in both VO2 max and ride time to fatigue following quercetin supplementation 
compared to placebo (44).  Nieman et al. conducted a study in young, healthy males with 
2-wk of quercetin supplementation (1000 mg/d) versus placebo (132). Following a 12-
min treadmill running trial at a 15% grade and self-selected speed, Nieman et al. 
reported a significantly greater pre-supplementation versus post-supplementation change 
in distance covered with quercetin supplementation versus placebo (132).  The 
polyphenol content of fruit-derived supplements similar to tart cherry were proven 
beneficial after 30-d of supplementation in a study conducted by Kang et al. on regular 
endurance exercisers (89).  Kang et al. demonstrated that 30-d supplementation of 
oligomerized lychee fruit extract significantly elevated both submaximal running time 
and anaerobic threshold compared to a vitamin C/E mixture and a placebo (89).  The 
difference in race pace and times within the current study may have correlated to a 
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discrepancy in running intensity between the groups, thus utilization of half-marathon 
finish time as a covariate in a separate ANCOVA statistical analysis was necessary to 
determine if significant statistical interactions were attributed to differences in running 
intensity or supplementation.  
Muscle Damage and Catabolism 
 Attenuation of muscle catabolism and secondary markers of muscle damage 
following prolonged endurance exercise physiologically provides the body optimal 
conditions for quicker recovery and repair in preparation for subsequent performance 
bouts.  Studying trained endurance runners, Kratz et al. (99) analyzed hemodynamic 
clinical chemistry makers before, 4-h, and 24-h post-Boston marathon.  The results of 
demonstrated significant increases in total CK, AST, ALT, total protein, uric acid, total 
bilirubin, BUN, and creatinine 4-h post-race and confirmed elevations in CK, BUN, 
creatinine, uric acid, ALT, and AST remaining significantly greater than pre-race values 
24-h post-race (99).  This study demonstrates normative changes in markers of muscle 
catabolism following acute bouts of high volume endurance exercise in trained 
endurance athletes.  In an eccentrically-braked endurance running study, Donnelly et al. 
(48) acutely supplemented subjects with ibuprofen (8400 mg) surrounding a 45-min 
downhill treadmill run.  Donnelly et al. (48) documented a post-run increase in serum 
CK and AST with maximal activity occurring at 24-h of recovery, while both serum 
creatinine and urea markers peaked 6-h post-run.  Bell et al. (13) in an acute endurance 
study following a combination of cycling sprints and time trials reported results similar 
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to the current study, demonstrated no differences in the CK response between 
Montmorency tart cherry concentrate and placebo supplementation.  Unlike the current 
acute endurance study, Howatson et al. (76) following marathon running demonstrated a 
trend of lower post-resistance exercise CK levels when supplementing with tart cherry 
juice compared to placebo up to 48-h of recovery.  Despite conflicting evidence among 
previous endurance-supplemented tart cherry research, the post-run attenuation of these 
markers in the current study within the powdered tart cherry group, demonstrates a 
beneficial effect of supplementation on indices of muscle catabolism.   
Inflammatory Response 
 Previous research in the literature seems to conclude that the inflammatory 
process is mediated by both pro-inflammatory cytokines (63) and neuroendocrinological 
factors (138).  However, it has also been demonstrated that as major players in the 
development of secondary muscle damage, neutrophils, may also amplify the release of 
inflammatory cytokines (26, 172).  Nieman et al. (131) supplemented trained cyclists 
with quercetin, quercetin-EGCG (epigallocatechin 3-gallate), or placebo soft chews for 
24-d surrounding 3-d of consecutive bouts of 3-h submaximal cycling.  Nieman et al. 
(131) reported a significant decreases in plasma concentrations IL-6 immediately post-
exercise on the third exercise day in the quercetin-EGCG group compared to placebo 
(131).  Howatson et al. (76) reported significantly lower inflammation through analysis 
of IL-6 after running a marathon that coincided with quicker recovery of knee extensor 
maximal strength following the marathon in Montmorency tart cherry juice 
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supplemented subjects compared to placebo.  IL-6 markers where significantly 
attenuated immediately post-race with tart cherry consumption compared to placebo (9, 
76).  Coinciding with reduced inflammatory findings of Nieman et al. (131) and 
Howatson et al. (76) following endurance challenges, the current half-marathon study 
also reported a post-run attenuation in IL-6 with powdered tart cherry supplementation 
versus placebo.  Similar to the reduction in anti-inflammatory response (IL-10) in the 
quercetin-EGCG group immediately following a submaximal cycling bout published by 
Nieman et al. (131), the powdered tart cherry group in the current study also 
demonstrated similar changes via an attenuated IL-13 response over the 48-h recovery 
compared to placebo.   
Catabolic and Physiological Stress Hormone Response 
 Glucocorticoids, specifically cortisol, released due to activation of the stress 
response through muscle mechanical microtrauma and ROS production have 
demonstrated an immunosuppressive influence.  Davison and Gleeson (45), in an 
investigation of moderately trained males during 2.5-h moderate intensity cycling 
compared the effects of a beverage containing a vitamin C supplement with and without 
carbohydrate before and during endurance exercise.  The study by Davison and Gleeson 
(45) revealed a significant increase in plasma cortisol levels immediately and 1-h post-
exercise in both the placebo and vitamin C only supplemented groups with no significant 
difference between these two groups at 1-h post-exercise (45).  The addition of 
carbohydrates (alone or with vitamin C) significantly lowered the cortisol response 
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during the exercise recovery up to 1-h post-exercise (45).  This result demonstrates a 
potentially lower physiological stress in the short-term post-exercise period due to a 
higher energy state.  The results of the current study revealed a similar cortisol response 
60-min and 24-h post-run as both fasted groups demonstrated an increase from pre-run 
values, but the placebo group response from pre-run values was significantly greater 
than tart cherry group levels.  Based on the findings reported by Davison and Gleeson 
(45), the attenuation of the cortisol response 60-min post-run may be due to a 
combination of anti-inflammatory and antioxidant effects of tart cherry anthocyanins.   
 Due to the reduced cortisol response 60-min post-run following tart cherry 
supplementation in the current study, it is likely that this anthocyanin-rich 
supplementation may modulate endogenous cytokine secretion following stressful 
exercise challenges. This tart cherry anthocyanin modulation resulted in an attenuated 
release of IL-6 throughout the 48-h post-run recovery compared to placebo.  An acute 
supplementation study providing moderately active subjects with 48 g of anthocyanin-
rich black currant extract immediately surrounding a single bout of high-intensity rowing 
conducted by Lyall et al. (109) demonstrated a significant post-exercise attenuation of 
pro-inflammatory cytokine production from LPS-stimulated cells.  Lyall et al. (109) 
postulated from subsequent in vitro experimentation that this reduced cytokine 
production may have resulted from anthocyanin-based inhibition of NF-κB-mediated 
mechanisms.  In the current study, attenutated IL-6 levels over the 48-h recovery with 
tart cherry supplementation coupled with lower recovery serum cortisol levels compared 
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to the placebo group, demonstrates a potential relationship between the perception of 
physiological stress, regulation of anti-inflammatory cytokines, and cortisol release 
through NF-κB-mediation.   
Free Radical Production, Antioxidant Response, and Redox Balance 
 The attenuation muscle catabolic indices demonstrated in the current study may 
also be partially attributed to an improved post-run redox balance with tart cherry 
supplementation compared to placebo.  The increase in antioxidant bioavailability from 
acute tart cherry supplementation containing high levels of flavonoids and anthocyanins 
(166, 199) has been hypothesized to be one of the primary benefits in support of 
endogenous antioxidant systems following strenuous exercise and excessive ROS-
production.  Howatson et al. (84) analyzed plasma TAS, as a measure of antioxidant or 
antiradical activity across all biological components, following a full marathon in trained 
endurance runners, and found that TAS was significantly greater in the tart cherry 
supplemented group compared to control across all time points (pre-race and up to 48-h 
post-race) (9, 76, 172).  Unlike the tart cherry group, TAS levels dropped below baseline 
48-h following endurance exercise in the placebo group as they failed to maintain redox 
balance.  This discrepancy between supplementation groups demonstrates possible tart 
cherry antioxidant effectiveness on excessive ROS production with bouts of endurance 
exercise (9).  The current study reported lower pre-run TAS levels in the tart cherry 
group compared to placebo.  However, similar to the recovery findings of Howatson et 
al. (84), the current study revealed a linear increase in TAS activity culminating in a 48-
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h recovery TAS activity that was greater in the tart cherry group compared to placebo.  
Despite a different exercise protocol and antioxidant supplement, Childs et al. (32), 
analyzing TAS following arm eccentric exercise-induced injury also demonstrated 
significantly greater TAS levels with vitamin C + NAC supplementation compared to 
placebo 48-h through 7-d post-exercise recovery in healthy, untrained males.  
Interestingly, in a study conducted in trained cyclists by Morillas-Ruiz et al. (125), 
subjects performed a 90-min submaximal endurance time trial on a cycle ergometer 
while consuming a commercial antioxidant beverage containing fruit concentrates and 
carbohydrates over the course of the entire testing protocol.  Morillas-Ruiz et al. (125) 
found no difference in TAS immediately and 45-min post-exercise between antioxidant 
beverage and placebo groups.  Contradictory results may have been attributed to the 
limited supplementation and recovery analysis time table as well as the supplement 
itself.  This demonstrates a potentially short-term antioxidant effect of powdered tart 
cherry consumption surrounding a single endurance challenge with better achievement 
of redox balance compared to placebo supplementation. 
 The reduction in the hemodynamic markers of muscle catabolism and enhanced 
redox balance in the current study demonstrate beneficial effects of supplementation.  
Ducharme et al. (9) piloted the first endurance-based study to investigate the effects of 
Montmorency tart cherry juice supplementation on oxidative stress created by an 
exhaustive incremental treadmill running protocol in thoroughbred horses.  Overall 
indications of exercise-induced oxidative stress were reported through significant 
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elevations in lipid hydroperoxidation decomposition products over time as measured by 
TBARS (58), but similar to the current study, no differences between groups were 
reported (50).  In an endurance study, similar to the current protocol, Howatson et al. 
examined the effects of tart cherry juice supplementation on oxidative stress following a 
marathon run.  Supplementing with a tart cherry juice blend or placebo for 8-d 
surrounding the marathon, Howatson et al. (76) demonstrated significantly lower 
TBARS levels 48-h post-marathon in the tart cherry supplemented group versus placebo.  
In coordination with Howatson et al. (76), Pilaczynska-Szczesniak et al. (144) reported 
significantly attenuated serum TBARS levels at 1-min and 24-h post-2,000 m 
incremental rowing test following 4-wk of chokeberry supplementation in trained 
rowing athletes compared to those supplemented with the placebo.  In two more recent 
studies within the same trained rowing athlete population used by Pilaczynska-
Szczesniak et al. (144), Skarpanska-Stejnborn et al. (168, 169) reported no differences in 
post-2,000 m incremental rowing test TBARS levels following 4-5-wk of 
supplementation with either Rhodiola rosea L. extract or artichoke extract.  
Contradictory outcomes between studies may be due to mode of exercise, training and 
nutrition status, and duration of supplementation.  Further, evidence in the literature 
utilizing lipid peroxidation (TBARS assays) analysis has presented a potential lack of 
oxidative damage detection specificity in human studies that may also explain the 
variability in results between the current and previous studies (9, 12, 13, 193).   
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 As a highly reactive oxide metabolite of nitric oxide, peroxynitrate-bound 
tyrosine residues forming nitrotyrosine (NT) (196) was measured by Sureda et al. (178) 
following supplementation of vitamin C + vitamin E surrounding a half-marathon.  
Suerda et al. (178) reported a significant increase in NT immediately post-race and 3-h 
post-race in the placebo group compared to the vitamin C + vitamin E supplemented 
group, indicating that antioxidant supplementation may have a dampening effect on 
oxidation of nitrogen-containing compounds with endurance exercise.  Contrarily, a 
previous tart cherry study conducted by Bowtell et al. (20) surrounding an intensive 
resistance exercise workout of repeated leg extensions in resistance trained males found 
no difference in serum nitrotyrosine measures between supplementation groups in the 
post-strength exercise period.  The current study also reported no differences in NT 
levels over the study protocol and between supplementation groups.  The outcome 
inconsistency may also be attributable to the differences in exercise modality or 
antioxidant supplement, thus exhibiting a disparity in metabolic system reliance for 
energy production and potential mechanistic variability in whole fruit-derived versus 
extracted antioxidant supplements (e.g. vitamins C and E).  
Muscle Soreness Perception 
 The effect of phytochemical or vitamin containing anti-inflammatory 
supplements on the perception of muscle soreness after an endurance exercise challenge 
is inconsistent within the literature.  In an endurance relay race-based study with trained 
runners (average running distance 26.3 km), Kuehl et al. (101) used a VAS to track 
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muscle pain and found that those who supplemented with a Montmorency tart cherry 
juice blend had significantly lower post-race pain compared to a placebo.  Due to the 
nature of this endurance event, the post-race pain measurement timeline and individual 
running segment distances were not standardized across all participants (9, 101).  
Similarly, in an eccentrically breaking endurance trial where physically active subjects 
ran downhill continuously for 30-min and were acutely supplemented with either 
ascorbic acid or a placebo, Close et al. (37) reported no significant differences in VAS 
pain ratings nor pressure algometry between groups up to 14-d post-exercise on six 
lower extremity locomotion muscle groups.  With no effect on post-aerobic exercise 
delayed onset muscle soreness (DOMS) coupled with previous evidence in the literature, 
Close et al. (37) suggested a dissociation between post-exercise ROS production and 
DOMS.  Following a marathon running event and a bout of high intensity stochastic 
cycling using a similar 200 mm VAS protocol, Howatson et al. (76) and Bell et al. (13) 
respectively, reported no difference in DOMS ratings between Montmorency tart cherry 
juice supplementation and placebo up to 72-h post-exercise.  Within the current study, 
the pre-run perception of vastus medialis muscle soreness was significantly greater in the 
placebo group compared to tart cherry with no soreness differences between groups over 
the three recovery time points.  Due to the significant difference in pre-run medial 
quadriceps soreness between supplementation groups, delta changes calculated from pre-
run revealed greater recovery muscle soreness with tart cherry supplementation 
compared to placebo.  Without a baseline measure of quadriceps soreness perception and 
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a subject training load record before the start of the study or beyond the 48-h pre-testing 
session exercise limitation, it is difficult to rationalize the pre-run muscle soreness 
discrepancy.  However, the variability in soreness perceptions across muscle groups 
within the current study compared to previous research may also be due to the disparity 
in measurement protocol, tart cherry supplements, exercise modality, and/or subject pool 
training status.  Limited muscle damage in the current study may also be attributed to the 
minimal changes in elevation over the duration of the flat race course, which minimized 
excessive eccentric loading during the run.  Measurement of muscle soreness perception 
in the present study utilizing both an algometer and a GRPS was implemented to help 
ameliorate the purely subjective nature of a VAS as the only measure of pain or 
soreness.   
Research Investigation Strengths and Weaknesses 
 The strengths of this particular study revolve around the cohort of soreness 
measures and hemodynamic markers that contribute a more comprehensive analysis to 
the existing body of published literature.  Some of the more recent endurance-based tart 
cherry supplementation research studies have investigated phytonutrient effectiveness on 
a comprehensive panel of hemodynamic markers, which will allow for parallels to be 
drawn to the powdered tart cherry supplement used in the current study.  The current 
study did not enter the study cohort into a previously established race competition, but 
rather created a half-marathon race exclusively for the study that started and ended near 
the laboratory building for convenient and consistent testing surrounding the race.  The 
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utilization of this supplement within a trained population demonstrated its effectiveness 
under normative training, diet, and performance conditions.  Subject compliance with 
supplementation was likely enhanced over past tart cherry supplement studies due to the 
simplicity of encapsulated powdered supplement versus a potentially inconvenient 
and/or unpalatable juice used previously.  Potential limitations and weakness of the 
current study should also be considered.  The placebo-control matched design of this 
study was effective in equalizing study subject exposure to the conditions of the half-
marathon irrespective of supplement group.  However, compared to some of the 
previous research implementing a cross-over design, there might have been some 
variability associated with subject pairing.  A large portion of the study cohort were 
triathletes who train together on a regular basis, but VO2 max testing was not 
implemented in this study design to determine aerobic capacity of each runner at the 
time of the study.  Differences in aerobic state of training beyond the study 
inclusion/exclusion criteria may also have been a source of variability in the study cohort 
recruitment.  Due to the large number of hemodynamic markers measured in this study, 
the five selected time points of blood draws over the course of the experimental period 
may have not fully represented the pharmacokinetic profile of each marker.  Despite 
controlling 48-h training activity and NSAID intake with a 10-h fast before each session, 
the hydration status of each subject prior to the half-marathon was not controlled nor 
tested.  Differences in hydration status among study subjects could have created 
variability in a cohort of this size.  The 48-hour NSAID ingestion limitation may not 
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have been a sufficient washout time for all NSAID-type medications considering the 
large range in reported half-life of common NSAIDs (1.6 to 30-h), which may have also 
been a contributing source of acute variability.  However, chronic or habitual NSAID 
users were excluded from the study pool during the initial study screening process, so 
the 48-h NSAID restriction was utilized as a secondary control point to help eliminate 
potential effects of acute NSAID ingestion and strengthen study validity.  The study 
design could have also been improved with the incorporation of aerobic and/or muscular 
strength testing at each of the recovery time points to help elucidate the effect of the 
supplement on performance recovery in this study population.  The major overriding 
strength of the current study is that this is the first study to be conducted utilizing a 
powdered form of tart cherries rather than a juice or concentrate.   
Conclusion 
 The findings of the current study revealed that consumption of a Montmorency 
powdered tart cherry supplement 7-d before, the day of, and 2-d after completing an 
endurance running challenge, appears to be an effective dietary supplement that may 
help attenuate post-run markers of muscle catabolism and physiological stress in 
aerobically trained individuals.  Attenuation of inflammatory markers over the 48-h 
recovery also demonstrates significant promise with powdered tart cherry 
supplementation.  Coupled with the dampening of the inflammatory response, the 
powdered tart cherry runners seemed to better maintain post-run redox balance 
compared to placebo supplemented runners.  The initial effectiveness on aerobic 
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performance, serum markers of muscle catabolism, physiological stress, and 
inflammatory mechanisms coupled with a more stable post-run redox balance potentially 
indicates a reduction in secondary muscle damage as a result of powdered tart cherry 
supplementation.  Despite inconclusive evidence surrounding the perceptions of medial 
quadriceps soreness, the primary findings of the current study demonstrate that 
powdered tart cherry supplementation in endurance-trained individuals provides similar 
benefits as previously studied tart cherry juices or concentrates following acute bouts of 
aerobic-based exercise.  
Future Direction of Research 
 Short-term supplementation with powdered tart cherries surrounding single bouts 
of demanding resistance and endurance exercise in trained populations has demonstrated 
beneficial effects in the current two studies.  The results of the current two studies align 
closely with or exhibit more beneficial effects than previous performance research 
conducting utilizing tart cherry juice or concentrate ingestion.  At the basic level, future 
research needs to directly compare short-term tart cherry juice, concentrate, and powder 
ingestion of equal anthocyanin content, gallic acid equivalence, and ORAC (Oxygen 
Radical Absorbance Capacity) surrounding a single bout of endurance or resistance 
exercise.  Several endurance exercise modalities should be examined utilizing this type 
of supplementation protocol to help elucidate comparisons between previous studies, 
such as endurance running (e.g. half-marathon, marathon), endurance cycling, running 
and cycling intervals conducted on a flat grade or downhill.  Further, several resistance-
 216 
 
 
 
based exercise modalities should be implemented as a basis for comparison between 
previous research such as eccentrically-resisted single leg elbow flexion and knee 
extension, upper body strength exercise protocol (e.g. bench press), lower body strength 
exercise protocol (e.g. barbell back squat), or repeated eccentrically-braked plyometrics 
(e.g. progressive double or single leg depth jump workout).   
 Expanding beyond the short-term supplementation studies surrounding a single 
bout of exercise, research could also be extended to longer term supplementation 
surrounding periods of intensive training regimens (e.g. 2-wk pre-season training, ultra-
endurance competitions, or military basic training for new recruits).  While there has 
been some previous antioxidant vitamin and phytochemical/functional food 
supplementation research conducted over longer periods (e.g. 4-6-wk) in both trained 
and untrained populations, there has not been any extended supplementation studies in 
the tart cherry literature.  Due to limited research literature examining the combination 
of phytochemical/functional foods (e.g. tart cherry powder) with other recovery 
supplements such as amino acids and/or protein on similar, there is another future 
research opportunity to study measures of exercise performance, muscle, and overall 
physiological recovery as a result of this type of combination supplementation.  
 Additionally, little pharmacokinetic and pharmacodynamics research has been 
conducted in studies.  Understanding differences in bioavailability of the active 
compounds within certain functional foods or beverages is crucial in determining the 
most beneficial supplements, ideal timetable of ingestion, and most effective 
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formulation.  Some of the most recently published research in the clinical nutrition field 
has hypothesized and explored whether the active bioactive compounds exist within the 
food supplement or whether ingestion of certain natural supplement compounds spawn 
the activation of internal bioactives as a result of the digestive process.  A future 
research direction may examine this debate with various forms of tart cherry 
supplementation in diseased, healthy, and exercising populations. 
 When examining the individual results of both the resistance and endurance 
studies, there is evidence that some individuals responded considerably to the 
supplementation whereas others did not.  An interesting future research direction would 
compare the demographic, nutritional, performance, and physiological differences in 
responders versus non-responders.  As a more detailed expansion of this future research, 
varying dosage levels of tart cherry powder could be studied to determine effects of 
supplementation on criteria similar to that presented in the current research coupled with 
effects of dosage on responders versus non-responders.   
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APPENDIX A 
Tart Cherry Resistance Study Consent Form 
Project Title:  Effects of Tart Cherry Supplementation on Markers of Inflammation, 
Muscle Damage, and Muscle Soreness Following Intense Resistance Exercise  
 
You are invited to take part in a research study being conducted by Dr. Richard 
Kreider, a researcher from Texas A&M University and funded by Anderson 
Global Group, LLC. The information in this form is provided to help you decide 
whether or not to take part. If you decide to take part in the study, you will be 
asked to sign this consent form. If you decide you do not want to participate, there 
will be no penalty to you, and you will not lose any benefits you normally would 
have. 
 
Why Is This Study Being Done? 
The purpose of this study is to determine if consumption of powdered tart cherries prior 
to and following intense resistance exercise will lessen the inflammatory and/or muscle 
damaging effects of that exercise.   
 
Why Am I Being Asked To Be In This Study?  
You are being asked to be in this study because you are an apparently healthy resistance-
trained male between the ages of 18 and 40.  You must have been involved in a 
progressive resistance-training program that included squat exercise training for at least 
six months prior to the initiation of this study and be able to perform a standard barbell 
squat in a power rack of at least 1.5 times your body weight.  You will not be allowed to 
participate in this study if you have any metabolic disorders including known electrolyte 
abnormalities; heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; a 
history of hypertension, hepatorenal, musculoskeletal, autoimmune, or neurologic 
disease; if you are taking thyroid, anti-hyperlipidemic, hypoglycemic, anti-hypertensive, 
anti-inflammatory, or androgenic medications; and/or any known allergies to cherries, 
other berries, or foods and juices containing high levels of phenolic compounds or 
anthocyanins (see Tables 1 and 2).  If you meet eligibility criteria you will be informed 
of the requirements of the study and sign an informed consent statement in compliance 
with the Human Subject’s Guidelines of Texas A&M University and the American 
College of Sports Medicine (ACSM).           
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Table 1.  Phenolic compound and anthocyanin content of fruits and vegetables.  
  
Phenolic Compounds                                                                                                              
[Gallic Acid Equilivants (GAE)]                                                     
Total Anthocyanins 
 
(mg/100g) (mg/4oz)* (mg/100g) (mg/4oz)* 
FRUIT 
    
Acai berry, raw 
  
320 mg 358.4 mg 
Apple, raw 
  
0.6 mg 0.67 mg 
Blackberry, Evergreen, raw 2-5 mg 2.2-5.6 mg 83-326 mg 93.0-365.1 mg 
Blackberry, Merion, raw 3-6 mg 3.4-6.7 mg 109-317 mg 122.1-355.0 mg 
Black currant, raw 
  
130-400 mg 145.6-448.0 mg 
Blood orange, raw 
  
200 mg 224.0 mg 
Blueberry, raw 315-1291 mg 352.8-1445.9 mg 25-497 mg 28.0-556.6 mg 
Boysenberry, raw 6-9 mg 6.7-10.1 mg 120-160 mg 134.4-179.2 mg 
Cherry, sweet bing, raw 80-205 mg 89.6-229.6 mg 122-400 mg 136.6-448.0 mg 
Cherry, raw 
  
350-400 mg 392.0-448.0 mg 
Chokeberry, raw 
  
200-1480 mg 224.0-1657.6 mg 
Cranberry, raw 
  
60-200 mg 67.2-224.0 mg 
Elderberry, raw 
  
450 mg 504.0 mg 
Goji-WF, dried 562-1036 mg 629.4-1160.3mg 
  
Goji-B, dried 530-895 mg 593.6-1002.4 mg 
  
Grape, black, raw 372-572 mg 416.6-640.6 mg 36.7 mg 41.1 mg 
Jujube, dried 595-944 mg 666.4-1057.3 mg 
  
Mango, puree 19.5-166.7 mg 21.8-1867 mg 
  
Nectarine, raw 
  
6.8 mg 7.6 mg 
Orange, raw 
  
200 mg 224.0 mg 
Peach, white peeled, raw 46-91 mg 51.5-101.9 mg 4.8 mg 5.4 mg 
Plum, red, raw 69-161 mg 77.3-180.3 mg 2-71.8 mg 2.2-80.4 mg 
Plum, black, raw 131-441 mg 146.7-493.9 mg 2-71.8 mg 2.2-80.4 mg 
Prune, dried 337-399 mg 377.4-446.9 mg 
  
Raspberry, red, raw 163-393 mg 182.6-440.2 mg 11-390 mg 12.3-436.8 mg 
Raspberry, black, raw 9.8 mg 11.0 mg 5.9 mg 6.6 mg 
Red currant 
  
80-420 mg 89.6-470.4 mg 
Red grape, raw 
  
30-750 mg 33.6-840.0 mg 
Strawberry, organic, raw 159-282 mg 178.1-315.8 mg 15-75 mg 16.8-84.0 mg 
VEGETABLES 
    
Eggplant (aubergine), raw 
  
85.7-750 mg 96.0-84.0 mg 
Cabbage, red, raw 1107 mg 1239.8 mg 322 mg 360.6 mg 
Kale, raw  3689 mg 4131.7 mg 
  
Lettuce, red leaf, raw 
  
2.2 mg 2.5 mg 
Red raddish, raw 
  
100 mg 112.0 mg 
Radish, raw 
  
11-60 mg 12.3 mg-67.2 mg 
Red onion, raw 
  
13-25 mg 14.6-28.0 mg 
Onion, raw 
  
7-21 mg 7.8-23.5 mg 
Bean, black, raw 
  
44.5 mg 49.8 mg 
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Table 2.  Phenolic compound and total anthocyanin content of fruit and vegetable juices.  
  
Phenolic Compounds                                                                                                              
[Gallic Acid Equilivants (GAE)]                                                     
Total Anthocyanins 
  (mg/100 mL) (mg/240 mL)* (mg/240 mL)* (mg/L) 
JUICE     
 
  
Red wine 
  
0.24-8.4 mg 1-35 mg/L 
Acai + Lime juice 338-1227 mg 811-2945 mg 
  
Acai-I juice 315-858 mg 756-2059 mg 
  
Acai-M juice 276-495 mg 662-1188 mg 
  
Acai-Z juice 114-395 mg 274-948 mg 
  
Berry boost juice 172-283 mg 413-679 mg 
  
Black currant juice 115-261 mg 276-626 mg 
  
Black currant nectar, organic 70-120 mg 168-288 mg 
  
Blood orange juice, fresh squeeze 129-295 mg 310-708 mg 0.72-2.4 mg 3-10 mg/L 
Montmorency tart cherry juice 
  
2188 mg 9117 mg/L 
Blackberry fruit juice 
  
276 mg 1150 mg/L 
Blueberry fruit juice 
  
198-1008 mg 825-4200 mg/L 
Grape, red fruit juice 
  
72-180 mg 300-750 mg/L 
Cherry, sweet fruit juice 
  
4.8-1080 mg 20-4500 mg/L 
Strawberry fruit juice 
  
36-84 mg 150-350 mg/L 
Cranberry fruit juice 
  
144-480 mg 600-2000 mg/L 
Pomegranate juice, fresh extract 142-168 mg 341-403 mg 
  
Chicha juice (purple corn drink) 144-501 mg 346-1202 mg 
  
* Normal serving size 
 
How Many People Will Be Asked To Be In This Study? 
Approximately 20 people will be invited to participate in this study locally.  
 
What Are the Alternatives to being in this study? 
The alternative to being in the study is not to participate.  
 
What Will I Be Asked To Do In This Study? 
You will be asked to not exercise for 48 hours nor eat or drink calorie containing drinks 
for 12 hours before the 3
rd
, 4
th
 and 5
th
 testing sessions/visits.  You will also be asked to 
record all food and drink you eat and drink on food record forms for four days (including 
Shallots, raw 2528 mg 2831.4 mg 
  
Spinach, raw 7167 mg 8027.0 mg 
  
Swamp cabbage, raw 4175 mg 4676.0 mg 
  
Purple corn, raw 
  
1642 mg 1839.0 mg 
* Normal serving size 
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one weekend day) prior to the baseline testing session/visit.  Your participation in this 
study will last up to approximately ten days and include five visits (visit 1 ~ 1 hour/visit 
2 ~ 1 hour/visit 3 ~ 2 hours/visit 4 and 5 ~ 30 min.).  These visits are detailed below and 
in Table 3.   
 
Visit 1 (Week one) – Familiarization and Entry 
This visit will last about one hour.  During this visit the details of the study will be 
explained, human subject consent forms will be signed, personal and medical history 
information will be completed, and you will have a general physical that will include 
measurement of fasting blood to determine if you can participate in the study.  You will 
donate approximately 5 ml (about 1 teaspoon) of fasting blood from a vein in your arm 
according to standard procedures.  You will be asked to restrict taking any non-steroidal 
anti-inflammatory drugs (NSAID) 48 hours prior to testing and during recovery.  You 
will also have your height and weight measured.   
 
Visit 2 (Day 0) – Baseline assessments 
This visit will last about one hour.  During this visit you will first have your height and 
weight measured.  You will then have your body composition determined using a Dual 
Energy X-ray Absorptiometry (DEXA) machine.  This will involve lying down on your 
back on the DEXA exam table in a pair of shorts or gown for about six minutes.  A low 
dose of radiation will scan your body to determine the amount of fat weight, muscle 
weight, and bone weight.  You will then warm-up on an isokinetic knee extension 
dynamometer (3 sets of 5 repetitions) at about half of your estimated one repetition 
maximum weight using your dominant leg followed by determination of three maximal 
voluntary contractions (MVC) on your dominant leg.  After 5 minutes of recovery you 
will then warm-up performing 3 sets of 5 repetitions at 50% of your anticipated one 
repetition maximum (1 RM) on the back squat performed in a power rack and have 1 
RM determined using standard procedures.  You will then be asked to record all food 
ingestion on food record forms for four days and asked to not eat or drink for 12 hours 
and abstain from exercise and consumption of non-steroidal anti-inflammatory 
medications (NSAIDS) for 48 hours prior to the start of the study or visit 3.       
 
Visit 3 (Day 8) – Pre-exercise, exercise and 60 minutes post-exercise 
This visit will last about two hours.  During this visit you will first donate approximately 
20 ml (4 teaspoons) of blood using standard clinical procedures and rate perceptions to a 
standardized application of pressure using an algometer on your dominant thigh at 3 
designated locations using a 10 point visual analogue scale to assess muscle 
soreness/tenderness.  You will then warm-up and perform 3 sets of 5 repetitions at 50% 
of MVC of dominate knee extension/flexion with 1 minute recovery between sets 
followed by performing 3 MVC’s on the dominant leg.  You will then rest for 5 minutes 
and perform 1 warm-up set of 10 repetitions at 50% of 1 RM on the back squat.  After a 
3 minute recovery you will perform 10 sets of 10 repetitions at 50% of 1 RM on the back 
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squat.  After a 3 minute recovery you will perform 10 sets of 10 repetitions at 70% of 1 
RM with 3 minutes recovery between sets.  A Tendo unit will be attached to the bar to 
determine peak power, average force, and total work for each repetition performed.  If 
necessary the weight will be reduced so that you can complete 10 repetitions for each 
set.  After a 60 minute recovery a blood sample, VAS ratings of muscle soreness to a 
standardized amount of pressure and 3 isokinetic knee extension MVC’s will be taken on 
the dominant leg.        
 
Visit 4 (Day 9) – 24 hour post-exercise 
This visit will last about 30 minutes.  During this visit you will first donate 
approximately 20 ml (4 teaspoons) of blood using standard clinical procedures.  Next 
VAS ratings of muscle soreness to a standardized amount of pressure and 3 isokinetic 
knee extension MVC’s will be taken on the dominant leg.   
 
Visit 5 (Day 10) – 48 hour post-exercise 
This visit will last about 30 minutes.  During this visit you will first donate 
approximately 20 ml (4 teaspoons) of blood using standard clinical procedures.  Next 
VAS ratings of muscle soreness to a standardized amount of pressure and 3 isokinetic 
knee extension MVC’s will be taken on the dominant leg.   
 
 
Supplementation 
You will be matched into one of two groups according to age, body weight, and fat free 
mass.  You will then be randomly assigned to ingest in a double blind manner capsules 
containing a placebo or powdered tart cherries.  You will be asked to ingest the 
supplements with breakfast at 8:00 a.m. for 7 days prior to performing the exercise tests, 
the day of the testing, and for 2 days following testing (10 total days).  The supplements 
will contain 480 mg of freeze dried Montmorency tart cherry skin powder derived from 
tart cherry skins obtained after juicing (CherryPURE
TM
 Tart Cherry Powder, Shoreline 
fruit, LLC, Traverse City, MI).   
 
You may be removed from the study by the investigator for these reasons: 
 You do not show up for your scheduled testing sessions/visits and the 
investigators are unable to contact you to reschedule.   
 The investigators are unable to obtain a blood sample from you.  
 You do not follow your assigned supplementation protocol 
 
Table 3.  Overview of Study 1 - Effects of Tart Cherry Supplementation on Markers of 
Inflammation, Muscle Damage, and Muscle Soreness following Intense Resistance Exercise 
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Are There Any Risks To Me? 
The things that you will be doing are greater than risks that you would come across in 
everyday life. Although the researchers have tried to avoid risks, you may feel that some 
questions/procedures that are asked of you will be stressful or upsetting.  You do not 
have to answer anything you do not want to.  You will be exposed to a low level of 
radiation during the DEXA body composition test, which is similar to the amount of 
natural background radiation you would receive in one month while living in College 
Station Texas.  The use of the DEXA analyzer has been shown to be a safe method of 
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Familiarization 
and Entry 
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measuring body composition and is approved by the FDA.  You will donate 
approximately 5 ml (about 1 teaspoon) of blood during the initial 
familiarization/screening visit and then approximately 20 ml (about 4 teaspoons) four 
additional times throughout the duration of the study (twice during the testing session 
and once 24 hours post exercise and once 48 hours post exercise) using standard 
procedures.  These procedures may cause a small amount of pain when the needle is 
inserted into the vein as well as some bleeding and bruising.  You may also experience 
some dizziness, nausea, and/or faint if you are unaccustomed to having blood drawn.  
The exercise tests that will be performed may cause symptoms of fatigue, shortness of 
breath, and/or muscular fatigue/discomfort.  The exercise tests may also cause short-term 
muscle soreness and moderate fatigue for several days following the tests.  You may also 
experience muscle strains/pulls during the exercise testing and/or training program.  
However, exercise sessions will be conducted by trained personnel and monitored to 
ensure you follow appropriate exercise guidelines.  The likelihood of any of these 
occurring is slim.         
   
Are There Any Benefits To Me? 
The direct benefit to you being in this study is to know more about your health and 
fitness status from the tests to be performed.  However, even if no individual benefit is 
obtained, you will be paid for your participation.     
 
Will There Be Any Costs To Me?  
Aside from your time, there are no costs for taking part in the study. 
 
Will I Have To Pay Anything If I Get Hurt In This Study? 
If you suffer any injury as a result of taking part in this research study, please understand 
that nothing has been arranged to provide free treatment of the injury or any other type 
of payment. However, all needed facilities, emergency treatment and professional 
services will be available to you, just as they are to the community in general. You 
should report any injury to Dr. Richard Kreider at 979-845-1333.  You will not give up 
any of your legal rights by signing this consent form. 
 
Side effects (injury) can happen in any research study. These effects may not be your 
fault or the fault of the researcher involved. Known side effects have been described in 
the “Are there any risks to me?” section of this consent form. However, side effects that 
are not currently known may happen and require care. You do not give up any of your 
legal rights by signing this form. 
 
Will I Be Paid To Be In This Study? 
You will receive a total of $100 ($20 for the Familiarization and $20 for each of the 
additional four testing sessions) in one check at the end of the study.  Payment will occur 
after finishing all five sessions and after all study materials (food records, etc.) have 
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been turned in to the study staff.  You will be paid on a prorated basis if you are unable 
to complete the entire study.      
 
Will Information From This Study Be Kept Private? 
The records of this study will be kept private.  No identifiers linking you to this study 
will be included in any sort of report that might be published.  Research records will be 
stored securely and only Exercise & Sport Nutrition Laboratory staff will have access to 
the records. 
 
Information about you will be stored in locked file cabinets in a locked file room in an 
ID card swipe access controlled laboratory.  Computer files will be protected with a 
password.  This consent form will be filed securely in an official area.  People who have 
access to your information include the Principal Investigator and research study 
personnel.  Representatives of regulatory agencies such as the Office of Human 
Research Protections (OHRP) and entities such as the Texas A&M University Human 
Subjects Protection Program (HSPP) may access your records to make sure the study is 
being run correctly and that information is collected properly.  
 
The agency that is funding this study (Anderson Global Group, LLC) and the 
institutions(s) where study procedures are being performed (Texas A&M University) 
may also see your information.  However, any information that is sent to them will be 
coded with a number so that they cannot tell who you are.  Representatives from these 
entities can see information that has your name on it if they come to the study site to 
view records.  If there are any reports about this study, your name will not be in them.   
 
Information about and related to this study will be kept confidential to the extent 
permitted or required by law. 
 
Who may I Contact for More Information? 
You may contact the Principal Investigator, Richard Kreider, PhD, to tell him about a 
concern or complaint about this research at 979-845-1333 or rkreider@hlkn.tamu.edu.  
You may also contact the Co-Investigator/Laboratory Research Associate, Chris 
Rasmussen, at 979-458-1741 or crasmussen@hlkn.tamu.edu.   
 
For questions about your rights as a research participant; or if you have questions, 
complaints, or concerns about the research, you may call the Texas A&M University 
Human Subjects Protection Program office at (979) 458-4067 or irb@tamu.edu.  
 
What if I Change My Mind About Participating? 
This research is voluntary and you have the choice whether or not to be in this research 
study.  You may decide to not begin or to stop participating at any time.  If you choose 
not to be in this study or stop being in the study, there will be no effect on your student 
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status, medical care, employment, evaluation, relationship with Texas A&M University, 
etc.  Any new information discovered about the research will be provided to you.  This 
information could affect your willingness to continue your participation 
 
 
STATEMENT OF CONSENT 
I agree to be in this study and know that I am not giving up any legal rights by 
signing this form.  The procedures, risks, and benefits have been explained to me, 
and my questions have been answered.  I know that new information about this 
research study will be provided to me as it becomes available and that the 
researcher will tell me if I must be removed from the study.   I can ask more 
questions if I want.  A copy of this entire consent form will be given to me. 
 
 
___________________________________  _____________________________ 
Participant’s Signature    Date 
 
 
___________________________________ ____________________________ 
Printed Name Date 
 
 
INVESTIGATOR'S AFFIDAVIT: 
Either I have or my agent has carefully explained to the participant the nature of the 
above project. I hereby certify that to the best of my knowledge the person who signed 
this consent form was informed of the nature, demands, benefits, and risks involved in 
his/her participation. 
 
__________________________________ _____________________________ 
Signature of Presenter Date 
 
___________________________________ _____________________________ 
Printed Name Date 
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Tart Cherry Endurance Study Consent Form 
Project Title:  Effects of Tart Cherry Supplementation on Markers of Inflammation, 
Muscle Damage and Muscle Soreness Following Endurance Running    
 
You are invited to take part in a research study being conducted by Dr. Richard 
Kreider, a researcher from Texas A&M University and funded by Anderson 
Global Group, LLC.  The information in this form is provided to help you decide 
whether or not to take part. If you decide to take part in the study, you will be 
asked to sign this consent form. If you decide you do not want to participate, there 
will be no penalty to you, and you will not lose any benefits you normally would 
have. 
 
Why Is This Study Being Done? 
The purpose of this study is to determine if consumption of powdered tart cherries prior 
to and following intense endurance exercise will lessen the inflammatory and/or muscle 
damaging effects of that exercise.     
 
Why Am I Being Asked To Be In This Study?  
You are being asked to be in this study because you are an apparently healthy male or 
female runner or triathlete between the ages of 18 and 40.  You must have been involved 
in a consistent running program for at least one year and be able to run 13.1 miles in less 
than 2 hours.  You will not be allowed to participant in this study if you have any 
metabolic disorders including known electrolyte abnormalities; heart disease, 
arrhythmias, diabetes, thyroid disease, or hypogonadism; a history of hypertension, 
hepatorenal, musculoskeletal, autoimmune, or neurologic disease; if you are taking 
thyroid, anti-hyperlipidemic, hypoglycemic, anti-hypertensive, anti-inflammatory, or 
androgenic medication; and/or any known allergies to cherries, other berries, or foods 
and juices containing high levels of phenolic compounds or anthocyanins (see Tables 1 
and 2).  If you meet eligibility criteria you will be informed of the requirements of the 
study and sign an informed consent statement in compliance with the Human Subject’s 
Guidelines of Texas A&M University and the American College of Sports Medicine 
(ACSM).       
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Table 1.  Phenolic compound and anthocyanin content of fruits and vegetables.  
  
Phenolic Compounds                                                                                                              
[Gallic Acid Equilivants (GAE)]                                                     
Total Anthocyanins 
 
(mg/100g) (mg/4oz)* (mg/100g) (mg/4oz)* 
FRUIT 
    
Acai berry, raw 
  
320 mg 358.4 mg 
Apple, raw 
  
0.6 mg 0.67 mg 
Blackberry, Evergreen, raw 2-5 mg 2.2-5.6 mg 83-326 mg 93.0-365.1 mg 
Blackberry, Merion, raw 3-6 mg 3.4-6.7 mg 109-317 mg 122.1-355.0 mg 
Black currant, raw 
  
130-400 mg 145.6-448.0 mg 
Blood orange, raw 
  
200 mg 224.0 mg 
Blueberry, raw 315-1291 mg 352.8-1445.9 mg 25-497 mg 28.0-556.6 mg 
Boysenberry, raw 6-9 mg 6.7-10.1 mg 120-160 mg 134.4-179.2 mg 
Cherry, sweet bing, raw 80-205 mg 89.6-229.6 mg 122-400 mg 136.6-448.0 mg 
Cherry, raw 
  
350-400 mg 392.0-448.0 mg 
Chokeberry, raw 
  
200-1480 mg 224.0-1657.6 mg 
Cranberry, raw 
  
60-200 mg 67.2-224.0 mg 
Elderberry, raw 
  
450 mg 504.0 mg 
Goji-WF, dried 562-1036 mg 629.4-1160.3mg 
  
Goji-B, dried 530-895 mg 593.6-1002.4 mg 
  
Grape, black, raw 372-572 mg 416.6-640.6 mg 36.7 mg 41.1 mg 
Jujube, dried 595-944 mg 666.4-1057.3 mg 
  
Mango, puree 19.5-166.7 mg 21.8-1867 mg 
  
Nectarine, raw 
  
6.8 mg 7.6 mg 
Orange, raw 
  
200 mg 224.0 mg 
Peach, white peeled, raw 46-91 mg 51.5-101.9 mg 4.8 mg 5.4 mg 
Plum, red, raw 69-161 mg 77.3-180.3 mg 2-71.8 mg 2.2-80.4 mg 
Plum, black, raw 131-441 mg 146.7-493.9 mg 2-71.8 mg 2.2-80.4 mg 
Prune, dried 337-399 mg 377.4-446.9 mg 
  
Raspberry, red, raw 163-393 mg 182.6-440.2 mg 11-390 mg 12.3-436.8 mg 
Raspberry, black, raw 9.8 mg 11.0 mg 5.9 mg 6.6 mg 
Red currant 
  
80-420 mg 89.6-470.4 mg 
Red grape, raw 
  
30-750 mg 33.6-840.0 mg 
Strawberry, organic, raw 159-282 mg 178.1-315.8 mg 15-75 mg 16.8-84.0 mg 
VEGETABLES 
    
Eggplant (aubergine), raw 
  
85.7-750 mg 96.0-84.0 mg 
Cabbage, red, raw 1107 mg 1239.8 mg 322 mg 360.6 mg 
Kale, raw  3689 mg 4131.7 mg 
  
Lettuce, red leaf, raw 
  
2.2 mg 2.5 mg 
Red raddish, raw 
  
100 mg 112.0 mg 
Radish, raw 
  
11-60 mg 12.3 mg-67.2 mg 
Red onion, raw 
  
13-25 mg 14.6-28.0 mg 
Onion, raw 
  
7-21 mg 7.8-23.5 mg 
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Table 2.  Phenolic compound and total anthocyanin content of fruit and vegetable juices.  
  
Phenolic Compounds                                                                                                              
[Gallic Acid Equilivants (GAE)]                                                     
Total Anthocyanins 
  (mg/100 mL) (mg/240 mL)* (mg/240 mL)* (mg/L) 
JUICE     
 
  
Red wine 
  
0.24-8.4 mg 1-35 mg/L 
Acai + Lime juice 338-1227 mg 811-2945 mg 
  
Acai-I juice 315-858 mg 756-2059 mg 
  
Acai-M juice 276-495 mg 662-1188 mg 
  
Acai-Z juice 114-395 mg 274-948 mg 
  
Berry boost juice 172-283 mg 413-679 mg 
  
Black currant juice 115-261 mg 276-626 mg 
  
Black currant nectar, organic 70-120 mg 168-288 mg 
  
Blood orange juice, fresh squeeze 129-295 mg 310-708 mg 0.72-2.4 mg 3-10 mg/L 
Montmorency tart cherry juice 
  
2188 mg 9117 mg/L 
Blackberry fruit juice 
  
276 mg 1150 mg/L 
Blueberry fruit juice 
  
198-1008 mg 825-4200 mg/L 
Grape, red fruit juice 
  
72-180 mg 300-750 mg/L 
Cherry, sweet fruit juice 
  
4.8-1080 mg 20-4500 mg/L 
Strawberry fruit juice 
  
36-84 mg 150-350 mg/L 
Cranberry fruit juice 
  
144-480 mg 600-2000 mg/L 
Pomegranate juice, fresh extract 142-168 mg 341-403 mg 
  
Chicha juice (purple corn drink) 144-501 mg 346-1202 mg 
  
* Normal serving size 
 
How Many People Will Be Asked To Be In This Study? 
Approximately 30 people will be invited to participate in this study locally.   
 
What Are the Alternatives to being in this study? 
The alternative to being in the study is not to participate.  
 
What Will I Be Asked To Do In This Study? 
You will be asked to not exercise for 48 hours nor eat or drink calorie containing drinks 
for 12 hours before the 3
rd
, 4
th
 and 5
th
 testing sessions/visits.  You will also be asked to 
Bean, black, raw 
  
44.5 mg 49.8 mg 
Shallots, raw 2528 mg 2831.4 mg 
  
Spinach, raw 7167 mg 8027.0 mg 
  
Swamp cabbage, raw 4175 mg 4676.0 mg 
  
Purple corn, raw 
  
1642 mg 1839.0 mg 
* Normal serving size 
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record all food and drink you eat and drink on food record forms for four days (including 
one weekend day) prior to the exercise testing session/visit.  Your participation in this 
study will last up to approximately ten days and include five visits (visit 1 ~ 1 hour/visit 
2 ~ 1 hour/visit 3 ~ 3 hours/visit 4 and 5 ~ 30 min.).  These visits are detailed below and 
in Table 3.   
 
Visit 1 (Week one) – Familiarization and entry 
This visit will last about one hour.  During this visit the details of the study will be 
explained, human subject consent forms will be signed, personal and medical history 
information will be completed, and you will have a general physical that will include 
measurement of fasting blood to determine if you can participate in the study.  You will 
donate approximately 5 ml (about 1 teaspoon) of fasting blood from a vein in your arm 
according to standard procedures.  You will be asked to restrict taking any non-steroidal 
anti-inflammatory drugs (NSAID) 48 hours prior to testing and during recovery.  You 
will also have your height and weight measured.   
 
Visit 2 (Day 0) – Baseline assessments 
This visit will last about one hour.  During this visit you will first have your height and 
weight measured.  You will then have your body composition determined using a Dual 
Energy X-ray Absorptiometry (DEXA) machine.  This will involve lying down on your 
back on the DEXA exam table in a pair of shorts or gown for about six minutes.  A low 
dose of radiation will scan your body to determine the amount of fat weight, muscle 
weight, and bone weight.  You will then be asked to record all food ingestion on food 
record forms for four days and asked to not eat or drink for 12 hours and abstain from 
exercise and consumption of non-steroidal anti-inflammatory medications (NSAIDS) for 
48 hours prior to the start of the study or visit 3.       
 
Visit 3 (Day 8) – Pre-exercise, exercise and 60 minutes post-exercise 
This visit will last about three hours.  During this visit you will first donate 
approximately 20 ml (4 teaspoons) of blood using standard clinical procedures and rate 
perceptions to a standardized application of pressure using an algometer on your 
dominant thigh at 3 designated locations using a 10 point visual analogue scale to assess 
muscle soreness/tenderness.  You will then be asked to warm-up as you normally would 
before running a road race.  The race will be conducted on campus and around the 
ESNL.  You will then be asked to run a 13.1 mile run outdoors at your normal 
race/competition pace.  You will be provided a standard amount of a glucose-electrolyte 
drink at regular intervals during the run.  After a 60 minute recovery a blood sample and 
VAS ratings of muscle soreness to a standardized amount of pressure will be taken.          
 
Visit 4 (Day 9) – 24 hour post-exercise 
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This visit will last about 30 minutes.  During this visit you will first donate 
approximately 20 ml (4 teaspoons) of blood using standard clinical procedures.  Next 
VAS ratings of muscle soreness to a standardized amount of pressure will be taken.   
 
Visit 5 (Day 10) – 48 hour post-exercise 
This visit will last about 30 minutes.  During this visit you will first donate 
approximately 20 ml (4 teaspoons) of blood using standard clinical procedures.  Next 
VAS ratings of muscle soreness to a standardized amount of pressure will be taken.   
 
Supplementation 
You will be matched into one of two groups according to age, body weight, and fat free 
mass.    You will then be randomly assigned to ingest in a double blind manner capsules 
containing a placebo or powdered tart cherries.  You will be asked to ingest the 
supplements with breakfast at 8:00 a.m. for 7 days prior to performing the exercise test, 
the day of the testing, and for 2 days following testing (10 total days).  The supplements 
will contain 480 mg of freeze dried Montmorency tart cherry skin powder derived from 
tart cherry skins obtained after juicing (CherryPURE
TM
 Tart Cherry Powder, Shoreline 
fruit, LLC, Traverse City, MI). 
 
You may be removed from the study by the investigator for these reasons: 
 You do not show up for your scheduled testing sessions/visits and the 
investigators are unable to contact you to reschedule.   
 The investigators are unable to obtain a blood sample from you.  
 You do not follow your assigned supplementation protocol.   
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Table 3.  Overview of Study - Effects of Tart Cherry Supplementation on Markers 
of Inflammation, Muscle Damage, and Muscle Soreness following Endurance 
Exercise 
 
Are There Any Risks To Me? 
The things that you will be doing are greater than risks than you would come across in 
everyday life. Although the researchers have tried to avoid risks, you may feel that some 
questions/procedures that are asked of you will be stressful or upsetting.  You do not 
have to answer anything you do not want to.  You will be exposed to a low level of 
radiation during the DEXA body composition test, which is similar to the amount of 
Visit 1:  
Familiarization 
and Entry 
(FAM) 
 
Visit 2: Baseline 
Assessment 
(BASE) 
Visit 3: Exercise Testing Session (T1) Visit 4: 24-
HR Post-
Exercise                                                 
(T2)                                                   
Visit 5: 48-
HR Post-
Exercise
(T3)                                                 
Pre-Exercise 
 
Exercise 
Stimulus 
60-MIN                                   
Post-
Exercise 
 
Familiarization 
session 
 
Informed 
Consent Form 
 
Demographic 
Form 
 
Health History 
Form 
 
Exercise 
Training History 
Form 
 
Fasting Blood 
Sample 
 
General 
Physical Exam 
to Determine 
Qualifications 
to Participate in 
Study 
 
Restrict training 
and NSAID 
intake from 48-
hrs prior to 
testing and 
during recovery 
 
 
 
Determination of 
Height,  Body 
Weight, Body 
Composition 
 
Start 4-day 
Dietary History 
 
Randomization 
into 2 Groups  
 
Instructions for 
Supplementation 
 
Supplementation 
Begins                                                                        
(480 mg of 
freeze dried tart 
cherry skins 
taken orally with 
breakfast) 
 
 
 
 
 
 
  
Fasting 
Blood 
Sample 
 
VAS pain 
rating to 
standardized 
pressure 
application 
 
 
 
 
 
 
 
 
13.1 mile 
outdoor run 
 
 
Blood 
Sample 
 
VAS pain 
rating to 
standardized 
pressure 
application 
 
 
 
Fasting 
Blood 
Sample 
 
VAS pain 
rating to 
standardized 
pressure 
application 
 
 
 
Fasting 
Blood 
Sample 
 
VAS pain 
rating to 
standardized 
pressure 
application 
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natural background radiation you would receive in one month while living in College 
Station Texas.  The use of the DEXA analyzer has been shown to be a safe method of 
measuring body composition and is approved by the FDA.  You will donate 
approximately 5 ml (about 1 teaspoon) of blood during the initial 
familiarization/screening visit and then approximately 20 ml (about 4 teaspoons) four 
additional times throughout the duration of the study (twice during the testing session 
and once 24 hours post exercise and once 48 hours post exercise) using standard 
procedures.  These procedures may cause a small amount of pain when the needle is 
inserted into the vein as well as some bleeding and bruising.  You may also experience 
some dizziness, nausea, and/or faint if you are unaccustomed to having blood drawn.  
The exercise test that will be performed may cause symptoms of fatigue, shortness of 
breath, and/or muscular fatigue/discomfort.  The exercise test may also cause short-term 
muscle soreness and moderate fatigue for several days following the test.  You may also 
experience muscle strains/pulls during the exercise testing and/or training program.  
However, exercise sessions will be conducted by trained personnel and monitored to 
ensure you follow appropriate exercise guidelines.  The likelihood of any of these 
occurring is slim.    
Are There Any Benefits To Me?  
The direct benefit to you by being in this study is to know more about your health and 
fitness status from the tests to be performed.  However, even if no individual benefit is 
obtained, you will be paid for your participation.     
 
Will There Be Any Costs To Me?  
Aside from your time, there are no costs for taking part in the study. 
 
Will I Have To Pay Anything If I Get Hurt In This Study?  
If you suffer any injury as a result of taking part in this research study, please understand 
that nothing has been arranged to provide free treatment of the injury or any other type 
of payment. However, all needed facilities, emergency treatment and professional 
services will be available to you, just as they are to the community in general. You 
should report any injury to Dr. Richard Kreider at 979-845-1333.  You will not give up 
any of your legal rights by signing this consent form. 
 
Side effects (injury) can happen in any research study. These effects may not be your 
fault or the fault of the researcher involved. Known side effects have been described in 
the “Are there any risks to me?” section of this consent form. However, side effects that 
are not currently known may happen and require care. You do not give up any of your 
legal rights by signing this form. 
 
Will I Be Paid To Be In This Study? 
You will receive a total of $100 ($20 for the Familiarization and $20 for each of the 
additional four testing sessions) in one check at the end of the study.  Payment will occur 
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after finishing all testing sessions and after all study materials (food records, etc.) have 
been turned in to the study staff.  You will be paid on a prorated basis if you are unable 
to complete the entire study.        
 
Will Information From This Study Be Kept Private? 
The records of this study will be kept private.  No identifiers linking you to this study 
will be included in any sort of report that might be published.  Research records will be 
stored securely and only Exercise & Sport Nutrition Laboratory staff will have access to 
the records.   
 
Information about you will be stored in locked file cabinets in a locked file room in an 
ID card swipe access controlled laboratory.  Computer files will be protected with a 
password.  This consent form will be filed securely in an official area. 
 
People who have access to your information include the Principal Investigator and 
research study personnel.  Representatives of regulatory agencies such as the Office of 
Human Research Protections (OHRP) and entities such as the Texas A&M University 
Human Subjects Protection Program (HSPP) may access your records to make sure the 
study is being run correctly and that information is collected properly.  
 
The agency that is funding this study (Anderson Global Group, LLC) and the 
institutions(s) where study procedures are being performed (Texas A&M University) 
may also see your information.  However, any information that is sent to them will be 
coded with a number so that they cannot tell who you are.  Representatives from these 
entities can see information that has your name on it if they come to the study site to 
view records.  If there are any reports about this study, your name will not be on them.   
  
Information about you and related to this study will be kept confidential to the extent 
permitted or required by law.  
 
Who may I Contact for More Information? 
You may contact the Principal Investigator, Richard Kreider, PhD, to tell him about a 
concern or complaint about this research at 979-845-1333 or rkreider@hlkn.tamu.edu.  
You may also contact the Co-Investigator/Laboratory Research Associate, Chris 
Rasmussen, at 979-458-1741 or crasmussen@hlkn.tamu.edu.   
 
For questions about your rights as a research participant; or if you have questions, 
complaints, or concerns about the research, you may call the Texas A&M University 
Human Subjects Protection Program office at (979) 458-4067 or irb@tamu.edu.  
 
What if I Change My Mind About Participating? 
This research is voluntary and you have the choice whether or not to be in this research 
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study.  You may decide to not begin or to stop participating at any time.  If you choose 
not to be in this study or stop being in the study, there will be no effect on your student 
status, medical care, employment, evaluation, relationship with Texas A&M University, 
etc.  Any new information discovered about the research will be provided to you.  This 
information could affect your willingness to continue your participation.   
 
STATEMENT OF CONSENT 
I agree to be in this study and know that I am not giving up any legal rights by 
signing this form.  The procedures, risks, and benefits have been explained to me, 
and my questions have been answered.  I know that new information about this 
research study will be provided to me as it becomes available and that the 
researcher will tell me if I must be removed from the study.   I can ask more 
questions if I want.  A copy of this entire consent form will be given to me. 
 
 
___________________________________  _____________________________ 
Participant’s Signature    Date 
 
 
___________________________________ ____________________________ 
Printed Name Date 
 
INVESTIGATOR'S AFFIDAVIT: 
Either I have or my agent has carefully explained to the participant the nature of the 
above project. I hereby certify that to the best of my knowledge the person who signed 
this consent form was informed of the nature, demands, benefits, and risks involved in 
his/her participation. 
 
___________________________________ ____________________________ 
Signature of Presenter Date 
 
___________________________________ ____________________________ 
Printed Name Date 
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APPENDIX B  
Tart Cherry Research Medical History Questionnaire 
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APPENDIX C 
Tart Cherry Research Radiation Exposure Consent Form 
Texas A&M University: Exercise & Sport Nutrition Laboratory 
Trial:  Effects of Tart Cherry Supplementation on Markers of Inflammation, 
Muscle Damage, and Muscle Soreness Following Endurance Running 
     
Radiation Exposure Questionnaire for Women of Child Bearing Age 
Radiation exposure may affect fetal development.  Although the DEXA test 
will only expose you to a small amount of radiation (1.5mR per scan), you 
should be aware that there is a possibility that if you become pregnant 
during the course of the study that the x-ray exposure may be harmful to 
the fetus. Therefore, it is important to conduct x-ray tests within 10-14 days 
of the start of a female’s menstrual cycle if the she is of child bearing age, 
sexually active, and/or is not taking birth control pills.  The following 
questionnaire must be completed so that we know when it is an appropriate 
time to conduct the DEXA body composition tests.  Please be assured that 
this information will be kept confidential within the limits permitted by law. 
 
Current Age?        _______            
Age of first period?       _______           
Date of last period?       _______             
Normal length of menstrual cycle?    _______ 
Do you use birth control pills?     _______ 
Are you pregnant or have a desire for pregnancy?  _______ 
 
Note:  If you happen to get pregnant during the course of this study, you must 
notify research assistants so that appropriate precautions can be made.     
 
I confirm that I have completed this questionnaire honestly and agree to 
notify researchers within the ESNL of any change in the length of my 
menstrual cycle and/or pregnancy status. 
 
____________________________________  
Participant Name        
 
____________________________________ ____________________ 
Participant Signature     Date  
 
____________________________________ ____________________ 
Staff Signature      Date 
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APPENDIX D            
Tart Cherry Resistance Screening Face Sheet 
Texas A&M University: Exercise & Sport Nutrition Laboratory  
Trial:  Effects of Tart Cherry Supplementation on Markers of Inflammation, Muscle 
Damage, and Muscle Soreness following Intense Resistance Exercise 
           
Demographics             ESNL Staff Initials: _____
           
Name: ________________________________  Testing Session: 
Familiarization (FAM)  
Date: _____________  DOB: ___________  Age: _________ 
 
Screening Measures             ESNL Staff Initials: _____ 
Psychological Questionnaires/Informed Consent: 
 
HLKN Informed Consent: _____               Exercise Training History Form: _____ 
Demographic Form:  _____  Health History & General Screening Form:  _____ 
Financial Paperwork:  _____  Review Medical History/Screening (CTRAL RN):  _____ 
                                                                                                                
Physiological Parameters: 
 
Last Meal: ______ am/pm  Resting H.R.:  ______ bpm 
Hours Fasted:  ______ hrs.   Resting B.P.:  ______ /______ mmHg 
Lab (ESNL/CTRAL): ______ (2) SST tubes / (1) EDTA tube   
Blood Draw Time:   ______ am/pm 
 
Baseline Assessment Measures            ESNL Staff Initials: _____ 
 
Date: _____________  Age: _________ Testing Session: Baseline 
Assessment (BASE) 
 
Physiological Parameters:            ESNL Staff Initials: _____ 
 
Height:  ______ in.            Weight:  ______ lbs.            DEXA #2:  ______           
Time:  ______ am/pm 
                                                     
Exercise/Strength Parameters:           ESNL Staff Initials: _____ 
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Kin Com Isokinetic Testing:    Dominant Leg:  R  or  L  (circle one) 
Seat Bottom Distance (G):  ______ cm  Seat Track Position:  ______ cm
  
Dynamometer Track Position:   ______ cm  Leg Lever Arm Length:  ______ cm 
 
Isokinetic EXT/FLEX SMVC Warm-up (3 sets x ESTIMATED 50% MVC x 5 reps): ______ 
   
Isokinetic EXT/FLEX MVC Determination (1 set x MVC x 3 reps): ______ 
 
Smith Machine Maximal Back Squat: 
Foot Position:    Heel Distance from Rack Front: ______ in.   
Distance between Feet: ______ in. 
 
Estimated Back Squat 1RM: _______ lbs.   
 
50% Estimated Back Squat 1RM: _______ lbs. 
Warm-up 50% 1RM (3 sets x 5 reps): ______ 
 
Preceding Weights/Reps for Back Squat 1RM Determination: 
______x______: ______x______: ______x______: ______x______: ______x______  
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Tart Cherry Endurance Screening Face Sheet 
Texas A&M University: Exercise & Sport Nutrition Laboratory  
Trial:  Effects of Tart Cherry Supplementation on Markers of Inflammation, Muscle 
Damage, and Muscle Soreness following Endurance Running 
           
Demographics             ESNL Staff Initials: _____
           
Name: _____________________________       Testing Session: Familiarization (FAM)
  
Date: _____________  DOB: ___________  Age: _________ 
  
 
Screening Measures                         ESNL Staff Initials: _____ 
Psychological Questionnaires/Informed Consent: 
 
HLKN Informed Consent: _____     Exercise Training History Form:  _____ 
Demographic Form:  _____  Health History & General Screening Form:  _____ 
Financial Paperwork:  _____  Review Medical History/Screening (CTRAL RN):  _____ 
                                                                                                                
Physiological Parameters: 
 
Last Meal: ______ am/pm  Resting H.R.:  ______ bpm 
Hours Fasted:  ______ hrs.   Resting B.P.:  ______ /______ mmHg 
 
Lab (ESNL/CTRAL): ______ (2) SST tubes / (1) EDTA tube   
Blood Draw Time:   ______ am/pm 
 
 
Baseline Assessment Measures            ESNL Staff Initials: _____ 
 
Date: _____________   Age: _________  
Testing Session: Baseline Assessment (BASE) 
 
Physiological Parameters:            ESNL Staff Initials: _____ 
 
Height:   ______ in.              DEXA #2:  ______ 
Weight:  ______ lbs.                       Time:   ______ am/pm 
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Self-Reported Endurance Capabilities:          ESNL Staff Initials: _____ 
 
Recent Performances and Results: 
1] __________________________________ Finish Time: _________ min:sec 
 Average Race Pace: _________ min:sec/km   OR  
 Average Race Pace: _________ min:sec/mi  
 
2] __________________________________ Finish Time: _________ min:sec 
 Average Race Pace: _________ min:sec/km   OR  
 Average Race Pace: _________ min:sec/mi  
 
 Average Weekly Training Mileage: _________ miles/wk 
 
 Average/Typical Training Pace: _________ min:sec/mi 
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APPENDIX E 
Tart Cherry Resistance Testing Face Sheet 
Texas A&M University: Exercise & Sport Nutrition Laboratory  
Trial:  Effects of Tart Cherry Supplementation on Markers of Inflammation, Muscle 
Damage, and Muscle Soreness following Intense Resistance Exercise 
           
Demographics             ESNL Staff Initials: _____
           
Name: ________________________________ Testing Session:    Exercise (EX) 
Date: _____________  DOB: ___________  Age: _________  
Food Logs:  _______ 
 
Testing Measures             ESNL Staff Initials: _____ 
 
Physiological Parameters: 
Last Meal: ______ am/pm   Height:  ______ in.             
Hours Fasted:  ______ hrs.    Weight:  ______ lbs.             
Last Exercise: M  T  W  TH  F  SA  SU (circle one) Resting H.R.:  ______ bpm 
Abstained Exercise:   ______ hrs.   Resting B.P.: _____ /______ mmHg 
Abstained NSAIDs:  ______ hrs.   
 
Lab (ESNL/CTRAL): ______ (2) SST tubes / (1) EDTA tube   
Blood Draw Time:  ______ am/pm 
Algometer GPRS Evaluation Completed:  ______              
 
Exercise/Strength Parameters:           ESNL Staff Initials: _____ 
Kin Com Isokinetic Testing:    Dominant Leg:  R  or  L  (circle one) 
Seat Bottom Distance (G):  ______ cm  Seat Track Position:  ______ cm 
Dynamometer Track Position:   ______ cm  Leg Lever Arm Length:  ______ cm 
 
Isokinetic EXT/FLEX 50% MVC:  ________ (from Baseline Testing)  
Isokinetic EXT/FLEX SMVC Warm-up (3 sets x 50% MVC x 5 reps): ______      
Isokinetic EXT/FLEX MVC (1 set x MVC x 3 reps):  ______    
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Smith Machine Maximal Back Squat: 
Foot Position:    Heel Distance from Rack Front: ______ in.  
Distance between Feet: ______ in. 
 
Back Squat 1RM:  _______ lbs.   50% Back Squat 1RM:  _______ lbs. 
Warm-up 50% 1RM (1 sets x 10 reps):  ______  70% Back Squat 1RM:  _______ lbs. 
 Preceding Performance Data for Back Squat Exercise 70% 1RM (10 sets x 10 reps): 
SET REPS WEIGHT (lbs.) PEAK POWER AVG POWER AVG VELOCITY 
1 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
2 
1     
2     
3     
4     
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5     
6     
7     
8     
9     
10     
3 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
4 
1     
2     
3     
4     
5     
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6     
7     
8     
9     
10     
5 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
6 
1     
2     
3     
4     
5     
6     
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7     
8     
9     
10     
7 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
8 
1     
2     
3     
4     
5     
6     
7     
 272 
 
 
 
8     
9     
10     
9 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
10 
1     
2     
3     
4     
5     
6     
7     
8     
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9     
10     
 
Bar Displacement: ______ in.  ______ cm  
 
Recovery Measures 
60 Minute Post Physiological Parameters:          ESNL Staff Initials: _____ 
Lab (ESNL/CTRAL):  ______ (2) SST tubes / (1) EDTA tube  
Blood Draw Time:  ______ am/pm 
Algometer GPRS Evaluation Completed:  ______ 
Isokinetic EXT/FLEX SMVC Warm-up (3 sets x 50% MVC x 5 reps):  ______      
Isokinetic EXT/FLEX MVC (1 set x MVC x 3 reps):  ______ 
 
24 Hour Post Physiological Parameters:       
Date: _____________                    ESNL Staff Initials: _____ 
Lab (ESNL/CTRAL):  ______ (2) SST tubes / (1) EDTA tube  
Blood Draw Time:  ______ am/pm 
Last Meal: ______ am/pm (Hours Fasted:  ______)  
Algometer GPRS Evaluation Completed:  ______         
     
Isokinetic EXT/FLEX SMVC Warm-up (3 sets x 50% MVC x 5 reps):  ______      
Isokinetic EXT/FLEX MVC (1 set x MVC x 3 reps):  ______ 
 
48 Hour Post Physiological Parameters:   
Date: _____________                     ESNL Staff Initials: _____ 
Lab (ESNL/CTRAL):  ______ (2) SST tubes / (1) EDTA tube  
Blood Draw Time:  ______ am/pm 
 
Last Meal: ______ am/pm (Hours Fasted:  ______)  
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Algometer GPRS Evaluation Completed:  ______             
 
Isokinetic EXT/FLEX SMVC Warm-up (3 sets x 50% MVC x 5 reps):  ______      
Isokinetic EXT/FLEX MVC (1 set x MVC x 3 reps):  ______ 
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Tart Cherry Endurance Testing Face Sheet 
Texas A&M University: Exercise & Sport Nutrition Laboratory  
Trial:  Effects of Tart Cherry Supplementation on Markers of Inflammation, Muscle 
Damage, and Muscle Soreness following Endurance Running 
           
Demographics             ESNL Staff Initials: _____
           
Name: ________________________________      Testing Session:     Exercise (EX) 
Date: _____________  DOB: ___________  Age: _________ Food 
Logs:  _______ 
 
Testing Measures             ESNL Staff Initials: _____ 
 
Physiological Parameters: 
Last Meal: ______ am/pm    Height:  ______ in.             
Hours Fasted:  ______ hrs.     Weight:  ______ lbs.             
Last Exercise: M  T  W  TH  F  SA  SU (circle one)  Resting H.R.:  ______ bpm 
Abstained Exercise:   ______ hrs.              Resting B.P.: ______ /______ mmHg 
Abstained NSAIDs:  ______ hrs. 
 
Lab (ESNL/CTRAL): ______ (2) SST tubes / (1) EDTA tube   
Blood Draw Time:  ______ am/pm 
Algometer GPRS Evaluation Completed:  ______              
 
Exercise/Strength Parameters:           ESNL Staff Initials: _____ 
 
Endurance Exercise Testing:  
 
Outdoor Half Marathon (13.1 miles) 
 Weight:  ______ lbs.                Time: ________ : _________ (min:sec)  
 H.R.:  ______ bpm  Pace:    ________ : _________ (min:sec/mile)
  
Recovery Measures 
 
60 Minute Post Physiological Parameters:                      ESNL Staff Initials: _____ 
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Lab (ESNL/CTRAL):  ______ (2) SST tubes / (1) EDTA tube Blood Draw Time:  ______ 
am/pm 
Algometer GPRS Evaluation Completed:  ______             
 
 
24 Hour Post Physiological Parameters:                                         ESNL Staff Initials: _____ 
Date: _____________  
 
Lab (ESNL/CTRAL):  ______ (2) SST tubes / (1) EDTA tube    
Blood Draw Time:  ______ am/pm 
Last Meal: ______ am/pm (Hours Fasted:  ______)  
 
Algometer GPRS Evaluation Completed:  ______             
 
 
48 Hour Post Physiological Parameters:                      ESNL Staff Initials: _____ 
Date: _____________ 
 
Lab (ESNL/CTRAL):  ______ (2) SST tubes / (1) EDTA tube  
Blood Draw Time:  ______ am/pm 
Last Meal: ______ am/pm (Hours Fasted:  ______)  
 
Algometer GPRS Evaluation Completed:  ______             
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APPENDIX F 
Tart Cherry Research Algometer GPRS Data Sheet 
Texas A&M University: Exercise & Sport Nutrition Laboratory  
Trials:  Effects of Tart Cherry Supplementation on Markers of Inflammation, Muscle 
Damage, and Muscle Soreness following Intense Resistance and Endurance Exercise 
                      
Name: __________________________________               Date: __________________
     PRE-EXERCISE 
Algometer Graphic Pain Rating Scale (GPRS) 
INSTRUCTIONS:   
Please place an ‘X’ on the line below at the point on the line that best describes your knee pain 
using the following definitions as a guide: 
 
Dull Ache:  A feeling of discomfort during activity.  
Slight Pain:  An awareness of pain without distress.  
More Slight Pain:  Pain distracts attention during physical exertion.  
Painful:  Pain distracts attention from routine occupation such as reading & writing. 
Very Painful:  Pain fills the field of consciousness to the exclusion of other events.  
Unbearable Pain:  Comparable to the worst pain you can imagine. 
 
Pre-Exercise Graphic Pain Rating Scale:          ESNL Staff Initials: _____ 
 
VAS Location #1 [¼ distance between patella and g. troch on VASTUS MEDIALIS]:  
 
  
 
 
VAS Location #2 [¼ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
 
 
VAS Location #3 [½ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
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Name: __________________________________               Date: __________________
     60-MIN POST-EXERCISE 
Algometer Graphic Pain Rating Scale (GPRS) 
INSTRUCTIONS:   
Please place an ‘X’ on the line below at the point on the line that best describes your knee pain 
using the following definitions as a guide: 
 
Dull Ache:  A feeling of discomfort during activity.  
Slight Pain:  An awareness of pain without distress.  
More Slight Pain:  Pain distracts attention during physical exertion.  
Painful:  Pain distracts attention from routine occupation such as reading & writing. 
Very Painful:  Pain fills the field of consciousness to the exclusion of other events.  
Unbearable Pain:  Comparable to the worst pain you can imagine. 
 
Pre-Exercise Graphic Pain Rating Scale:          ESNL Staff Initials: _____ 
 
VAS Location #1 [¼ distance between patella and g. troch on VASTUS MEDIALIS]:  
 
  
 
 
VAS Location #2 [¼ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
 
 
VAS Location #3 [½ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
 
 
 
 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
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Name: __________________________________               Date: __________________
     24-HR POST-EXERCISE 
Algometer Graphic Pain Rating Scale (GPRS) 
INSTRUCTIONS:   
Please place an ‘X’ on the line below at the point on the line that best describes your knee pain 
using the following definitions as a guide: 
 
Dull Ache:  A feeling of discomfort during activity.  
Slight Pain:  An awareness of pain without distress.  
More Slight Pain:  Pain distracts attention during physical exertion.  
Painful:  Pain distracts attention from routine occupation such as reading & writing. 
Very Painful:  Pain fills the field of consciousness to the exclusion of other events.  
Unbearable Pain:  Comparable to the worst pain you can imagine. 
 
Pre-Exercise Graphic Pain Rating Scale:          ESNL Staff Initials: _____ 
 
VAS Location #1 [¼ distance between patella and g. troch on VASTUS MEDIALIS]:  
 
  
 
 
VAS Location #2 [¼ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
 
 
VAS Location #3 [½ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
 
 
 
 
 
 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
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Name: __________________________________               Date: __________________
     48-HR POST-EXERCISE 
Algometer Graphic Pain Rating Scale (GPRS) 
INSTRUCTIONS:   
Please place an ‘X’ on the line below at the point on the line that best describes your knee pain 
using the following definitions as a guide: 
 
Dull Ache:  A feeling of discomfort during activity.  
Slight Pain:  An awareness of pain without distress.  
More Slight Pain:  Pain distracts attention during physical exertion.  
Painful:  Pain distracts attention from routine occupation such as reading & writing. 
Very Painful:  Pain fills the field of consciousness to the exclusion of other events.  
Unbearable Pain:  Comparable to the worst pain you can imagine. 
 
Pre-Exercise Graphic Pain Rating Scale:          ESNL Staff Initials: _____ 
 
VAS Location #1 [¼ distance between patella and g. troch on VASTUS MEDIALIS]:  
 
  
 
 
VAS Location #2 [¼ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
 
 
VAS Location #3 [½ distance between patella and g. troch on VASTUS LATERALIS]: 
 
 
 
 
 
 
 
 
 
 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
Dull 
Ache 
No Pain Unbearable 
Pain 
Slight Pain More Slight Pain Painful Very Painful 
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APPENDIX G 
Tart Cherry Endurance Study Half Marathon Running Route  
 
 
Half-Marathon Running Course = 10.55 km (6.55 mi)  
Subjects completed two laps to finish half-marathon race = 21.1 km (13.1 mi) total 
 
 
 
 
 
 
